Hugging Face's logo

Datasets:
Liu-Hy
/
GenoTEX

Tasks:
Text Generation
Text2Text Generation
Table Question Answering
Languages:
English
Size:
100B<n<1T
ArXiv:
Tags:
ai4science
agent
llm
genomics
biology
License:
Dataset card Files Community
Liu-Hy commited on
Commit
3431c22
·
verified ·
1 Parent(s): cbe622e

Add files using upload-large-folder tool

Browse files
This view is limited to 50 files because it contains too many changes.   See raw diff
Files changed (50) hide show
  1. input/TCGA/TCGA_Acute_Myeloid_Leukemia_(LAML)/TCGA.LAML.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  2. input/TCGA/TCGA_Acute_Myeloid_Leukemia_(LAML)/TCGA.LAML.sampleMap_LAML_clinicalMatrix +0 -0
  3. input/TCGA/TCGA_Adrenocortical_Cancer_(ACC)/TCGA.ACC.sampleMap_ACC_clinicalMatrix +0 -0
  4. input/TCGA/TCGA_Adrenocortical_Cancer_(ACC)/TCGA.ACC.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  5. input/TCGA/TCGA_Bile_Duct_Cancer_(CHOL)/TCGA.CHOL.sampleMap_CHOL_clinicalMatrix +46 -0
  6. input/TCGA/TCGA_Bile_Duct_Cancer_(CHOL)/TCGA.CHOL.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  7. input/TCGA/TCGA_Cervical_Cancer_(CESC)/.DS_Store +0 -0
  8. input/TCGA/TCGA_Colon_Cancer_(COAD)/TCGA.COAD.sampleMap_COAD_clinicalMatrix +0 -0
  9. input/TCGA/TCGA_Colon_and_Rectal_Cancer_(COADREAD)/TCGA.COADREAD.sampleMap_COADREAD_clinicalMatrix +0 -0
  10. input/TCGA/TCGA_Endometrioid_Cancer_(UCEC)/TCGA.UCEC.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  11. input/TCGA/TCGA_Endometrioid_Cancer_(UCEC)/TCGA.UCEC.sampleMap_UCEC_clinicalMatrix +0 -0
  12. input/TCGA/TCGA_Esophageal_Cancer_(ESCA)/TCGA.ESCA.sampleMap_ESCA_clinicalMatrix +0 -0
  13. input/TCGA/TCGA_Esophageal_Cancer_(ESCA)/TCGA.ESCA.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  14. input/TCGA/TCGA_Glioblastoma_(GBM)/.DS_Store +0 -0
  15. input/TCGA/TCGA_Glioblastoma_(GBM)/TCGA.GBM.sampleMap_GBM_clinicalMatrix +0 -0
  16. input/TCGA/TCGA_Glioblastoma_(GBM)/TCGA.GBM.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  17. input/TCGA/TCGA_Head_and_Neck_Cancer_(HNSC)/TCGA.HNSC.sampleMap_HNSC_clinicalMatrix +0 -0
  18. input/TCGA/TCGA_Kidney_Chromophobe_(KICH)/TCGA.KICH.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  19. input/TCGA/TCGA_Kidney_Chromophobe_(KICH)/TCGA.KICH.sampleMap_KICH_clinicalMatrix +92 -0
  20. input/TCGA/TCGA_Kidney_Clear_Cell_Carcinoma_(KIRC)/TCGA.KIRC.sampleMap_KIRC_clinicalMatrix +0 -0
  21. input/TCGA/TCGA_Kidney_Papillary_Cell_Carcinoma_(KIRP)/TCGA.KIRP.sampleMap_KIRP_clinicalMatrix +0 -0
  22. input/TCGA/TCGA_Large_Bcell_Lymphoma_(DLBC)/TCGA.DLBC.sampleMap_DLBC_clinicalMatrix +49 -0
  23. input/TCGA/TCGA_Large_Bcell_Lymphoma_(DLBC)/TCGA.DLBC.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  24. input/TCGA/TCGA_Ocular_melanomas_(UVM)/TCGA.UVM.sampleMap_UVM_clinicalMatrix +81 -0
  25. input/TCGA/TCGA_Ovarian_Cancer_(OV)/TCGA.OV.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  26. input/TCGA/TCGA_Ovarian_Cancer_(OV)/TCGA.OV.sampleMap_OV_clinicalMatrix +0 -0
  27. input/TCGA/TCGA_Pancreatic_Cancer_(PAAD)/TCGA.PAAD.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  28. input/TCGA/TCGA_Pancreatic_Cancer_(PAAD)/TCGA.PAAD.sampleMap_PAAD_clinicalMatrix +0 -0
  29. input/TCGA/TCGA_Pheochromocytoma_Paraganglioma_(PCPG)/TCGA.PCPG.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  30. input/TCGA/TCGA_Pheochromocytoma_Paraganglioma_(PCPG)/TCGA.PCPG.sampleMap_PCPG_clinicalMatrix +0 -0
  31. input/TCGA/TCGA_Prostate_Cancer_(PRAD)/TCGA.PRAD.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  32. input/TCGA/TCGA_Prostate_Cancer_(PRAD)/TCGA.PRAD.sampleMap_PRAD_clinicalMatrix +0 -0
  33. input/TCGA/TCGA_Rectal_Cancer_(READ)/TCGA.READ.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  34. input/TCGA/TCGA_Rectal_Cancer_(READ)/TCGA.READ.sampleMap_READ_clinicalMatrix +0 -0
  35. input/TCGA/TCGA_Sarcoma_(SARC)/TCGA.SARC.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  36. input/TCGA/TCGA_Sarcoma_(SARC)/TCGA.SARC.sampleMap_SARC_clinicalMatrix +0 -0
  37. input/TCGA/TCGA_Stomach_Cancer_(STAD)/TCGA.STAD.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  38. input/TCGA/TCGA_Stomach_Cancer_(STAD)/TCGA.STAD.sampleMap_STAD_clinicalMatrix +0 -0
  39. input/TCGA/TCGA_Testicular_Cancer_(TGCT)/TCGA.TGCT.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  40. input/TCGA/TCGA_Testicular_Cancer_(TGCT)/TCGA.TGCT.sampleMap_TGCT_clinicalMatrix +0 -0
  41. input/TCGA/TCGA_Thymoma_(THYM)/TCGA.THYM.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  42. input/TCGA/TCGA_Thymoma_(THYM)/TCGA.THYM.sampleMap_THYM_clinicalMatrix +0 -0
  43. input/TCGA/TCGA_Thyroid_Cancer_(THCA)/TCGA.THCA.sampleMap_THCA_clinicalMatrix +0 -0
  44. input/TCGA/TCGA_Uterine_Carcinosarcoma_(UCS)/TCGA.UCS.sampleMap_HiSeqV2_PANCAN.gz +3 -0
  45. input/TCGA/TCGA_Uterine_Carcinosarcoma_(UCS)/TCGA.UCS.sampleMap_UCS_clinicalMatrix +58 -0
  46. metadata/gene_synonym.json +0 -0
  47. metadata/task_info.json +0 -0
  48. output/preprocess/Pheochromocytoma_and_Paraganglioma/clinical_data/GSE19422.csv +91 -0
  49. output/preprocess/Pheochromocytoma_and_Paraganglioma/clinical_data/GSE19987.csv +2 -0
  50. output/preprocess/Pheochromocytoma_and_Paraganglioma/clinical_data/GSE33371.csv +4 -0
input/TCGA/TCGA_Acute_Myeloid_Leukemia_(LAML)/TCGA.LAML.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:f8f3ba50c1b2e5d6fd446b69c620c1c9d53b62b0aec29f94f35737745d3fb3b7
3
+ size 11920738
input/TCGA/TCGA_Acute_Myeloid_Leukemia_(LAML)/TCGA.LAML.sampleMap_LAML_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Adrenocortical_Cancer_(ACC)/TCGA.ACC.sampleMap_ACC_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Adrenocortical_Cancer_(ACC)/TCGA.ACC.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:709db84f0b6c32f1158e4fe3232a7a74e394dbdaac30e13fcaafe4d6a6a8d308
3
+ size 6218415
input/TCGA/TCGA_Bile_Duct_Cancer_(CHOL)/TCGA.CHOL.sampleMap_CHOL_clinicalMatrix ADDED
@@ -0,0 +1,46 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ sampleID _INTEGRATION _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy age_at_initial_pathologic_diagnosis albumin_result_lower_limit albumin_result_specified_value albumin_result_upper_limit bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode bilirubin_lower_limit bilirubin_upper_limit ca_19_9_level ca_19_9_level_lower ca_19_9_level_upper cancer_first_degree_relative child_pugh_classification_grade cholangitis_tissue_evidence creatinine_lower_level creatinine_upper_limit creatinine_value_in_mg_dl days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_after_initial_treatment eastern_cancer_oncology_group family_cancer_type_txt family_member_relationship_type fetoprotein_outcome_lower_limit fetoprotein_outcome_upper_limit fetoprotein_outcome_value fibrosis_ishak_score form_completion_date gender height hist_hepato_carc_fact hist_hepato_carcinoma_risk histological_type history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified initial_weight inter_norm_ratio_lower_limit intern_norm_ratio_upper_limit is_ffpe lost_follow_up neoplasm_histologic_grade new_neoplasm_event_occurrence_anatomic_site new_neoplasm_event_type new_tumor_event_ablation_embo_tx new_tumor_event_additional_surgery_procedure new_tumor_event_after_initial_treatment new_tumor_event_liver_transplant oct_embedded other_dx pathologic_M pathologic_N pathologic_T pathologic_stage pathology_report_file_name patient_id perineural_invasion_present person_neoplasm_cancer_status platelet_result_count platelet_result_lower_limit platelet_result_upper_limit post_op_ablation_embolization_tx postoperative_rx_tx prothrombin_time_result_value radiation_therapy relative_family_cancer_history residual_tumor sample_type sample_type_id specimen_collection_method_name system_version tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site total_bilirubin_upper_limit tumor_tissue_site vascular_tumor_cell_type vial_number vital_status weight year_of_initial_pathologic_diagnosis _GENOMIC_ID_TCGA_CHOL_mutation_broad_gene _GENOMIC_ID_TCGA_CHOL_mutation_bcgsc_gene _GENOMIC_ID_TCGA_CHOL_hMethyl450 _GENOMIC_ID_TCGA_CHOL_exp_HiSeqV2 _GENOMIC_ID_TCGA_CHOL_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_CHOL_mutation_bcm_gene _GENOMIC_ID_TCGA_CHOL_miRNA_HiSeq _GENOMIC_ID_TCGA_CHOL_gistic2thd _GENOMIC_ID_TCGA_CHOL_gistic2 _GENOMIC_ID_TCGA_CHOL_PDMRNAseqCNV _GENOMIC_ID_TCGA_CHOL_exp_HiSeqV2_exon _GENOMIC_ID_data/public/TCGA/CHOL/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_CHOL_mutation_ucsc_maf_gene _GENOMIC_ID_TCGA_CHOL_PDMRNAseq _GENOMIC_ID_TCGA_CHOL_exp_HiSeqV2_percentile _GENOMIC_ID_TCGA_CHOL_RPPA
2
+ TCGA-3X-AAV9-01 TCGA-3X-AAV9-01 TCGA-3X-AAV9 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 72 3.3 2.7 4.8 TCGA-3X-AAV9 TCGA-3X-AAV9-01A 0 0.2 538 0 35 2 B None 0.6 1.4 1.1 -26349 1113 339 0 0 |Probably Kidney Cancer Brother|Brother 0 - No Fibrosis 2014-7-9 MALE 169 Ulcerative colitis Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 740 NO G2 YES true Yes M0 N0 T1 Stage I TCGA-3X-AAV9.3E7DD345-7A2C-4D7B-B5A2-2207949186CA.pdf AAV9 YES WITH TUMOR 254 150 400 NO YES NO YES R0 Primary Tumor 01 Other (specify) 7th YES NO 3X 1.4 Bile duct None A DECEASED 52 2010 TCGA-3X-AAV9-01A-72D-A417-09 TCGA-3X-AAV9-01A-72D-A417-09 TCGA-3X-AAV9-01A-72D-A418-05 59012a78-0e8f-4b99-af97-0dbb1d3d0513 59012a78-0e8f-4b99-af97-0dbb1d3d0513 TCGA-3X-AAV9-01A-72D-A417-09 TCGA-3X-AAV9-01 TCGA-3X-AAV9-01A-72D-A416-01 TCGA-3X-AAV9-01A-72D-A416-01 TCGA-3X-AAV9-01 59012a78-0e8f-4b99-af97-0dbb1d3d0513 TCGA-3X-AAV9-01 TCGA-3X-AAV9-01A-72D-A417-09 TCGA-3X-AAV9-01 59012a78-0e8f-4b99-af97-0dbb1d3d0513 AEB48F2C-59ED-45B1-BC10-1875590E7C47
3
+ TCGA-3X-AAVA-01 TCGA-3X-AAVA-01 TCGA-3X-AAVA TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 50 TCGA-3X-AAVA TCGA-3X-AAVA-01A 8 None 0.4 1.1 0.5 -18303 510 445 0 1 0 10 5.4 1,2 - Portal Fibrosis 2014-9-2 FEMALE Diabetes mellitus|Smoking Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 480 NO G2 YES true No M0 NX T2b Stage II TCGA-3X-AAVA.4C9A220D-03E9-41CF-8FA9-4B7FD05A625A.pdf AAVA YES WITH TUMOR 214 150 400 NO NO NO NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO 3X Bile duct None A DECEASED 92 2012 TCGA-3X-AAVA-01A-11D-A417-09 TCGA-3X-AAVA-01A-11D-A417-09 TCGA-3X-AAVA-01A-11D-A418-05 6a8ffc5d-444e-4864-bafd-ddf1ef900ef0 6a8ffc5d-444e-4864-bafd-ddf1ef900ef0 TCGA-3X-AAVA-01A-11D-A417-09 TCGA-3X-AAVA-01 TCGA-3X-AAVA-01A-11D-A416-01 TCGA-3X-AAVA-01A-11D-A416-01 TCGA-3X-AAVA-01 6a8ffc5d-444e-4864-bafd-ddf1ef900ef0 TCGA-3X-AAVA-01 TCGA-3X-AAVA-01A-11D-A417-09 TCGA-3X-AAVA-01 6a8ffc5d-444e-4864-bafd-ddf1ef900ef0 51164357-1D61-4499-82ED-169A9DA8A4C0
4
+ TCGA-3X-AAVB-01 TCGA-3X-AAVB-01 TCGA-3X-AAVB TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 70 3.3 4.3 4.8 TCGA-3X-AAVB-F67237 TCGA-3X-AAVB TCGA-3X-AAVB-01A 0 1.7 322 0 35 A None 0.4 1.1 0.9 -25819 386 0 402 0 2014-11-3 FEMALE 170 No History of Primary Risk Factors Cholangiocarcinoma; distal No C24.0 8160/3 C24.0 YES 420 0.9 1.1 NO NO G1 true No M1 N1 T3 Stage IVB TCGA-3X-AAVB.BEA4C577-73ED-48F0-9417-AA8BD143B5C8.pdf AAVB YES 215 150 400 1.1 NO R0 Primary Tumor 01 Pancreaticoduodenectomy (Whipple Resection) 7th NO YES 3X 1.2 Bile duct None A LIVING 76 2012 TCGA-3X-AAVB-01A-31D-A417-09 TCGA-3X-AAVB-01A-31D-A417-09 TCGA-3X-AAVB-01A-31D-A418-05 88336d42-a31c-448f-a077-2608786c80fe 88336d42-a31c-448f-a077-2608786c80fe TCGA-3X-AAVB-01A-31D-A417-09 TCGA-3X-AAVB-01 TCGA-3X-AAVB-01A-31D-A416-01 TCGA-3X-AAVB-01A-31D-A416-01 TCGA-3X-AAVB-01 88336d42-a31c-448f-a077-2608786c80fe TCGA-3X-AAVB-01 TCGA-3X-AAVB-01A-31D-A417-09 TCGA-3X-AAVB-01 88336d42-a31c-448f-a077-2608786c80fe
5
+ TCGA-3X-AAVC-01 TCGA-3X-AAVC-01 TCGA-3X-AAVC TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 72 3.3 2.4 4.8 TCGA-3X-AAVC-F67116 TCGA-3X-AAVC TCGA-3X-AAVC-01A 0 0.5 B None 0.4 1.1 0.8 -26493 428 0 709 0 1,2 - Portal Fibrosis 2014-10-30 FEMALE 159 Other Pancreatitis Cholangiocarcinoma; hilar/perihilar No C24.0 8160/3 C24.0 YES 230 0.9 1.1 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-3X-AAVC.88206A8B-257B-4C0F-B42C-905DEA9483FB.pdf AAVC NO TUMOR FREE 255 150 400 NO NO 1.1 NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES 3X 1.2 Bile duct None A LIVING 104 2012 TCGA-3X-AAVC-01A-21D-A417-09 TCGA-3X-AAVC-01A-21D-A417-09 TCGA-3X-AAVC-01A-21D-A418-05 8c8d5e98-023b-4496-a237-2632c609f627 8c8d5e98-023b-4496-a237-2632c609f627 TCGA-3X-AAVC-01A-21D-A417-09 TCGA-3X-AAVC-01 TCGA-3X-AAVC-01A-21D-A416-01 TCGA-3X-AAVC-01A-21D-A416-01 TCGA-3X-AAVC-01 8c8d5e98-023b-4496-a237-2632c609f627 TCGA-3X-AAVC-01 TCGA-3X-AAVC-01A-21D-A417-09 TCGA-3X-AAVC-01 8c8d5e98-023b-4496-a237-2632c609f627 D423C8E5-02C2-445A-BA13-C74C0012E2B4
6
+ TCGA-3X-AAVE-01 TCGA-3X-AAVE-01 TCGA-3X-AAVE TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 60 3.3 4 4.8 TCGA-3X-AAVE-F72744 TCGA-3X-AAVE 0 1 A None 0.6 1.4 0.9 -21943 0 650 0 0 10 3.6 3,4 - Fibrous Speta 2015-11-24 MALE 160 Hepatitis B|Smoking Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 0.9 1.1 NO G2 NO No M0 N0 T2 Stage II AAVE NO TUMOR FREE 233 150 400 NO NO 0.9 NO R0 Primary Tumor 01 Segmentectomy, Single 7th YES NO 3X 1.4 Bile duct Micro LIVING 59 2013 TCGA-3X-AAVE-01A-11D-A417-09 TCGA-3X-AAVE-01A-11D-A417-09 TCGA-3X-AAVE-01A-11D-A418-05 c49a7f2a-f7ef-419d-829a-0b3a9f915aad c49a7f2a-f7ef-419d-829a-0b3a9f915aad TCGA-3X-AAVE-01A-11D-A417-09 TCGA-3X-AAVE-01 TCGA-3X-AAVE-01A-11D-A416-01 TCGA-3X-AAVE-01A-11D-A416-01 TCGA-3X-AAVE-01 c49a7f2a-f7ef-419d-829a-0b3a9f915aad TCGA-3X-AAVE-01 TCGA-3X-AAVE-01A-11D-A417-09 TCGA-3X-AAVE-01 c49a7f2a-f7ef-419d-829a-0b3a9f915aad
7
+ TCGA-4G-AAZO-01 TCGA-4G-AAZO-01 TCGA-4G-AAZO TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 71 3.4 3.8 4.8 TCGA-4G-AAZO-F72742 TCGA-4G-AAZO 0.3 0.7 6 0 35.0 None 0.6 1.1 0.9 -25989 0 1177 1 0 9.0 2.4 1,2 - Portal Fibrosis 2015-12-10 FEMALE 161 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 10 13 NO G2 YES No M0 N0 T2a Stage II AAZO NO WITH TUMOR 164000 140000 450000 NO YES 11.6 NO NO R1 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES 4G 1.2 Bile duct None LIVING 67 2012 TCGA-4G-AAZO-01A-12D-A417-09 TCGA-4G-AAZO-01A-12D-A417-09 TCGA-4G-AAZO-01A-12D-A418-05 f36ef26a-5c56-422b-bcdf-4693615d026b f36ef26a-5c56-422b-bcdf-4693615d026b TCGA-4G-AAZO-01A-12D-A417-09 TCGA-4G-AAZO-01 TCGA-4G-AAZO-01A-12D-A416-01 TCGA-4G-AAZO-01A-12D-A416-01 TCGA-4G-AAZO-01 f36ef26a-5c56-422b-bcdf-4693615d026b TCGA-4G-AAZO-01 TCGA-4G-AAZO-01A-12D-A417-09 TCGA-4G-AAZO-01 f36ef26a-5c56-422b-bcdf-4693615d026b
8
+ TCGA-4G-AAZT-01 TCGA-4G-AAZT-01 TCGA-4G-AAZT TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 62 3.4 4.4 4.8 TCGA-4G-AAZT-F72743 TCGA-4G-AAZT TCGA-4G-AAZT-01A 0.3 0.6 52.8 0 35.0 None 0.6 1.1 0.6 -22777 45 0 420 0 0 9.0 2 1,2 - Portal Fibrosis 2015-11-24 MALE 175 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 330 10 13 NO NO G2 NO false No M0 N0 T1 Stage I TCGA-4G-AAZT.C75C91FD-D4DE-4A58-A4C7-8F020AAC59EB.pdf AAZT NO TUMOR FREE 354000 140000 450000 NO NO 11.7 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES 4G 1.2 Bile duct None A LIVING 65 2013 TCGA-4G-AAZT-01A-11D-A417-09 TCGA-4G-AAZT-01A-11D-A417-09 TCGA-4G-AAZT-01A-11D-A418-05 355d81ff-9689-4301-bd41-3df7403b533c 355d81ff-9689-4301-bd41-3df7403b533c TCGA-4G-AAZT-01A-11D-A417-09 TCGA-4G-AAZT-01 TCGA-4G-AAZT-01A-11D-A416-01 TCGA-4G-AAZT-01A-11D-A416-01 TCGA-4G-AAZT-01 355d81ff-9689-4301-bd41-3df7403b533c TCGA-4G-AAZT-01 TCGA-4G-AAZT-01A-11D-A417-09 TCGA-4G-AAZT-01 355d81ff-9689-4301-bd41-3df7403b533c 3580629A-CE72-4A05-9811-5347E590A68B
9
+ TCGA-W5-AA2G-01 TCGA-W5-AA2G-01 TCGA-W5-AA2G TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 62 3.5 4.1 5.0 TCGA-W5-AA2G-F66604 TCGA-W5-AA2G TCGA-W5-AA2G-01A 0.1 0.7 71 0 55 1 A None 0.6 1.1 0.7 -22933 2087 0 1976 1 Testicular|Prostate|Leukemia Father|Father|Father 0 6.0 2.5 0 - No Fibrosis 2014-10-21 FEMALE 159 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 250 0.8 1.2 NO YES G3 NO true No M0 N0 T1 Stage I TCGA-W5-AA2G.1E7EDF0B-283F-44F9-A89A-83DB12A0D58A.pdf AA2G NO TUMOR FREE 159 150 450 NO NO 1.2 NO YES R0 Primary Tumor 01 Extended Lobectomy 7th NO YES W5 1.0 Bile duct None A LIVING 52 2008 TCGA-W5-AA2G-01A-11D-A417-09 TCGA-W5-AA2G-01A-11D-A417-09 TCGA-W5-AA2G-01A-11D-A418-05 0431cd43-2dd6-4319-8017-6ed8b8e77dc0 0431cd43-2dd6-4319-8017-6ed8b8e77dc0 TCGA-W5-AA2G-01A-11D-A417-09 TCGA-W5-AA2G-01 TCGA-W5-AA2G-01A-11D-A416-01 TCGA-W5-AA2G-01A-11D-A416-01 TCGA-W5-AA2G-01 0431cd43-2dd6-4319-8017-6ed8b8e77dc0 TCGA-W5-AA2G-01 TCGA-W5-AA2G-01A-11D-A417-09 TCGA-W5-AA2G-01 0431cd43-2dd6-4319-8017-6ed8b8e77dc0 936F1B55-9593-4BCF-ADEF-F9F96D092DD5
10
+ TCGA-W5-AA2H-01 TCGA-W5-AA2H-01 TCGA-W5-AA2H TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 70 3.5 4.3 5.0 TCGA-W5-AA2H-F72736 TCGA-W5-AA2H TCGA-W5-AA2H-01A 0.1 1.2 44 0 55 2 A None 0.6 1.1 0.9 -25775 474 0 1077 0 colon/rectal cancer|lung Father|Sister 0 6.0 3.1 0 - No Fibrosis 2015-11-23 FEMALE 162 No History of Primary Risk Factors Cholangiocarcinoma; distal No C22.1 8160/3 C22.1 YES 180 0.8 1.2 NO NO G3 NO true No M0 N0 T3 Stage III TCGA-W5-AA2H.46A92484-5ECB-4F04-9207-4188D015B9CD.pdf AA2H NO TUMOR FREE 369 150 450 NO YES 0.9 NO YES R0 Primary Tumor 01 Pancreaticoduodenectomy (Whipple Resection) 7th NO YES W5 1.0 Bile duct None A LIVING 71 2012 TCGA-W5-AA2H-01A-31D-A417-09 TCGA-W5-AA2H-01A-31D-A417-09 TCGA-W5-AA2H-01A-31D-A418-05 b0ada585-0834-406b-b02c-b06c171882ff b0ada585-0834-406b-b02c-b06c171882ff TCGA-W5-AA2H-01A-31D-A417-09 TCGA-W5-AA2H-01 TCGA-W5-AA2H-01A-31D-A416-01 TCGA-W5-AA2H-01A-31D-A416-01 TCGA-W5-AA2H-01 b0ada585-0834-406b-b02c-b06c171882ff TCGA-W5-AA2H-01 TCGA-W5-AA2H-01A-31D-A417-09 TCGA-W5-AA2H-01 b0ada585-0834-406b-b02c-b06c171882ff B2998B9E-3F52-416C-80A2-87B1A3B0860D
11
+ TCGA-W5-AA2I-01 TCGA-W5-AA2I-01 TCGA-W5-AA2I TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 66 3.5 4.4 5.0 TCGA-W5-AA2I TCGA-W5-AA2I-01A 0.1 0.7 296 0 40 A None 0.9 1.4 1.4 -24388 3131 1939 0 0 0 6.0 2.9 0 - No Fibrosis 2014-5-22 MALE 178 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 280 0.9 1.2 NO G2 YES true No M0 N0 T1 Stage I TCGA-W5-AA2I.7C977B78-0280-4078-BA64-4D8D9554B38F.pdf AA2I NO WITH TUMOR 138 150 450 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES W5 1.0 Bile duct None A DECEASED 125 2005 TCGA-W5-AA2I-01A-32D-A417-09 TCGA-W5-AA2I-01A-32D-A417-09 TCGA-W5-AA2I-01A-32D-A418-05 51dfbd25-fa30-4ac5-b375-fde6ddbaa151 51dfbd25-fa30-4ac5-b375-fde6ddbaa151 TCGA-W5-AA2I-01A-32D-A417-09 TCGA-W5-AA2I-01 TCGA-W5-AA2I-01A-32D-A416-01 TCGA-W5-AA2I-01A-32D-A416-01 TCGA-W5-AA2I-01 51dfbd25-fa30-4ac5-b375-fde6ddbaa151 TCGA-W5-AA2I-01 TCGA-W5-AA2I-01A-32D-A417-09 TCGA-W5-AA2I-01 51dfbd25-fa30-4ac5-b375-fde6ddbaa151 C5E92850-7441-47DB-8512-FE6A49708548
12
+ TCGA-W5-AA2I-11 TCGA-W5-AA2I-11 TCGA-W5-AA2I TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 66 3.5 4.4 5.0 TCGA-W5-AA2I 0.1 0.7 296 0 40 A None 0.9 1.4 1.4 -24388 1939 0 0 0 6.0 2.9 0 - No Fibrosis 2014-5-22 MALE 178 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 0.9 1.2 G2 YES No M0 N0 T1 Stage I AA2I NO WITH TUMOR 138 150 450 NO NO 1.1 NO NO R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES W5 1.0 Bile duct None DECEASED 125 2005 TCGA-W5-AA2I-11A-11D-A418-05 a8aea83d-802a-48b3-aea2-65e78fefc9b0 a8aea83d-802a-48b3-aea2-65e78fefc9b0 TCGA-W5-AA2I-11 a8aea83d-802a-48b3-aea2-65e78fefc9b0 TCGA-W5-AA2I-11 a8aea83d-802a-48b3-aea2-65e78fefc9b0
13
+ TCGA-W5-AA2O-01 TCGA-W5-AA2O-01 TCGA-W5-AA2O TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 57 3.5 4.1 5.0 TCGA-W5-AA2O TCGA-W5-AA2O-01A 0.0 0.4 34 0 55 A None 0.9 1.4 1.1 -21118 2771 640 0 0 0 6.0 3.5 0 - No Fibrosis 2014-5-23 MALE 167 Smoking Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 210 0.8 1.2 NO G3 YES true No M0 N0 T1 Stage I TCGA-W5-AA2O.EDB0DC9B-6D0C-4591-81CA-BECD1BC27983.pdf AA2O NO WITH TUMOR 150 150 450 NO NO 0.8 NO NO R0 Primary Tumor 01 Extended Lobectomy 6th NO YES W5 0.3 Bile duct None A DECEASED 73 2006 TCGA-W5-AA2O-01A-11D-A417-09 TCGA-W5-AA2O-01A-11D-A417-09 TCGA-W5-AA2O-01A-11D-A418-05 0e8deabe-78a0-4960-8dc0-1afb483f409d 0e8deabe-78a0-4960-8dc0-1afb483f409d TCGA-W5-AA2O-01A-11D-A417-09 TCGA-W5-AA2O-01 TCGA-W5-AA2O-01A-11D-A416-01 TCGA-W5-AA2O-01A-11D-A416-01 TCGA-W5-AA2O-01 0e8deabe-78a0-4960-8dc0-1afb483f409d TCGA-W5-AA2O-01 TCGA-W5-AA2O-01A-11D-A417-09 TCGA-W5-AA2O-01 0e8deabe-78a0-4960-8dc0-1afb483f409d 302D85AD-761B-486B-B85B-F5751C06C25C
14
+ TCGA-W5-AA2Q-01 TCGA-W5-AA2Q-01 TCGA-W5-AA2Q TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 68 3.4 3.7 4.7 TCGA-W5-AA2Q-F66605 TCGA-W5-AA2Q TCGA-W5-AA2Q-01A 0.1 1.4 247 0 55 1 A None 0.9 1.4 1.0 -25069 2626 0 50 0 Bone cancer Mother 0 6.0 4.3 1,2 - Portal Fibrosis 2014-10-21 MALE 165 Smoking Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 120 8.4 12.0 NO YES G2 NO true No M0 N0 T2b Stage II TCGA-W5-AA2Q.ED7C4C0A-BBCE-4136-B95F-4E49DB17EEE3.pdf AA2Q NO TUMOR FREE 174 150 450 NO NO 9.3 NO YES R0 Primary Tumor 01 Extended Lobectomy 6th NO YES W5 1.0 Bile duct None A LIVING 67 2006 TCGA-W5-AA2Q-01A-11D-A417-09 TCGA-W5-AA2Q-01A-11D-A417-09 TCGA-W5-AA2Q-01A-11D-A418-05 60f80712-30c2-4026-9853-9733f641c05f 60f80712-30c2-4026-9853-9733f641c05f TCGA-W5-AA2Q-01A-11D-A417-09 TCGA-W5-AA2Q-01 TCGA-W5-AA2Q-01A-11D-A416-01 TCGA-W5-AA2Q-01A-11D-A416-01 TCGA-W5-AA2Q-01 60f80712-30c2-4026-9853-9733f641c05f TCGA-W5-AA2Q-01 TCGA-W5-AA2Q-01A-11D-A417-09 TCGA-W5-AA2Q-01 60f80712-30c2-4026-9853-9733f641c05f D86931F8-7166-464C-98BB-0BFA21496CD0
15
+ TCGA-W5-AA2Q-11 TCGA-W5-AA2Q-11 TCGA-W5-AA2Q TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 68 3.4 3.7 4.7 TCGA-W5-AA2Q-F66605 TCGA-W5-AA2Q 0.1 1.4 247 0 55 1 A None 0.9 1.4 1.0 -25069 0 50 0 Bone cancer Mother 0 6.0 4.3 1,2 - Portal Fibrosis 2014-10-21 MALE 165 Smoking Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 8.4 12.0 YES G2 NO No M0 N0 T2b Stage II AA2Q NO TUMOR FREE 174 150 450 NO NO 9.3 NO YES R0 Solid Tissue Normal 11 Extended Lobectomy 6th NO YES W5 1.0 Bile duct None LIVING 67 2006 TCGA-W5-AA2Q-11A-11D-A418-05 f86273ce-18c0-47f3-af69-2eac38089508 f86273ce-18c0-47f3-af69-2eac38089508 TCGA-W5-AA2Q-11 f86273ce-18c0-47f3-af69-2eac38089508 TCGA-W5-AA2Q-11 f86273ce-18c0-47f3-af69-2eac38089508
16
+ TCGA-W5-AA2R-01 TCGA-W5-AA2R-01 TCGA-W5-AA2R TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 77 3.5 4.2 5.0 TCGA-W5-AA2R-F72737 TCGA-W5-AA2R TCGA-W5-AA2R-01A 0.1 0.5 11 0 55 3 A None 0.6 1.1 0.9 -28367 2542 0 1542 0 colon cancer|transitional cell cancer|colon cancer Brother|Brother|Sister 0 6.0 3.6 0 - No Fibrosis 2015-11-23 FEMALE 158 Smoking Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 0.9 1.2 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-W5-AA2R.153949E2-169E-4138-8D39-9EC9C61C7F3C.pdf AA2R NO TUMOR FREE 272 150 450 NO NO 0.8 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES W5 1.0 Bile duct None A LIVING 72 2006 TCGA-W5-AA2R-01A-11D-A417-09 TCGA-W5-AA2R-01A-11D-A417-09 TCGA-W5-AA2R-01A-11D-A418-05 d3b1d5c8-a823-4630-a160-599bc0d5fb9a d3b1d5c8-a823-4630-a160-599bc0d5fb9a TCGA-W5-AA2R-01A-11D-A417-09 TCGA-W5-AA2R-01 TCGA-W5-AA2R-01A-11D-A416-01 TCGA-W5-AA2R-01A-11D-A416-01 TCGA-W5-AA2R-01 d3b1d5c8-a823-4630-a160-599bc0d5fb9a TCGA-W5-AA2R-01 TCGA-W5-AA2R-01A-11D-A417-09 TCGA-W5-AA2R-01 d3b1d5c8-a823-4630-a160-599bc0d5fb9a F6AEF1B0-C13B-4B98-B36F-88A5C6AE06F1
17
+ TCGA-W5-AA2R-11 TCGA-W5-AA2R-11 TCGA-W5-AA2R TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 77 3.5 4.2 5.0 TCGA-W5-AA2R-F72737 TCGA-W5-AA2R TCGA-W5-AA2R-11A 0.1 0.5 11 0 55 3 A None 0.6 1.1 0.9 -28367 2542 0 1542 0 colon cancer|transitional cell cancer|colon cancer Brother|Brother|Sister 0 6.0 3.6 0 - No Fibrosis 2015-11-23 FEMALE 158 Smoking Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 220 0.9 1.2 NO NO G3 NO true No M0 N0 T1 Stage I AA2R NO TUMOR FREE 272 150 450 NO NO 0.8 NO YES R0 Solid Tissue Normal 11 Segmentectomy, Multiple 6th NO YES W5 1.0 Bile duct None A LIVING 72 2006 TCGA-W5-AA2R-11A-11D-A418-05 2649a2ec-8bb0-486e-9eec-ac9c76021b60 2649a2ec-8bb0-486e-9eec-ac9c76021b60 TCGA-W5-AA2R-11 2649a2ec-8bb0-486e-9eec-ac9c76021b60 TCGA-W5-AA2R-11 2649a2ec-8bb0-486e-9eec-ac9c76021b60
18
+ TCGA-W5-AA2T-01 TCGA-W5-AA2T-01 TCGA-W5-AA2T TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 64 3.5 4.4 5.0 TCGA-W5-AA2T 0.1 0.4 33 0 55 A None 0.6 1.1 0.6 -23560 1220 0 0 0 - No Fibrosis 2014-5-24 FEMALE 155 Smoking Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 0.8 1.2 G3 YES Yes M0 N0 T2 Stage II AA2T NO WITH TUMOR 274 150 450 NO YES 1.0 NO NO R0 Primary Tumor 01 Extended Lobectomy 6th NO YES W5 1.0 Bile duct None DECEASED 62 2008 TCGA-W5-AA2T-01A-12D-A417-09 TCGA-W5-AA2T-01A-12D-A417-09 TCGA-W5-AA2T-01A-12D-A418-05 d6580402-f691-479a-8b3c-582547b22b0c d6580402-f691-479a-8b3c-582547b22b0c TCGA-W5-AA2T-01A-12D-A417-09 TCGA-W5-AA2T-01 TCGA-W5-AA2T-01A-12D-A416-01 TCGA-W5-AA2T-01A-12D-A416-01 TCGA-W5-AA2T-01 d6580402-f691-479a-8b3c-582547b22b0c TCGA-W5-AA2T-01 TCGA-W5-AA2T-01A-12D-A417-09 TCGA-W5-AA2T-01 d6580402-f691-479a-8b3c-582547b22b0c
19
+ TCGA-W5-AA2U-01 TCGA-W5-AA2U-01 TCGA-W5-AA2U TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 78 3.5 4.5 5.0 TCGA-W5-AA2U TCGA-W5-AA2U-01A 0.1 0.7 91 0 55 1 A None 0.6 1.1 0.8 -28552 1430 627 0 1 Sister 0 - No Fibrosis 2014-5-24 FEMALE 156 Smoking Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 120 0.9 1.2 NO G3 YES true No M0 N0 T1 Stage I TCGA-W5-AA2U.205BDA9B-D391-4075-B1A6-32CBF06B06EF.pdf AA2U NO WITH TUMOR 305 150 450 NO NO 1.0 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES W5 1.0 Bile duct None A DECEASED 60 2010 TCGA-W5-AA2U-01A-11D-A417-09 TCGA-W5-AA2U-01A-11D-A417-09 TCGA-W5-AA2U-01A-11D-A418-05 41df36db-590f-4410-8d1d-b9afbbc9cecc 41df36db-590f-4410-8d1d-b9afbbc9cecc TCGA-W5-AA2U-01A-11D-A417-09 TCGA-W5-AA2U-01 TCGA-W5-AA2U-01A-11D-A416-01 TCGA-W5-AA2U-01A-11D-A416-01 TCGA-W5-AA2U-01 41df36db-590f-4410-8d1d-b9afbbc9cecc TCGA-W5-AA2U-01 TCGA-W5-AA2U-01A-11D-A417-09 TCGA-W5-AA2U-01 41df36db-590f-4410-8d1d-b9afbbc9cecc 2C55FA24-21FD-4B4A-9703-9FF914C7276C
20
+ TCGA-W5-AA2U-11 TCGA-W5-AA2U-11 TCGA-W5-AA2U TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 78 3.5 4.5 5.0 TCGA-W5-AA2U 0.1 0.7 91 0 55 1 A None 0.6 1.1 0.8 -28552 627 0 1 Sister 0 - No Fibrosis 2014-5-24 FEMALE 156 Smoking Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 0.9 1.2 G3 YES No M0 N0 T1 Stage I AA2U NO WITH TUMOR 305 150 450 NO NO 1.0 NO YES R0 Solid Tissue Normal 11 Segmentectomy, Multiple 7th NO YES W5 1.0 Bile duct None DECEASED 60 2010 TCGA-W5-AA2U-11A-11D-A418-05 a59098ee-abee-46cc-af4a-cca9d501daec a59098ee-abee-46cc-af4a-cca9d501daec TCGA-W5-AA2U-11 a59098ee-abee-46cc-af4a-cca9d501daec TCGA-W5-AA2U-11 a59098ee-abee-46cc-af4a-cca9d501daec
21
+ TCGA-W5-AA2W-01 TCGA-W5-AA2W-01 TCGA-W5-AA2W TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 31 3.5 3.7 5.0 TCGA-W5-AA2W TCGA-W5-AA2W-01A 0.1 0.4 104 0 55 A None 0.6 1.1 0.6 -11438 1314 924 0 0 0 - No Fibrosis 2014-5-24 FEMALE 167 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 160 0.9 1.2 NO G3 YES true No M0 N1 T2a Stage IVA TCGA-W5-AA2W.EB47A378-F3DA-4892-8126-99CEE6BFA8EE.pdf AA2W NO WITH TUMOR 217 150 450 NO NO 1.1 NO NO R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES W5 1.0 Bile duct None A DECEASED 91 2010 TCGA-W5-AA2W-01A-11D-A417-09 TCGA-W5-AA2W-01A-11D-A417-09 TCGA-W5-AA2W-01A-11D-A418-05 6fcc3918-f4b0-42ab-b00c-027175606cbd 6fcc3918-f4b0-42ab-b00c-027175606cbd TCGA-W5-AA2W-01A-11D-A417-09 TCGA-W5-AA2W-01 TCGA-W5-AA2W-01A-11D-A416-01 TCGA-W5-AA2W-01A-11D-A416-01 TCGA-W5-AA2W-01 6fcc3918-f4b0-42ab-b00c-027175606cbd TCGA-W5-AA2W-01 TCGA-W5-AA2W-01A-11D-A417-09 TCGA-W5-AA2W-01 6fcc3918-f4b0-42ab-b00c-027175606cbd 3D6C2B3C-A94D-4593-B040-F9C09695401B
22
+ TCGA-W5-AA2X-01 TCGA-W5-AA2X-01 TCGA-W5-AA2X TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 67 3.5 4.0 5.0 TCGA-W5-AA2X TCGA-W5-AA2X-01A 0.1 0.7 203 0 55 1 A None 0.8 1.3 0.8 -24797 1238 271 0 0 breast Sister 0 6.0 4.0 1,2 - Portal Fibrosis 2014-5-24 MALE 167 No History of Primary Risk Factors Cholangiocarcinoma; hilar/perihilar No C24.0 8160/3 C24.0 YES 120 0.9 1.2 NO G4 true No M1 N1 T2b Stage IVB TCGA-W5-AA2X.D2B18607-E16D-4570-9E96-5A7CBAFD79FC.pdf AA2X NO 541 150 450 NO NO 1.0 NO YES RX Primary Tumor 01 Pancreaticoduodenectomy (Whipple Resection) 7th NO YES W5 1.0 Bile duct Micro A DECEASED 88 2010 TCGA-W5-AA2X-01A-11D-A417-09 TCGA-W5-AA2X-01A-11D-A417-09 TCGA-W5-AA2X-01A-11D-A418-05 1d507dd2-bb72-4305-a858-68fccae00d5e 1d507dd2-bb72-4305-a858-68fccae00d5e TCGA-W5-AA2X-01A-11D-A417-09 TCGA-W5-AA2X-01 TCGA-W5-AA2X-01A-11D-A416-01 TCGA-W5-AA2X-01A-11D-A416-01 TCGA-W5-AA2X-01 1d507dd2-bb72-4305-a858-68fccae00d5e TCGA-W5-AA2X-01 TCGA-W5-AA2X-01A-11D-A417-09 TCGA-W5-AA2X-01 1d507dd2-bb72-4305-a858-68fccae00d5e 8D1E6CEA-D755-4076-A2E1-F6F81E7162FB
23
+ TCGA-W5-AA2X-11 TCGA-W5-AA2X-11 TCGA-W5-AA2X TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 67 3.5 4.0 5.0 TCGA-W5-AA2X 0.1 0.7 203 0 55 1 A None 0.8 1.3 0.8 -24797 271 0 0 breast Sister 0 6.0 4.0 1,2 - Portal Fibrosis 2014-5-24 MALE 167 No History of Primary Risk Factors Cholangiocarcinoma; hilar/perihilar No C24.0 8160/3 C24.0 YES 0.9 1.2 G4 No M1 N1 T2b Stage IVB AA2X NO 541 150 450 NO NO 1.0 NO YES RX Solid Tissue Normal 11 Pancreaticoduodenectomy (Whipple Resection) 7th NO YES W5 1.0 Bile duct Micro DECEASED 88 2010 TCGA-W5-AA2X-11A-11D-A418-05 a6369fb0-1ca6-4215-9f2b-f4e8647e6f5a a6369fb0-1ca6-4215-9f2b-f4e8647e6f5a TCGA-W5-AA2X-11 a6369fb0-1ca6-4215-9f2b-f4e8647e6f5a TCGA-W5-AA2X-11 a6369fb0-1ca6-4215-9f2b-f4e8647e6f5a
24
+ TCGA-W5-AA2Z-01 TCGA-W5-AA2Z-01 TCGA-W5-AA2Z TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 29 3.5 4.6 5.0 TCGA-W5-AA2Z-F72738 TCGA-W5-AA2Z TCGA-W5-AA2Z-01A 0.1 0.5 495 0 55 1 A None 0.6 1.1 0.8 -10659 1178 0 1614 0 breast cancer Grandmother 0 6.0 1.6 1,2 - Portal Fibrosis 2015-11-23 FEMALE 162 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 120 0.9 1.2 NO NO G3 true No M0 N0 T2 Stage II TCGA-W5-AA2Z.22F994D3-20A5-46CD-958F-2AAAB3F2D2EC.pdf AA2Z NO WITH TUMOR 242 150 450 NO YES 1.0 NO YES R1 Primary Tumor 01 Lobectomy 7th NO YES W5 1.0 Bile duct None A LIVING 82 2010 TCGA-W5-AA2Z-01A-11D-A417-09 TCGA-W5-AA2Z-01A-11D-A417-09 TCGA-W5-AA2Z-01A-11D-A418-05 df40ecd0-42b7-45be-9789-098cc3c85f34 df40ecd0-42b7-45be-9789-098cc3c85f34 TCGA-W5-AA2Z-01A-11D-A417-09 TCGA-W5-AA2Z-01 TCGA-W5-AA2Z-01A-11D-A416-01 TCGA-W5-AA2Z-01A-11D-A416-01 TCGA-W5-AA2Z-01 df40ecd0-42b7-45be-9789-098cc3c85f34 TCGA-W5-AA2Z-01 TCGA-W5-AA2Z-01A-11D-A417-09 TCGA-W5-AA2Z-01 df40ecd0-42b7-45be-9789-098cc3c85f34 165A72AC-663B-4748-B047-C1E46CCB41FF
25
+ TCGA-W5-AA30-01 TCGA-W5-AA30-01 TCGA-W5-AA30 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 82 3.5 4.3 5.0 TCGA-W5-AA30-F72739 TCGA-W5-AA30 TCGA-W5-AA30-01A 0.1 0.9 265 0 55 1 None 0.8 1.3 1.0 -30039 1134 0 1153 0 colon cancer Brother 0 6.0 3.7 0 - No Fibrosis 2015-11-23 MALE 188 Smoking Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 200 0.8 1.2 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-W5-AA30.9C2BEED7-DB8C-4BFE-920A-DD716B884777.pdf AA30 NO TUMOR FREE 134 150 450 NO NO 1.0 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES W5 1.0 Bile duct None A LIVING 102 2010 TCGA-W5-AA30-01A-31D-A417-09 TCGA-W5-AA30-01A-31D-A417-09 TCGA-W5-AA30-01A-31D-A418-05 f53d3bb4-4d10-4321-b41b-87fed60e6fc1 f53d3bb4-4d10-4321-b41b-87fed60e6fc1 TCGA-W5-AA30-01A-31D-A417-09 TCGA-W5-AA30-01 TCGA-W5-AA30-01A-31D-A416-01 TCGA-W5-AA30-01A-31D-A416-01 TCGA-W5-AA30-01 f53d3bb4-4d10-4321-b41b-87fed60e6fc1 TCGA-W5-AA30-01 TCGA-W5-AA30-01A-31D-A417-09 TCGA-W5-AA30-01 f53d3bb4-4d10-4321-b41b-87fed60e6fc1 9C4BC985-43F5-421E-A479-3CFD9AE12506
26
+ TCGA-W5-AA30-11 TCGA-W5-AA30-11 TCGA-W5-AA30 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 82 3.5 4.3 5.0 TCGA-W5-AA30-F72739 TCGA-W5-AA30 0.1 0.9 265 0 55 1 None 0.8 1.3 1.0 -30039 0 1153 0 colon cancer Brother 0 6.0 3.7 0 - No Fibrosis 2015-11-23 MALE 188 Smoking Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 0.8 1.2 NO G3 NO No M0 N0 T1 Stage I AA30 NO TUMOR FREE 134 150 450 NO NO 1.0 NO YES R0 Solid Tissue Normal 11 Lobectomy 7th NO YES W5 1.0 Bile duct None LIVING 102 2010 TCGA-W5-AA30-11A-11D-A418-05 e819d2ae-9cfb-4256-a15c-23fbb3683ee7 e819d2ae-9cfb-4256-a15c-23fbb3683ee7 TCGA-W5-AA30-11 e819d2ae-9cfb-4256-a15c-23fbb3683ee7 TCGA-W5-AA30-11 e819d2ae-9cfb-4256-a15c-23fbb3683ee7
27
+ TCGA-W5-AA31-01 TCGA-W5-AA31-01 TCGA-W5-AA31 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 71 TCGA-W5-AA31-F66611 TCGA-W5-AA31 TCGA-W5-AA31-01A 0.1 0.6 18 0 55 2 None 0.8 1.3 0.9 -26139 1079 0 10 0 Gastric Cancer|Testicular Cancer Sister|Child 0 6.0 4.4 0 - No Fibrosis 2014-10-21 MALE 184 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 180 0.9 1.2 NO YES G3 NO true Yes M0 N0 T1 Stage I TCGA-W5-AA31.A3B869CE-5B61-4F3E-930E-BC6CB37DD4F0.pdf AA31 NO TUMOR FREE 151 150 450 NO NO 1.1 NO YES R0 Primary Tumor 01 Extended Lobectomy 7th NO YES W5 1.1 Bile duct None A LIVING 105 2010 TCGA-W5-AA31-01A-11D-A417-09 TCGA-W5-AA31-01A-11D-A417-09 TCGA-W5-AA31-01A-11D-A418-05 b4468779-3068-40d2-809c-7b513d0a752f b4468779-3068-40d2-809c-7b513d0a752f TCGA-W5-AA31-01A-11D-A417-09 TCGA-W5-AA31-01 TCGA-W5-AA31-01A-11D-A416-01 TCGA-W5-AA31-01A-11D-A416-01 TCGA-W5-AA31-01 b4468779-3068-40d2-809c-7b513d0a752f TCGA-W5-AA31-01 TCGA-W5-AA31-01A-11D-A417-09 TCGA-W5-AA31-01 b4468779-3068-40d2-809c-7b513d0a752f 4D8A1449-67BD-4B03-BC47-29A5ECFD1FDB
28
+ TCGA-W5-AA31-11 TCGA-W5-AA31-11 TCGA-W5-AA31 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 71 TCGA-W5-AA31-F66611 TCGA-W5-AA31 TCGA-W5-AA31-11A 0.1 0.6 18 0 55 2 None 0.8 1.3 0.9 -26139 1079 0 10 0 Gastric Cancer|Testicular Cancer Sister|Child 0 6.0 4.4 0 - No Fibrosis 2014-10-21 MALE 184 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 150 0.9 1.2 NO YES G3 NO true Yes M0 N0 T1 Stage I AA31 NO TUMOR FREE 151 150 450 NO NO 1.1 NO YES R0 Solid Tissue Normal 11 Extended Lobectomy 7th NO YES W5 1.1 Bile duct None A LIVING 105 2010 TCGA-W5-AA31-11A-11D-A418-05 699c7545-9b63-4b7d-9f65-fc538ac31ff3 699c7545-9b63-4b7d-9f65-fc538ac31ff3 TCGA-W5-AA31-11 699c7545-9b63-4b7d-9f65-fc538ac31ff3 TCGA-W5-AA31-11 699c7545-9b63-4b7d-9f65-fc538ac31ff3
29
+ TCGA-W5-AA33-01 TCGA-W5-AA33-01 TCGA-W5-AA33 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 60 3.5 4.4 5.0 TCGA-W5-AA33-F72740 TCGA-W5-AA33 TCGA-W5-AA33-01A 0.1 0.5 17 0 55 2 A None 0.8 1.3 1.0 -22090 959 0 1449 1 Prostate Cancer|Breast Cancer and skin cancer Father|Grandmother 0 6.0 2.0 0 - No Fibrosis 2015-11-23 MALE 192 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 170 0.8 1.2 NO NO G3 NO true No M0 N0 T1 Stage I TCGA-W5-AA33.FAB26B40-D86E-4937-9D4D-2473D2AA838F.pdf AA33 NO TUMOR FREE 231 150 450 NO NO 1.1 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th NO YES W5 1.0 Bile duct None A LIVING 128 2011 TCGA-W5-AA33-01A-11D-A417-09 TCGA-W5-AA33-01A-11D-A417-09 TCGA-W5-AA33-01A-11D-A418-05 e67b53ac-771f-4b92-aad8-da78c97f4bcb e67b53ac-771f-4b92-aad8-da78c97f4bcb TCGA-W5-AA33-01A-11D-A417-09 TCGA-W5-AA33-01 TCGA-W5-AA33-01A-11D-A416-01 TCGA-W5-AA33-01A-11D-A416-01 TCGA-W5-AA33-01 e67b53ac-771f-4b92-aad8-da78c97f4bcb TCGA-W5-AA33-01 TCGA-W5-AA33-01A-11D-A417-09 TCGA-W5-AA33-01 e67b53ac-771f-4b92-aad8-da78c97f4bcb B5D126FD-6373-4859-A8A2-959DF66AAD29
30
+ TCGA-W5-AA34-01 TCGA-W5-AA34-01 TCGA-W5-AA34 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct NO NO 75 3.5 4.2 5.0 TCGA-W5-AA34-F66612 TCGA-W5-AA34 TCGA-W5-AA34-01A 0.1 0.4 25 0 55 4 A None 0.6 1.1 0.6 -27535 461 555 0 168 40 1 Stomach cancer|Prostate and colon cancer|lung cancer|non-invasive ductal carcinoma in situ of the breast Mother|Father|Sister|Sister 0 6.0 2.5 0 - No Fibrosis 2014-10-21 FEMALE 160 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 140 0.8 1.2 NO NO G2 Liver Intrahepatic Recurrence YES YES NO true No M0 N0 T1 Stage I TCGA-W5-AA34.36EAF28B-5091-4C1A-8BA6-D18C0407FC47.pdf AA34 NO WITH TUMOR 203 150 450 NO NO 1.0 NO YES R0 Primary Tumor 01 Segmentectomy, Single 7th NO YES W5 1.0 Bile duct None A DECEASED 71 2012 TCGA-W5-AA34-01A-11D-A417-09 TCGA-W5-AA34-01A-11D-A417-09 TCGA-W5-AA34-01A-11D-A418-05 84e6718b-08c9-475d-906d-045e8f5477a0 84e6718b-08c9-475d-906d-045e8f5477a0 TCGA-W5-AA34-01A-11D-A417-09 TCGA-W5-AA34-01 TCGA-W5-AA34-01A-11D-A416-01 TCGA-W5-AA34-01A-11D-A416-01 TCGA-W5-AA34-01 84e6718b-08c9-475d-906d-045e8f5477a0 TCGA-W5-AA34-01 TCGA-W5-AA34-01A-11D-A417-09 TCGA-W5-AA34-01 84e6718b-08c9-475d-906d-045e8f5477a0 607DC467-8DB8-424B-BFDA-05AC7B83186B
31
+ TCGA-W5-AA34-11 TCGA-W5-AA34-11 TCGA-W5-AA34 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct NO NO 75 3.5 4.2 5.0 TCGA-W5-AA34-F66612 TCGA-W5-AA34 TCGA-W5-AA34-11A 0.1 0.4 25 0 55 4 A None 0.6 1.1 0.6 -27535 461 555 0 168 40 1 Stomach cancer|Prostate and colon cancer|lung cancer|non-invasive ductal carcinoma in situ of the breast Mother|Father|Sister|Sister 0 6.0 2.5 0 - No Fibrosis 2014-10-21 FEMALE 160 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 250 0.8 1.2 NO NO G2 Liver Intrahepatic Recurrence YES YES NO true No M0 N0 T1 Stage I AA34 NO WITH TUMOR 203 150 450 NO NO 1.0 NO YES R0 Solid Tissue Normal 11 Segmentectomy, Single 7th NO YES W5 1.0 Bile duct None A DECEASED 71 2012 TCGA-W5-AA34-11A-11D-A418-05 9d7ac93a-ca45-44ed-a326-5e404e0d3b85 9d7ac93a-ca45-44ed-a326-5e404e0d3b85 TCGA-W5-AA34-11 9d7ac93a-ca45-44ed-a326-5e404e0d3b85 TCGA-W5-AA34-11 9d7ac93a-ca45-44ed-a326-5e404e0d3b85
32
+ TCGA-W5-AA36-01 TCGA-W5-AA36-01 TCGA-W5-AA36 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 51 3.5 4.6 5.0 TCGA-W5-AA36 TCGA-W5-AA36-01A 0.1 0.8 1 0 55 A None 0.6 1.1 0.8 -18882 2007 1402 0 0 0 6 14 0 - No Fibrosis 2014-5-27 FEMALE 165 No History of Primary Risk Factors Cholangiocarcinoma; hilar/perihilar Yes C22.1 8160/3 C22.1 YES 100 0.8 1.2 NO G3 YES true No M1 N0 T3 Stage IV TCGA-W5-AA36.6EC57D32-953A-4B46-AF10-A3AFCF636ED4.pdf AA36 NO WITH TUMOR 197 150 450 NO YES 1.3 NO R0 Primary Tumor 01 Extended Lobectomy 6th NO YES W5 1.0 Bile duct None A DECEASED 68 2008 TCGA-W5-AA36-01A-11D-A417-09 TCGA-W5-AA36-01A-11D-A417-09 TCGA-W5-AA36-01A-11D-A418-05 b8dabef1-a207-4c40-bf80-d61ad7dbf571 b8dabef1-a207-4c40-bf80-d61ad7dbf571 TCGA-W5-AA36-01A-11D-A417-09 TCGA-W5-AA36-01 TCGA-W5-AA36-01A-11D-A416-01 TCGA-W5-AA36-01A-11D-A416-01 TCGA-W5-AA36-01 b8dabef1-a207-4c40-bf80-d61ad7dbf571 TCGA-W5-AA36-01 TCGA-W5-AA36-01A-11D-A417-09 TCGA-W5-AA36-01 b8dabef1-a207-4c40-bf80-d61ad7dbf571 75CAFA30-1E76-47C9-9ED2-392C23E5E1D7
33
+ TCGA-W5-AA38-01 TCGA-W5-AA38-01 TCGA-W5-AA38 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 55 3.5 4.8 5.0 TCGA-W5-AA38-F72741 TCGA-W5-AA38 TCGA-W5-AA38-01A 0.1 0.3 199 0 55 1 A None 0.6 1.1 0.6 -20285 875 0 1471 1 colorectal cancer Mother 0 6.0 2.2 1,2 - Portal Fibrosis 2015-11-23 FEMALE 168 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 150 0.8 1.2 NO NO G3 YES true No M0 N0 T1 Stage I TCGA-W5-AA38.626B6057-4EFB-4AC9-A761-6759D5EF9EC1.pdf AA38 NO TUMOR FREE 239 150 450 NO NO 1.0 NO YES R0 Primary Tumor 01 Lobectomy 7th NO YES W5 1.0 Bile duct None A LIVING 73 2011 TCGA-W5-AA38-01A-11D-A417-09 TCGA-W5-AA38-01A-11D-A417-09 TCGA-W5-AA38-01A-11D-A418-05 cf410999-4cac-4f7b-9062-bfd807c50355 cf410999-4cac-4f7b-9062-bfd807c50355 TCGA-W5-AA38-01A-11D-A417-09 TCGA-W5-AA38-01 TCGA-W5-AA38-01A-11D-A416-01 TCGA-W5-AA38-01A-11D-A416-01 TCGA-W5-AA38-01 cf410999-4cac-4f7b-9062-bfd807c50355 TCGA-W5-AA38-01 TCGA-W5-AA38-01A-11D-A417-09 TCGA-W5-AA38-01 cf410999-4cac-4f7b-9062-bfd807c50355 851ABA0D-40A6-4D93-89B7-0D46180B1FE0
34
+ TCGA-W5-AA39-01 TCGA-W5-AA39-01 TCGA-W5-AA39 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 81 3.5 3.5 5.0 TCGA-W5-AA39 TCGA-W5-AA39-01A 0.1 0.6 57 0 55 2 A None 0.8 1.3 1.1 -29594 1286 170 0 1 cervical cancer|lung cancer Mother|Father 0 6.0 2.7 0 - No Fibrosis 2014-5-27 MALE 176 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 220 0.9 1.2 NO G4 true No M0 N0 T2 Stage II TCGA-W5-AA39.733CC9D1-7D35-4976-9CD9-B8B8542313E2.pdf AA39 NO WITH TUMOR 350 150 450 NO NO 1.2 NO YES RX Primary Tumor 01 Lobectomy 7th NO YES W5 1.0 Bile duct None A DECEASED 80 2010 TCGA-W5-AA39-01A-11D-A417-09 TCGA-W5-AA39-01A-11D-A417-09 TCGA-W5-AA39-01A-11D-A418-05 342a4721-d5b0-487f-a2a7-a8ef6b7a924c 342a4721-d5b0-487f-a2a7-a8ef6b7a924c TCGA-W5-AA39-01A-11D-A417-09 TCGA-W5-AA39-01 TCGA-W5-AA39-01A-11D-A416-01 TCGA-W5-AA39-01A-11D-A416-01 TCGA-W5-AA39-01 342a4721-d5b0-487f-a2a7-a8ef6b7a924c TCGA-W5-AA39-01 TCGA-W5-AA39-01A-11D-A417-09 TCGA-W5-AA39-01 342a4721-d5b0-487f-a2a7-a8ef6b7a924c 4B196223-A359-4F08-9BA2-BE0E00587E91
35
+ TCGA-W6-AA0S-01 TCGA-W6-AA0S-01 TCGA-W6-AA0S TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct NO 46 3.5 4.0 4.8 TCGA-W6-AA0S-F67141 TCGA-W6-AA0S TCGA-W6-AA0S-01A 0.2 0.3 0 36 A None 0.5 1.0 0.6 -16951 235 0 808 549 0 0 8 1,2 - Portal Fibrosis 2015-11-24 FEMALE 144 Diabetes mellitus|Non-Alcoholic Fatty Liver Disease Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 210 0.9 1.2 NO NO G2 Non-regional / Distant Lymph Nodes Extrahepatic Recurrence NO NO NO NO true No MX N0 T1 Stage I TCGA-W6-AA0S.2F3CE1B3-0DFD-4729-8A52-5E0BDE92BD12.pdf AA0S YES TUMOR FREE 267 140 450 NO YES 1.0 NO NO R0 Primary Tumor 01 Extended Lobectomy 7th YES NO W6 1.3 Bile duct None A LIVING 61 2013 TCGA-W6-AA0S-01A-11D-A417-09 TCGA-W6-AA0S-01A-11D-A417-09 TCGA-W6-AA0S-01A-11D-A418-05 f5475a42-4520-4124-9ace-8c0ed9eabefb f5475a42-4520-4124-9ace-8c0ed9eabefb TCGA-W6-AA0S-01A-11D-A417-09 TCGA-W6-AA0S-01 TCGA-W6-AA0S-01A-11D-A416-01 TCGA-W6-AA0S-01A-11D-A416-01 TCGA-W6-AA0S-01 f5475a42-4520-4124-9ace-8c0ed9eabefb TCGA-W6-AA0S-01 TCGA-W6-AA0S-01A-11D-A417-09 TCGA-W6-AA0S-01 f5475a42-4520-4124-9ace-8c0ed9eabefb C97EF18D-DC2E-441E-B7CB-AB02A59B702A
36
+ TCGA-WD-A7RX-01 TCGA-WD-A7RX-01 TCGA-WD-A7RX TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 71 3.5 3.7 4.8 TCGA-WD-A7RX TCGA-WD-A7RX-01A 0.3 0.6 34 0 37 1 0.40 1.00 0.9 -26006 86 21 0 0 multiple myeloma Mother 0 8.1 2.6 3,4 - Fibrous Speta 2013-12-23 FEMALE 147 Cirrhosis|Diabetes mellitus|Smoking Cholangiocarcinoma; intrahepatic No C22.0 8160/3 C22.0 YES 250 10.4 13.1 NO G2 NO true No MX NX T2b Stage II TCGA-WD-A7RX.9D3F4AEF-2F52-4035-AFFC-A5AD2A31EE5D.pdf A7RX TUMOR FREE 156 150 400 NO NO 12.2 NO YES RX Primary Tumor 01 Other (specify) 7th YES NO WD 1.2 Bile duct None A DECEASED 51 2013 TCGA-WD-A7RX-01A-12D-A417-09 TCGA-WD-A7RX-01A-12D-A417-09 TCGA-WD-A7RX-01A-12D-A418-05 015b2409-ca2e-4141-8266-fe619793761c 015b2409-ca2e-4141-8266-fe619793761c TCGA-WD-A7RX-01A-12D-A417-09 TCGA-WD-A7RX-01 TCGA-WD-A7RX-01A-12D-A416-01 TCGA-WD-A7RX-01A-12D-A416-01 TCGA-WD-A7RX-01 015b2409-ca2e-4141-8266-fe619793761c TCGA-WD-A7RX-01 TCGA-WD-A7RX-01A-12D-A417-09 TCGA-WD-A7RX-01 015b2409-ca2e-4141-8266-fe619793761c 168F37C1-CDC4-46FE-809C-B775ECEBD99C
37
+ TCGA-YR-A95A-01 TCGA-YR-A95A-01 TCGA-YR-A95A TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 52 3.4 4.3 4.8 TCGA-YR-A95A TCGA-YR-A95A-01A 2 18.15 0 39 0.7 1.2 0.8 -19292 1589 26 0 Brain tumor Sister 0 15 1.38 2014-10-23 MALE 177 No History of Primary Risk Factors Cholangiocarcinoma; hilar/perihilar No C24.0 8160/3 C24.0 YES 130 0 1.2 NO G2 YES false No M1 NX T2 Stage IV TCGA-YR-A95A.AB615D8F-E4A3-48A9-86A3-C89861C89A5D.pdf A95A YES WITH TUMOR 240000 125000 450000 NO NO 0.9 NO YES R1 Primary Tumor 01 Segmentectomy, Multiple 6th NO YES YR Bile duct A DECEASED 77 2009 TCGA-YR-A95A-01A-12D-A417-09 TCGA-YR-A95A-01A-12D-A417-09 TCGA-YR-A95A-01A-12D-A418-05 7bb15e31-2b7d-4926-b78a-0d2aa7bddd78 7bb15e31-2b7d-4926-b78a-0d2aa7bddd78 TCGA-YR-A95A-01A-12D-A417-09 TCGA-YR-A95A-01 TCGA-YR-A95A-01A-12D-A416-01 TCGA-YR-A95A-01A-12D-A416-01 TCGA-YR-A95A-01 7bb15e31-2b7d-4926-b78a-0d2aa7bddd78 TCGA-YR-A95A-01 TCGA-YR-A95A-01A-12D-A417-09 TCGA-YR-A95A-01 7bb15e31-2b7d-4926-b78a-0d2aa7bddd78 C8B9157D-FDC5-44D4-852D-C231457D467E
38
+ TCGA-ZD-A8I3-01 TCGA-ZD-A8I3-01 TCGA-ZD-A8I3 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct NO NO 73 TCGA-ZD-A8I3-F69616 TCGA-ZD-A8I3 TCGA-ZD-A8I3-01A -26754 173 169 0 0 59 3 2015-1-15 FEMALE 152 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 250 NO NO G3 Liver Locoregional Recurrence NO NO YES NO true No M0 N0 T2 Stage II TCGA-ZD-A8I3.0A18D59B-0D93-409E-8E7F-156B1C77964B.pdf A8I3 WITH TUMOR NO NO NO NO R0 Primary Tumor 01 Lobectomy 7th YES NO ZD Bile duct A DECEASED 49 2013 TCGA-ZD-A8I3-01A-11D-A417-09 TCGA-ZD-A8I3-01A-11D-A417-09 TCGA-ZD-A8I3-01A-11D-A418-05 be89bf4d-75f7-4596-9251-490976f7e254 be89bf4d-75f7-4596-9251-490976f7e254 TCGA-ZD-A8I3-01A-11D-A417-09 TCGA-ZD-A8I3-01 TCGA-ZD-A8I3-01A-11D-A416-01 TCGA-ZD-A8I3-01A-11D-A416-01 TCGA-ZD-A8I3-01 be89bf4d-75f7-4596-9251-490976f7e254 TCGA-ZD-A8I3-01 TCGA-ZD-A8I3-01A-11D-A417-09 TCGA-ZD-A8I3-01 be89bf4d-75f7-4596-9251-490976f7e254 CF371F36-D0C6-4371-9525-E0C0EBADF201
39
+ TCGA-ZH-A8Y1-01 TCGA-ZH-A8Y1-01 TCGA-ZH-A8Y1 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 74 3.5 4.6 5.0 TCGA-ZH-A8Y1 TCGA-ZH-A8Y1-01A 0.0 0.7 6910 55 0.6 1.0 0.8 -27279 426 385 0 1 2014-3-11 FEMALE 165 Smoking Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 550 NO G2 YES false Yes M0 N1 T3 Stage IVA TCGA-ZH-A8Y1.B4025F42-46CB-4D4E-ABB4-DBF701615F14.pdf A8Y1 WITH TUMOR 272000 150000 440000 NO NO 0.9 NO NO R1 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO ZH 1.2 Bile duct Micro A DECEASED 78 2012 TCGA-ZH-A8Y1-01A-11D-A417-09 TCGA-ZH-A8Y1-01A-11D-A417-09 TCGA-ZH-A8Y1-01A-11D-A418-05 11aba6d6-271d-4d59-a2be-8cbd88a48d40 11aba6d6-271d-4d59-a2be-8cbd88a48d40 TCGA-ZH-A8Y1-01A-11D-A417-09 TCGA-ZH-A8Y1-01 TCGA-ZH-A8Y1-01A-11D-A416-01 TCGA-ZH-A8Y1-01A-11D-A416-01 TCGA-ZH-A8Y1-01 11aba6d6-271d-4d59-a2be-8cbd88a48d40 TCGA-ZH-A8Y1-01 TCGA-ZH-A8Y1-01A-11D-A417-09 TCGA-ZH-A8Y1-01 11aba6d6-271d-4d59-a2be-8cbd88a48d40 1D74BEBF-3581-4383-8009-EC2A10B36FE2
40
+ TCGA-ZH-A8Y2-01 TCGA-ZH-A8Y2-01 TCGA-ZH-A8Y2 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 59 TCGA-ZH-A8Y2 TCGA-ZH-A8Y2-01A 3 -21743 897 701 0 Colon Sister|Sister|Brother 0.0 10.0 7.8 2014-3-11 FEMALE 173 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 400 NO G2 YES false No M0 NX T1 Stage I TCGA-ZH-A8Y2.1D1D2814-ECEE-463D-9EF9-E27F9CDCFEB6.pdf A8Y2 NO WITH TUMOR NO NO NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO ZH Bile duct Micro A DECEASED 80 2011 TCGA-ZH-A8Y2-01A-11D-A417-09 TCGA-ZH-A8Y2-01A-11D-A417-09 TCGA-ZH-A8Y2-01A-11D-A418-05 63a3bd41-6a68-4eb5-ad4f-0fd05be97ac1 63a3bd41-6a68-4eb5-ad4f-0fd05be97ac1 TCGA-ZH-A8Y2-01A-11D-A417-09 TCGA-ZH-A8Y2-01 TCGA-ZH-A8Y2-01A-11D-A416-01 TCGA-ZH-A8Y2-01A-11D-A416-01 TCGA-ZH-A8Y2-01 63a3bd41-6a68-4eb5-ad4f-0fd05be97ac1 TCGA-ZH-A8Y2-01 TCGA-ZH-A8Y2-01A-11D-A417-09 TCGA-ZH-A8Y2-01 63a3bd41-6a68-4eb5-ad4f-0fd05be97ac1 A22CAEBD-B501-46FB-9DCE-BD22261601E5
41
+ TCGA-ZH-A8Y4-01 TCGA-ZH-A8Y4-01 TCGA-ZH-A8Y4 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 58 3.5 4.2 5.0 TCGA-ZH-A8Y4 TCGA-ZH-A8Y4-01A 0.0 0.3 27 55 1 0.7 1.3 0.9 -21503 1315 741 0 Melanoma Mother 0.0 10.0 6.0 2014-3-11 MALE 183 Diabetes mellitus|Smoking Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 80 NO G3 YES false Yes M0 N0 T1 Stage I TCGA-ZH-A8Y4.8C44AB5C-5F49-4F12-9273-F8AEDD9F0316.pdf A8Y4 NO WITH TUMOR 208000 150000 440000 NO YES 1.1 NO YES R1 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO ZH 1.2 Bile duct None A DECEASED 88 2010 TCGA-ZH-A8Y4-01A-11D-A417-09 TCGA-ZH-A8Y4-01A-11D-A417-09 TCGA-ZH-A8Y4-01A-11D-A418-05 012cd145-9f6c-4b79-b929-3f42f61e3dce 012cd145-9f6c-4b79-b929-3f42f61e3dce TCGA-ZH-A8Y4-01A-11D-A417-09 TCGA-ZH-A8Y4-01 TCGA-ZH-A8Y4-01A-11D-A416-01 TCGA-ZH-A8Y4-01A-11D-A416-01 TCGA-ZH-A8Y4-01 012cd145-9f6c-4b79-b929-3f42f61e3dce TCGA-ZH-A8Y4-01 TCGA-ZH-A8Y4-01A-11D-A417-09 TCGA-ZH-A8Y4-01 012cd145-9f6c-4b79-b929-3f42f61e3dce
42
+ TCGA-ZH-A8Y5-01 TCGA-ZH-A8Y5-01 TCGA-ZH-A8Y5 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 69 3.5 4.3 5.0 TCGA-ZH-A8Y5-F72746 TCGA-ZH-A8Y5 TCGA-ZH-A8Y5-01A 0.0 0.7 7 55 1 0.7 1.3 1.0 -25268 622 0 1229 0 Breast Sister 2015-11-20 MALE 175 Smoking Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 240 NO NO G3 YES false No M1 N1 T3 Stage IVB TCGA-ZH-A8Y5.793D6E81-1D43-4C8F-9490-F55217AF4E8E.pdf A8Y5 NO WITH TUMOR 269000 150000 440000 NO YES 1.0 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO ZH 1.2 Bile duct Micro A LIVING 85 2012 TCGA-ZH-A8Y5-01A-11D-A417-09 TCGA-ZH-A8Y5-01A-11D-A417-09 TCGA-ZH-A8Y5-01A-11D-A418-05 f7f581cf-3c93-4eaf-9f10-299006f058ce f7f581cf-3c93-4eaf-9f10-299006f058ce TCGA-ZH-A8Y5-01A-11D-A417-09 TCGA-ZH-A8Y5-01 TCGA-ZH-A8Y5-01A-11D-A416-01 TCGA-ZH-A8Y5-01A-11D-A416-01 TCGA-ZH-A8Y5-01 f7f581cf-3c93-4eaf-9f10-299006f058ce TCGA-ZH-A8Y5-01 TCGA-ZH-A8Y5-01A-11D-A417-09 TCGA-ZH-A8Y5-01 f7f581cf-3c93-4eaf-9f10-299006f058ce EAE08C09-848E-4EC5-BC01-B22F80E82B80
43
+ TCGA-ZH-A8Y6-01 TCGA-ZH-A8Y6-01 TCGA-ZH-A8Y6 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 41 3.4 3.9 5.0 TCGA-ZH-A8Y6-F70052 TCGA-ZH-A8Y6 TCGA-ZH-A8Y6-01A 0.2 0.3 29 0 35 3 0.6 1.3 1.2 -14976 148 0 519 uterine|uterine|breast Mother|Grandmother|Grandmother 2015-1-26 FEMALE 152 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 350 NO NO G2 NO false No M0 N0 T1 Stage I TCGA-ZH-A8Y6.1308ED5B-3B3F-4E9A-91D6-64507F549473.pdf A8Y6 NO TUMOR FREE 279000 130000 400000 NO NO 1.0 NO YES R0 Primary Tumor 01 Segmentectomy, Multiple 7th YES NO ZH 1.0 Bile duct None A LIVING 89 2013 TCGA-ZH-A8Y6-01A-11D-A417-09 TCGA-ZH-A8Y6-01A-11D-A417-09 TCGA-ZH-A8Y6-01A-11D-A418-05 f322aedd-a561-4b14-b2e3-f60087b705f7 f322aedd-a561-4b14-b2e3-f60087b705f7 TCGA-ZH-A8Y6-01A-11D-A417-09 TCGA-ZH-A8Y6-01 TCGA-ZH-A8Y6-01A-11D-A416-01 TCGA-ZH-A8Y6-01A-11D-A416-01 TCGA-ZH-A8Y6-01 f322aedd-a561-4b14-b2e3-f60087b705f7 TCGA-ZH-A8Y6-01 TCGA-ZH-A8Y6-01A-11D-A417-09 TCGA-ZH-A8Y6-01 f322aedd-a561-4b14-b2e3-f60087b705f7 376510BA-DA10-4B45-ABFC-68AB37AB8408
44
+ TCGA-ZH-A8Y8-01 TCGA-ZH-A8Y8-01 TCGA-ZH-A8Y8 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 73 TCGA-ZH-A8Y8-F72747 TCGA-ZH-A8Y8 TCGA-ZH-A8Y8-01A 0.0 0.7 39.2 0.0 36.9 2 0.7 1.0 0.8 -26744 69 0 602 Thyroid|Lung Sister|Sister 2015-11-24 MALE 183 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 390 NO NO G2 NO false Yes M0 N0 T1 Stage I TCGA-ZH-A8Y8.D35938C2-CFED-444E-8284-B1A4D5EAD0F3.pdf A8Y8 YES TUMOR FREE 261000 150000 440000 NO NO 1.1 NO YES R0 Primary Tumor 01 Lobectomy 7th YES NO ZH 1.2 Bile duct None A LIVING 98 2013 TCGA-ZH-A8Y8-01A-51D-A417-09 TCGA-ZH-A8Y8-01A-51D-A417-09 TCGA-ZH-A8Y8-01A-51D-A418-05 6d6c5a87-0773-418f-ae97-52e1cec8b8b1 6d6c5a87-0773-418f-ae97-52e1cec8b8b1 TCGA-ZH-A8Y8-01A-51D-A417-09 TCGA-ZH-A8Y8-01 TCGA-ZH-A8Y8-01A-51D-A416-01 TCGA-ZH-A8Y8-01A-51D-A416-01 TCGA-ZH-A8Y8-01 6d6c5a87-0773-418f-ae97-52e1cec8b8b1 TCGA-ZH-A8Y8-01 TCGA-ZH-A8Y8-01A-51D-A417-09 TCGA-ZH-A8Y8-01 6d6c5a87-0773-418f-ae97-52e1cec8b8b1 2FE6B28F-6DC8-45C3-AAC0-C83C46EDA9F0
45
+ TCGA-ZU-A8S4-01 TCGA-ZU-A8S4-01 TCGA-ZU-A8S4 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 52 3.5 4.2 5.0 TCGA-ZU-A8S4 TCGA-ZU-A8S4-01A 0.2 0.4 115 0 35.0 0.60 1.30 0.9 -19264 356 98 0 0 8.0 1.9 0 - No Fibrosis 2014-4-8 MALE 183 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 70 0.9 1.2 NO G3 YES false No MX NX T1 Stage I TCGA-ZU-A8S4.92337E74-DF14-48C7-90AC-907A787E1D0E.pdf A8S4 YES WITH TUMOR 279 140 400 NO YES 1.1 NO NO R0 Primary Tumor 01 Lobectomy 7th NO YES ZU 1.0 Bile duct None A DECEASED 122 2012 TCGA-ZU-A8S4-01A-11D-A417-09 TCGA-ZU-A8S4-01A-11D-A417-09 TCGA-ZU-A8S4-01A-11D-A418-05 5cd9444b-4c4c-489a-b491-583da5510c80 5cd9444b-4c4c-489a-b491-583da5510c80 TCGA-ZU-A8S4-01A-11D-A417-09 TCGA-ZU-A8S4-01 TCGA-ZU-A8S4-01A-11D-A416-01 TCGA-ZU-A8S4-01A-11D-A416-01 TCGA-ZU-A8S4-01 5cd9444b-4c4c-489a-b491-583da5510c80 TCGA-ZU-A8S4-01 TCGA-ZU-A8S4-01A-11D-A417-09 TCGA-ZU-A8S4-01 5cd9444b-4c4c-489a-b491-583da5510c80
46
+ TCGA-ZU-A8S4-11 TCGA-ZU-A8S4-11 TCGA-ZU-A8S4 TCGA Bile Duct Cancer (CHOL) cholangiocarcinoma Bile duct 52 3.5 4.2 5.0 TCGA-ZU-A8S4 0.2 0.4 115 0 35.0 0.60 1.30 0.9 -19264 98 0 0 8.0 1.9 0 - No Fibrosis 2014-4-8 MALE 183 No History of Primary Risk Factors Cholangiocarcinoma; intrahepatic No C22.1 8160/3 C22.1 YES 0.9 1.2 G3 YES No MX NX T1 Stage I A8S4 YES WITH TUMOR 279 140 400 NO YES 1.1 NO NO R0 Solid Tissue Normal 11 Lobectomy 7th NO YES ZU 1.0 Bile duct None DECEASED 122 2012 TCGA-ZU-A8S4-11A-11D-A418-05 bd5dc5da-bd55-45d8-a045-93d99b737f0a bd5dc5da-bd55-45d8-a045-93d99b737f0a TCGA-ZU-A8S4-11 bd5dc5da-bd55-45d8-a045-93d99b737f0a TCGA-ZU-A8S4-11 bd5dc5da-bd55-45d8-a045-93d99b737f0a
input/TCGA/TCGA_Bile_Duct_Cancer_(CHOL)/TCGA.CHOL.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:12a456c492bda108c724dbe4c0c7debad8ff8ace8c248cec674a2cb2b3419456
3
+ size 3855033
input/TCGA/TCGA_Cervical_Cancer_(CESC)/.DS_Store ADDED
Binary file (6.15 kB). View file
 
input/TCGA/TCGA_Colon_Cancer_(COAD)/TCGA.COAD.sampleMap_COAD_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Colon_and_Rectal_Cancer_(COADREAD)/TCGA.COADREAD.sampleMap_COADREAD_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Endometrioid_Cancer_(UCEC)/TCGA.UCEC.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:bdc50b7c525c85fac9c91aced2ea3d21b9d75ddddf65478243229fbc1f9aaedb
3
+ size 15323459
input/TCGA/TCGA_Endometrioid_Cancer_(UCEC)/TCGA.UCEC.sampleMap_UCEC_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Esophageal_Cancer_(ESCA)/TCGA.ESCA.sampleMap_ESCA_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Esophageal_Cancer_(ESCA)/TCGA.ESCA.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:c9147b6dd6838bbb9ec0adc726feeffebc39c455cbb34f3e20095603c4d452e1
3
+ size 15164241
input/TCGA/TCGA_Glioblastoma_(GBM)/.DS_Store ADDED
Binary file (6.15 kB). View file
 
input/TCGA/TCGA_Glioblastoma_(GBM)/TCGA.GBM.sampleMap_GBM_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Glioblastoma_(GBM)/TCGA.GBM.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:2a546257a1e82b201401434af5980e1ff1b9b57579e0055ef21c06ad8dc8e543
3
+ size 12861351
input/TCGA/TCGA_Head_and_Neck_Cancer_(HNSC)/TCGA.HNSC.sampleMap_HNSC_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Kidney_Chromophobe_(KICH)/TCGA.KICH.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:473fb4842f4962cdf84c233a4c1a6123dca5473820757fa01d980645887c7ac6
3
+ size 7138002
input/TCGA/TCGA_Kidney_Chromophobe_(KICH)/TCGA.KICH.sampleMap_KICH_clinicalMatrix ADDED
@@ -0,0 +1,92 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ sampleID _INTEGRATION _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy additional_surgery_locoregional_procedure additional_surgery_metastatic_procedure age_at_initial_pathologic_diagnosis bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode clinical_M days_to_additional_surgery_metastatic_procedure days_to_birth days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_after_initial_treatment eastern_cancer_oncology_group followup_case_report_form_submission_reason followup_treatment_success form_completion_date gender hemoglobin_result histological_type history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified intermediate_dimension is_ffpe karnofsky_performance_score lactate_dehydrogenase_result laterality longest_dimension lost_follow_up lymph_node_examined_count new_tumor_event_after_initial_treatment number_of_lymphnodes_positive number_pack_years_smoked other_dx pathologic_M pathologic_N pathologic_T pathologic_stage pathology_report_file_name patient_id percent_tumor_sarcomatoid performance_status_scale_timing person_neoplasm_cancer_status platelet_qualitative_result presence_of_sarcomatoid_features primary_lymph_node_presentation_assessment primary_therapy_outcome_success radiation_therapy sample_type sample_type_id serum_calcium_result shortest_dimension stopped_smoking_year system_version targeted_molecular_therapy tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tobacco_smoking_history tumor_tissue_site vial_number vital_status white_cell_count_result year_of_initial_pathologic_diagnosis year_of_tobacco_smoking_onset _GENOMIC_ID_TCGA_KICH_PDMRNAseq _GENOMIC_ID_TCGA_KICH_exp_HiSeqV2_percentile _GENOMIC_ID_TCGA_KICH_gistic2thd _GENOMIC_ID_TCGA_KICH_mutation_bcgsc_gene _GENOMIC_ID_TCGA_KICH_exp_HiSeqV2 _GENOMIC_ID_TCGA_KICH_RPPA _GENOMIC_ID_TCGA_KICH_miRNA_HiSeq _GENOMIC_ID_TCGA_KICH_mutation_bcm_gene _GENOMIC_ID_TCGA_KICH_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_KICH_PDMRNAseqCNV _GENOMIC_ID_TCGA_KICH_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_KICH_hMethyl450 _GENOMIC_ID_TCGA_KICH_mutation_broad_gene _GENOMIC_ID_data/public/TCGA/KICH/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_KICH_gistic2
2
+ TCGA-KL-8323-01 TCGA-KL-8323-01 TCGA-KL-8323 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney YES NO NO 57 TCGA-KL-8323-F33909 TCGA-KL-8323 -20849 1158 0 911 Additional New Tumor Event 2012-7-24 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES Right YES No M0 NX T3b Stage III 8323 WITH TUMOR Normal NO NO Primary Tumor 01 Low 5th YES NO YES KL 1 Kidney DECEASED Elevated 2000 TCGA-KL-8323-01 cb8180ec-ce5f-4c1f-ab1a-38717607169f TCGA-KL-8323-01A-21D-2308-01 TCGA-KL-8323-01A-21D-2310-10 cb8180ec-ce5f-4c1f-ab1a-38717607169f TCGA-KL-8323-01 TCGA-KL-8323-01A-21D-2310-10 cb8180ec-ce5f-4c1f-ab1a-38717607169f TCGA-KL-8323-01 cb8180ec-ce5f-4c1f-ab1a-38717607169f TCGA-KL-8323-01A-21D-2312-05 TCGA-KL-8323-01A-21D-2310-10 TCGA-KL-8323-01 TCGA-KL-8323-01A-21D-2308-01
3
+ TCGA-KL-8324-01 TCGA-KL-8324-01 TCGA-KL-8324 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 67 TCGA-KL-8324-F33914 TCGA-KL-8324 TCGA-KL-8324-01A -24650 0 4676 Scheduled Follow-up Submission 2012-7-24 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1 NO Right 1.4 NO 1 No M0 NX T2 Stage II TCGA-KL-8324.c32c31e3-4491-42f8-9560-715fe982434b.pdf 8324 TUMOR FREE Normal NO NO Primary Tumor 01 Low 0.3 2000 5th NO NO YES KL 4 Kidney A LIVING Normal 2000 TCGA-KL-8324-01 bc33e129-174b-4193-b65a-844e06984a81 TCGA-KL-8324-01A-11D-2308-01 TCGA-KL-8324-01A-11D-2310-10 bc33e129-174b-4193-b65a-844e06984a81 04E5F9F1-6DD0-46D5-A0B0-B4832258271C TCGA-KL-8324-01 TCGA-KL-8324-01A-11D-2310-10 bc33e129-174b-4193-b65a-844e06984a81 TCGA-KL-8324-01 bc33e129-174b-4193-b65a-844e06984a81 TCGA-KL-8324-01A-11D-2312-05 TCGA-KL-8324-01A-11D-2310-10 TCGA-KL-8324-01 TCGA-KL-8324-01A-11D-2308-01
4
+ TCGA-KL-8324-11 TCGA-KL-8324-11 TCGA-KL-8324 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 67 TCGA-KL-8324-F33914 TCGA-KL-8324 TCGA-KL-8324-11A -24650 0 4676 Scheduled Follow-up Submission 2012-7-24 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1 NO Right 1.5 NO 1 No M0 NX T2 Stage II 8324 TUMOR FREE Normal NO NO Solid Tissue Normal 11 Low 0.2 2000 5th NO NO YES KL 4 Kidney A LIVING Normal 2000 6a753497-6d42-4c65-a54a-c14bcbcaaf62 6a753497-6d42-4c65-a54a-c14bcbcaaf62 TCGA-KL-8324-11 6a753497-6d42-4c65-a54a-c14bcbcaaf62 6a753497-6d42-4c65-a54a-c14bcbcaaf62 TCGA-KL-8324-11
5
+ TCGA-KL-8325-01 TCGA-KL-8325-01 TCGA-KL-8325 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 56 TCGA-KL-8325-F33916 TCGA-KL-8325 TCGA-KL-8325-01A -20768 725 0 Scheduled Follow-up Submission 2012-7-24 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.2 NO Left 2.3 NO No M0 NX T2 Stage II TCGA-KL-8325.e148eb96-a6c1-4748-88ae-b4f95743f3c7.pdf 8325 TUMOR FREE Normal NO NO Primary Tumor 01 Low 0.4 5th NO NO YES KL 1 Kidney A DECEASED Elevated 2000 TCGA-KL-8325-01 faad58ae-6000-4ab9-8469-ecd92f0344ff TCGA-KL-8325-01A-11D-2308-01 TCGA-KL-8325-01A-11D-2310-10 faad58ae-6000-4ab9-8469-ecd92f0344ff 337E84F0-9D30-4F6F-B9F4-880ADE1DDB15 TCGA-KL-8325-01 TCGA-KL-8325-01A-11D-2310-10 faad58ae-6000-4ab9-8469-ecd92f0344ff TCGA-KL-8325-01 faad58ae-6000-4ab9-8469-ecd92f0344ff TCGA-KL-8325-01A-11D-2312-05 TCGA-KL-8325-01A-11D-2310-10 TCGA-KL-8325-01 TCGA-KL-8325-01A-11D-2308-01
6
+ TCGA-KL-8326-01 TCGA-KL-8326-01 TCGA-KL-8326 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 69 TCGA-KL-8326-F33952 TCGA-KL-8326 TCGA-KL-8326-01A -25267 0 3322 Scheduled Follow-up Submission 2012-7-24 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.3 NO Right 2.4 YES 14 NO 0 No M0 N0 T3a Stage III TCGA-KL-8326.24e2925b-4f7b-40c0-87d4-68568f3fdf17.pdf 8326 TUMOR FREE Normal YES NO Primary Tumor 01 Low 0.4 5th NO NO YES KL 1 Kidney A LIVING Elevated 2001 TCGA-KL-8326-01 90c36d60-f8f2-4bf6-9f01-fc02e19dde5d TCGA-KL-8326-01A-11D-2308-01 TCGA-KL-8326-01A-11D-2310-10 90c36d60-f8f2-4bf6-9f01-fc02e19dde5d 0091C6F2-FD15-487C-84F8-427B9143DE90 TCGA-KL-8326-01 TCGA-KL-8326-01A-11D-2310-10 90c36d60-f8f2-4bf6-9f01-fc02e19dde5d TCGA-KL-8326-01 90c36d60-f8f2-4bf6-9f01-fc02e19dde5d TCGA-KL-8326-01A-11D-2312-05 TCGA-KL-8326-01A-11D-2310-10 TCGA-KL-8326-01 TCGA-KL-8326-01A-11D-2308-01
7
+ TCGA-KL-8326-11 TCGA-KL-8326-11 TCGA-KL-8326 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 69 TCGA-KL-8326-F33952 TCGA-KL-8326 TCGA-KL-8326-11A -25267 0 3322 Scheduled Follow-up Submission 2012-7-24 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.4 NO Right 2.3 YES 14 NO 0 No M0 N0 T3a Stage III 8326 TUMOR FREE Normal YES NO Solid Tissue Normal 11 Low 0.4 5th NO NO YES KL 1 Kidney A LIVING Elevated 2001 34864a18-2c95-4cbd-9f73-405a38f6d37e 34864a18-2c95-4cbd-9f73-405a38f6d37e TCGA-KL-8326-11 34864a18-2c95-4cbd-9f73-405a38f6d37e 34864a18-2c95-4cbd-9f73-405a38f6d37e TCGA-KL-8326-11
8
+ TCGA-KL-8327-01 TCGA-KL-8327-01 TCGA-KL-8327 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 46 TCGA-KL-8327-F33954 TCGA-KL-8327 TCGA-KL-8327-01A -17121 0 4169 Scheduled Follow-up Submission 2012-7-24 FEMALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.1 NO Right 1.7 3 NO 0 No M0 N0 T1b Stage I TCGA-KL-8327.527b9836-1e08-48d7-bf13-cd58a0ac6318.pdf 8327 TUMOR FREE Normal YES NO Primary Tumor 01 Low 0.8 5th NO NO YES KL 1 Kidney A LIVING Elevated 2001 TCGA-KL-8327-01 680b6b06-1331-4060-adb3-c44e862895b0 TCGA-KL-8327-01A-11D-2308-01 TCGA-KL-8327-01A-11D-2310-10 680b6b06-1331-4060-adb3-c44e862895b0 0EB074D4-E15C-418A-A3D3-4E3071E06639 TCGA-KL-8327-01 TCGA-KL-8327-01A-11D-2310-10 680b6b06-1331-4060-adb3-c44e862895b0 TCGA-KL-8327-01 680b6b06-1331-4060-adb3-c44e862895b0 TCGA-KL-8327-01A-11D-2312-05 TCGA-KL-8327-01A-11D-2310-10 TCGA-KL-8327-01 TCGA-KL-8327-01A-11D-2308-01
9
+ TCGA-KL-8328-01 TCGA-KL-8328-01 TCGA-KL-8328 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 60 TCGA-KL-8328-F32696 TCGA-KL-8328 TCGA-KL-8328-01A -21976 0 3127 Scheduled Follow-up Submission 2012-6-7 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 2.2 NO Left 2.2 NO 4 NO 0 Yes, History of Prior Malignancy M0 N0 T2b Stage II TCGA-KL-8328.aed25fd2-56a8-4b87-8351-82ec4a7ac271.pdf 8328 TUMOR FREE Normal YES NO Primary Tumor 01 Low 0.2 6th NO NO YES KL 1 Kidney A LIVING Normal 2003 TCGA-KL-8328-01 777339be-465d-4877-9f73-6c49b9326e73 TCGA-KL-8328-01A-11D-2308-01 TCGA-KL-8328-01A-11D-2310-10 777339be-465d-4877-9f73-6c49b9326e73 D3354669-11F9-4869-8750-AA4A24AB65D4 TCGA-KL-8328-01 TCGA-KL-8328-01A-11D-2310-10 777339be-465d-4877-9f73-6c49b9326e73 TCGA-KL-8328-01 777339be-465d-4877-9f73-6c49b9326e73 TCGA-KL-8328-01A-11D-2312-05 TCGA-KL-8328-01A-11D-2310-10 TCGA-KL-8328-01 TCGA-KL-8328-01A-11D-2308-01
10
+ TCGA-KL-8329-01 TCGA-KL-8329-01 TCGA-KL-8329 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 57 TCGA-KL-8329-F33944 TCGA-KL-8329 TCGA-KL-8329-01A -20972 0 2752 Scheduled Follow-up Submission 2012-7-24 FEMALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 2 NO Left 2.5 1 NO 0 No M0 N0 T1b Stage I TCGA-KL-8329.86e6cf70-83ee-4701-8f54-52a56ba8c83e.pdf 8329 TUMOR FREE Normal YES NO Primary Tumor 01 Low 0.3 6th NO NO YES KL 1 Kidney A LIVING Elevated 2003 TCGA-KL-8329-01 e5ea7704-6e27-4c1e-878e-1bcc809cbf2b TCGA-KL-8329-01A-11D-2308-01 TCGA-KL-8329-01A-11D-2310-10 e5ea7704-6e27-4c1e-878e-1bcc809cbf2b ED6E126E-4824-4D06-8ED9-6B002D5DF3CB TCGA-KL-8329-01 TCGA-KL-8329-01A-11D-2310-10 e5ea7704-6e27-4c1e-878e-1bcc809cbf2b TCGA-KL-8329-01 e5ea7704-6e27-4c1e-878e-1bcc809cbf2b TCGA-KL-8329-01A-11D-2312-05 TCGA-KL-8329-01A-11D-2310-10 TCGA-KL-8329-01 TCGA-KL-8329-01A-11D-2308-01
11
+ TCGA-KL-8329-11 TCGA-KL-8329-11 TCGA-KL-8329 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 57 TCGA-KL-8329-F33944 TCGA-KL-8329 TCGA-KL-8329-11A -20972 0 2752 Scheduled Follow-up Submission 2012-7-24 FEMALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.1 NO Left 1.6 1 NO 0 No M0 N0 T1b Stage I 8329 TUMOR FREE Normal YES NO Solid Tissue Normal 11 Low 0.4 6th NO NO YES KL 1 Kidney A LIVING Elevated 2003 7af273bb-bede-495c-8a07-0a1d5d23a0eb 7af273bb-bede-495c-8a07-0a1d5d23a0eb TCGA-KL-8329-11 7af273bb-bede-495c-8a07-0a1d5d23a0eb 7af273bb-bede-495c-8a07-0a1d5d23a0eb TCGA-KL-8329-11
12
+ TCGA-KL-8330-01 TCGA-KL-8330-01 TCGA-KL-8330 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 44 TCGA-KL-8330-F33988 TCGA-KL-8330 TCGA-KL-8330-01A -16250 0 3304 Scheduled Follow-up Submission 2012-7-24 FEMALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1 NO Right 1.6 8 NO 0 35 No M0 N0 T2b Stage II TCGA-KL-8330.1e3df59f-dd7c-4718-be8b-ce7c0adce23c.pdf 8330 TUMOR FREE Elevated YES NO Primary Tumor 01 Low 0.6 6th NO NO YES KL 2 Kidney A LIVING Elevated 2003 1977 TCGA-KL-8330-01 ab48f18b-485b-4258-9940-b8b536bd2d04 TCGA-KL-8330-01A-11D-2308-01 TCGA-KL-8330-01A-11D-2310-10 ab48f18b-485b-4258-9940-b8b536bd2d04 5EAF08E3-2DCE-407B-ADC3-7559350A070D TCGA-KL-8330-01 TCGA-KL-8330-01A-11D-2310-10 ab48f18b-485b-4258-9940-b8b536bd2d04 TCGA-KL-8330-01 ab48f18b-485b-4258-9940-b8b536bd2d04 TCGA-KL-8330-01A-11D-2312-05 TCGA-KL-8330-01A-11D-2310-10 TCGA-KL-8330-01 TCGA-KL-8330-01A-11D-2308-01
13
+ TCGA-KL-8331-01 TCGA-KL-8331-01 TCGA-KL-8331 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 48 TCGA-KL-8331-F33956 TCGA-KL-8331 TCGA-KL-8331-01A -17710 0 3010 Scheduled Follow-up Submission 2012-7-24 FEMALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1 NO Right 1.8 15 NO 0 No M0 N0 T2 Stage II TCGA-KL-8331.13b03f3f-1ca6-49c2-b6a6-d935e98446bc.pdf 8331 TUMOR FREE Normal YES NO Primary Tumor 01 Low 0.3 6th NO NO YES KL 1 Kidney A LIVING Elevated 2004 TCGA-KL-8331-01 97fd79a1-7275-47c2-bd10-b62eb0622856 TCGA-KL-8331-01A-11D-2308-01 TCGA-KL-8331-01A-11D-2310-10 97fd79a1-7275-47c2-bd10-b62eb0622856 F330371D-27E7-41E6-8EE3-F165E8176337 TCGA-KL-8331-01 TCGA-KL-8331-01A-11D-2310-10 97fd79a1-7275-47c2-bd10-b62eb0622856 TCGA-KL-8331-01 97fd79a1-7275-47c2-bd10-b62eb0622856 TCGA-KL-8331-01A-11D-2312-05 TCGA-KL-8331-01A-11D-2310-10 TCGA-KL-8331-01 TCGA-KL-8331-01A-11D-2308-01
14
+ TCGA-KL-8332-01 TCGA-KL-8332-01 TCGA-KL-8332 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 55 TCGA-KL-8332-F33961 TCGA-KL-8332 TCGA-KL-8332-01A -20128 0 2582 Scheduled Follow-up Submission 2012-7-24 MALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1 NO Right 1.7 1 NO 0 No M0 N0 T1b Stage I TCGA-KL-8332.4151b14a-435f-450d-b1df-c27c050ce39c.pdf 8332 TUMOR FREE Normal YES NO Primary Tumor 01 Low 0.8 6th NO NO YES KL 1 Kidney A LIVING Normal 2004 TCGA-KL-8332-01 d937a17b-e4a9-4299-bb8a-6147483ee11e TCGA-KL-8332-01A-11D-2308-01 TCGA-KL-8332-01A-11D-2310-10 d937a17b-e4a9-4299-bb8a-6147483ee11e 12DD5D23-F174-41CA-B3A3-619438AE1011 TCGA-KL-8332-01 TCGA-KL-8332-01A-11D-2310-10 d937a17b-e4a9-4299-bb8a-6147483ee11e TCGA-KL-8332-01 d937a17b-e4a9-4299-bb8a-6147483ee11e TCGA-KL-8332-01A-11D-2312-05 TCGA-KL-8332-01A-11D-2310-10 TCGA-KL-8332-01 TCGA-KL-8332-01A-11D-2308-01
15
+ TCGA-KL-8332-11 TCGA-KL-8332-11 TCGA-KL-8332 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 55 TCGA-KL-8332-F33961 TCGA-KL-8332 TCGA-KL-8332-11A -20128 0 2582 Scheduled Follow-up Submission 2012-7-24 MALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.6 NO Right 1.3 1 NO 0 No M0 N0 T1b Stage I 8332 TUMOR FREE Normal YES NO Solid Tissue Normal 11 Low 0.5 6th NO NO YES KL 1 Kidney A LIVING Normal 2004 4b5102ee-e3a7-4ea6-b993-853180be3e05 4b5102ee-e3a7-4ea6-b993-853180be3e05 TCGA-KL-8332-11 4b5102ee-e3a7-4ea6-b993-853180be3e05 4b5102ee-e3a7-4ea6-b993-853180be3e05 TCGA-KL-8332-11
16
+ TCGA-KL-8333-01 TCGA-KL-8333-01 TCGA-KL-8333 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney NO NO 69 TCGA-KL-8333-F33965 TCGA-KL-8333 TCGA-KL-8333-01A -25229 0 2991 Scheduled Follow-up Submission 2012-7-24 MALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.2 NO Left 1.6 NO 5 NO 0 No M0 N0 T2 Stage II TCGA-KL-8333.46b555ed-5abe-4a4d-99ad-f5bb5d46a473.pdf 8333 TUMOR FREE Normal YES NO Primary Tumor 01 Low 0.3 6th NO NO YES KL 1 Kidney A LIVING Elevated 2005 TCGA-KL-8333-01 b7b1b89b-13f9-4cae-9673-34e4c31cd3ca TCGA-KL-8333-01A-11D-2308-01 TCGA-KL-8333-01A-11D-2310-10 b7b1b89b-13f9-4cae-9673-34e4c31cd3ca 4C267C53-8AF7-460B-AC0B-C78548D4701B TCGA-KL-8333-01 TCGA-KL-8333-01A-11D-2310-10 b7b1b89b-13f9-4cae-9673-34e4c31cd3ca TCGA-KL-8333-01 b7b1b89b-13f9-4cae-9673-34e4c31cd3ca TCGA-KL-8333-01A-11D-2312-05 TCGA-KL-8333-01A-11D-2310-10 TCGA-KL-8333-01 TCGA-KL-8333-01A-11D-2308-01
17
+ TCGA-KL-8334-01 TCGA-KL-8334-01 TCGA-KL-8334 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 37 TCGA-KL-8334-F33950 TCGA-KL-8334 TCGA-KL-8334-01A -13602 0 2949 Scheduled Follow-up Submission 2012-7-24 FEMALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1 NO Left 2 NO 6 NO 0 No M0 N0 T3a Stage III TCGA-KL-8334.50ac65a3-8395-4da3-b4e5-f4a2df9414b7.pdf 8334 TUMOR FREE Normal YES NO Primary Tumor 01 Low 0.4 6th NO NO YES KL 1 Kidney A LIVING Elevated 2005 TCGA-KL-8334-01 733eaed2-1df1-4832-bc6a-a401b1021795 TCGA-KL-8334-01A-11D-2308-01 TCGA-KL-8334-01A-11D-2310-10 733eaed2-1df1-4832-bc6a-a401b1021795 72C6DAC6-C37B-413D-960D-2AFD0EE420C9 TCGA-KL-8334-01 TCGA-KL-8334-01A-11D-2310-10 733eaed2-1df1-4832-bc6a-a401b1021795 TCGA-KL-8334-01 733eaed2-1df1-4832-bc6a-a401b1021795 TCGA-KL-8334-01A-11D-2312-05 TCGA-KL-8334-01A-11D-2310-10 TCGA-KL-8334-01 TCGA-KL-8334-01A-11D-2308-01
18
+ TCGA-KL-8335-01 TCGA-KL-8335-01 TCGA-KL-8335 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 67 TCGA-KL-8335-F33959 TCGA-KL-8335 TCGA-KL-8335-01A -24832 0 2815 Scheduled Follow-up Submission 2012-7-24 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.2 NO Left 2 NO 8 NO 0 27 No M0 N0 T3a Stage III TCGA-KL-8335.c0288dc5-8075-4d1c-a0d4-25c8a72eeaf4.pdf 8335 TUMOR FREE Normal YES NO Primary Tumor 01 Low 0.8 1979 6th NO NO YES KL 3 Kidney A LIVING Normal 2005 1961 TCGA-KL-8335-01 1e9eb42f-6c0c-4bfe-8ffe-f300d2700697 TCGA-KL-8335-01A-11D-2308-01 TCGA-KL-8335-01A-11D-2310-10 1e9eb42f-6c0c-4bfe-8ffe-f300d2700697 9196399E-FE16-4A15-9EF9-1612472A300E TCGA-KL-8335-01 TCGA-KL-8335-01A-11D-2310-10 1e9eb42f-6c0c-4bfe-8ffe-f300d2700697 TCGA-KL-8335-01 1e9eb42f-6c0c-4bfe-8ffe-f300d2700697 TCGA-KL-8335-01A-11D-2312-05 TCGA-KL-8335-01A-11D-2310-10 TCGA-KL-8335-01 TCGA-KL-8335-01A-11D-2308-01
19
+ TCGA-KL-8336-01 TCGA-KL-8336-01 TCGA-KL-8336 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney YES NO NO 51 TCGA-KL-8336-F33937 TCGA-KL-8336 TCGA-KL-8336-01A -18821 920 0 817 Additional New Tumor Event 2012-7-24 FEMALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1 NO Right 2 26 YES 4 No M0 N2 T3b Stage IV TCGA-KL-8336.3ed070a2-cc04-451c-b4a1-546ce3207427.pdf 8336 WITH TUMOR Low YES NO Primary Tumor 01 Low 0.4 6th YES NO YES KL 1 Kidney A DECEASED Normal 2006 TCGA-KL-8336-01 cac2a45e-6d54-4e63-a921-3b4183b8677a TCGA-KL-8336-01A-11D-2308-01 TCGA-KL-8336-01A-11D-2310-10 cac2a45e-6d54-4e63-a921-3b4183b8677a FD5223E0-DF06-460F-BA0E-998E5788CEAF TCGA-KL-8336-01 TCGA-KL-8336-01A-11D-2310-10 cac2a45e-6d54-4e63-a921-3b4183b8677a TCGA-KL-8336-01 cac2a45e-6d54-4e63-a921-3b4183b8677a TCGA-KL-8336-01A-11D-2312-05 TCGA-KL-8336-01A-11D-2310-10 TCGA-KL-8336-01 TCGA-KL-8336-01A-11D-2308-01
20
+ TCGA-KL-8336-11 TCGA-KL-8336-11 TCGA-KL-8336 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney YES NO NO 51 TCGA-KL-8336-F33937 TCGA-KL-8336 -18821 920 0 817 Additional New Tumor Event 2012-7-24 FEMALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES Right 26 YES 4 No M0 N2 T3b Stage IV 8336 WITH TUMOR Low YES NO Solid Tissue Normal 11 Low 6th YES NO YES KL 1 Kidney DECEASED Normal 2006 cc2d2364-0f6a-4387-8b01-41402bfa15ee cc2d2364-0f6a-4387-8b01-41402bfa15ee TCGA-KL-8336-11 cc2d2364-0f6a-4387-8b01-41402bfa15ee cc2d2364-0f6a-4387-8b01-41402bfa15ee TCGA-KL-8336-11
21
+ TCGA-KL-8337-01 TCGA-KL-8337-01 TCGA-KL-8337 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 26 TCGA-KL-8337-F33991 TCGA-KL-8337 TCGA-KL-8337-01A -9819 0 1364 Scheduled Follow-up Submission 2012-7-24 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.7 NO Right 2.4 YES 1 NO 0 No M0 N0 T2 Stage II TCGA-KL-8337.83b8b92e-2989-47c1-9ced-6614f63b8caa.pdf 8337 TUMOR FREE Normal YES NO Primary Tumor 01 Low 0.4 6th NO NO YES KL 1 Kidney A LIVING Normal 2006 TCGA-KL-8337-01 44b567d8-025b-4f5b-80aa-4e19c6a6afc7 TCGA-KL-8337-01A-11D-2308-01 TCGA-KL-8337-01A-11D-2310-10 44b567d8-025b-4f5b-80aa-4e19c6a6afc7 FC7DB766-86C5-4D4C-8B29-354781D78DF7 TCGA-KL-8337-01 TCGA-KL-8337-01A-11D-2310-10 44b567d8-025b-4f5b-80aa-4e19c6a6afc7 TCGA-KL-8337-01 44b567d8-025b-4f5b-80aa-4e19c6a6afc7 TCGA-KL-8337-01A-11D-2312-05 TCGA-KL-8337-01A-11D-2310-10 TCGA-KL-8337-01 TCGA-KL-8337-01A-11D-2308-01
22
+ TCGA-KL-8338-01 TCGA-KL-8338-01 TCGA-KL-8338 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 51 TCGA-KL-8338-F33993 TCGA-KL-8338 TCGA-KL-8338-01A -18667 0 2633 Scheduled Follow-up Submission 2012-7-24 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1 NO Left 1.5 6 NO 0 No M0 N0 T3a Stage III TCGA-KL-8338.c7322e2d-4068-49aa-b8e0-d4fd1b2cdba0.pdf 8338 TUMOR FREE Normal YES NO Primary Tumor 01 Low 0.5 6th NO NO YES KL 1 Kidney A LIVING Elevated 2006 TCGA-KL-8338-01 c8506a16-e3ac-445d-bd12-65adf10e813f TCGA-KL-8338-01A-11D-2308-01 TCGA-KL-8338-01A-11D-2310-10 c8506a16-e3ac-445d-bd12-65adf10e813f 68949EA4-7DEC-4EB2-8D97-E1260D8D4791 TCGA-KL-8338-01 TCGA-KL-8338-01A-11D-2310-10 c8506a16-e3ac-445d-bd12-65adf10e813f TCGA-KL-8338-01 c8506a16-e3ac-445d-bd12-65adf10e813f TCGA-KL-8338-01A-11D-2312-05 TCGA-KL-8338-01A-11D-2310-10 TCGA-KL-8338-01 TCGA-KL-8338-01A-11D-2308-01
23
+ TCGA-KL-8339-01 TCGA-KL-8339-01 TCGA-KL-8339 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney NO NO NO 67 TCGA-KL-8339-F32703 TCGA-KL-8339 TCGA-KL-8339-01A -24545 855 0 363 Additional New Tumor Event 2012-6-7 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.5 NO Left 2 NO 33 YES 1 Yes, History of Prior Malignancy M1 N1 T3a Stage IV TCGA-KL-8339.73432cd8-3edc-42d2-acd6-09c1e72e81f7.pdf 8339 WITH TUMOR Normal YES NO Primary Tumor 01 Low 0.5 6th YES NO YES KL 5 Kidney A DECEASED Elevated 2006 TCGA-KL-8339-01 c2a7dae3-028c-4434-b7f1-07dafe196acf TCGA-KL-8339-01A-11D-2308-01 TCGA-KL-8339-01A-11D-2310-10 c2a7dae3-028c-4434-b7f1-07dafe196acf E6CD4BBA-4A4E-453C-967C-E0F9DFC17668 TCGA-KL-8339-01 TCGA-KL-8339-01A-11D-2310-10 c2a7dae3-028c-4434-b7f1-07dafe196acf TCGA-KL-8339-01 c2a7dae3-028c-4434-b7f1-07dafe196acf TCGA-KL-8339-01A-11D-2312-05 TCGA-KL-8339-01A-11D-2310-10 TCGA-KL-8339-01 TCGA-KL-8339-01A-11D-2308-01
24
+ TCGA-KL-8339-11 TCGA-KL-8339-11 TCGA-KL-8339 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney NO NO NO 67 TCGA-KL-8339-F32703 TCGA-KL-8339 -24545 855 0 363 Additional New Tumor Event 2012-6-7 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES Left NO 33 YES 1 Yes, History of Prior Malignancy M1 N1 T3a Stage IV 8339 WITH TUMOR Normal YES NO Solid Tissue Normal 11 Low 6th YES NO YES KL 5 Kidney DECEASED Elevated 2006 ce000792-03e1-4f52-b65c-046b2b504cf1 ce000792-03e1-4f52-b65c-046b2b504cf1 TCGA-KL-8339-11 ce000792-03e1-4f52-b65c-046b2b504cf1 ce000792-03e1-4f52-b65c-046b2b504cf1 TCGA-KL-8339-11
25
+ TCGA-KL-8340-01 TCGA-KL-8340-01 TCGA-KL-8340 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 34 TCGA-KL-8340-F33995 TCGA-KL-8340 TCGA-KL-8340-01A -12696 0 2024 Scheduled Follow-up Submission 2012-7-24 MALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.2 NO Right 1.5 13 NO 0 No M0 N0 T2 Stage II TCGA-KL-8340.30d105d6-26a7-4e14-a7fe-d2c3660d3d13.pdf 8340 TUMOR FREE Normal YES NO Primary Tumor 01 Normal 0.7 6th NO NO YES KL 1 Kidney A LIVING Elevated 2006 TCGA-KL-8340-01 102bbfea-fb71-41c8-899d-75670fda81e8 TCGA-KL-8340-01A-11D-2308-01 TCGA-KL-8340-01A-11D-2310-10 102bbfea-fb71-41c8-899d-75670fda81e8 2BD65C1F-D4F4-4A82-96A8-8863D3534E26 TCGA-KL-8340-01 TCGA-KL-8340-01A-11D-2310-10 102bbfea-fb71-41c8-899d-75670fda81e8 TCGA-KL-8340-01 102bbfea-fb71-41c8-899d-75670fda81e8 TCGA-KL-8340-01A-11D-2312-05 TCGA-KL-8340-01A-11D-2310-10 TCGA-KL-8340-01 TCGA-KL-8340-01A-11D-2308-01
26
+ TCGA-KL-8341-01 TCGA-KL-8341-01 TCGA-KL-8341 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney YES NO NO 41 TCGA-KL-8341-F33921 TCGA-KL-8341 TCGA-KL-8341-01A -15045 754 0 616 Additional New Tumor Event 2012-7-24 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.5 NO Left 2 30 YES 2 10 No M0 N2 T3b Stage IV TCGA-KL-8341.1db5a796-25f1-4a8c-b88c-08b5391ffe1e.pdf 8341 WITH TUMOR Normal YES NO Primary Tumor 01 Low 0.5 2006 6th YES NO YES KL 4 Kidney A DECEASED Normal 2006 1986 TCGA-KL-8341-01 ca134742-0f02-4178-b1bf-c6f7a9ff8cce TCGA-KL-8341-01A-11D-2308-01 TCGA-KL-8341-01A-11D-2310-10 ca134742-0f02-4178-b1bf-c6f7a9ff8cce DB47DCFA-AFF0-4F4F-8415-8F3AF88D51E4 TCGA-KL-8341-01 TCGA-KL-8341-01A-11D-2310-10 ca134742-0f02-4178-b1bf-c6f7a9ff8cce TCGA-KL-8341-01 ca134742-0f02-4178-b1bf-c6f7a9ff8cce TCGA-KL-8341-01A-11D-2312-05 TCGA-KL-8341-01A-11D-2310-10 TCGA-KL-8341-01 TCGA-KL-8341-01A-11D-2308-01
27
+ TCGA-KL-8342-01 TCGA-KL-8342-01 TCGA-KL-8342 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 45 TCGA-KL-8342-F33974 TCGA-KL-8342 TCGA-KL-8342-01A -16550 0 2248 Scheduled Follow-up Submission 2012-7-24 FEMALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1 NO Left 1.5 9 NO 0 No M0 N0 T2b Stage II TCGA-KL-8342.ac7b5dcd-a2ba-4bb7-8bd8-d5eb0b9e01e8.pdf 8342 TUMOR FREE Normal YES NO Primary Tumor 01 Low 0.3 6th NO NO YES KL 1 Kidney A LIVING Elevated 2006 TCGA-KL-8342-01 baa1261d-78ae-4a47-8459-2513361ba6de TCGA-KL-8342-01A-11D-2308-01 TCGA-KL-8342-01A-11D-2310-10 baa1261d-78ae-4a47-8459-2513361ba6de 388FE5EA-DB24-4319-9AEF-1A42EC591569 TCGA-KL-8342-01 TCGA-KL-8342-01A-11D-2310-10 baa1261d-78ae-4a47-8459-2513361ba6de TCGA-KL-8342-01 baa1261d-78ae-4a47-8459-2513361ba6de TCGA-KL-8342-01A-11D-2312-05 TCGA-KL-8342-01A-11D-2310-10 TCGA-KL-8342-01 TCGA-KL-8342-01A-11D-2308-01
28
+ TCGA-KL-8343-01 TCGA-KL-8343-01 TCGA-KL-8343 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 72 TCGA-KL-8343-F33978 TCGA-KL-8343 TCGA-KL-8343-01A -26562 2172 0 1815 Scheduled Follow-up Submission 2012-7-24 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.2 NO Right 1.5 6 NO 0 No M0 N0 T3 Stage III TCGA-KL-8343.3a3ecff1-7ee1-475b-8482-aa576affe1ac.pdf 8343 WITH TUMOR Normal YES NO Primary Tumor 01 Low 0.1 6th NO NO YES KL 1 Kidney A DECEASED Elevated 2007 TCGA-KL-8343-01 131cd009-c2f2-4e38-a72d-2018af79986a TCGA-KL-8343-01A-11D-2308-01 TCGA-KL-8343-01A-11D-2310-10 131cd009-c2f2-4e38-a72d-2018af79986a E571E8F0-BA96-4054-BBA9-DCD405B68A17 TCGA-KL-8343-01 TCGA-KL-8343-01A-11D-2310-10 131cd009-c2f2-4e38-a72d-2018af79986a TCGA-KL-8343-01 131cd009-c2f2-4e38-a72d-2018af79986a TCGA-KL-8343-01A-11D-2312-05 TCGA-KL-8343-01A-11D-2310-10 TCGA-KL-8343-01 TCGA-KL-8343-01A-11D-2308-01
29
+ TCGA-KL-8344-01 TCGA-KL-8344-01 TCGA-KL-8344 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 51 TCGA-KL-8344-F33982 TCGA-KL-8344 TCGA-KL-8344-01A -18742 0 876 Scheduled Follow-up Submission 2012-7-24 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.6 NO Right 2.1 15 NO 0 No M0 N0 T3a Stage III TCGA-KL-8344.c4304ef6-2f5a-4aab-88ad-8d5cc721a04e.pdf 8344 TUMOR FREE Elevated YES NO Primary Tumor 01 Low 0.5 6th NO NO YES KL 1 Kidney A LIVING Elevated 2007 TCGA-KL-8344-01 5cb8881d-dc6e-4b62-b9a3-d96c83d2567e TCGA-KL-8344-01A-11D-2308-01 TCGA-KL-8344-01A-11D-2310-10 5cb8881d-dc6e-4b62-b9a3-d96c83d2567e 66E98635-322D-4F6C-82AF-F44732E36806 TCGA-KL-8344-01 TCGA-KL-8344-01A-11D-2310-10 5cb8881d-dc6e-4b62-b9a3-d96c83d2567e TCGA-KL-8344-01 5cb8881d-dc6e-4b62-b9a3-d96c83d2567e TCGA-KL-8344-01A-11D-2312-05 TCGA-KL-8344-01A-11D-2310-10 TCGA-KL-8344-01 TCGA-KL-8344-01A-11D-2308-01
30
+ TCGA-KL-8345-01 TCGA-KL-8345-01 TCGA-KL-8345 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 75 TCGA-KL-8345-F33984 TCGA-KL-8345 TCGA-KL-8345-01A -27412 0 1665 Scheduled Follow-up Submission 2012-7-24 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.2 NO Right 2 13 NO 0 6 No M0 N0 T3a Stage III TCGA-KL-8345.5f84d5ac-c1d1-4009-95ff-b0ae508a1b2a.pdf 8345 TUMOR FREE Normal YES NO Primary Tumor 01 Low 0.2 1955 6th NO NO YES KL 3 Kidney A LIVING Elevated 2008 1949 TCGA-KL-8345-01 182a5fad-d6f5-4656-b198-aceb2ac081d1 TCGA-KL-8345-01A-11D-2308-01 TCGA-KL-8345-01A-11D-2310-10 182a5fad-d6f5-4656-b198-aceb2ac081d1 65D6EAC3-4280-4121-AB88-4DAA29FB51EA TCGA-KL-8345-01 TCGA-KL-8345-01A-11D-2310-10 182a5fad-d6f5-4656-b198-aceb2ac081d1 TCGA-KL-8345-01 182a5fad-d6f5-4656-b198-aceb2ac081d1 TCGA-KL-8345-01A-11D-2312-05 TCGA-KL-8345-01A-11D-2310-10 TCGA-KL-8345-01 TCGA-KL-8345-01A-11D-2308-01
31
+ TCGA-KL-8346-01 TCGA-KL-8346-01 TCGA-KL-8346 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 62 TCGA-KL-8346-F33986 TCGA-KL-8346 TCGA-KL-8346-01A -22651 0 1897 Scheduled Follow-up Submission 2012-7-24 MALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.8 NO Right 1 1 NO 0 No M0 N0 T2b Stage II TCGA-KL-8346.36d69d54-a29d-43ef-ab2f-4d24f62a9e2e.pdf 8346 TUMOR FREE Normal YES NO Primary Tumor 01 Normal 0.4 6th NO NO YES KL 1 Kidney A LIVING Elevated 2008 TCGA-KL-8346-01 7e8e0292-b1af-48af-9c53-823d7e0432c9 TCGA-KL-8346-01A-11D-2308-01 TCGA-KL-8346-01A-11D-2310-10 7e8e0292-b1af-48af-9c53-823d7e0432c9 D64F1B2E-E3BE-453E-B451-157115A1AC8D TCGA-KL-8346-01 TCGA-KL-8346-01A-11D-2310-10 7e8e0292-b1af-48af-9c53-823d7e0432c9 TCGA-KL-8346-01 7e8e0292-b1af-48af-9c53-823d7e0432c9 TCGA-KL-8346-01A-11D-2312-05 TCGA-KL-8346-01A-11D-2310-10 TCGA-KL-8346-01 TCGA-KL-8346-01A-11D-2308-01
32
+ TCGA-KM-8438-01 TCGA-KM-8438-01 TCGA-KM-8438 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney YES NO NO NO 45 TCGA-KM-8438-F39554 TCGA-KM-8438 TCGA-KM-8438-01A MX -16683 0 4622 4622 1 Scheduled Follow-up Submission Stable Disease 2013-1-30 FEMALE Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.8 NO 80 Left 1.8 YES 5 YES 0 No MX N0 T2 Stage II TCGA-KM-8438.e26cb4d8-057e-43ce-9733-6c2b31e02c58.pdf 8438 Other WITH TUMOR YES YES Complete Remission/Response NO Primary Tumor 01 0.5 5th NO NO YES KM 1 Kidney A LIVING 2000 TCGA-KM-8438-01 894cd09b-645d-43b8-93ea-5f7f48db12da TCGA-KM-8438-01A-11D-2308-01 TCGA-KM-8438-01A-11D-2310-10 894cd09b-645d-43b8-93ea-5f7f48db12da A856C87F-DBB5-4621-89D3-CE7A1DE400B8 TCGA-KM-8438-01 TCGA-KM-8438-01A-11D-2310-10 894cd09b-645d-43b8-93ea-5f7f48db12da TCGA-KM-8438-01 894cd09b-645d-43b8-93ea-5f7f48db12da TCGA-KM-8438-01A-11D-2312-05 TCGA-KM-8438-01A-11D-2310-10 TCGA-KM-8438-01 TCGA-KM-8438-01A-11D-2308-01
33
+ TCGA-KM-8439-01 TCGA-KM-8439-01 TCGA-KM-8439 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 30 TCGA-KM-8439-F52741 TCGA-KM-8439 TCGA-KM-8439-01A MX -11266 0 708 0 Scheduled Follow-up Submission Partial Remission/Response 2013-12-5 MALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.2 NO 100 Normal Left 2 NO NO Yes, History of Synchronous/Bilateral Malignancy MX NX T1b Stage I TCGA-KM-8439.174672ef-6475-44c2-9934-8726b8e5e98e.pdf 8439 Other WITH TUMOR Normal NO NO Partial Remission/Response NO Primary Tumor 01 Normal 0.5 7th NO NO YES KM 1 Kidney A LIVING Normal 2011 TCGA-KM-8439-01 e03cb807-3698-434e-8145-6f1620bfd1b4 TCGA-KM-8439-01A-11D-2308-01 TCGA-KM-8439-01A-11D-2310-10 e03cb807-3698-434e-8145-6f1620bfd1b4 DA549418-5787-4588-B669-5086506C9046 TCGA-KM-8439-01 TCGA-KM-8439-01A-11D-2310-10 e03cb807-3698-434e-8145-6f1620bfd1b4 TCGA-KM-8439-01 e03cb807-3698-434e-8145-6f1620bfd1b4 TCGA-KM-8439-01A-11D-2312-05 TCGA-KM-8439-01A-11D-2310-10 TCGA-KM-8439-01 TCGA-KM-8439-01A-11D-2308-01
34
+ TCGA-KM-8440-01 TCGA-KM-8440-01 TCGA-KM-8440 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 37 TCGA-KM-8440-F52739 TCGA-KM-8440 TCGA-KM-8440-01A MX -13860 0 1366 0 Scheduled Follow-up Submission Complete Remission/Response 2013-12-5 MALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1 NO 100 Normal Left 1.5 NO NO No MX NX T3a Stage III TCGA-KM-8440.e300318d-e9e2-44f3-86dd-75b42c91b5c5.pdf 8440 Other TUMOR FREE Normal NO NO Complete Remission/Response NO Primary Tumor 01 Normal 0.6 6th NO NO YES KM 1 Kidney A LIVING Normal 2009 TCGA-KM-8440-01 fd4eb5ce-47b3-4c31-b9c5-ca08b3f580db TCGA-KM-8440-01A-11D-2308-01 TCGA-KM-8440-01A-11D-2310-10 fd4eb5ce-47b3-4c31-b9c5-ca08b3f580db F56A0073-6A63-4745-9E77-B31F211F71DA TCGA-KM-8440-01 TCGA-KM-8440-01A-11D-2310-10 fd4eb5ce-47b3-4c31-b9c5-ca08b3f580db TCGA-KM-8440-01 fd4eb5ce-47b3-4c31-b9c5-ca08b3f580db TCGA-KM-8440-01A-11D-2312-05 TCGA-KM-8440-01A-11D-2310-10 TCGA-KM-8440-01 TCGA-KM-8440-01A-11D-2308-01
35
+ TCGA-KM-8441-01 TCGA-KM-8441-01 TCGA-KM-8441 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney NO NO NO NO 61 TCGA-KM-8441-F64824 TCGA-KM-8441 TCGA-KM-8441-01A MX -22303 0 876 876 1 Scheduled Follow-up Submission Partial Remission/Response 2014-9-17 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.8 NO 90 Right 1.2 NO YES Yes, History of Prior Malignancy MX NX T1b Stage I TCGA-KM-8441.bf0ad8a6-436d-4a8f-b89e-93f2d78fe9af.pdf 8441 Other WITH TUMOR Normal NO NO Complete Remission/Response NO Primary Tumor 01 Normal 0.2 7th NO NO YES KM 1 Kidney A LIVING Normal 2011 TCGA-KM-8441-01 93543d44-72a0-4f35-bc35-3acffc85ced6 TCGA-KM-8441-01A-11D-2308-01 TCGA-KM-8441-01A-11D-2310-10 93543d44-72a0-4f35-bc35-3acffc85ced6 26B6714C-8CDB-41A2-8EA6-A7229FBAAABB TCGA-KM-8441-01 TCGA-KM-8441-01A-11D-2310-10 93543d44-72a0-4f35-bc35-3acffc85ced6 TCGA-KM-8441-01 93543d44-72a0-4f35-bc35-3acffc85ced6 TCGA-KM-8441-01A-11D-2312-05 TCGA-KM-8441-01A-11D-2310-10 TCGA-KM-8441-01 TCGA-KM-8441-01A-11D-2308-01
36
+ TCGA-KM-8442-01 TCGA-KM-8442-01 TCGA-KM-8442 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 38 TCGA-KM-8442-F52737 TCGA-KM-8442 TCGA-KM-8442-01A MX -14212 0 1437 0 Scheduled Follow-up Submission Complete Remission/Response 2013-12-5 MALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.5 NO 90 Normal Right 1.5 NO NO Yes, History of Synchronous/Bilateral Malignancy MX NX T2 Stage II TCGA-KM-8442.7b12ca00-9cce-46bd-8da0-203fc698d64d.pdf 8442 Other TUMOR FREE Normal NO NO Partial Remission/Response NO Primary Tumor 01 Normal 0.5 6th NO NO YES KM 1 Kidney A LIVING Normal 2009 TCGA-KM-8442-01 efc2a8d3-1ef2-4719-b60d-bd752edda684 TCGA-KM-8442-01A-11D-2308-01 TCGA-KM-8442-01A-11D-2310-10 efc2a8d3-1ef2-4719-b60d-bd752edda684 01ED109C-478B-41E6-9EC6-13377C9A79C1 TCGA-KM-8442-01 TCGA-KM-8442-01A-11D-2310-10 efc2a8d3-1ef2-4719-b60d-bd752edda684 TCGA-KM-8442-01 efc2a8d3-1ef2-4719-b60d-bd752edda684 TCGA-KM-8442-01A-11D-2312-05 TCGA-KM-8442-01A-11D-2310-10 TCGA-KM-8442-01 TCGA-KM-8442-01A-11D-2308-01
37
+ TCGA-KM-8443-01 TCGA-KM-8443-01 TCGA-KM-8443 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 57 TCGA-KM-8443-F52728 TCGA-KM-8443 TCGA-KM-8443-01A MX -21183 0 1520 0 Scheduled Follow-up Submission Complete Remission/Response 2013-12-5 MALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.2 NO 100 Low Right 1.2 NO 2 NO 0 No MX N0 T2 Stage II TCGA-KM-8443.1bea0219-8760-4808-b36b-08616599a76d.pdf 8443 Other TUMOR FREE Elevated NO YES Complete Remission/Response NO Primary Tumor 01 Elevated 0.3 6th NO NO YES KM Kidney A LIVING Normal 2009 TCGA-KM-8443-01 114b9dbd-0672-4b83-8bdc-cc2432f4fd91 TCGA-KM-8443-01A-11D-2308-01 TCGA-KM-8443-01A-11D-2310-10 114b9dbd-0672-4b83-8bdc-cc2432f4fd91 FBE09C4C-5E45-4842-8827-FECA70AFB340 TCGA-KM-8443-01 TCGA-KM-8443-01A-11D-2310-10 114b9dbd-0672-4b83-8bdc-cc2432f4fd91 TCGA-KM-8443-01 114b9dbd-0672-4b83-8bdc-cc2432f4fd91 TCGA-KM-8443-01A-11D-2312-05 TCGA-KM-8443-01A-11D-2310-10 TCGA-KM-8443-01 TCGA-KM-8443-01A-11D-2308-01
38
+ TCGA-KM-8476-01 TCGA-KM-8476-01 TCGA-KM-8476 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 47 TCGA-KM-8476-F52733 TCGA-KM-8476 TCGA-KM-8476-01A MX -17240 0 3745 1 2013-12-5 MALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.7 NO 90 Right 1.1 YES NO No MX NX T1 Stage I TCGA-KM-8476.4721ab86-f4fa-43d9-a4ae-0be5814335de.pdf 8476 Other TUMOR FREE Normal NO NO Complete Remission/Response NO Primary Tumor 01 Normal 0.3 5th NO NO YES KM 1 Kidney A LIVING Normal 2002 TCGA-KM-8476-01 19f0564c-19e3-4e32-8362-750fc676f576 TCGA-KM-8476-01A-11D-2308-01 TCGA-KM-8476-01A-11D-2310-10 19f0564c-19e3-4e32-8362-750fc676f576 41E07C6F-681D-4B98-8744-DE0C675C3E62 TCGA-KM-8476-01 TCGA-KM-8476-01A-11D-2310-10 19f0564c-19e3-4e32-8362-750fc676f576 TCGA-KM-8476-01 19f0564c-19e3-4e32-8362-750fc676f576 TCGA-KM-8476-01A-11D-2312-05 TCGA-KM-8476-01A-11D-2310-10 TCGA-KM-8476-01 TCGA-KM-8476-01A-11D-2308-01
39
+ TCGA-KM-8477-01 TCGA-KM-8477-01 TCGA-KM-8477 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 56 TCGA-KM-8477-F39548 TCGA-KM-8477 MX -20491 0 1553 1 Scheduled Follow-up Submission 2013-1-24 MALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 90 Normal Right YES NO No MX NX T1a Stage I 8477 Other TUMOR FREE Normal NO NO Complete Remission/Response NO Primary Tumor 01 Normal 6th NO NO YES KM 1 Kidney LIVING Elevated 2005 TCGA-KM-8477-01 b06483d3-e2c0-4f6f-9af4-871c922eb506 TCGA-KM-8477-01A-11D-2308-01 TCGA-KM-8477-01A-11D-2310-10 b06483d3-e2c0-4f6f-9af4-871c922eb506 TCGA-KM-8477-01 TCGA-KM-8477-01A-11D-2310-10 b06483d3-e2c0-4f6f-9af4-871c922eb506 TCGA-KM-8477-01 b06483d3-e2c0-4f6f-9af4-871c922eb506 TCGA-KM-8477-01A-11D-2312-05 TCGA-KM-8477-01A-11D-2310-10 TCGA-KM-8477-01 TCGA-KM-8477-01A-11D-2308-01
40
+ TCGA-KM-8639-01 TCGA-KM-8639-01 TCGA-KM-8639 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 67 TCGA-KM-8639-F39706 TCGA-KM-8639 TCGA-KM-8639-01A MX -24640 0 953 2 Scheduled Follow-up Submission 2013-1-30 MALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.8 NO 70 Right 1.2 YES NO 20 No MX NX T1a Stage I TCGA-KM-8639.22db1914-7524-48cd-8059-af661c35c5a5.pdf 8639 Other TUMOR FREE Low NO NO Complete Remission/Response NO Primary Tumor 01 Normal 0.3 1985 6th NO NO YES KM 5 Kidney A LIVING Normal 2005 1965 TCGA-KM-8639-01 01816f78-7cee-4160-8a99-85cb23d3a124 TCGA-KM-8639-01A-11D-2389-01 TCGA-KM-8639-01A-11D-2397-10 01816f78-7cee-4160-8a99-85cb23d3a124 255776C5-C275-40A0-A55D-BB36959DFFE7 TCGA-KM-8639-01 TCGA-KM-8639-01A-11D-2397-10 01816f78-7cee-4160-8a99-85cb23d3a124 TCGA-KM-8639-01 01816f78-7cee-4160-8a99-85cb23d3a124 TCGA-KM-8639-01A-11D-2398-05 TCGA-KM-8639-01A-11D-2397-10 TCGA-KM-8639-01 TCGA-KM-8639-01A-11D-2389-01
41
+ TCGA-KN-8418-01 TCGA-KN-8418-01 TCGA-KN-8418 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 41 TCGA-KN-8418-F63065 TCGA-KN-8418 TCGA-KN-8418-01A M0 -15086 0 3935 Scheduled Follow-up Submission 2014-7-31 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.5 NO Right 1.5 YES 3 NO 0 No N0 T2 Stage II TCGA-KN-8418.5cf28de7-02eb-4cf2-82cf-6b0f6f0b6fd4.pdf 8418 TUMOR FREE Normal YES NO Primary Tumor 01 Low 0.4 5th NO NO YES KN 1 Kidney A LIVING Elevated 2002 TCGA-KN-8418-01 4421b2c6-8de1-41c3-a47a-20c60a86b694 TCGA-KN-8418-01A-11D-2308-01 TCGA-KN-8418-01A-11D-2310-10 4421b2c6-8de1-41c3-a47a-20c60a86b694 B4F19E65-F7A5-4D12-9A86-C004EBBBF793 TCGA-KN-8418-01 TCGA-KN-8418-01A-11D-2310-10 4421b2c6-8de1-41c3-a47a-20c60a86b694 TCGA-KN-8418-01 4421b2c6-8de1-41c3-a47a-20c60a86b694 TCGA-KN-8418-01A-11D-2312-05 TCGA-KN-8418-01A-11D-2310-10 TCGA-KN-8418-01 TCGA-KN-8418-01A-11D-2308-01
42
+ TCGA-KN-8419-01 TCGA-KN-8419-01 TCGA-KN-8419 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 43 TCGA-KN-8419-F63068 TCGA-KN-8419 TCGA-KN-8419-01A M0 -15769 0 714 Scheduled Follow-up Submission 2014-7-31 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.5 NO Left 2.5 YES NO No N0 T2 Stage II TCGA-KN-8419.7c6ce9a3-898a-4080-ae98-dbc9b529adb7.pdf 8419 TUMOR FREE Low NO Complete Remission/Response NO Primary Tumor 01 Low 0.8 6th NO NO YES KN Kidney A LIVING Elevated 2004 TCGA-KN-8419-01 67e21e3d-63a0-4fca-9880-58a71c938294 TCGA-KN-8419-01A-11D-2308-01 TCGA-KN-8419-01A-11D-2310-10 67e21e3d-63a0-4fca-9880-58a71c938294 B8BAEAFA-EAC6-4C06-9139-8335838F1307 TCGA-KN-8419-01 TCGA-KN-8419-01A-11D-2310-10 67e21e3d-63a0-4fca-9880-58a71c938294 TCGA-KN-8419-01 67e21e3d-63a0-4fca-9880-58a71c938294 TCGA-KN-8419-01A-11D-2312-05 TCGA-KN-8419-01A-11D-2310-10 TCGA-KN-8419-01 TCGA-KN-8419-01A-11D-2308-01
43
+ TCGA-KN-8419-11 TCGA-KN-8419-11 TCGA-KN-8419 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 43 TCGA-KN-8419-F63068 TCGA-KN-8419 TCGA-KN-8419-11A M0 -15769 0 714 Scheduled Follow-up Submission 2014-7-31 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1 NO Left 1.6 YES NO No N0 T2 Stage II 8419 TUMOR FREE Low NO Complete Remission/Response NO Solid Tissue Normal 11 Low 0.5 6th NO NO YES KN Kidney A LIVING Elevated 2004 0d5727f8-2f06-4b7e-bc23-0241d44594cc 0d5727f8-2f06-4b7e-bc23-0241d44594cc TCGA-KN-8419-11 0d5727f8-2f06-4b7e-bc23-0241d44594cc 0d5727f8-2f06-4b7e-bc23-0241d44594cc TCGA-KN-8419-11
44
+ TCGA-KN-8421-01 TCGA-KN-8421-01 TCGA-KN-8421 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 47 TCGA-KN-8421-F63132 TCGA-KN-8421 TCGA-KN-8421-01A M0 -17524 0 2674 Scheduled Follow-up Submission 2014-7-31 FEMALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1 NO Left 1 YES 2 NO 0 No N0 T2 Stage II TCGA-KN-8421.9e8f8afd-e0a0-4ae2-ab6b-30f344e372de.pdf 8421 TUMOR FREE Normal YES NO Primary Tumor 01 Low 0.6 6th NO NO YES KN Kidney A LIVING Normal 2004 TCGA-KN-8421-01 17aa0cc6-c07e-4512-8c0a-e520863a58e4 TCGA-KN-8421-01A-11D-2308-01 TCGA-KN-8421-01A-11D-2310-10 17aa0cc6-c07e-4512-8c0a-e520863a58e4 11C3165C-6F49-46B4-9A2A-82CB4256E126 TCGA-KN-8421-01 TCGA-KN-8421-01A-11D-2310-10 17aa0cc6-c07e-4512-8c0a-e520863a58e4 TCGA-KN-8421-01 17aa0cc6-c07e-4512-8c0a-e520863a58e4 TCGA-KN-8421-01A-11D-2312-05 TCGA-KN-8421-01A-11D-2310-10 TCGA-KN-8421-01 TCGA-KN-8421-01A-11D-2308-01
45
+ TCGA-KN-8422-01 TCGA-KN-8422-01 TCGA-KN-8422 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 28 TCGA-KN-8422-F63136 TCGA-KN-8422 M0 -10303 0 775 Scheduled Follow-up Submission 2014-7-31 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES Right YES 1 NO 0 No N0 T1a Stage I 8422 TUMOR FREE Normal YES Complete Remission/Response NO Primary Tumor 01 Low 2005 6th NO NO YES KN 4 Kidney LIVING Elevated 2005 TCGA-KN-8422-01 d5965538-4255-4877-88a8-9a71b5cea58c TCGA-KN-8422-01A-11D-2308-01 TCGA-KN-8422-01A-11D-2310-10 d5965538-4255-4877-88a8-9a71b5cea58c TCGA-KN-8422-01 TCGA-KN-8422-01A-11D-2310-10 d5965538-4255-4877-88a8-9a71b5cea58c TCGA-KN-8422-01 d5965538-4255-4877-88a8-9a71b5cea58c TCGA-KN-8422-01A-11D-2312-05 TCGA-KN-8422-01A-11D-2310-10 TCGA-KN-8422-01 TCGA-KN-8422-01A-11D-2308-01
46
+ TCGA-KN-8422-11 TCGA-KN-8422-11 TCGA-KN-8422 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 28 TCGA-KN-8422-F63136 TCGA-KN-8422 TCGA-KN-8422-11A M0 -10303 0 775 Scheduled Follow-up Submission 2014-7-31 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.2 NO Right 1.5 YES 1 NO 0 No N0 T1a Stage I 8422 TUMOR FREE Normal YES Complete Remission/Response NO Solid Tissue Normal 11 Low 0.4 2005 6th NO NO YES KN 4 Kidney A LIVING Elevated 2005 981a7d0e-ca01-476d-bd58-a46b8d8595cc 981a7d0e-ca01-476d-bd58-a46b8d8595cc TCGA-KN-8422-11 981a7d0e-ca01-476d-bd58-a46b8d8595cc 981a7d0e-ca01-476d-bd58-a46b8d8595cc TCGA-KN-8422-11
47
+ TCGA-KN-8423-01 TCGA-KN-8423-01 TCGA-KN-8423 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 44 TCGA-KN-8423-F63137 TCGA-KN-8423 TCGA-KN-8423-01A M0 -16335 0 788 Scheduled Follow-up Submission 2014-7-31 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.6 NO Left 1.8 YES 6 NO 0 No N0 T1b Stage I TCGA-KN-8423.d3379505-cda9-4d23-bc41-9dca06be301e.pdf 8423 TUMOR FREE Normal YES Complete Remission/Response NO Primary Tumor 01 Low 0.5 6th NO NO YES KN Kidney A LIVING Elevated 2005 TCGA-KN-8423-01 ec85470e-1f9c-46fd-87d2-02b00947abb5 TCGA-KN-8423-01A-11D-2308-01 TCGA-KN-8423-01A-11D-2310-10 ec85470e-1f9c-46fd-87d2-02b00947abb5 179BC6FA-A8C4-425C-BB54-403F1D22B0FB TCGA-KN-8423-01 TCGA-KN-8423-01A-11D-2310-10 ec85470e-1f9c-46fd-87d2-02b00947abb5 TCGA-KN-8423-01 ec85470e-1f9c-46fd-87d2-02b00947abb5 TCGA-KN-8423-01A-11D-2312-05 TCGA-KN-8423-01A-11D-2310-10 TCGA-KN-8423-01 TCGA-KN-8423-01A-11D-2308-01
48
+ TCGA-KN-8423-11 TCGA-KN-8423-11 TCGA-KN-8423 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 44 TCGA-KN-8423-F63137 TCGA-KN-8423 M0 -16335 0 788 Scheduled Follow-up Submission 2014-7-31 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES Left YES 6 NO 0 No N0 T1b Stage I 8423 TUMOR FREE Normal YES Complete Remission/Response NO Solid Tissue Normal 11 Low 6th NO NO YES KN Kidney LIVING Elevated 2005 d7dcd997-63d5-4e12-9c26-c5ddd0e02fb0 d7dcd997-63d5-4e12-9c26-c5ddd0e02fb0 TCGA-KN-8423-11 d7dcd997-63d5-4e12-9c26-c5ddd0e02fb0 d7dcd997-63d5-4e12-9c26-c5ddd0e02fb0 TCGA-KN-8423-11
49
+ TCGA-KN-8424-01 TCGA-KN-8424-01 TCGA-KN-8424 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 42 TCGA-KN-8424-F63138 TCGA-KN-8424 TCGA-KN-8424-01A M0 -15384 0 1983 Scheduled Follow-up Submission 2014-7-31 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.9 NO Right 1.4 YES NO No N0 T1b Stage I TCGA-KN-8424.60b044b4-9f1a-43db-b421-325471a068f8.pdf 8424 TUMOR FREE Normal NO Complete Remission/Response NO Primary Tumor 01 Low 0.2 6th NO NO YES KN 1 Kidney A LIVING Elevated 2005 TCGA-KN-8424-01 e8cc9981-3f57-49cc-9779-72d1c50bc59a TCGA-KN-8424-01A-11D-2308-01 TCGA-KN-8424-01A-11D-2310-10 e8cc9981-3f57-49cc-9779-72d1c50bc59a CD99189F-3D73-498A-A676-119DBD2B7D21 TCGA-KN-8424-01 TCGA-KN-8424-01A-11D-2310-10 e8cc9981-3f57-49cc-9779-72d1c50bc59a TCGA-KN-8424-01 e8cc9981-3f57-49cc-9779-72d1c50bc59a TCGA-KN-8424-01A-11D-2312-05 TCGA-KN-8424-01A-11D-2310-10 TCGA-KN-8424-01 TCGA-KN-8424-01A-11D-2308-01
50
+ TCGA-KN-8424-11 TCGA-KN-8424-11 TCGA-KN-8424 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 42 TCGA-KN-8424-F63138 TCGA-KN-8424 TCGA-KN-8424-11A M0 -15384 0 1983 Scheduled Follow-up Submission 2014-7-31 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.2 NO Right 1.3 YES NO No N0 T1b Stage I 8424 TUMOR FREE Normal NO Complete Remission/Response NO Solid Tissue Normal 11 Low 0.4 6th NO NO YES KN 1 Kidney A LIVING Elevated 2005 365edca8-a3eb-4e98-9243-90b121b7222c 365edca8-a3eb-4e98-9243-90b121b7222c TCGA-KN-8424-11 365edca8-a3eb-4e98-9243-90b121b7222c 365edca8-a3eb-4e98-9243-90b121b7222c TCGA-KN-8424-11
51
+ TCGA-KN-8425-01 TCGA-KN-8425-01 TCGA-KN-8425 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 53 TCGA-KN-8425-F63139 TCGA-KN-8425 TCGA-KN-8425-01A M0 -19692 0 3179 Scheduled Follow-up Submission 2014-9-18 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.2 NO Left 2 NO NO No N0 T1b Stage I TCGA-KN-8425.6c97d5a0-8519-4d0c-ae9d-065019d53621.pdf 8425 TUMOR FREE Normal NO Complete Remission/Response NO Primary Tumor 01 Low 0.5 6th NO NO YES KN 1 Kidney A LIVING Elevated 2005 TCGA-KN-8425-01 d42c9589-3960-4964-be28-83d275bdc672 TCGA-KN-8425-01A-11D-2308-01 TCGA-KN-8425-01A-11D-2310-10 d42c9589-3960-4964-be28-83d275bdc672 79BD5043-8267-44FC-8386-546E629F2090 TCGA-KN-8425-01 TCGA-KN-8425-01A-11D-2310-10 d42c9589-3960-4964-be28-83d275bdc672 TCGA-KN-8425-01 d42c9589-3960-4964-be28-83d275bdc672 TCGA-KN-8425-01A-11D-2312-05 TCGA-KN-8425-01A-11D-2310-10 TCGA-KN-8425-01 TCGA-KN-8425-01A-11D-2308-01
52
+ TCGA-KN-8425-11 TCGA-KN-8425-11 TCGA-KN-8425 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 53 TCGA-KN-8425-F63139 TCGA-KN-8425 M0 -19692 0 3179 Scheduled Follow-up Submission 2014-9-18 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES Left NO NO No N0 T1b Stage I 8425 TUMOR FREE Normal NO Complete Remission/Response NO Solid Tissue Normal 11 Low 6th NO NO YES KN 1 Kidney LIVING Elevated 2005 ba365c68-a51f-4802-98b4-7fbf7e35bafc ba365c68-a51f-4802-98b4-7fbf7e35bafc TCGA-KN-8425-11 ba365c68-a51f-4802-98b4-7fbf7e35bafc ba365c68-a51f-4802-98b4-7fbf7e35bafc TCGA-KN-8425-11
53
+ TCGA-KN-8426-01 TCGA-KN-8426-01 TCGA-KN-8426 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 50 TCGA-KN-8426-F64767 TCGA-KN-8426 TCGA-KN-8426-01A -18345 0 108 Scheduled Follow-up Submission 2014-9-11 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.1 NO Left 1.8 YES NO No M1 NX T3a Stage IV TCGA-KN-8426.0467a5c3-3959-45bb-8d3a-d4fc8e7d2ebc.pdf 8426 WITH TUMOR Normal NO Progressive Disease NO Primary Tumor 01 Low 0.5 6th YES NO YES KN 1 Kidney A LIVING Elevated 2006 TCGA-KN-8426-01 2a70e115-e2dd-4c26-bd20-b09c58f551c7 TCGA-KN-8426-01A-11D-2308-01 TCGA-KN-8426-01A-11D-2310-10 2a70e115-e2dd-4c26-bd20-b09c58f551c7 D804EB70-781C-4955-BA8D-66B492015B01 TCGA-KN-8426-01 TCGA-KN-8426-01A-11D-2310-10 2a70e115-e2dd-4c26-bd20-b09c58f551c7 TCGA-KN-8426-01 2a70e115-e2dd-4c26-bd20-b09c58f551c7 TCGA-KN-8426-01A-11D-2312-05 TCGA-KN-8426-01A-11D-2310-10 TCGA-KN-8426-01 TCGA-KN-8426-01A-11D-2308-01
54
+ TCGA-KN-8426-11 TCGA-KN-8426-11 TCGA-KN-8426 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 50 TCGA-KN-8426-F64767 TCGA-KN-8426 TCGA-KN-8426-11A -18345 0 108 Scheduled Follow-up Submission 2014-9-11 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.5 NO Left 1.6 YES NO No M1 NX T3a Stage IV 8426 WITH TUMOR Normal NO Progressive Disease NO Solid Tissue Normal 11 Low 0.6 6th YES NO YES KN 1 Kidney A LIVING Elevated 2006 2b684237-e6b2-4f87-882e-3fa8ffbb829e 2b684237-e6b2-4f87-882e-3fa8ffbb829e TCGA-KN-8426-11 2b684237-e6b2-4f87-882e-3fa8ffbb829e 2b684237-e6b2-4f87-882e-3fa8ffbb829e TCGA-KN-8426-11
55
+ TCGA-KN-8427-01 TCGA-KN-8427-01 TCGA-KN-8427 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 54 TCGA-KN-8427-F64769 TCGA-KN-8427 TCGA-KN-8427-01A M0 -19854 0 30 Scheduled Follow-up Submission 2014-9-11 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.2 NO Left 2 YES 4 NO 1 No N1 T4 Stage IV TCGA-KN-8427.f2a42c36-a475-43c7-bcd1-48b83c3ab5a6.pdf 8427 TUMOR FREE Normal YES YES NO Primary Tumor 01 Low 0.5 6th NO NO YES KN 1 Kidney A LIVING Elevated 2006 TCGA-KN-8427-01 ee8417b7-5d4b-42e7-b0f1-094a9990fda8 TCGA-KN-8427-01A-11D-2308-01 TCGA-KN-8427-01A-11D-2310-10 ee8417b7-5d4b-42e7-b0f1-094a9990fda8 D8E31CC4-B15E-41BE-B295-B73DCE70377D TCGA-KN-8427-01 TCGA-KN-8427-01A-11D-2310-10 ee8417b7-5d4b-42e7-b0f1-094a9990fda8 TCGA-KN-8427-01 ee8417b7-5d4b-42e7-b0f1-094a9990fda8 TCGA-KN-8427-01A-11D-2312-05 TCGA-KN-8427-01A-11D-2310-10 TCGA-KN-8427-01 TCGA-KN-8427-01A-11D-2308-01
56
+ TCGA-KN-8427-11 TCGA-KN-8427-11 TCGA-KN-8427 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 54 TCGA-KN-8427-F64769 TCGA-KN-8427 TCGA-KN-8427-11A M0 -19854 0 30 Scheduled Follow-up Submission 2014-9-11 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.5 NO Left 1.1 YES 4 NO 1 No N1 T4 Stage IV 8427 TUMOR FREE Normal YES YES NO Solid Tissue Normal 11 Low 0.2 6th NO NO YES KN 1 Kidney A LIVING Elevated 2006 1a2a7cd4-e8cb-4333-b5bd-990a37041df1 1a2a7cd4-e8cb-4333-b5bd-990a37041df1 TCGA-KN-8427-11 1a2a7cd4-e8cb-4333-b5bd-990a37041df1 1a2a7cd4-e8cb-4333-b5bd-990a37041df1 TCGA-KN-8427-11
57
+ TCGA-KN-8428-01 TCGA-KN-8428-01 TCGA-KN-8428 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 71 TCGA-KN-8428 TCGA-KN-8428-01A M0 -26252 1590 0 2012-8-13 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.4 NO Left 1.8 1 YES 0 48 No N0 T2 Stage II TCGA-KN-8428.206325f6-9479-4588-bc44-b0e1bccdbec3.pdf 8428 WITH TUMOR Normal YES Stable Disease NO Primary Tumor 01 Low 0.3 6th NO NO YES KN 3 Kidney A DECEASED Elevated 2006 TCGA-KN-8428-01 91aaef0d-6d3f-43e8-90b9-7c8e86beb2c6 TCGA-KN-8428-01A-11D-2308-01 TCGA-KN-8428-01A-11D-2310-10 91aaef0d-6d3f-43e8-90b9-7c8e86beb2c6 CC5CC5D2-1945-4323-998C-76C869A8C85C TCGA-KN-8428-01 TCGA-KN-8428-01A-11D-2310-10 91aaef0d-6d3f-43e8-90b9-7c8e86beb2c6 TCGA-KN-8428-01 91aaef0d-6d3f-43e8-90b9-7c8e86beb2c6 TCGA-KN-8428-01A-11D-2312-05 TCGA-KN-8428-01A-11D-2310-10 TCGA-KN-8428-01 TCGA-KN-8428-01A-11D-2308-01
58
+ TCGA-KN-8428-11 TCGA-KN-8428-11 TCGA-KN-8428 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 71 TCGA-KN-8428 M0 -26252 1590 0 2012-8-13 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES Left 1 YES 0 48 No N0 T2 Stage II 8428 WITH TUMOR Normal YES Stable Disease NO Solid Tissue Normal 11 Low 6th NO NO YES KN 3 Kidney DECEASED Elevated 2006 a882f372-5345-4810-87d1-bf82a4be5aa3 a882f372-5345-4810-87d1-bf82a4be5aa3 TCGA-KN-8428-11 a882f372-5345-4810-87d1-bf82a4be5aa3 a882f372-5345-4810-87d1-bf82a4be5aa3 TCGA-KN-8428-11
59
+ TCGA-KN-8429-01 TCGA-KN-8429-01 TCGA-KN-8429 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney NO NO YES 38 TCGA-KN-8429-F63146 TCGA-KN-8429 TCGA-KN-8429-01A M0 2023 -13903 0 2650 2023 0 Scheduled Follow-up Submission Complete Remission/Response 2014-7-31 FEMALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.5 NO 100 Right 1.8 NO YES No N0 T3a Stage III TCGA-KN-8429.44b1f6e7-9fab-4055-946a-e05c02873261.pdf 8429 TUMOR FREE Normal NO Complete Remission/Response NO Primary Tumor 01 Low 0.6 6th NO NO YES KN Kidney A LIVING Elevated 2006 TCGA-KN-8429-01 1573fde6-2abe-4ef8-b2f3-3c33507aca0c TCGA-KN-8429-01A-11D-2308-01 TCGA-KN-8429-01A-11D-2310-10 1573fde6-2abe-4ef8-b2f3-3c33507aca0c DCED901E-D3F5-412A-A8CD-C803339D312A TCGA-KN-8429-01 TCGA-KN-8429-01A-11D-2310-10 1573fde6-2abe-4ef8-b2f3-3c33507aca0c TCGA-KN-8429-01 1573fde6-2abe-4ef8-b2f3-3c33507aca0c TCGA-KN-8429-01A-11D-2312-05 TCGA-KN-8429-01A-11D-2310-10 TCGA-KN-8429-01 TCGA-KN-8429-01A-11D-2308-01
60
+ TCGA-KN-8429-11 TCGA-KN-8429-11 TCGA-KN-8429 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney NO NO YES 38 TCGA-KN-8429-F63146 TCGA-KN-8429 M0 2023 -13903 0 2650 2023 0 Scheduled Follow-up Submission Complete Remission/Response 2014-7-31 FEMALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 100 Right NO YES No N0 T3a Stage III 8429 TUMOR FREE Normal NO Complete Remission/Response NO Solid Tissue Normal 11 Low 6th NO NO YES KN Kidney LIVING Elevated 2006 a6adbcc1-dc20-4d7f-8397-d699a64287e0 a6adbcc1-dc20-4d7f-8397-d699a64287e0 TCGA-KN-8429-11 a6adbcc1-dc20-4d7f-8397-d699a64287e0 a6adbcc1-dc20-4d7f-8397-d699a64287e0 TCGA-KN-8429-11
61
+ TCGA-KN-8430-01 TCGA-KN-8430-01 TCGA-KN-8430 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 75 TCGA-KN-8430 TCGA-KN-8430-01A M0 -27467 0 2012-8-13 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.2 NO Left 1.7 Yes, History of Prior Malignancy N0 T1b Stage I TCGA-KN-8430.48d9a36d-d5eb-4cc1-aa5c-bd4476db8cde.pdf 8430 WITH TUMOR Normal NO NO Primary Tumor 01 Low 0.3 6th NO NO YES KN 1 Kidney A DECEASED Normal 2007 TCGA-KN-8430-01 632dbd49-0206-4a3e-9791-3c51c2c40af5 TCGA-KN-8430-01A-11D-2308-01 TCGA-KN-8430-01A-11D-2310-10 632dbd49-0206-4a3e-9791-3c51c2c40af5 F57D292E-7570-4E95-886C-4CA509E23359 TCGA-KN-8430-01A-11D-2310-10 632dbd49-0206-4a3e-9791-3c51c2c40af5 TCGA-KN-8430-01 632dbd49-0206-4a3e-9791-3c51c2c40af5 TCGA-KN-8430-01A-11D-2312-05 TCGA-KN-8430-01A-11D-2310-10 TCGA-KN-8430-01A-11D-2308-01
62
+ TCGA-KN-8430-11 TCGA-KN-8430-11 TCGA-KN-8430 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 75 TCGA-KN-8430 TCGA-KN-8430-11A M0 -27467 0 2012-8-13 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.4 NO Left 1.2 Yes, History of Prior Malignancy N0 T1b Stage I 8430 WITH TUMOR Normal NO NO Solid Tissue Normal 11 Low 0.3 6th NO NO YES KN 1 Kidney A DECEASED Normal 2007 deb2a587-f82c-4e0c-8902-7cd307900574 deb2a587-f82c-4e0c-8902-7cd307900574 deb2a587-f82c-4e0c-8902-7cd307900574 deb2a587-f82c-4e0c-8902-7cd307900574
63
+ TCGA-KN-8431-01 TCGA-KN-8431-01 TCGA-KN-8431 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 35 TCGA-KN-8431-F63147 TCGA-KN-8431 TCGA-KN-8431-01A MX -13043 0 588 Scheduled Follow-up Submission 2014-7-31 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.6 NO Right 1.8 YES No NX T2 Stage II TCGA-KN-8431.4f6f403c-d6a8-4a5f-aa4f-16dee40f5068.pdf 8431 TUMOR FREE Normal NO NO Primary Tumor 01 Low 0.6 6th NO NO YES KN 1 Kidney A LIVING Elevated 2007 TCGA-KN-8431-01 58d4d6ea-cb30-47f9-87ff-d2dec6e3385e TCGA-KN-8431-01A-11D-2308-01 TCGA-KN-8431-01A-11D-2310-10 58d4d6ea-cb30-47f9-87ff-d2dec6e3385e 1F89D862-9CBE-4A11-8A23-3DD84A39AB07 TCGA-KN-8431-01 TCGA-KN-8431-01A-11D-2310-10 58d4d6ea-cb30-47f9-87ff-d2dec6e3385e TCGA-KN-8431-01 58d4d6ea-cb30-47f9-87ff-d2dec6e3385e TCGA-KN-8431-01A-11D-2312-05 TCGA-KN-8431-01A-11D-2310-10 TCGA-KN-8431-01 TCGA-KN-8431-01A-11D-2308-01
64
+ TCGA-KN-8431-11 TCGA-KN-8431-11 TCGA-KN-8431 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 35 TCGA-KN-8431-F63147 TCGA-KN-8431 MX -13043 0 588 Scheduled Follow-up Submission 2014-7-31 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES Right YES No NX T2 Stage II 8431 TUMOR FREE Normal NO NO Solid Tissue Normal 11 Low 6th NO NO YES KN 1 Kidney LIVING Elevated 2007 dcdeb647-e266-4494-ab18-1798ccbfabf4 dcdeb647-e266-4494-ab18-1798ccbfabf4 TCGA-KN-8431-11 dcdeb647-e266-4494-ab18-1798ccbfabf4 dcdeb647-e266-4494-ab18-1798ccbfabf4 TCGA-KN-8431-11
65
+ TCGA-KN-8432-01 TCGA-KN-8432-01 TCGA-KN-8432 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 86 TCGA-KN-8432-F61620 TCGA-KN-8432 TCGA-KN-8432-01A MX -31591 0 76 0 Scheduled Follow-up Submission 2014-7-31 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1 NO Right 1.3 YES NO No NX T2b Stage II TCGA-KN-8432.6478555f-281d-458d-8e6f-82d22180512b.pdf 8432 Other Normal NO NO Complete Remission/Response NO Primary Tumor 01 0.4 7th NO NO YES KN 1 Kidney A LIVING Normal 2010 TCGA-KN-8432-01 4300d79a-b4c8-4d95-8a42-4d5d8962eadc TCGA-KN-8432-01A-11D-2308-01 TCGA-KN-8432-01A-11D-2310-10 4300d79a-b4c8-4d95-8a42-4d5d8962eadc D3506899-CBE9-47B4-BBEC-F226168E414F TCGA-KN-8432-01 TCGA-KN-8432-01A-11D-2310-10 4300d79a-b4c8-4d95-8a42-4d5d8962eadc TCGA-KN-8432-01 4300d79a-b4c8-4d95-8a42-4d5d8962eadc TCGA-KN-8432-01A-11D-2312-05 TCGA-KN-8432-01A-11D-2310-10 TCGA-KN-8432-01 TCGA-KN-8432-01A-11D-2308-01
66
+ TCGA-KN-8432-11 TCGA-KN-8432-11 TCGA-KN-8432 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 86 TCGA-KN-8432-F61620 TCGA-KN-8432 TCGA-KN-8432-11A MX -31591 0 76 0 Scheduled Follow-up Submission 2014-7-31 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.5 NO Right 1.4 YES NO No NX T2b Stage II 8432 Other Normal NO NO Complete Remission/Response NO Solid Tissue Normal 11 0.4 7th NO NO YES KN 1 Kidney A LIVING Normal 2010 4d3c1834-7351-4aaa-aa2c-70e0c06ebbce 4d3c1834-7351-4aaa-aa2c-70e0c06ebbce TCGA-KN-8432-11 4d3c1834-7351-4aaa-aa2c-70e0c06ebbce 4d3c1834-7351-4aaa-aa2c-70e0c06ebbce TCGA-KN-8432-11
67
+ TCGA-KN-8433-01 TCGA-KN-8433-01 TCGA-KN-8433 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 46 TCGA-KN-8433-F63056 TCGA-KN-8433 TCGA-KN-8433-01A MX -17108 0 341 Scheduled Follow-up Submission 2014-7-31 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.8 NO Left 1.2 YES NO 24 No NX T3a Stage III TCGA-KN-8433.3a55068f-37b4-4113-8fd8-241d70d0658e.pdf 8433 TUMOR FREE Normal NO Complete Remission/Response NO Primary Tumor 01 0.2 6th NO NO YES KN 2 Kidney A LIVING Normal 2008 1984 TCGA-KN-8433-01 a259c8ba-80df-4398-bc4a-34ee841becdb TCGA-KN-8433-01A-11D-2308-01 TCGA-KN-8433-01A-11D-2310-10 a259c8ba-80df-4398-bc4a-34ee841becdb 6B5820EE-8A18-4017-9816-0876D276B0CB TCGA-KN-8433-01 TCGA-KN-8433-01A-11D-2310-10 a259c8ba-80df-4398-bc4a-34ee841becdb TCGA-KN-8433-01 a259c8ba-80df-4398-bc4a-34ee841becdb TCGA-KN-8433-01A-11D-2312-05 TCGA-KN-8433-01A-11D-2310-10 TCGA-KN-8433-01 TCGA-KN-8433-01A-11D-2308-01
68
+ TCGA-KN-8433-11 TCGA-KN-8433-11 TCGA-KN-8433 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 46 TCGA-KN-8433-F63056 TCGA-KN-8433 TCGA-KN-8433-11A MX -17108 0 341 Scheduled Follow-up Submission 2014-7-31 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1 NO Left 1.1 YES NO 24 No NX T3a Stage III 8433 TUMOR FREE Normal NO Complete Remission/Response NO Solid Tissue Normal 11 0.6 6th NO NO YES KN 2 Kidney A LIVING Normal 2008 1984 13f286ad-31e3-4ac7-94d2-d6f6a6c12c0e 13f286ad-31e3-4ac7-94d2-d6f6a6c12c0e TCGA-KN-8433-11 13f286ad-31e3-4ac7-94d2-d6f6a6c12c0e 13f286ad-31e3-4ac7-94d2-d6f6a6c12c0e TCGA-KN-8433-11
69
+ TCGA-KN-8434-01 TCGA-KN-8434-01 TCGA-KN-8434 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 65 TCGA-KN-8434-F63058 TCGA-KN-8434 TCGA-KN-8434-01A M0 -23934 0 1797 0 Scheduled Follow-up Submission Complete Remission/Response 2014-8-20 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.2 NO 100 Right 1.7 NO NO No NX T2 Stage II TCGA-KN-8434.70619a71-e4f2-4bdf-bfa5-15787eaed4ed.pdf 8434 Other TUMOR FREE Normal NO Complete Remission/Response NO Primary Tumor 01 0.3 6th NO NO YES KN 1 Kidney A LIVING Normal 2009 TCGA-KN-8434-01 17238de6-eab7-47ed-948e-be06ee5de5b7 TCGA-KN-8434-01A-11D-2308-01 TCGA-KN-8434-01A-11D-2310-10 17238de6-eab7-47ed-948e-be06ee5de5b7 677AC9CE-A151-4FCC-A3E4-9BA087D729B2 TCGA-KN-8434-01 TCGA-KN-8434-01A-11D-2310-10 17238de6-eab7-47ed-948e-be06ee5de5b7 TCGA-KN-8434-01 17238de6-eab7-47ed-948e-be06ee5de5b7 TCGA-KN-8434-01A-11D-2312-05 TCGA-KN-8434-01A-11D-2310-10 TCGA-KN-8434-01 TCGA-KN-8434-01A-11D-2308-01
70
+ TCGA-KN-8434-11 TCGA-KN-8434-11 TCGA-KN-8434 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 65 TCGA-KN-8434-F63058 TCGA-KN-8434 TCGA-KN-8434-11A M0 -23934 0 1797 0 Scheduled Follow-up Submission Complete Remission/Response 2014-8-20 FEMALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.6 NO 100 Right 1.5 NO NO No NX T2 Stage II 8434 Other TUMOR FREE Normal NO Complete Remission/Response NO Solid Tissue Normal 11 0.5 6th NO NO YES KN 1 Kidney A LIVING Normal 2009 8d1db793-102c-4ddf-a006-c69b7c96d099 8d1db793-102c-4ddf-a006-c69b7c96d099 TCGA-KN-8434-11 8d1db793-102c-4ddf-a006-c69b7c96d099 8d1db793-102c-4ddf-a006-c69b7c96d099 TCGA-KN-8434-11
71
+ TCGA-KN-8435-01 TCGA-KN-8435-01 TCGA-KN-8435 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 59 TCGA-KN-8435-F63060 TCGA-KN-8435 TCGA-KN-8435-01A MX -21891 0 3498 0 Scheduled Follow-up Submission Complete Remission/Response 2014-8-20 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1 NO Right 1.5 NO NO No NX T2 Stage II TCGA-KN-8435.5dc00796-fb11-462c-a869-c0eb786cd295.pdf 8435 Other TUMOR FREE Normal NO Complete Remission/Response NO Primary Tumor 01 Normal 0.4 6th NO NO YES KN 1 Kidney A LIVING Elevated 2004 TCGA-KN-8435-01 0acf650f-8275-4319-bdb4-bb0a6c35c235 TCGA-KN-8435-01A-11D-2308-01 TCGA-KN-8435-01A-11D-2310-10 0acf650f-8275-4319-bdb4-bb0a6c35c235 AE1DE141-8CAA-4FB3-A23F-E0863594B0A1 TCGA-KN-8435-01 TCGA-KN-8435-01A-11D-2310-10 0acf650f-8275-4319-bdb4-bb0a6c35c235 TCGA-KN-8435-01 0acf650f-8275-4319-bdb4-bb0a6c35c235 TCGA-KN-8435-01A-11D-2312-05 TCGA-KN-8435-01A-11D-2310-10 TCGA-KN-8435-01 TCGA-KN-8435-01A-11D-2308-01
72
+ TCGA-KN-8435-11 TCGA-KN-8435-11 TCGA-KN-8435 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 59 TCGA-KN-8435-F63060 TCGA-KN-8435 TCGA-KN-8435-11A MX -21891 0 3498 0 Scheduled Follow-up Submission Complete Remission/Response 2014-8-20 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.1 NO Right 1.2 NO NO No NX T2 Stage II 8435 Other TUMOR FREE Normal NO Complete Remission/Response NO Solid Tissue Normal 11 Normal 0.2 6th NO NO YES KN 1 Kidney A LIVING Elevated 2004 7e49cf6c-9feb-43a9-a123-917cd38e4f1d 7e49cf6c-9feb-43a9-a123-917cd38e4f1d TCGA-KN-8435-11 7e49cf6c-9feb-43a9-a123-917cd38e4f1d 7e49cf6c-9feb-43a9-a123-917cd38e4f1d TCGA-KN-8435-11
73
+ TCGA-KN-8436-01 TCGA-KN-8436-01 TCGA-KN-8436 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 62 TCGA-KN-8436-F63062 TCGA-KN-8436 TCGA-KN-8436-01A M0 -22997 0 1288 0 Scheduled Follow-up Submission Complete Remission/Response 2014-8-20 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.3 NO Right 1.8 NO NO No NX T2 Stage II TCGA-KN-8436.fae13077-3ab2-448e-a45c-66c090c32c92.pdf 8436 Other TUMOR FREE Normal NO Complete Remission/Response NO Primary Tumor 01 0.5 6th NO NO YES KN 1 Kidney A LIVING Normal 2009 TCGA-KN-8436-01 034d17f6-d3ef-474c-867a-2fa51eab60f2 TCGA-KN-8436-01A-11D-2308-01 TCGA-KN-8436-01A-11D-2310-10 034d17f6-d3ef-474c-867a-2fa51eab60f2 F89FEB2F-EB49-4DF4-B221-D66B351A0DDC TCGA-KN-8436-01 TCGA-KN-8436-01A-11D-2310-10 034d17f6-d3ef-474c-867a-2fa51eab60f2 TCGA-KN-8436-01 034d17f6-d3ef-474c-867a-2fa51eab60f2 TCGA-KN-8436-01A-11D-2312-05 TCGA-KN-8436-01A-11D-2310-10 TCGA-KN-8436-01 TCGA-KN-8436-01A-11D-2308-01
74
+ TCGA-KN-8436-11 TCGA-KN-8436-11 TCGA-KN-8436 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 62 TCGA-KN-8436-F63062 TCGA-KN-8436 TCGA-KN-8436-11A M0 -22997 0 1288 0 Scheduled Follow-up Submission Complete Remission/Response 2014-8-20 MALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.5 NO Right 1 NO NO No NX T2 Stage II 8436 Other TUMOR FREE Normal NO Complete Remission/Response NO Solid Tissue Normal 11 0.1 6th NO NO YES KN 1 Kidney A LIVING Normal 2009 15c869eb-856e-4dda-9efd-4a4252b33464 15c869eb-856e-4dda-9efd-4a4252b33464 TCGA-KN-8436-11 15c869eb-856e-4dda-9efd-4a4252b33464 15c869eb-856e-4dda-9efd-4a4252b33464 TCGA-KN-8436-11
75
+ TCGA-KN-8437-01 TCGA-KN-8437-01 TCGA-KN-8437 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 42 TCGA-KN-8437-F63064 TCGA-KN-8437 TCGA-KN-8437-01A M0 -15475 0 3068 Scheduled Follow-up Submission Complete Remission/Response 2014-8-20 FEMALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.9 NO Normal Right 1.7 NO NO No NX T1a Stage I TCGA-KN-8437.9f926dde-901c-4611-aee6-3ecde5a7c165.pdf 8437 TUMOR FREE Normal NO Complete Remission/Response NO Primary Tumor 01 Low 0.5 6th NO NO YES KN Kidney A LIVING Normal 2006 TCGA-KN-8437-01 9e634d59-f421-4a8c-b840-21fd612de48f TCGA-KN-8437-01A-11D-2308-01 TCGA-KN-8437-01A-11D-2310-10 9e634d59-f421-4a8c-b840-21fd612de48f FFBEAFE0-9A39-49BF-9FFC-783DED388A93 TCGA-KN-8437-01 TCGA-KN-8437-01A-11D-2310-10 9e634d59-f421-4a8c-b840-21fd612de48f TCGA-KN-8437-01 9e634d59-f421-4a8c-b840-21fd612de48f TCGA-KN-8437-01A-11D-2312-05 TCGA-KN-8437-01A-11D-2310-10 TCGA-KN-8437-01 TCGA-KN-8437-01A-11D-2308-01
76
+ TCGA-KN-8437-11 TCGA-KN-8437-11 TCGA-KN-8437 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 42 TCGA-KN-8437-F63064 TCGA-KN-8437 TCGA-KN-8437-11A M0 -15475 0 3068 Scheduled Follow-up Submission Complete Remission/Response 2014-8-20 FEMALE Low Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.8 NO Normal Right 1 NO NO No NX T1a Stage I 8437 TUMOR FREE Normal NO Complete Remission/Response NO Solid Tissue Normal 11 Low 0.7 6th NO NO YES KN Kidney A LIVING Normal 2006 070ff02a-0851-4538-939c-01507b152e26 070ff02a-0851-4538-939c-01507b152e26 TCGA-KN-8437-11 070ff02a-0851-4538-939c-01507b152e26 070ff02a-0851-4538-939c-01507b152e26 TCGA-KN-8437-11
77
+ TCGA-KO-8403-01 TCGA-KO-8403-01 TCGA-KO-8403 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 49 TCGA-KO-8403-F71894 TCGA-KO-8403 TCGA-KO-8403-01A M0 -18171 0 3208 Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.8 NO Left 2 NO NO No NX T1a Stage I TCGA-KO-8403.a1dc9294-01ce-466b-99ad-e065fee12d5a.pdf 8403 TUMOR FREE Normal NO NO NO Primary Tumor 01 0.7 7th NO NO YES KO 1 Kidney A LIVING Normal 2005 TCGA-KO-8403-01 362473ea-d151-4a1b-8ba7-66a3634dca7b TCGA-KO-8403-01A-11D-2308-01 TCGA-KO-8403-01A-11D-2310-10 362473ea-d151-4a1b-8ba7-66a3634dca7b 250AC391-D4B6-459F-810E-EE115B3B97A2 TCGA-KO-8403-01 TCGA-KO-8403-01A-11D-2310-10 362473ea-d151-4a1b-8ba7-66a3634dca7b TCGA-KO-8403-01 362473ea-d151-4a1b-8ba7-66a3634dca7b TCGA-KO-8403-01A-11D-2312-05 TCGA-KO-8403-01A-11D-2310-10 TCGA-KO-8403-01 TCGA-KO-8403-01A-11D-2308-01
78
+ TCGA-KO-8403-11 TCGA-KO-8403-11 TCGA-KO-8403 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 49 TCGA-KO-8403-F71894 TCGA-KO-8403 M0 -18171 0 3208 Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE Normal Kidney Chromophobe No C64.9 8317/3 C64.9 YES Left NO NO No NX T1a Stage I 8403 TUMOR FREE Normal NO NO NO Solid Tissue Normal 11 7th NO NO YES KO 1 Kidney LIVING Normal 2005 bfaa88c7-f004-411b-9b5d-23edf91e758b bfaa88c7-f004-411b-9b5d-23edf91e758b TCGA-KO-8403-11 bfaa88c7-f004-411b-9b5d-23edf91e758b bfaa88c7-f004-411b-9b5d-23edf91e758b TCGA-KO-8403-11
79
+ TCGA-KO-8404-01 TCGA-KO-8404-01 TCGA-KO-8404 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 78 TCGA-KO-8404 TCGA-KO-8404-01A M0 -28705 325 0 2013-1-28 MALE Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.9 NO Right 2.1 YES No NX T4 Stage IV TCGA-KO-8404.06e8aa74-45f1-46e8-adf8-84c69958ee5e.pdf 8404 90 WITH TUMOR YES NO Progressive Disease NO Primary Tumor 01 0.8 7th YES NO YES KO 1 Kidney A DECEASED 2005 TCGA-KO-8404-01 d06c82c3-9575-4d5d-8796-7b4a6323f881 TCGA-KO-8404-01A-11D-2308-01 TCGA-KO-8404-01A-11D-2310-10 d06c82c3-9575-4d5d-8796-7b4a6323f881 A323772B-75B5-43A8-810C-45B10F8AC11A TCGA-KO-8404-01 TCGA-KO-8404-01A-11D-2310-10 d06c82c3-9575-4d5d-8796-7b4a6323f881 TCGA-KO-8404-01 d06c82c3-9575-4d5d-8796-7b4a6323f881 TCGA-KO-8404-01A-11D-2312-05 TCGA-KO-8404-01A-11D-2310-10 TCGA-KO-8404-01 TCGA-KO-8404-01A-11D-2308-01
80
+ TCGA-KO-8405-01 TCGA-KO-8405-01 TCGA-KO-8405 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 29 TCGA-KO-8405-F71896 TCGA-KO-8405 TCGA-KO-8405-01A M0 -10671 0 3056 Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.8 NO Left 1.2 NO 7 NO 0 No M0 N0 T3a Stage III TCGA-KO-8405.742b536b-b13b-43ef-8e04-3e019f06cd73.pdf 8405 TUMOR FREE NO YES Complete Remission/Response NO Primary Tumor 01 0.5 7th NO NO YES KO 1 Kidney A LIVING 2005 TCGA-KO-8405-01 f6e81351-3d0e-4a4b-aec4-e88011e8f3f9 TCGA-KO-8405-01A-11D-2308-01 TCGA-KO-8405-01A-11D-2310-10 f6e81351-3d0e-4a4b-aec4-e88011e8f3f9 414D99A3-809A-474D-9000-0A4AF2589823 TCGA-KO-8405-01 TCGA-KO-8405-01A-11D-2310-10 f6e81351-3d0e-4a4b-aec4-e88011e8f3f9 TCGA-KO-8405-01 f6e81351-3d0e-4a4b-aec4-e88011e8f3f9 TCGA-KO-8405-01A-11D-2312-05 TCGA-KO-8405-01A-11D-2310-10 TCGA-KO-8405-01 TCGA-KO-8405-01A-11D-2308-01
81
+ TCGA-KO-8406-01 TCGA-KO-8406-01 TCGA-KO-8406 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 17 TCGA-KO-8406-F71901 TCGA-KO-8406 TCGA-KO-8406-01A M0 -6556 0 3145 Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 FEMALE Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.8 NO Right 1 NO NO No M0 N0 T1 Stage I TCGA-KO-8406.0ec526a4-0f75-46a9-b247-48378a938ec1.pdf 8406 TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 0.4 7th NO NO YES KO 1 Kidney A LIVING 2005 TCGA-KO-8406-01 d324b289-764c-46e0-8aa3-8d10f6a8c495 TCGA-KO-8406-01A-11D-2308-01 TCGA-KO-8406-01A-11D-2310-10 d324b289-764c-46e0-8aa3-8d10f6a8c495 C4E5D3C4-AC93-4D35-8AC9-1D26C2385ED9 TCGA-KO-8406-01 TCGA-KO-8406-01A-11D-2310-10 d324b289-764c-46e0-8aa3-8d10f6a8c495 TCGA-KO-8406-01 d324b289-764c-46e0-8aa3-8d10f6a8c495 TCGA-KO-8406-01A-11D-2312-05 TCGA-KO-8406-01A-11D-2310-10 TCGA-KO-8406-01 TCGA-KO-8406-01A-11D-2308-01
82
+ TCGA-KO-8407-01 TCGA-KO-8407-01 TCGA-KO-8407 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 42 TCGA-KO-8407-F71904 TCGA-KO-8407 TCGA-KO-8407-01A M0 -15407 0 2820 Scheduled Follow-up Submission 2015-5-1 MALE Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.9 NO Left 3.2 YES 10 NO 0 No M0 N0 T2 Stage II TCGA-KO-8407.b93a7dcb-4c2c-4ae3-b3d1-1a052d437e1e.pdf 8407 TUMOR FREE NO YES Complete Remission/Response NO Primary Tumor 01 0.8 7th NO NO YES KO 1 Kidney A LIVING 2005 TCGA-KO-8407-01 c30a6cac-b8c1-490a-b897-bbf35dcf0cbc TCGA-KO-8407-01A-11D-2308-01 TCGA-KO-8407-01A-11D-2310-10 c30a6cac-b8c1-490a-b897-bbf35dcf0cbc 919A7B26-BC88-408B-841A-91F27A4CC393 TCGA-KO-8407-01 TCGA-KO-8407-01A-11D-2310-10 c30a6cac-b8c1-490a-b897-bbf35dcf0cbc TCGA-KO-8407-01 c30a6cac-b8c1-490a-b897-bbf35dcf0cbc TCGA-KO-8407-01A-11D-2312-05 TCGA-KO-8407-01A-11D-2310-10 TCGA-KO-8407-01 TCGA-KO-8407-01A-11D-2308-01
83
+ TCGA-KO-8408-01 TCGA-KO-8408-01 TCGA-KO-8408 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 47 TCGA-KO-8408 TCGA-KO-8408-01A M0 -17299 507 0 2013-4-23 MALE Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1 NO Left 3.1 3 YES 3 75 No N1 T3a Stage III TCGA-KO-8408.cc6473fc-ffbd-4572-943e-dee1e9e51628.pdf 8408 TUMOR FREE NO YES NO Primary Tumor 01 0.8 7th NO NO YES KO 2 Kidney A DECEASED 2004 1971 TCGA-KO-8408-01 3405fefa-29da-429f-9cac-01e07abcfedc TCGA-KO-8408-01A-11D-2308-01 TCGA-KO-8408-01A-11D-2310-10 3405fefa-29da-429f-9cac-01e07abcfedc 4247A327-4AA2-4B0F-8DF9-870ECDA8C8E3 TCGA-KO-8408-01 TCGA-KO-8408-01A-11D-2310-10 3405fefa-29da-429f-9cac-01e07abcfedc TCGA-KO-8408-01 3405fefa-29da-429f-9cac-01e07abcfedc TCGA-KO-8408-01A-11D-2312-05 TCGA-KO-8408-01A-11D-2310-10 TCGA-KO-8408-01 TCGA-KO-8408-01A-11D-2308-01
84
+ TCGA-KO-8409-01 TCGA-KO-8409-01 TCGA-KO-8409 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 69 TCGA-KO-8409-F71906 TCGA-KO-8409 TCGA-KO-8409-01A M0 -25419 0 3180 Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.5 NO Left 2.8 NO 1 NO 0 3 No M0 N0 T2b Stage II TCGA-KO-8409.dbafac56-9724-4ec3-9cba-005ec26a645a.pdf 8409 TUMOR FREE NO YES Complete Remission/Response NO Primary Tumor 01 0.5 2003 7th NO NO YES KO 4 Kidney A LIVING 2004 1997 TCGA-KO-8409-01 a805252c-7dca-4e09-9bfa-ded6b5213c2b TCGA-KO-8409-01A-11D-2308-01 TCGA-KO-8409-01A-11D-2310-10 a805252c-7dca-4e09-9bfa-ded6b5213c2b 97A777BB-D3B4-4135-8F42-AD377209C467 TCGA-KO-8409-01 TCGA-KO-8409-01A-11D-2310-10 a805252c-7dca-4e09-9bfa-ded6b5213c2b TCGA-KO-8409-01 a805252c-7dca-4e09-9bfa-ded6b5213c2b TCGA-KO-8409-01A-11D-2312-05 TCGA-KO-8409-01A-11D-2310-10 TCGA-KO-8409-01 TCGA-KO-8409-01A-11D-2308-01
85
+ TCGA-KO-8410-01 TCGA-KO-8410-01 TCGA-KO-8410 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 74 TCGA-KO-8410-F71939 TCGA-KO-8410 TCGA-KO-8410-01A M0 -27084 0 3136 Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 FEMALE Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.8 NO Left 2 NO 1 NO 0 No M0 N0 T1b Stage I TCGA-KO-8410.7ef2010a-ce34-4c99-87a9-d42c23e6f0bb.pdf 8410 TUMOR FREE NO YES NO Primary Tumor 01 0.8 7th NO NO YES KO 1 Kidney A LIVING 2004 TCGA-KO-8410-01 16af7da5-68af-4af9-9a2b-66241dfa4d84 TCGA-KO-8410-01A-11D-2308-01 TCGA-KO-8410-01A-11D-2310-10 16af7da5-68af-4af9-9a2b-66241dfa4d84 EAA22323-3B41-4006-A2E6-979305DAFD99 TCGA-KO-8410-01 TCGA-KO-8410-01A-11D-2310-10 16af7da5-68af-4af9-9a2b-66241dfa4d84 TCGA-KO-8410-01 16af7da5-68af-4af9-9a2b-66241dfa4d84 TCGA-KO-8410-01A-11D-2312-05 TCGA-KO-8410-01A-11D-2310-10 TCGA-KO-8410-01 TCGA-KO-8410-01A-11D-2308-01
86
+ TCGA-KO-8411-01 TCGA-KO-8411-01 TCGA-KO-8411 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 58 TCGA-KO-8411-F71940 TCGA-KO-8411 TCGA-KO-8411-01A M0 -21371 0 3958 0 Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.8 NO 100 Left 1.4 NO NO Yes, History of Prior Malignancy M0 NX T1b Stage I TCGA-KO-8411.c494ba8d-1e0e-420a-b513-dbbac8f72994.pdf 8411 Other TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 0.7 7th NO NO YES KO 1 Kidney A LIVING 2004 TCGA-KO-8411-01 d4d86182-64cd-4b99-91ee-b41b57de112f TCGA-KO-8411-01A-11D-2308-01 TCGA-KO-8411-01A-11D-2310-10 d4d86182-64cd-4b99-91ee-b41b57de112f 0D1763C0-729E-413D-8F24-B624CCD035D5 TCGA-KO-8411-01 TCGA-KO-8411-01A-11D-2310-10 d4d86182-64cd-4b99-91ee-b41b57de112f TCGA-KO-8411-01 d4d86182-64cd-4b99-91ee-b41b57de112f TCGA-KO-8411-01A-11D-2312-05 TCGA-KO-8411-01A-11D-2310-10 TCGA-KO-8411-01 TCGA-KO-8411-01A-11D-2308-01
87
+ TCGA-KO-8413-01 TCGA-KO-8413-01 TCGA-KO-8413 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 46 TCGA-KO-8413-F71941 TCGA-KO-8413 TCGA-KO-8413-01A M0 -17067 0 3038 0 Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.8 NO 100 Right 3 NO NO No M0 N0 T1 Stage I TCGA-KO-8413.80abaee2-d3cf-4090-93a6-80ee50ebebfa.pdf 8413 Other TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 0.8 7th NO NO YES KO 1 Kidney A LIVING 2006 TCGA-KO-8413-01 4c416913-332a-47e4-bb98-94927c050db4 TCGA-KO-8413-01A-11D-2308-01 TCGA-KO-8413-01A-11D-2310-10 4c416913-332a-47e4-bb98-94927c050db4 81A0224B-65A4-4CE2-AAC2-B7F3B8FBE330 TCGA-KO-8413-01 TCGA-KO-8413-01A-11D-2310-10 4c416913-332a-47e4-bb98-94927c050db4 TCGA-KO-8413-01 4c416913-332a-47e4-bb98-94927c050db4 TCGA-KO-8413-01A-11D-2312-05 TCGA-KO-8413-01A-11D-2310-10 TCGA-KO-8413-01 TCGA-KO-8413-01A-11D-2308-01
88
+ TCGA-KO-8414-01 TCGA-KO-8414-01 TCGA-KO-8414 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 50 TCGA-KO-8414-F71943 TCGA-KO-8414 TCGA-KO-8414-01A M0 -18502 0 3212 Scheduled Follow-up Submission Complete Remission/Response 2015-5-1 FEMALE Kidney Chromophobe No C64.9 8317/3 C64.9 YES 1.3 NO Left 3.1 NO 9 NO 0 No M0 N0 T2 Stage II TCGA-KO-8414.1f2924e6-1aef-4775-82b5-16e2282243da.pdf 8414 TUMOR FREE NO YES Complete Remission/Response NO Primary Tumor 01 1 7th NO NO YES KO 1 Kidney A LIVING 2006 TCGA-KO-8414-01 42ac5002-fdad-426e-9037-e5cc99d093eb TCGA-KO-8414-01A-11D-2308-01 TCGA-KO-8414-01A-11D-2310-10 42ac5002-fdad-426e-9037-e5cc99d093eb BEBA4AE4-C615-4EEA-89F5-6260BC5C8F4D TCGA-KO-8414-01 TCGA-KO-8414-01A-11D-2310-10 42ac5002-fdad-426e-9037-e5cc99d093eb TCGA-KO-8414-01 42ac5002-fdad-426e-9037-e5cc99d093eb TCGA-KO-8414-01A-11D-2312-05 TCGA-KO-8414-01A-11D-2310-10 TCGA-KO-8414-01 TCGA-KO-8414-01A-11D-2308-01
89
+ TCGA-KO-8415-01 TCGA-KO-8415-01 TCGA-KO-8415 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 44 TCGA-KO-8415-F71945 TCGA-KO-8415 TCGA-KO-8415-01A M0 -16395 0 2939 Scheduled Follow-up Submission Complete Remission/Response 2015-5-1 FEMALE Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.9 NO Right 2.7 NO NO No M0 N0 T1 Stage I TCGA-KO-8415.7d23e227-9d0e-47c3-af54-dd60de59bd46.pdf 8415 TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 0.7 7th NO NO YES KO 1 Kidney A LIVING 2007 TCGA-KO-8415-01 5ee3613b-e8d8-44fb-a17b-1d5e59ed5fb8 TCGA-KO-8415-01A-11D-2308-01 TCGA-KO-8415-01A-11D-2310-10 5ee3613b-e8d8-44fb-a17b-1d5e59ed5fb8 95FADFBB-C414-4A90-A3BE-CF00F2905A9F TCGA-KO-8415-01 TCGA-KO-8415-01A-11D-2310-10 5ee3613b-e8d8-44fb-a17b-1d5e59ed5fb8 TCGA-KO-8415-01 5ee3613b-e8d8-44fb-a17b-1d5e59ed5fb8 TCGA-KO-8415-01A-11D-2312-05 TCGA-KO-8415-01A-11D-2310-10 TCGA-KO-8415-01 TCGA-KO-8415-01A-11D-2308-01
90
+ TCGA-KO-8415-11 TCGA-KO-8415-11 TCGA-KO-8415 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 44 TCGA-KO-8415-F71945 TCGA-KO-8415 M0 -16395 0 2939 Scheduled Follow-up Submission Complete Remission/Response 2015-5-1 FEMALE Kidney Chromophobe No C64.9 8317/3 C64.9 YES Right NO NO No M0 N0 T1 Stage I 8415 TUMOR FREE NO NO Complete Remission/Response NO Solid Tissue Normal 11 7th NO NO YES KO 1 Kidney LIVING 2007 e887731b-227e-458c-9a91-375ff7a91de1 e887731b-227e-458c-9a91-375ff7a91de1 TCGA-KO-8415-11 e887731b-227e-458c-9a91-375ff7a91de1 e887731b-227e-458c-9a91-375ff7a91de1 TCGA-KO-8415-11
91
+ TCGA-KO-8416-01 TCGA-KO-8416-01 TCGA-KO-8416 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 41 TCGA-KO-8416-F71946 TCGA-KO-8416 TCGA-KO-8416-01A M0 -15261 0 2752 Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 MALE Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.8 NO Right 2.5 NO NO 27 No M0 N0 T3a Stage III TCGA-KO-8416.a1c0eb6f-5aba-4b11-8303-434e976e89d6.pdf 8416 TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 0.6 7th NO NO YES KO 2 Kidney A LIVING 2007 TCGA-KO-8416-01 9d5d8b6b-f214-4549-92d9-4ac85f21d25e TCGA-KO-8416-01A-11D-2308-01 TCGA-KO-8416-01A-11D-2310-10 9d5d8b6b-f214-4549-92d9-4ac85f21d25e D9FCCF50-79FF-49E0-84E8-38653913C53A TCGA-KO-8416-01 TCGA-KO-8416-01A-11D-2310-10 9d5d8b6b-f214-4549-92d9-4ac85f21d25e TCGA-KO-8416-01 9d5d8b6b-f214-4549-92d9-4ac85f21d25e TCGA-KO-8416-01A-11D-2312-05 TCGA-KO-8416-01A-11D-2310-10 TCGA-KO-8416-01 TCGA-KO-8416-01A-11D-2308-01
92
+ TCGA-KO-8417-01 TCGA-KO-8417-01 TCGA-KO-8417 TCGA Kidney Chromophobe (KICH) kidney chromophobe Kidney 30 TCGA-KO-8417-F71947 TCGA-KO-8417 TCGA-KO-8417-01A M0 -11139 0 2815 Scheduled Follow-up Submission Complete Remission/Response 2015-3-31 FEMALE Kidney Chromophobe No C64.9 8317/3 C64.9 YES 0.9 NO Right 3.2 NO NO No M0 N0 T1 Stage I TCGA-KO-8417.6cd3d366-b7cc-4e94-874e-a8ea2ba07701.pdf 8417 TUMOR FREE NO NO Complete Remission/Response NO Primary Tumor 01 0.9 7th NO NO YES KO 1 Kidney A LIVING 2007 TCGA-KO-8417-01 6ec3effa-f0dd-4fae-90d3-c7a90a8e5041 TCGA-KO-8417-01A-11D-2308-01 TCGA-KO-8417-01A-11D-2310-10 6ec3effa-f0dd-4fae-90d3-c7a90a8e5041 523F5C06-E487-457E-B33C-5CD4F74592A3 TCGA-KO-8417-01 TCGA-KO-8417-01A-11D-2310-10 6ec3effa-f0dd-4fae-90d3-c7a90a8e5041 TCGA-KO-8417-01 6ec3effa-f0dd-4fae-90d3-c7a90a8e5041 TCGA-KO-8417-01A-11D-2312-05 TCGA-KO-8417-01A-11D-2310-10 TCGA-KO-8417-01 TCGA-KO-8417-01A-11D-2308-01
input/TCGA/TCGA_Kidney_Clear_Cell_Carcinoma_(KIRC)/TCGA.KIRC.sampleMap_KIRC_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Kidney_Papillary_Cell_Carcinoma_(KIRP)/TCGA.KIRP.sampleMap_KIRP_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Large_Bcell_Lymphoma_(DLBC)/TCGA.DLBC.sampleMap_DLBC_clinicalMatrix ADDED
@@ -0,0 +1,49 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ sampleID _INTEGRATION _PATIENT _cohort _primary_disease _primary_site age_at_initial_pathologic_diagnosis b_lymphocyte_genotyping_method bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode bone_marrow_biopsy_done bone_marrow_involvement bone_marrow_sample_histology clinical_stage days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_after_initial_treatment eastern_cancer_oncology_group ebv_positive_malignant_cells_percent ebv_status_malignant_cells_method epstein_barr_viral_status extranodal_involvement extranodal_involvment_site_other extranodal_sites_involvement_number first_progression_histology_type first_progression_histology_type_other first_recurrence_biopsy_confirmed follicular_percent followup_case_report_form_submission_reason followup_treatment_success form_completion_date gender genetic_abnormality_method_other genetic_abnormality_results genetic_abnormality_results_other genetic_abnormality_tested genetic_abnormality_tested_other height histological_type history_immunological_disease history_immunological_disease_other history_immunosuppresive_rx history_immunosuppressive_rx_other history_of_neoadjuvant_treatment history_relevant_infectious_dx hiv_status icd_10 icd_o_3_histology icd_o_3_site igh_genotype_results immunophenotypic_analysis_method immunophenotypic_analysis_results immunophenotypic_analysis_tested informed_consent_verified initial_weight intermediate_dimension is_ffpe ldh_level ldh_norm_range_upper longest_dimension lost_follow_up lymph_node_involvement_site maximum_tumor_bulk_anatomic_site maximum_tumor_dimension mib1_positive_percentage_range new_neoplasm_event_occurrence_anatomic_site new_neoplasm_occurrence_anatomic_site_text new_tumor_event_after_initial_treatment oct_embedded other_dx pathology_report_file_name patient_id person_neoplasm_cancer_status pet_scan_results primary_therapy_outcome_success radiation_therapy sample_type sample_type_id shortest_dimension system_version targeted_molecular_therapy tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tumor_tissue_site vial_number vital_status weight year_of_initial_pathologic_diagnosis _GENOMIC_ID_TCGA_DLBC_exp_HiSeqV2 _GENOMIC_ID_TCGA_DLBC_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_DLBC_PDMRNAseq _GENOMIC_ID_TCGA_DLBC_hMethyl450 _GENOMIC_ID_TCGA_DLBC_miRNA_HiSeq _GENOMIC_ID_TCGA_DLBC_gistic2thd _GENOMIC_ID_TCGA_DLBC_PDMRNAseqCNV _GENOMIC_ID_data/public/TCGA/DLBC/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_DLBC_gistic2 _GENOMIC_ID_TCGA_DLBC_mutation_bcm_gene _GENOMIC_ID_TCGA_DLBC_exp_HiSeqV2_percentile _GENOMIC_ID_TCGA_DLBC_RPPA _GENOMIC_ID_TCGA_DLBC_exp_HiSeqV2_PANCAN
2
+ TCGA-FA-8693-01 TCGA-FA-8693-01 TCGA-FA-8693 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 75 TCGA-FA-8693-F42020 TCGA-FA-8693 TCGA-FA-8693-01A Stage I -27468 0 132 YES 1 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2013-4-9 MALE 169 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C83.3 9680/3 C16.9 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Positive|Negative|Negative CD10 > 30%|CD20|CD5|Cyclin D1 YES 1.5 NO 2.8 YES 51 - 75% NO No TCGA-FA-8693.977683b9-1cad-4033-9825-7dbb84b171e1.pdf 8693 TUMOR FREE Not Done Complete Remission/Response NO Primary Tumor 01 0.5 7th YES YES NO FA Stomach A LIVING 82 2012 74108a37-6306-4389-93c2-b2d306ad6709 74108a37-6306-4389-93c2-b2d306ad6709 TCGA-FA-8693-01 TCGA-FA-8693-01A-11D-2399-05 TCGA-FA-8693-01 TCGA-FA-8693-01A-11D-2389-01 TCGA-FA-8693-01 TCGA-FA-8693-01 TCGA-FA-8693-01A-11D-2389-01 TCGA-FA-8693-01A-11D-2397-10 74108a37-6306-4389-93c2-b2d306ad6709 E80F1E78-0477-4A56-8F2C-CB88B6BB8938 74108a37-6306-4389-93c2-b2d306ad6709
3
+ TCGA-FA-A4BB-01 TCGA-FA-A4BB-01 TCGA-FA-A4BB TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 67 TCGA-FA-A4BB-F49912 TCGA-FA-A4BB TCGA-FA-A4BB-01A NO NO Stage IV -24590 97 0 132 YES Spleen 2 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2013-10-14 MALE 178 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C83.3 9680/3 C77.3 Immunohistochemistry|Immunohistochemistry Positive|Positive CD20|CD30 YES 1430 NO YES Axillary|Inguinal Axillary lymph nodes 3.5 NO true No TCGA-FA-A4BB.05B34041-D414-4215-9A66-2B7E4D09F4D5.pdf A4BB TUMOR FREE Not Done Complete Remission/Response NO Primary Tumor 01 7th YES YES NO FA Liver|Other Extranodal Site A LIVING 85 2012 d4923060-b733-42cb-ab55-b43a2c9a9151 d4923060-b733-42cb-ab55-b43a2c9a9151 TCGA-FA-A4BB-01 TCGA-FA-A4BB-01A-11D-A31Y-05 TCGA-FA-A4BB-01 TCGA-FA-A4BB-01A-11D-A31W-01 TCGA-FA-A4BB-01 TCGA-FA-A4BB-01 TCGA-FA-A4BB-01A-11D-A31W-01 TCGA-FA-A4BB-01A-11D-A31X-10 d4923060-b733-42cb-ab55-b43a2c9a9151 8071470F-41FB-441A-A3EA-43E08333109C d4923060-b733-42cb-ab55-b43a2c9a9151
4
+ TCGA-FA-A4XK-01 TCGA-FA-A4XK-01 TCGA-FA-A4XK TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 40 TCGA-FA-A4XK-F68091 TCGA-FA-A4XK TCGA-FA-A4XK-01A Stage II -14723 140 708 0 62 YES 1 < or = 10% Scheduled Follow-up Submission Progressive Disease 2014-11-21 MALE 165 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C83.3 9680/3 C17.1 Immunohistochemistry Positive CD20 YES 1370 NO NO other Small Intestine 10 NO true No TCGA-FA-A4XK.05EFF049-BF35-4D89-8968-5442C5FF375A.pdf A4XK TUMOR FREE Not Done Complete Remission/Response NO Primary Tumor 01 7th NO YES NO FA Small intestine A DECEASED 60 2012 95db81b0-d9e6-4cbf-b13f-7c1b92c26484 95db81b0-d9e6-4cbf-b13f-7c1b92c26484 TCGA-FA-A4XK-01 TCGA-FA-A4XK-01A-11D-A31Y-05 TCGA-FA-A4XK-01 TCGA-FA-A4XK-01A-11D-A31W-01 TCGA-FA-A4XK-01 TCGA-FA-A4XK-01 TCGA-FA-A4XK-01A-11D-A31W-01 TCGA-FA-A4XK-01A-11D-A31X-10 95db81b0-d9e6-4cbf-b13f-7c1b92c26484 923E2FAF-6F97-4D7E-983E-6D982490825B 95db81b0-d9e6-4cbf-b13f-7c1b92c26484
5
+ TCGA-FA-A6HN-01 TCGA-FA-A6HN-01 TCGA-FA-A6HN TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 73 TCGA-FA-A6HN-F63567 TCGA-FA-A6HN TCGA-FA-A6HN-01A NO -27025 97 58 0 6 NO < or = 10% Scheduled Follow-up Submission Progressive Disease 2014-8-13 MALE 162 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C83.3 9680/3 C77.0 Immunohistochemistry Positive CD20 YES 150 NO NO cervical Cervical lymph nodes 1.5 NO true No TCGA-FA-A6HN.8776C20D-275D-4859-86E3-0CE38C5B7912.pdf A6HN TUMOR FREE Not Done Progressive Disease NO Primary Tumor 01 7th YES YES NO FA A DECEASED 58 2013 f6788ba9-322e-49b0-93e4-f1b451f2a985 f6788ba9-322e-49b0-93e4-f1b451f2a985 TCGA-FA-A6HN-01 TCGA-FA-A6HN-01A-11D-A31Y-05 TCGA-FA-A6HN-01 TCGA-FA-A6HN-01A-11D-A31W-01 TCGA-FA-A6HN-01 TCGA-FA-A6HN-01 TCGA-FA-A6HN-01A-11D-A31W-01 TCGA-FA-A6HN-01A-11D-A31X-10 f6788ba9-322e-49b0-93e4-f1b451f2a985 567EC21A-D4DD-493B-BE78-57D4ECBA5A11 f6788ba9-322e-49b0-93e4-f1b451f2a985
6
+ TCGA-FA-A6HO-01 TCGA-FA-A6HO-01 TCGA-FA-A6HO TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 58 TCGA-FA-A6HO-F71473 TCGA-FA-A6HO TCGA-FA-A6HO-01A NO -21330 85 0 749 739 NO NO < or = 10% Scheduled Follow-up Submission Progressive Disease 2015-3-30 FEMALE 158 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C83.3 9680/3 C77.0 Immunohistochemistry Positive CD20 YES 140 NO NO cervical Cervical 1.5 Paraaortic lymph nodes YES true No TCGA-FA-A6HO.E2645414-D707-419D-B43D-92AE9D56DCD1.pdf A6HO WITH TUMOR Not Done Complete Remission/Response NO Primary Tumor 01 7th YES YES NO FA A LIVING 61 2013 52ece957-8f21-4f13-a61d-7b2e1c850ef5 52ece957-8f21-4f13-a61d-7b2e1c850ef5 TCGA-FA-A6HO-01 TCGA-FA-A6HO-01A-11D-A31Y-05 TCGA-FA-A6HO-01 TCGA-FA-A6HO-01A-11D-A31W-01 TCGA-FA-A6HO-01 TCGA-FA-A6HO-01 TCGA-FA-A6HO-01A-11D-A31W-01 TCGA-FA-A6HO-01A-11D-A31X-10 52ece957-8f21-4f13-a61d-7b2e1c850ef5 731E0A85-D8EA-4F5D-9EC4-35131FD15957 52ece957-8f21-4f13-a61d-7b2e1c850ef5
7
+ TCGA-FA-A7DS-01 TCGA-FA-A7DS-01 TCGA-FA-A7DS TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 54 TCGA-FA-A7DS-F71471 TCGA-FA-A7DS TCGA-FA-A7DS-01A NO Stage II -20087 138 0 719 NO 1 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2015-3-30 FEMALE 157 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C50.9 9680/3 C50.9 Immunohistochemistry Positive CD20 YES 780 NO NO other Breast 4 NO true No TCGA-FA-A7DS.F36A477E-88C9-476A-BF68-61CA129A30A1.pdf A7DS TUMOR FREE Not Done Complete Remission/Response NO Primary Tumor 01 7th YES YES NO FA Breast A LIVING 60 2013 c221049a-13bf-46fa-a049-20b853ea4091 c221049a-13bf-46fa-a049-20b853ea4091 TCGA-FA-A7DS-01 TCGA-FA-A7DS-01A-11D-A383-05 TCGA-FA-A7DS-01 TCGA-FA-A7DS-01A-11D-A381-01 TCGA-FA-A7DS-01 TCGA-FA-A7DS-01 TCGA-FA-A7DS-01A-11D-A381-01 TCGA-FA-A7DS-01A-11D-A382-10 c221049a-13bf-46fa-a049-20b853ea4091 58611192-9423-4830-9281-52DD014102B0 c221049a-13bf-46fa-a049-20b853ea4091
8
+ TCGA-FA-A7Q1-01 TCGA-FA-A7Q1-01 TCGA-FA-A7Q1 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 61 TCGA-FA-A7Q1-F63621 TCGA-FA-A7Q1 TCGA-FA-A7Q1-01A NO Stage I -22454 158 248 0 22 NO < or = 10% Scheduled Follow-up Submission 2014-12-11 FEMALE 157 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C48.1 9680/3 C48.1 Immunohistochemistry Positive CD20 YES 170 NO NO mesenteric Mesenteric lymph nodes 3 NO true No TCGA-FA-A7Q1.D9C18E71-3D93-4B22-87B7-E5C34CC670C5.pdf A7Q1 TUMOR FREE Not Done Complete Remission/Response NO Primary Tumor 01 7th YES YES NO FA A DECEASED 65 2013 d6edbae7-9967-4bf5-9fcf-433dc71b35f8 d6edbae7-9967-4bf5-9fcf-433dc71b35f8 TCGA-FA-A7Q1-01 TCGA-FA-A7Q1-01A-11D-A383-05 TCGA-FA-A7Q1-01 TCGA-FA-A7Q1-01A-11D-A381-01 TCGA-FA-A7Q1-01 TCGA-FA-A7Q1-01 TCGA-FA-A7Q1-01A-11D-A381-01 TCGA-FA-A7Q1-01A-11D-A382-10 d6edbae7-9967-4bf5-9fcf-433dc71b35f8 C696CE3E-8BAE-4015-ABE2-C4C21E778548 d6edbae7-9967-4bf5-9fcf-433dc71b35f8
9
+ TCGA-FA-A82F-01 TCGA-FA-A82F-01 TCGA-FA-A82F TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 48 TCGA-FA-A82F-F65335 TCGA-FA-A82F TCGA-FA-A82F-01A NO Stage II -17819 97 0 427 NO 1 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2014-9-22 FEMALE 157 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C83.3 9680/3 C17.9 Immunohistochemistry|Immunohistochemistry Positive|Positive CD20|PAX5 YES 580 NO NO mesenteric Small Intestine 6 NO true No TCGA-FA-A82F.9BDF3D5C-8203-4F43-9BE5-8F1F278C124B.pdf A82F TUMOR FREE Not Done Complete Remission/Response NO Primary Tumor 01 7th YES YES NO FA Small intestine A LIVING 50 2013 49237a86-9b3c-40ed-8b94-c0a5d9e15c82 49237a86-9b3c-40ed-8b94-c0a5d9e15c82 TCGA-FA-A82F-01 TCGA-FA-A82F-01A-11D-A383-05 TCGA-FA-A82F-01 TCGA-FA-A82F-01A-11D-A381-01 TCGA-FA-A82F-01 TCGA-FA-A82F-01 TCGA-FA-A82F-01A-11D-A381-01 TCGA-FA-A82F-01A-11D-A382-10 49237a86-9b3c-40ed-8b94-c0a5d9e15c82 1379785E-11E5-467C-B727-69C256F1F58E 49237a86-9b3c-40ed-8b94-c0a5d9e15c82
10
+ TCGA-FA-A86F-01 TCGA-FA-A86F-01 TCGA-FA-A86F TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 64 TCGA-FA-A86F-F70699 TCGA-FA-A86F TCGA-FA-A86F-01A NO Stage III -23641 86 0 553 150 NO NO < or = 10% Scheduled Follow-up Submission Partial Remission/Response 2015-3-2 FEMALE 156 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) No Negative C83.3 9680/3 C77.3 Immunohistochemistry|Immunohistochemistry Negative|Positive CD10 > 30%|CD20 YES 510 NO NO Axillary 2 26 - 50% Other, specify Inguinal, mediastinal, submandibular, hilar YES true No TCGA-FA-A86F.6D34FB3F-83A5-4B8D-AB2A-76931ED85F9F.pdf A86F WITH TUMOR Not Done Partial Remission/Response NO Primary Tumor 01 7th YES YES NO FA A LIVING 67 2013 a3ca2450-1f4e-4372-bdd4-46f83e2e9602 a3ca2450-1f4e-4372-bdd4-46f83e2e9602 TCGA-FA-A86F-01 TCGA-FA-A86F-01A-11D-A383-05 TCGA-FA-A86F-01 TCGA-FA-A86F-01A-11D-A381-01 TCGA-FA-A86F-01 TCGA-FA-A86F-01 TCGA-FA-A86F-01A-11D-A381-01 TCGA-FA-A86F-01A-11D-A382-10 a3ca2450-1f4e-4372-bdd4-46f83e2e9602 37D2BBC9-18DF-430A-9D98-BD71273FA2F0 a3ca2450-1f4e-4372-bdd4-46f83e2e9602
11
+ TCGA-FF-8041-01 TCGA-FF-8041-01 TCGA-FF-8041 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 28 TCGA-FF-8041-F30778 TCGA-FF-8041 TCGA-FF-8041-01A NO Stage I -10466 0 1081 0 NO < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2011-12-14 FEMALE FISH|FISH| Normal|Normal|Normal|Normal|Normal Normal|Normal| C-MYC|BCL2|BCL6|CCND1|MALT1 IGH|PAX5| 173 Primary mediastinal (thymic) DLBCL None No Negative C38.1 9680/3 C38.1 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD30|Cyclin D1 YES NO 499 380 mediastinal mediastinal 12 76 - 100% NO No TCGA-FF-8041.6d6d4023-46b1-41c8-8e41-b19aabe93504.pdf 8041 TUMOR FREE Negative Complete Remission/Response NO Primary Tumor 01 7th YES NO YES FF A LIVING 58.9 2010 40024e0a-a264-4dd8-9138-9a468b9c12ca 40024e0a-a264-4dd8-9138-9a468b9c12ca TCGA-FF-8041-01 TCGA-FF-8041-01A-11D-2211-05 TCGA-FF-8041-01 TCGA-FF-8041-01A-11D-2209-01 TCGA-FF-8041-01 TCGA-FF-8041-01 TCGA-FF-8041-01A-11D-2209-01 TCGA-FF-8041-01A-11D-2210-10 40024e0a-a264-4dd8-9138-9a468b9c12ca 69683AA1-5878-4F74-BE5A-40A19AF5A9BF 40024e0a-a264-4dd8-9138-9a468b9c12ca
12
+ TCGA-FF-8042-01 TCGA-FF-8042-01 TCGA-FF-8042 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 57 TCGA-FF-8042-F30771 TCGA-FF-8042 TCGA-FF-8042-01A NO Stage II -21005 0 946 0 NO < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2011-12-14 FEMALE FISH|FISH| Normal|Translocation|Normal|Normal|Normal Normal|Normal| C-MYC|BCL2|BCL6|CCND1|MALT1 PAX5|IGH| 171 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Hepatitis B Virus Negative C83.3 9680/3 C77.0 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative|Negative CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD79a|CD5|Cyclin D1 YES NO 461 380 cervical|supraclavicular Supraclavicular lymph nodes 1.5 76 - 100% NO No TCGA-FF-8042.6cdcaac9-0654-4bda-8344-ce0b810abb15.pdf 8042 TUMOR FREE Negative Complete Remission/Response NO Primary Tumor 01 7th YES NO YES FF A LIVING 89.9 2010 144739d3-b2d3-493c-8731-d652f03a5b37 144739d3-b2d3-493c-8731-d652f03a5b37 TCGA-FF-8042-01 TCGA-FF-8042-01A-11D-2211-05 TCGA-FF-8042-01 TCGA-FF-8042-01A-11D-2209-01 TCGA-FF-8042-01 TCGA-FF-8042-01 TCGA-FF-8042-01A-11D-2209-01 TCGA-FF-8042-01A-11D-2210-10 144739d3-b2d3-493c-8731-d652f03a5b37 DCF7BA40-E2A3-4FC8-9720-39B6426D2F2F 144739d3-b2d3-493c-8731-d652f03a5b37
13
+ TCGA-FF-8043-01 TCGA-FF-8043-01 TCGA-FF-8043 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 70 TCGA-FF-8043-F30759 TCGA-FF-8043 TCGA-FF-8043-01A NO Stage II -25612 0 965 1 YES 1 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2011-12-14 FEMALE FISH|FISH| Normal|Normal|Normal|Normal|Normal Normal|Normal| C-MYC|BCL2|BCL6|CCND1|MALT1 PAX5|IGH| 146 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Hepatitis B Virus Negative C83.3 9680/3 C18.9 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Positive|Positive|Positive|Positive|Negative|Negative CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD5|Cyclin D1 YES NO 536 380 mesenteric Colon 0.4 76 - 100% NO No TCGA-FF-8043.a6785541-7d40-4a2d-b828-19376217866b.pdf 8043 TUMOR FREE Negative Complete Remission/Response NO Primary Tumor 01 7th YES NO YES FF Colon A LIVING 41.5 2010 f43a92ce-fc88-4e40-be91-0b5641ad844e f43a92ce-fc88-4e40-be91-0b5641ad844e TCGA-FF-8043-01 TCGA-FF-8043-01A-11D-2211-05 TCGA-FF-8043-01 TCGA-FF-8043-01A-11D-2209-01 TCGA-FF-8043-01 TCGA-FF-8043-01 TCGA-FF-8043-01A-11D-2209-01 TCGA-FF-8043-01A-11D-2210-10 f43a92ce-fc88-4e40-be91-0b5641ad844e EB52A17E-5E44-4B21-9192-2A476171C5F8 f43a92ce-fc88-4e40-be91-0b5641ad844e
14
+ TCGA-FF-8046-01 TCGA-FF-8046-01 TCGA-FF-8046 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 51 TCGA-FF-8046-F30762 TCGA-FF-8046 TCGA-FF-8046-01A NO Stage II -18853 0 751 0 NO < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2011-12-14 MALE FISH|FISH|FISH|FISH| Translocation|Normal|Normal|Normal|Normal Normal|Translocation|Normal|Normal| C-MYC|BCL2|BCL6|CCND1|MALT1 PAX5|IGH|IGK|IGL| 178 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C08.0 9680/3 C08.0 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Positive|Negative|Positive|Positive|Positive|Negative CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|Cyclin D1 YES NO 623 380 cervical|Submandibular Thyroid 4.8 76 - 100% NO No TCGA-FF-8046.78b14526-0c81-4065-8c26-46197a6b2324.pdf 8046 TUMOR FREE Negative Complete Remission/Response NO Primary Tumor 01 7th YES YES NO FF A LIVING 81.9 2011 a0091162-1691-4b4c-990f-c58369e09548 a0091162-1691-4b4c-990f-c58369e09548 TCGA-FF-8046-01 TCGA-FF-8046-01A-11D-2211-05 TCGA-FF-8046-01 TCGA-FF-8046-01A-11D-2209-01 TCGA-FF-8046-01 TCGA-FF-8046-01 TCGA-FF-8046-01A-11D-2209-01 TCGA-FF-8046-01A-11D-2210-10 a0091162-1691-4b4c-990f-c58369e09548 EC8DB612-B2AB-4A29-9150-048BF6E25816 a0091162-1691-4b4c-990f-c58369e09548
15
+ TCGA-FF-8047-01 TCGA-FF-8047-01 TCGA-FF-8047 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 38 TCGA-FF-8047-F30870 TCGA-FF-8047 TCGA-FF-8047-01A NO Stage II -13996 0 126 24 2 NO Diffuse Large B-Cell Lymphoma YES < or = 10% Additional New Tumor Event Progressive Disease 2012-1-5 FEMALE FISH|FISH| Translocation|Normal|Translocation|Normal|Normal Normal|Translocation| C-MYC|BCL2|BCL6|CCND1|MALT1 PAX5|IGH| 155 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Hepatitis B Virus Negative C83.3 9680/3 C77.0 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Positive|Positive|Positive|Positive|Negative CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|Cyclin D1 YES NO 667 380 cervical|Inguinal Cervical 2.0 76 - 100% Leptomeninges YES No TCGA-FF-8047.eea72d00-007d-4b3c-8760-889d859674d0.pdf 8047 WITH TUMOR Positive Progressive Disease NO Primary Tumor 01 7th YES YES NO FF A LIVING 52.5 2011 6fbec533-7f89-4d12-b04c-cf92942c3f33 6fbec533-7f89-4d12-b04c-cf92942c3f33 TCGA-FF-8047-01 TCGA-FF-8047-01A-11D-2211-05 TCGA-FF-8047-01 TCGA-FF-8047-01A-11D-2209-01 TCGA-FF-8047-01 TCGA-FF-8047-01 TCGA-FF-8047-01A-11D-2209-01 TCGA-FF-8047-01A-11D-2210-10 6fbec533-7f89-4d12-b04c-cf92942c3f33 B05EB5CD-1C5B-47C3-80D5-59B0CB5BB3B4 6fbec533-7f89-4d12-b04c-cf92942c3f33
16
+ TCGA-FF-8061-01 TCGA-FF-8061-01 TCGA-FF-8061 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 42 TCGA-FF-8061-F30766 TCGA-FF-8061 TCGA-FF-8061-01A NO Stage II -15358 0 832 0 YES 1 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2012-1-17 MALE FISH|FISH| Normal|Normal|Normal|Normal|Normal Normal|Translocation| C-MYC|BCL2|BCL6|CCND1|MALT1 PAX5|IGH| 171 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C83.3 9680/3 C17.9 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Positive|Positive|Positive|Positive|Positive|Positive CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|PAX5 YES 0.6 NO 414 380 0.7 mesenteric Small Intestine 15 76 - 100% NO No TCGA-FF-8061.9ea8bb70-9001-4ba3-8f3d-6b97af99f875.pdf 8061 TUMOR FREE Negative Complete Remission/Response NO Primary Tumor 01 0.4 7th YES YES NO FF Small intestine A LIVING 48.1 2010 953e90e7-a9a6-47d6-bd4a-fe18e780b9e0 953e90e7-a9a6-47d6-bd4a-fe18e780b9e0 TCGA-FF-8061-01 TCGA-FF-8061-01A-11D-2211-05 TCGA-FF-8061-01 TCGA-FF-8061-01A-11D-2209-01 TCGA-FF-8061-01 TCGA-FF-8061-01 TCGA-FF-8061-01A-11D-2209-01 TCGA-FF-8061-01A-11D-2210-10 953e90e7-a9a6-47d6-bd4a-fe18e780b9e0 27280077-9303-47C8-B3AA-51B5C4C66B35 953e90e7-a9a6-47d6-bd4a-fe18e780b9e0
17
+ TCGA-FF-8062-01 TCGA-FF-8062-01 TCGA-FF-8062 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 60 TCGA-FF-8062-F30774 TCGA-FF-8062 TCGA-FF-8062-01A NO Stage I -21959 0 679 0 YES 1 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2012-1-17 FEMALE FISH|FISH|FISH|FISH| Normal|Normal|Normal|Normal|Normal Normal|Normal|Normal|Normal| C-MYC|BCL2|BCL6|CCND1|MALT1 PAX5|IGH|IGK|IGL| 157 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Hepatitis B Virus Negative C83.3 9680/3 C73.9 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Positive|Negative|Positive|Negative|Negative CD10 > 30%|BCL2|CD20|MUM1 > 30%|Cyclin D1 YES 0.9 NO 682 380 0.9 Thyroid 2.0 76 - 100% NO No TCGA-FF-8062.cd5128c3-d5f8-4efb-acc3-ed3d6b8aae3f.pdf 8062 TUMOR FREE Negative Complete Remission/Response NO Primary Tumor 01 0.5 7th YES YES NO FF Thyroid A LIVING 60.1 2011 594f57f1-a1a9-4a3d-ae9e-fa601a29c917 594f57f1-a1a9-4a3d-ae9e-fa601a29c917 TCGA-FF-8062-01 TCGA-FF-8062-01A-11D-2211-05 TCGA-FF-8062-01 TCGA-FF-8062-01A-11D-2209-01 TCGA-FF-8062-01 TCGA-FF-8062-01 TCGA-FF-8062-01A-11D-2209-01 TCGA-FF-8062-01A-11D-2210-10 594f57f1-a1a9-4a3d-ae9e-fa601a29c917 85287531-553A-4096-B931-1F2BAFA9D262 594f57f1-a1a9-4a3d-ae9e-fa601a29c917
18
+ TCGA-FF-A7CQ-01 TCGA-FF-A7CQ-01 TCGA-FF-A7CQ TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 74 TCGA-FF-A7CQ-F50787 TCGA-FF-A7CQ TCGA-FF-A7CQ-01A YES YES Concordant Histology Stage IV -27255 1062 0 298 255 3 YES bladder 6 NO < or = 10% Scheduled Follow-up Submission Stable Disease 2014-9-18 MALE FISH|FISH Normal|Amplification|Normal|Normal Normal|Normal C-MYC|BCL2|BCL6|MALT1 PAX 5|IGH 162 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C83.3 9680/3 C77.0 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Positive|Positive|Positive|Negative|Negative|Negative CD10 > 30%|BCL2|CD20|MUM1 > 30%|CD138|CD15|Cyclin D1 YES 70 NO 978 380 YES Axillary|cervical|hilar|Iliac-common|Iliac-external|mediastinal|mesenteric|para-aortic|retroperitoneal|Splenic Paratracheal/Mediastinal 3.4 51 - 75% Brain YES false No TCGA-FF-A7CQ.3CCFB076-52BE-4A5D-9E49-65516AA9C349.pdf A7CQ Positive Stable Disease NO Primary Tumor 01 7th YES NO YES FF Adrenal|Bone|Bone Marrow|Liver|Pleura/Pleural Effusion|Other Extranodal Site A LIVING 43.9 2010 7c955c67-e0be-4c07-b0e9-b70da3a7f116 7c955c67-e0be-4c07-b0e9-b70da3a7f116 TCGA-FF-A7CQ-01 TCGA-FF-A7CQ-01A-11D-A383-05 TCGA-FF-A7CQ-01 TCGA-FF-A7CQ-01A-11D-A381-01 TCGA-FF-A7CQ-01 TCGA-FF-A7CQ-01 TCGA-FF-A7CQ-01A-11D-A381-01 TCGA-FF-A7CQ-01A-11D-A382-10 7c955c67-e0be-4c07-b0e9-b70da3a7f116 7c955c67-e0be-4c07-b0e9-b70da3a7f116
19
+ TCGA-FF-A7CR-01 TCGA-FF-A7CR-01 TCGA-FF-A7CR TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 61 TCGA-FF-A7CR-F50793 TCGA-FF-A7CR TCGA-FF-A7CR-01A NO NO Stage IV -22471 464 313 0 290 0 YES 2 Diffuse Large B-Cell Lymphoma YES < or = 10% Additional New Tumor Event Progressive Disease 2013-10-30 MALE FISH|FISH|FISH|FISH| Normal|Normal|Normal|Normal|Normal Normal|Translocation|Normal|Normal| C-MYC|BCL2|BCL6|CCND1|MALT1 PAX5|IGH|FoxP1|BCL10| 170 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Hepatitis C Negative C83.3 9680/3 C77.0 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Positive|Positive|Positive|Positive|Positive|Positive|Positive|Negative|Negative|Negative CD10 > 30%|BCL2|CD20|MUM1 > 30%|CD138|BCL6 > 30%|CD23|CD5|CD30|EBER|Cyclin D1 YES 360 NO 446 380 NO Axillary|cervical|Inguinal|retroperitoneal Cervical lymph nodes 3 0 - 25% Other, specify Skin (Calf and Chest wall) YES false No TCGA-FF-A7CR.C522C0BD-7968-48C0-8E96-6143740993E7.pdf A7CR WITH TUMOR Not Done Progressive Disease NO Primary Tumor 01 7th YES NO YES FF Brain|Sinus A DECEASED 73 2012 bc8a3747-bd29-4388-94b9-74d92b6db3a3 bc8a3747-bd29-4388-94b9-74d92b6db3a3 TCGA-FF-A7CR-01 TCGA-FF-A7CR-01A-11D-A383-05 TCGA-FF-A7CR-01 TCGA-FF-A7CR-01A-11D-A381-01 TCGA-FF-A7CR-01 TCGA-FF-A7CR-01 TCGA-FF-A7CR-01A-11D-A381-01 TCGA-FF-A7CR-01A-11D-A382-10 bc8a3747-bd29-4388-94b9-74d92b6db3a3 8226E058-6678-4E67-AE03-88CA503D55B1 bc8a3747-bd29-4388-94b9-74d92b6db3a3
20
+ TCGA-FF-A7CW-01 TCGA-FF-A7CW-01 TCGA-FF-A7CW TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 72 TCGA-FF-A7CW-F59614 TCGA-FF-A7CW TCGA-FF-A7CW-01A YES NO Stage II -26520 544 0 791 0 YES 1 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2014-5-16 MALE FISH|FISH Normal|Normal|Normal|Normal Normal|Normal C-MYC|BCL2|BCL6|MALT1 PAX5|IGH 154 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C83.3 9680/3 C77.0 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Positive|Positive|Positive|Negative|Positive|Negative|Negative|Negative CD10 > 30%|BCL2|CD20|MUM1 > 30%|CD138|BCL6 > 30%|CD30|EBER|Cyclin D1 YES 230 NO 426 380 NO cervical Supraclavicular lymph nodes 2.1 51 - 75% NO false No TCGA-FF-A7CW.FF947398-211F-4ED6-A157-B86B7198B1B9.pdf A7CW TUMOR FREE Negative Complete Remission/Response NO Primary Tumor 01 7th YES NO YES FF Parotid Gland A LIVING 51 2012 153f39e2-7b24-47c4-83ac-18a4f7441928 153f39e2-7b24-47c4-83ac-18a4f7441928 TCGA-FF-A7CW-01 TCGA-FF-A7CW-01A-11D-A383-05 TCGA-FF-A7CW-01 TCGA-FF-A7CW-01A-11D-A381-01 TCGA-FF-A7CW-01 TCGA-FF-A7CW-01 TCGA-FF-A7CW-01A-11D-A381-01 TCGA-FF-A7CW-01A-11D-A382-10 153f39e2-7b24-47c4-83ac-18a4f7441928 F97B961B-EBFF-42C1-8C90-FEFC0E35B82E 153f39e2-7b24-47c4-83ac-18a4f7441928
21
+ TCGA-FF-A7CX-01 TCGA-FF-A7CX-01 TCGA-FF-A7CX TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 46 TCGA-FF-A7CX-F50789 TCGA-FF-A7CX TCGA-FF-A7CX-01A YES NO Stage IV -16924 747 0 385 0 EBER in situ hybridization negative YES 4 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2013-10-30 MALE FISH|FISH|FISH Normal|Normal|Normal|Normal|Normal Normal|Normal|Normal C-MYC|BCL2|BCL6|CCND1|MALT1 PAX 5|IGH|BCL10 174 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C49.0 9680/3 C49.0 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative|Negative CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD5|Cytoplasmic Ig|EBER|Cyclin D1 YES 160 NO 714 380 YES cervical Lung 2.4 51 - 75% NO false No TCGA-FF-A7CX.7CABE1CC-F2F2-4B54-9568-DCFE2065C86B.pdf A7CX TUMOR FREE Not Done Complete Remission/Response NO Primary Tumor 01 7th YES NO YES FF Adrenal|Soft Tissue (muscle ligaments subcutaneous)|Brain|Thyroid|Lung A LIVING 66 2011 50f79ec5-c16a-4c56-909a-e32439b3ce2c 50f79ec5-c16a-4c56-909a-e32439b3ce2c TCGA-FF-A7CX-01 TCGA-FF-A7CX-01A-12D-A383-05 TCGA-FF-A7CX-01 TCGA-FF-A7CX-01A-12D-A381-01 TCGA-FF-A7CX-01 TCGA-FF-A7CX-01 TCGA-FF-A7CX-01A-12D-A381-01 TCGA-FF-A7CX-01A-12D-A382-10 50f79ec5-c16a-4c56-909a-e32439b3ce2c 00476332-55DE-4045-B5C0-60FF4AE3C5B7 50f79ec5-c16a-4c56-909a-e32439b3ce2c
22
+ TCGA-FM-8000-01 TCGA-FM-8000-01 TCGA-FM-8000 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 70 TCGA-FM-8000-F64268 TCGA-FM-8000 TCGA-FM-8000-01A NO Discordant Histology Stage II -25724 0 972 YES 2 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2014-8-28 FEMALE 155.0 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) Other Diverticulitis requiring colectomy None No Negative C83.3 9680/3 C18.9 Flow cytometry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Positive|Negative|Positive|Negative|Positive|Positive|Positive|Positive|Negative CD19|CD10 > 30%|CD20|MUM1 > 30%|BCL6 > 30%|CD23|PAX5|CD5|Cyclin D1 YES 0.6 NO 321 260 1 NO Colon 12 26 - 50% NO No TCGA-FM-8000.a30ee8fa-e177-458d-b0db-2637de27c3d7.pdf 8000 TUMOR FREE Negative Complete Remission/Response NO Primary Tumor 01 0.4 7th YES YES NO FM Colon|Small intestine A LIVING 69.5 2011 a35b6840-486a-4384-a714-48f1c4fe4f04 a35b6840-486a-4384-a714-48f1c4fe4f04 TCGA-FM-8000-01 TCGA-FM-8000-01A-11D-2211-05 TCGA-FM-8000-01 TCGA-FM-8000-01A-11D-2209-01 TCGA-FM-8000-01 TCGA-FM-8000-01 TCGA-FM-8000-01A-11D-2209-01 TCGA-FM-8000-01A-11D-2210-10 a35b6840-486a-4384-a714-48f1c4fe4f04 820C6BBB-9436-49F7-B47F-4CD9B9452243 a35b6840-486a-4384-a714-48f1c4fe4f04
23
+ TCGA-G8-6324-01 TCGA-G8-6324-01 TCGA-G8-6324 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 43 IgH PCR TCGA-G8-6324-F37605 TCGA-G8-6324 TCGA-G8-6324-01A YES Discordant Histology Stage IV -15750 1252 0 338 1 YES 1 NO Scheduled Follow-up Submission Progressive Disease 2012-12-5 FEMALE Normal|Normal|Normal BCL2|BCL6|CCND1 165.5 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C83.3 9680/3 C77.2 Clonal Flow cytometry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Flow cytometry Positive|Negative|Positive|Positive|Positive|Positive|Positive|Positive|Positive|Positive|Negative|Negative CD19|CD10 > 30%|BCL2|CD20|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD23|PAX5|CD5|CD5 YES 0.3 NO 498 618 0.6 NO mesenteric 51 - 75% Supraclavicular lymph nodes YES No TCGA-G8-6324.d42f1d12-1281-4822-8342-a9b14729432a.pdf 6324 WITH TUMOR Negative Complete Remission/Response NO Primary Tumor 01 0.2 6th YES NO YES G8 Ascites/Peritoneum A DECEASED 60 2006 803db8de-5812-4dca-9e0e-aaa49096fd25 803db8de-5812-4dca-9e0e-aaa49096fd25 TCGA-G8-6324-01 TCGA-G8-6324-01A-11D-2211-05 TCGA-G8-6324-01 TCGA-G8-6324-01A-11D-2209-01 TCGA-G8-6324-01 TCGA-G8-6324-01 TCGA-G8-6324-01A-11D-2209-01 TCGA-G8-6324-01A-11D-2210-10 803db8de-5812-4dca-9e0e-aaa49096fd25 803db8de-5812-4dca-9e0e-aaa49096fd25
24
+ TCGA-G8-6325-01 TCGA-G8-6325-01 TCGA-G8-6325 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 69 IgH PCR TCGA-G8-6325-F40599 TCGA-G8-6325 TCGA-G8-6325-01A NO Stage IV -25256 0 1581 1 NO 0 Scheduled Follow-up Submission Stable Disease 2013-2-25 MALE 171 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) Rheumatoid Arthritis|Other Non-insulin dependent diabetes mellitus Methotrexate No Negative C83.3 9680/3 C77.2 Clonal Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Positive|Positive|Positive|Positive|Negative CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD30 YES 0.4 NO 618 1 NO retroperitoneal 51 - 75% NO No TCGA-G8-6325.addc26cd-1381-4a9b-882a-e55287f791ef.pdf 6325 TUMOR FREE Not Done Stable Disease NO Primary Tumor 01 0.4 6th YES NO YES G8 A LIVING 105.7 2008 05173547-1e4d-4a6d-ac36-9aaa92488a73 05173547-1e4d-4a6d-ac36-9aaa92488a73 TCGA-G8-6325-01 TCGA-G8-6325-01A-11D-2211-05 TCGA-G8-6325-01 TCGA-G8-6325-01A-11D-2209-01 TCGA-G8-6325-01 TCGA-G8-6325-01 TCGA-G8-6325-01A-11D-2209-01 TCGA-G8-6325-01A-11D-2210-10 05173547-1e4d-4a6d-ac36-9aaa92488a73 918C15AA-0B22-45FA-B10A-67F689815137 05173547-1e4d-4a6d-ac36-9aaa92488a73
25
+ TCGA-G8-6326-01 TCGA-G8-6326-01 TCGA-G8-6326 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 52 IgH PCR TCGA-G8-6326-F68655 TCGA-G8-6326 TCGA-G8-6326-01A YES Concordant Histology Stage IV -19238 0 2131 0 EBER in situ hybridization negative YES Omentum 2 Scheduled Follow-up Submission Complete Remission/Response 2014-12-5 MALE 185 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C48.1 9680/3 C48.1 Clonal Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Positive|Positive|Negative|Negative|Positive|Positive|Negative|Negative|Negative|Negative CD10 > 30%|CD20|BCL6 > 30%|MUM1 > 30%|CD23|CD79a|PAX5|CD5|CD30|CD15|ALK YES 0.5 NO 964 618 2.5 NO mesenteric NO No TCGA-G8-6326.3e506666-5cef-4416-9c02-1df6982b4ed1.pdf 6326 TUMOR FREE Indeterminate Progressive Disease NO Primary Tumor 01 0.4 6th YES NO YES G8 Ascites/Peritoneum|Other Extranodal Site A LIVING 127.7 2009 c66f6b85-0626-4e3a-8ec6-1cfc0a7def6b c66f6b85-0626-4e3a-8ec6-1cfc0a7def6b TCGA-G8-6326-01 TCGA-G8-6326-01A-11D-2211-05 TCGA-G8-6326-01 TCGA-G8-6326-01A-11D-2209-01 TCGA-G8-6326-01 TCGA-G8-6326-01 TCGA-G8-6326-01A-11D-2209-01 TCGA-G8-6326-01A-11D-2210-10 c66f6b85-0626-4e3a-8ec6-1cfc0a7def6b 91A967FA-0080-4BD3-AC2E-2096CEABE92A c66f6b85-0626-4e3a-8ec6-1cfc0a7def6b
26
+ TCGA-G8-6906-01 TCGA-G8-6906-01 TCGA-G8-6906 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 58 IgH Southern Blot TCGA-G8-6906-F32214 TCGA-G8-6906 TCGA-G8-6906-01A NO -21272 6425 0 6383 YES Spleen 1 Scheduled Follow-up Submission 2012-5-17 MALE 164.3 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) Yes Negative C83.3 9680/3 C77.2 Non-Clonal Flow cytometry|Flow cytometry|Immunohistochemistry Positive|Negative|Positive CD19|CD10 > 30%|BCL2 YES 1 NO 325 185 1.1 para-aortic|retroperitoneal YES No TCGA-G8-6906.78e17250-f41c-49af-8738-945cbba5c937.pdf 6906 TUMOR FREE Not Done Complete Remission/Response NO Primary Tumor 01 0.3 YES NO YES G8 Other Extranodal Site A DECEASED 59.2 1987 a8ed4489-1005-488c-9e8e-274b2cfd8a83 a8ed4489-1005-488c-9e8e-274b2cfd8a83 TCGA-G8-6906-01 TCGA-G8-6906-01A-11D-2211-05 TCGA-G8-6906-01 TCGA-G8-6906-01A-11D-2209-01 TCGA-G8-6906-01 TCGA-G8-6906-01 TCGA-G8-6906-01A-11D-2209-01 TCGA-G8-6906-01A-11D-2210-10 a8ed4489-1005-488c-9e8e-274b2cfd8a83 68D7ED3A-B6C8-4278-A7B8-E27426A0EE79 a8ed4489-1005-488c-9e8e-274b2cfd8a83
27
+ TCGA-G8-6907-01 TCGA-G8-6907-01 TCGA-G8-6907 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 57 IgH Southern Blot TCGA-G8-6907 TCGA-G8-6907-01A YES NO Stage IV -21021 595 0 NO 0 2012-5-17 FEMALE Normal BCL2 154.2 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C83.3 9680/3 C77.0 Non-Clonal Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Positive|Positive|Positive|Negative|Negative CD10 > 30%|BCL2|CD20|CD23|CD5 YES 0.3 NO 628 618 0.5 cervical YES No TCGA-G8-6907.47b6eb78-0dcf-4105-8cca-1835ecf8033d.pdf 6907 WITH TUMOR Stable Disease NO Primary Tumor 01 0.1 5th YES NO YES G8 A DECEASED 91.8 2000 5bce51af-fa6e-4fd2-b3b0-114eb8a275a9 5bce51af-fa6e-4fd2-b3b0-114eb8a275a9 TCGA-G8-6907-01 TCGA-G8-6907-01A-11D-2211-05 TCGA-G8-6907-01 TCGA-G8-6907-01A-11D-2209-01 TCGA-G8-6907-01 TCGA-G8-6907-01 TCGA-G8-6907-01A-11D-2209-01 TCGA-G8-6907-01A-11D-2210-10 5bce51af-fa6e-4fd2-b3b0-114eb8a275a9 5bce51af-fa6e-4fd2-b3b0-114eb8a275a9
28
+ TCGA-G8-6909-01 TCGA-G8-6909-01 TCGA-G8-6909 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 67 TCGA-G8-6909-F43062 TCGA-G8-6909 TCGA-G8-6909-01A NO Stage III -24661 3553 0 3227 0 NO 0 Scheduled Follow-up Submission Complete Remission/Response 2013-5-9 MALE 178 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C77.1 9680/3 C77.1 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Negative|Positive|Negative|Negative|Negative|Negative CD10 > 30%|BCL2|CD20|BCL6 > 30%|CD23|CD5|CD30 YES 0.4 NO 0.4 NO mediastinal NO No TCGA-G8-6909.5e9ffc0b-63ad-4720-8c82-8850f3cc57eb.pdf 6909 TUMOR FREE Not Done Complete Remission/Response NO Primary Tumor 01 0.3 5th YES NO YES G8 A DECEASED 90.5 2002 8c3c10a3-0fb4-4307-88ab-c8a99d0102cf 8c3c10a3-0fb4-4307-88ab-c8a99d0102cf TCGA-G8-6909-01 TCGA-G8-6909-01A-11D-2211-05 TCGA-G8-6909-01 TCGA-G8-6909-01A-11D-2209-01 TCGA-G8-6909-01 TCGA-G8-6909-01 TCGA-G8-6909-01A-11D-2209-01 TCGA-G8-6909-01A-11D-2210-10 8c3c10a3-0fb4-4307-88ab-c8a99d0102cf 8c3c10a3-0fb4-4307-88ab-c8a99d0102cf
29
+ TCGA-G8-6914-01 TCGA-G8-6914-01 TCGA-G8-6914 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 67 TCGA-G8-6914-F43065 TCGA-G8-6914 TCGA-G8-6914-01A NO Stage III -24569 0 5980 3669 NO Scheduled Follow-up Submission Complete Remission/Response 2013-5-10 MALE 172 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C83.3 9680/3 C77.0 Flow cytometry|Flow cytometry|Flow cytometry Positive|Positive|Positive CD19|CD20|CD22 YES 0.8 NO 1.2 NO cervical YES No TCGA-G8-6914.db52dbf0-0988-4c64-abc5-6c38fe32da83.pdf 6914 TUMOR FREE Not Done Complete Remission/Response NO Primary Tumor 01 0.4 4th YES NO YES G8 A LIVING 72.5 1996 d15202c0-099f-46c9-99c0-cc6bdf3e82b1 d15202c0-099f-46c9-99c0-cc6bdf3e82b1 TCGA-G8-6914-01 TCGA-G8-6914-01A-11D-2211-05 TCGA-G8-6914-01 TCGA-G8-6914-01A-11D-2209-01 TCGA-G8-6914-01 TCGA-G8-6914-01 TCGA-G8-6914-01A-11D-2209-01 TCGA-G8-6914-01A-11D-2210-10 d15202c0-099f-46c9-99c0-cc6bdf3e82b1 ED9F2B1A-05BC-442A-8ED5-BBEE278E2817 d15202c0-099f-46c9-99c0-cc6bdf3e82b1
30
+ TCGA-GR-7351-01 TCGA-GR-7351-01 TCGA-GR-7351 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 56 TCGA-GR-7351-F55516 TCGA-GR-7351 TCGA-GR-7351-01A YES NO Stage I -20812 0 4578 1 YES 1 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2014-7-1 FEMALE 166.5 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) Hashimotos Thyroiditis None No C83.3 9680/3 C73.9 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Positive|Positive|Positive CD10 > 30%|CD20|BCL6 > 30% YES 0 NO 498 618 0.1 NO Thyroid 5.5 NO No TCGA-GR-7351.32fa61f2-a17b-40da-b80d-1338a7bb9a7d.pdf 7351 TUMOR FREE Negative Complete Remission/Response YES Primary Tumor 01 0 YES NO YES GR Thyroid A LIVING 77.5 2001 9105777f-ef5a-4455-a762-52923fa38924 9105777f-ef5a-4455-a762-52923fa38924 TCGA-GR-7351-01 TCGA-GR-7351-01A-11D-2211-05 TCGA-GR-7351-01A-11D-2209-01 TCGA-GR-7351-01 TCGA-GR-7351-01A-11D-2209-01 TCGA-GR-7351-01A-11D-2210-10 9105777f-ef5a-4455-a762-52923fa38924 9105777f-ef5a-4455-a762-52923fa38924
31
+ TCGA-GR-7353-01 TCGA-GR-7353-01 TCGA-GR-7353 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 36 TCGA-GR-7353-F55519 TCGA-GR-7353 YES NO Stage II -13317 0 2983 1 NO 0 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2014-7-1 MALE 171.5 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) No C83.3 9680/3 C77.0 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Positive|Negative|Positive|Positive|Negative|Negative CD10 > 30%|BCL2|CD20|BCL6 > 30%|CD5|Cyclin D1 YES 164 250 NO cervical Cervical lymph nodes 4.4 NO No 7353 TUMOR FREE Not Done Complete Remission/Response NO Primary Tumor 01 YES NO YES GR LIVING 68.0 2005 e8483323-cee6-48ca-bc8d-e7b2f9e0707b e8483323-cee6-48ca-bc8d-e7b2f9e0707b TCGA-GR-7353-01 TCGA-GR-7353-01A-11D-2211-05 TCGA-GR-7353-01 TCGA-GR-7353-01A-11D-2209-01 TCGA-GR-7353-01 TCGA-GR-7353-01 TCGA-GR-7353-01A-11D-2209-01 TCGA-GR-7353-01A-11D-2210-10 e8483323-cee6-48ca-bc8d-e7b2f9e0707b e8483323-cee6-48ca-bc8d-e7b2f9e0707b
32
+ TCGA-GR-A4D4-01 TCGA-GR-A4D4-01 TCGA-GR-A4D4 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 57 TCGA-GR-A4D4-F68696 TCGA-GR-A4D4 YES NO Stage IV -20888 0 1581 2 YES 2 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2014-12-11 FEMALE 168.0 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) No C83.3 9680/3 C49.9 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Positive|Positive|Positive|Negative|Positive|Positive|Negative|Negative|Negative|Negative CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|PAX5|CD5|CD30|EBER|ALK YES 143 192 NO Soft Tissue (muscle, ligaments, subcutaneous) 5.4 NO No A4D4 TUMOR FREE Indeterminate Complete Remission/Response NO Primary Tumor 01 YES NO YES GR Bone|Soft Tissue (muscle ligaments subcutaneous) LIVING 76.1 2010 c6930a35-3476-46a0-adde-da76ee758390 c6930a35-3476-46a0-adde-da76ee758390 TCGA-GR-A4D4-01 TCGA-GR-A4D4-01A-11D-A31Y-05 TCGA-GR-A4D4-01 TCGA-GR-A4D4-01A-11D-A31W-01 TCGA-GR-A4D4-01 TCGA-GR-A4D4-01 TCGA-GR-A4D4-01A-11D-A31W-01 TCGA-GR-A4D4-01A-11D-A31X-10 c6930a35-3476-46a0-adde-da76ee758390 c6930a35-3476-46a0-adde-da76ee758390
33
+ TCGA-GR-A4D5-01 TCGA-GR-A4D5-01 TCGA-GR-A4D5 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 46 TCGA-GR-A4D5-F55579 TCGA-GR-A4D5 TCGA-GR-A4D5-01A YES NO Stage IV -17023 852 0 1299 1 YES 3 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2014-7-1 FEMALE 159.5 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) No Negative C83.3 9680/3 C77.0 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD5|CD30|CD15 YES 1 NO 851 618 NO Axillary|cervical|Inguinal|mesenteric|supraclavicular Cervical lymph nodes 4.5 NO false No TCGA-GR-A4D5.97EAEC1D-1C5A-4FE8-8D2B-80DD433DB18C.pdf A4D5 TUMOR FREE Negative Complete Remission/Response NO Primary Tumor 01 YES NO YES GR Bone|Skin|Soft Tissue (muscle ligaments subcutaneous) A LIVING 117.1 2010 0e814275-e5f4-4071-a65f-58eac29774ee 0e814275-e5f4-4071-a65f-58eac29774ee TCGA-GR-A4D5-01 TCGA-GR-A4D5-01A-11D-A31Y-05 TCGA-GR-A4D5-01 TCGA-GR-A4D5-01A-11D-A31W-01 TCGA-GR-A4D5-01 TCGA-GR-A4D5-01 TCGA-GR-A4D5-01A-11D-A31W-01 TCGA-GR-A4D5-01A-11D-A31X-10 0e814275-e5f4-4071-a65f-58eac29774ee 0e814275-e5f4-4071-a65f-58eac29774ee
34
+ TCGA-GR-A4D6-01 TCGA-GR-A4D6-01 TCGA-GR-A4D6 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 54 TCGA-GR-A4D6-F55581 TCGA-GR-A4D6 TCGA-GR-A4D6-01A YES NO Stage I -19838 880 0 1334 0 NO 0 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2014-7-1 FEMALE 155.0 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) No C83.3 9680/3 C77.0 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Positive|Positive|Positive|Positive|Positive|Negative CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD5 YES 1 NO 120 192 NO cervical Cervical lymph nodes 2.7 NO false No TCGA-GR-A4D6.ABBC803D-EFC5-4223-8309-0F06F6AAAF9E.pdf A4D6 TUMOR FREE Not Done Complete Remission/Response NO Primary Tumor 01 YES NO YES GR A LIVING 54.5 2010 01dbc8b9-99eb-4bb7-8c90-6fae272ebf63 01dbc8b9-99eb-4bb7-8c90-6fae272ebf63 TCGA-GR-A4D6-01 TCGA-GR-A4D6-01A-11D-A31Y-05 TCGA-GR-A4D6-01 TCGA-GR-A4D6-01A-11D-A31W-01 TCGA-GR-A4D6-01 TCGA-GR-A4D6-01 TCGA-GR-A4D6-01A-11D-A31W-01 TCGA-GR-A4D6-01A-11D-A31X-10 01dbc8b9-99eb-4bb7-8c90-6fae272ebf63 01dbc8b9-99eb-4bb7-8c90-6fae272ebf63
35
+ TCGA-GR-A4D9-01 TCGA-GR-A4D9-01 TCGA-GR-A4D9 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 66 TCGA-GR-A4D9-F55583 TCGA-GR-A4D9 TCGA-GR-A4D9-01B YES NO Stage IV -24405 1289 0 1739 1218 1 YES 3 Other Histological Type Composite Lymphoma: B-FL-3A (60%) & B-DLCL-NC (40%) YES < or = 10% Scheduled Follow-up Submission Progressive Disease 2014-7-1 FEMALE 164.7 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) Other Common variable immunodeficiency Other Immunoglobulin No C83.3 9680/3 C77.0 Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry Positive|Negative|Negative|Positive|Positive|Positive|Negative|Negative|Negative CD19|CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD5|EBER YES 1 NO 420 618 NO Axillary|cervical|hilar|Iliac-common|Iliac-external|Inguinal|mediastinal|retroperitoneal|supraclavicular Cervical lymph nodes 7.0 Soft Tissue YES false No TCGA-GR-A4D9.F4DE97A1-D58D-431F-8C93-8F0647F2F493.pdf A4D9 WITH TUMOR Not Done Complete Remission/Response NO Primary Tumor 01 YES NO YES GR Soft Tissue (muscle ligaments subcutaneous)|Lung|Pleura/Pleural Effusion B LIVING 96.8 2009 19aaa769-e404-4ecc-9e39-e07bfc9ba89c 19aaa769-e404-4ecc-9e39-e07bfc9ba89c TCGA-GR-A4D9-01 TCGA-GR-A4D9-01B-11D-A31Y-05 TCGA-GR-A4D9-01 TCGA-GR-A4D9-01B-11D-A31W-01 TCGA-GR-A4D9-01 TCGA-GR-A4D9-01 TCGA-GR-A4D9-01B-11D-A31W-01 TCGA-GR-A4D9-01B-11D-A31X-10 19aaa769-e404-4ecc-9e39-e07bfc9ba89c 19aaa769-e404-4ecc-9e39-e07bfc9ba89c
36
+ TCGA-GS-A9TQ-01 TCGA-GS-A9TQ-01 TCGA-GS-A9TQ TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 69 TCGA-GS-A9TQ-F72118 TCGA-GS-A9TQ TCGA-GS-A9TQ-01A YES NO Stage II -25292 549 0 982 1 NO 0 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2015-4-16 FEMALE Gain C-MYC 155 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C83.3 9680/3 C77.4 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Flow cytometry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Flow cytometry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry Positive|Positive|Positive|Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative|Negative|Indeterminate|Positive CD10 > 30%|BCL2|CD20|CD138|CD22|BCL6 > 30%|CD23|CD79a|CD5|CD19|P53 >20%|MUM1 > 30%|Cytoplasmic Ig|Surface Ig YES 90 NO 364 450 NO Femoral|Inguinal Inguinal 3 76 - 100% NO true No TCGA-GS-A9TQ.FA3E9D38-9A2D-43EC-AEBD-DDDA323F8BB2.pdf A9TQ TUMOR FREE Negative Complete Remission/Response NO Primary Tumor 01 7th YES NO YES GS A LIVING 68 2012 827ebf10-230a-442b-aaae-80e1e0210bb5 827ebf10-230a-442b-aaae-80e1e0210bb5 TCGA-GS-A9TQ-01 TCGA-GS-A9TQ-01A-11D-A383-05 TCGA-GS-A9TQ-01 TCGA-GS-A9TQ-01A-11D-A381-01 TCGA-GS-A9TQ-01 TCGA-GS-A9TQ-01 TCGA-GS-A9TQ-01A-11D-A381-01 TCGA-GS-A9TQ-01A-11D-A382-10 827ebf10-230a-442b-aaae-80e1e0210bb5 827ebf10-230a-442b-aaae-80e1e0210bb5
37
+ TCGA-GS-A9TT-01 TCGA-GS-A9TT-01 TCGA-GS-A9TT TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 70 TCGA-GS-A9TT-F66756 TCGA-GS-A9TT TCGA-GS-A9TT-01A YES NO Stage IV -25794 902 0 1163 1 EBER in situ hybridization negative YES 2 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2014-11-6 MALE 169 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C62.90 9680/3 C62.9 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Flow cytometry|Flow cytometry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Positive|Positive|Positive|Negative|Positive|Positive|Negative|Positive|Positive|Positive|Positive|Negative CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD79a|CD5|CD19|CD22|Cytoplasmic Ig|Surface Ig|EBER YES 130 NO 756 450 NO Axillary|para-aortic|Splenic|supraclavicular 3 76 - 100% NO true No TCGA-GS-A9TT.7F403F75-9100-4C68-8F36-14AD78B954FD.pdf A9TT TUMOR FREE Negative Complete Remission/Response YES Primary Tumor 01 7th YES NO YES GS Bone|Testes A LIVING 85 2011 defc682b-c70e-40b5-9d8b-3dd146bc7c0e defc682b-c70e-40b5-9d8b-3dd146bc7c0e TCGA-GS-A9TT-01 TCGA-GS-A9TT-01A-11D-A383-05 TCGA-GS-A9TT-01 TCGA-GS-A9TT-01A-11D-A381-01 TCGA-GS-A9TT-01 TCGA-GS-A9TT-01 TCGA-GS-A9TT-01A-11D-A381-01 TCGA-GS-A9TT-01A-11D-A382-10 defc682b-c70e-40b5-9d8b-3dd146bc7c0e 642A415A-E623-4A18-BD32-18E304F262B8 defc682b-c70e-40b5-9d8b-3dd146bc7c0e
38
+ TCGA-GS-A9TU-01 TCGA-GS-A9TU-01 TCGA-GS-A9TU TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 45 IgH PCR TCGA-GS-A9TU-F70366 TCGA-GS-A9TU NO Stage II -16720 0 3897 1 NO 0 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2015-2-10 MALE Normal BCL2 183 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) No Negative C83.3 9680/3 C77.4 Non-Clonal Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Positive|Negative|Positive|Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative|Positive CD19|CD10 > 30%|BCL2|P53 >20%|CD20|MUM1 > 30%|CD22|BCL6 > 30%|CD23|CD79a|CD5|Cytoplasmic Ig YES 337 450 NO Inguinal 2 51 - 75% NO No A9TU TUMOR FREE Negative Complete Remission/Response YES Primary Tumor 01 6th YES NO YES GS LIVING 90 2004 fbe73185-19de-4d0e-af7c-589ca5ffebf6 fbe73185-19de-4d0e-af7c-589ca5ffebf6 TCGA-GS-A9TU-01 TCGA-GS-A9TU-01A-11D-A383-05 TCGA-GS-A9TU-01 TCGA-GS-A9TU-01A-11D-A381-01 TCGA-GS-A9TU-01 TCGA-GS-A9TU-01 TCGA-GS-A9TU-01A-11D-A381-01 TCGA-GS-A9TU-01A-11D-A382-10 fbe73185-19de-4d0e-af7c-589ca5ffebf6 fbe73185-19de-4d0e-af7c-589ca5ffebf6
39
+ TCGA-GS-A9TV-01 TCGA-GS-A9TV-01 TCGA-GS-A9TV TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 40 TCGA-GS-A9TV-F70367 TCGA-GS-A9TV TCGA-GS-A9TV-01A YES NO Stage II -14838 339 0 730 0 EBER in situ hybridization negative NO 0 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2015-2-10 FEMALE 160 Primary mediastinal (thymic) DLBCL No Negative C83.3 9680/3 C77.0 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry Positive|Positive|Positive|Positive|Negative|Negative|Negative|Indeterminate|Indeterminate CD20|CD23|PAX5|CD30|CD15|EBER|CD5|Cytoplasmic Ig|Surface Ig YES 100 NO 450 NO cervical|mediastinal|para-aortic|supraclavicular mediastinal 5 26 - 50% NO true No TCGA-GS-A9TV.2197BDCD-266C-4256-A18A-D0E8EAA63518.pdf A9TV TUMOR FREE Negative Complete Remission/Response YES Primary Tumor 01 7th YES NO YES GS A LIVING 58 2013 fe20123e-6e24-4900-97b1-60965fe89c8c fe20123e-6e24-4900-97b1-60965fe89c8c TCGA-GS-A9TV-01 TCGA-GS-A9TV-01A-11D-A383-05 TCGA-GS-A9TV-01 TCGA-GS-A9TV-01A-11D-A381-01 TCGA-GS-A9TV-01 TCGA-GS-A9TV-01 TCGA-GS-A9TV-01A-11D-A381-01 TCGA-GS-A9TV-01A-11D-A382-10 fe20123e-6e24-4900-97b1-60965fe89c8c ADCD23CD-27CE-4B8A-9BF2-D203F0C8AA1D fe20123e-6e24-4900-97b1-60965fe89c8c
40
+ TCGA-GS-A9TW-01 TCGA-GS-A9TW-01 TCGA-GS-A9TW TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 23 TCGA-GS-A9TW-F70368 TCGA-GS-A9TW TCGA-GS-A9TW-01A YES NO Stage II -8493 1255 0 1617 0 EBER in situ hybridization negative NO 0 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2015-2-10 FEMALE 165 Primary mediastinal (thymic) DLBCL No Negative C83.3 9680/3 C77.3 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry Negative|Positive|Positive|Positive|Positive|Positive|Negative|Negative|Negative|Indeterminate|Indeterminate CD10 > 30%|BCL2|CD20|BCL6 > 30%|CD79a|CD30|CD15|EBER|CD5|Cytoplasmic Ig|Surface Ig YES 190 NO 252 450 NO Axillary|cervical|mediastinal|para-aortic mediastinal 4 76 - 100% NO true No TCGA-GS-A9TW.2D2E6687-CD36-42F1-A091-7B249A2FAFF6.pdf A9TW TUMOR FREE Negative Complete Remission/Response YES Primary Tumor 01 7th YES NO YES GS A LIVING 54 2010 64585cbf-917f-4d28-8b42-b085e7cd7e67 64585cbf-917f-4d28-8b42-b085e7cd7e67 TCGA-GS-A9TW-01 TCGA-GS-A9TW-01A-11D-A383-05 TCGA-GS-A9TW-01 TCGA-GS-A9TW-01A-11D-A381-01 TCGA-GS-A9TW-01 TCGA-GS-A9TW-01 TCGA-GS-A9TW-01A-11D-A381-01 TCGA-GS-A9TW-01A-11D-A382-10 64585cbf-917f-4d28-8b42-b085e7cd7e67 4A184274-82EA-4325-A1BA-9BDA4A224372 64585cbf-917f-4d28-8b42-b085e7cd7e67
41
+ TCGA-GS-A9TX-01 TCGA-GS-A9TX-01 TCGA-GS-A9TX TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 37 TCGA-GS-A9TX-F72119 TCGA-GS-A9TX TCGA-GS-A9TX-01A YES NO Stage I -13708 919 0 1373 0 NO 0 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2015-4-16 MALE FISH| Normal|Gain Loss| BCL2|BCL6 1p36| 187 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) No Negative C83.3 9680/3 C77.4 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Flow cytometry Positive|Positive|Negative|Negative|Positive|Positive|Positive|Positive|Positive|Negative|Negative|Positive|Positive CD19|CD10 > 30%|BCL2|P53 >20%|CD20|CD22|BCL6 > 30%|CD23|CD79a|CD5|CD30|Cytoplasmic Ig|Surface Ig YES 360 NO 257 450 NO Inguinal .42 51 - 75% NO true No TCGA-GS-A9TX.B7674358-B4F0-4348-954A-E6A2CBD9C076.pdf A9TX TUMOR FREE Negative Complete Remission/Response YES Primary Tumor 01 7th YES NO YES GS A LIVING 85 2011 17b87815-5cb8-49c1-a09f-d3e99a6c19c1 17b87815-5cb8-49c1-a09f-d3e99a6c19c1 TCGA-GS-A9TX-01 TCGA-GS-A9TX-01A-11D-A383-05 TCGA-GS-A9TX-01 TCGA-GS-A9TX-01A-11D-A381-01 TCGA-GS-A9TX-01 TCGA-GS-A9TX-01 TCGA-GS-A9TX-01A-11D-A381-01 TCGA-GS-A9TX-01A-11D-A382-10 17b87815-5cb8-49c1-a09f-d3e99a6c19c1 500B2B8B-F857-4768-A9E3-C769A720BA1F 17b87815-5cb8-49c1-a09f-d3e99a6c19c1
42
+ TCGA-GS-A9TY-01 TCGA-GS-A9TY-01 TCGA-GS-A9TY TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 82 TCGA-GS-A9TY-F66822 TCGA-GS-A9TY TCGA-GS-A9TY-01A NO Stage I -30256 3053 0 3333 3255 1 NO 0 NO < or = 10% Scheduled Follow-up Submission Progressive Disease 2014-11-6 FEMALE Normal BCL2 153 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) No Negative C83.3 9680/3 C77.3 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Negative|Positive|Positive|Negative|Positive|Negative|Indeterminate CD10 > 30%|BCL2|P53 >20%|CD20|MUM1 > 30%|BCL6 > 30%|CD5|Cytoplasmic Ig YES 20 NO 288 450 NO Axillary 1 51 - 75% Pleura/Pleural effusion YES true No TCGA-GS-A9TY.E7D2AFFA-14B9-436F-B76F-C1F5B88D7600.pdf A9TY WITH TUMOR Negative Complete Remission/Response NO Primary Tumor 01 6th YES NO YES GS A LIVING 77 2005 2cb30421-0335-4427-801d-221735b9beec 2cb30421-0335-4427-801d-221735b9beec TCGA-GS-A9TY-01 TCGA-GS-A9TY-01A-11D-A39G-05 TCGA-GS-A9TY-01 TCGA-GS-A9TY-01A-11D-A38W-01 TCGA-GS-A9TY-01 TCGA-GS-A9TY-01 TCGA-GS-A9TY-01A-11D-A38W-01 TCGA-GS-A9TY-01A-11D-A38X-10 2cb30421-0335-4427-801d-221735b9beec 2cb30421-0335-4427-801d-221735b9beec
43
+ TCGA-GS-A9TZ-01 TCGA-GS-A9TZ-01 TCGA-GS-A9TZ TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 51 TCGA-GS-A9TZ-F70392 TCGA-GS-A9TZ TCGA-GS-A9TZ-01A YES NO Stage II -18691 381 0 765 0 EBER in situ hybridization negative NO 0 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2015-2-11 MALE Cytogenetics Normal G Band Karyotype 168 Primary mediastinal (thymic) DLBCL No Negative C83.3 9680/3 C77.0 Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry Positive|Negative|Positive|Positive|Positive|Positive|Positive|Positive|Positive|Negative|Negative|Negative|Positive|Indeterminate|Indeterminate CD19|CD10 > 30%|BCL2|CD20|MUM1 > 30%|CD22|BCL6 > 30%|CD23|CD79a|CD5|CD15|EBER|CD30|Cytoplasmic Ig|Surface Ig YES 120 NO 450 YES cervical|mediastinal|supraclavicular mediastinal 17 51 - 75% NO true No TCGA-GS-A9TZ.9A705521-237B-429B-B4F6-5CBF2854E252.pdf A9TZ TUMOR FREE Negative Partial Remission/Response YES Primary Tumor 01 7th YES NO YES GS A LIVING 68 2012 9a66e6e2-7888-47c8-9655-9952d9ac546f 9a66e6e2-7888-47c8-9655-9952d9ac546f TCGA-GS-A9TZ-01 TCGA-GS-A9TZ-01A-11D-A39G-05 TCGA-GS-A9TZ-01 TCGA-GS-A9TZ-01A-11D-A38W-01 TCGA-GS-A9TZ-01 TCGA-GS-A9TZ-01 TCGA-GS-A9TZ-01A-11D-A38W-01 TCGA-GS-A9TZ-01A-11D-A38X-10 9a66e6e2-7888-47c8-9655-9952d9ac546f B6990D20-62D2-4156-B58E-4283A706866F 9a66e6e2-7888-47c8-9655-9952d9ac546f
44
+ TCGA-GS-A9U3-01 TCGA-GS-A9U3-01 TCGA-GS-A9U3 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 77 TCGA-GS-A9U3-F70370 TCGA-GS-A9U3 YES NO Stage III -28474 0 3394 1 NO < or = 10% Scheduled Follow-up Submission 2015-2-10 FEMALE Translocation BCL2 157 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) No Negative C83.3 9680/3 C77.4 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Flow cytometry|Immunohistochemistry|Flow cytometry Negative|Positive|Positive|Negative|Negative|Positive|Negative|Negative|Positive|Positive CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD22|CD5|CD30|Cytoplasmic Ig|Surface Ig YES 391 450 YES hilar|Iliac-common|Inguinal|para-aortic|Splenic 3 51 - 75% NO No A9U3 TUMOR FREE Negative Complete Remission/Response NO Primary Tumor 01 6th YES NO YES GS LIVING 80 2005 c1067d6d-aaa2-4d8b-b243-6bb625980a4b c1067d6d-aaa2-4d8b-b243-6bb625980a4b TCGA-GS-A9U3-01 TCGA-GS-A9U3-01A-11D-A39G-05 TCGA-GS-A9U3-01 TCGA-GS-A9U3-01A-11D-A38W-01 TCGA-GS-A9U3-01 TCGA-GS-A9U3-01 TCGA-GS-A9U3-01A-11D-A38W-01 TCGA-GS-A9U3-01A-11D-A38X-10 c1067d6d-aaa2-4d8b-b243-6bb625980a4b c1067d6d-aaa2-4d8b-b243-6bb625980a4b
45
+ TCGA-GS-A9U4-01 TCGA-GS-A9U4-01 TCGA-GS-A9U4 TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 27 IgH PCR TCGA-GS-A9U4-F66825 TCGA-GS-A9U4 TCGA-GS-A9U4-01A YES NO Stage II -10075 806 391 0 106 0 80 EBER in situ hybridization positive NO 0 NO < or = 10% Scheduled Follow-up Submission Progressive Disease 2014-11-6 FEMALE Loss C-MYC 163 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) Other Behgets disease Azathioprine|Other Prednisone No Negative C83.3 9680/3 C77.0 Clonal Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Positive|Positive|Positive|Negative|Positive|Negative|Positive|Negative|Positive|Negative|Indeterminate CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD79a|CD5|CD30|CD15|EBER|ALK|Cytoplasmic Ig YES 310 NO 385 450 NO supraclavicular|Submandibular 3 51 - 75% Cervical Lymph Nodes YES true No TCGA-GS-A9U4.599B4A65-9372-43BC-9236-0C49CD264979.pdf A9U4 WITH TUMOR Not Done Progressive Disease NO Primary Tumor 01 7th YES NO YES GS A DECEASED 50 2011 f89496fe-9413-4038-8e9c-c586ae83d0e1 f89496fe-9413-4038-8e9c-c586ae83d0e1 TCGA-GS-A9U4-01 TCGA-GS-A9U4-01A-11D-A39G-05 TCGA-GS-A9U4-01 TCGA-GS-A9U4-01A-11D-A38W-01 TCGA-GS-A9U4-01 TCGA-GS-A9U4-01 TCGA-GS-A9U4-01A-11D-A38W-01 TCGA-GS-A9U4-01A-11D-A38X-10 f89496fe-9413-4038-8e9c-c586ae83d0e1 B27DB265-1E06-4BD3-BC77-F5BA80C0EC4C f89496fe-9413-4038-8e9c-c586ae83d0e1
46
+ TCGA-RQ-A68N-01 TCGA-RQ-A68N-01 TCGA-RQ-A68N TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 63 TCGA-RQ-A68N-F64642 TCGA-RQ-A68N TCGA-RQ-A68N-01A YES NO -23127 461 0 788 3 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2014-9-9 MALE 162 Primary DLBCL of the CNS No C71.7 9680/3 C71.7 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry Negative|Positive|Positive CD10 > 30%|BCL2|CD20 YES 150 NO NO other NO true No TCGA-RQ-A68N.B40907C0-DA7B-436F-993A-53DA4C9A56A9.pdf A68N TUMOR FREE Not Done Complete Remission/Response NO Primary Tumor 01 7th YES NO YES RQ Brain A LIVING 58 2012 daf79c8a-16b5-4d69-aaad-93d25ddcaac4 daf79c8a-16b5-4d69-aaad-93d25ddcaac4 TCGA-RQ-A68N-01 TCGA-RQ-A68N-01A-11D-A31Y-05 TCGA-RQ-A68N-01 TCGA-RQ-A68N-01A-11D-A31W-01 TCGA-RQ-A68N-01 TCGA-RQ-A68N-01 TCGA-RQ-A68N-01A-11D-A31W-01 TCGA-RQ-A68N-01A-11D-A31X-10 daf79c8a-16b5-4d69-aaad-93d25ddcaac4 CC440064-46B5-4FC7-B1FA-5EC610CC066B daf79c8a-16b5-4d69-aaad-93d25ddcaac4
47
+ TCGA-RQ-A6JB-01 TCGA-RQ-A6JB-01 TCGA-RQ-A6JB TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 62 TCGA-RQ-A6JB-F68331 TCGA-RQ-A6JB TCGA-RQ-A6JB-01A -22859 541 0 1 YES 3 < or = 10% Scheduled Follow-up Submission 2014-11-14 FEMALE 167 Primary DLBCL of the CNS None No Negative C83.3 9680/3 C41.0 YES 370 NO YES other true No TCGA-RQ-A6JB.0250A7AA-A53D-4DCB-BF74-04FABD979B25.pdf A6JB Primary Tumor 01 7th NO YES RQ Bone|Skin|Soft Tissue (muscle ligaments subcutaneous) A LIVING 72 2011 2b22fd4d-014d-441f-a4d3-1502f03e931c 2b22fd4d-014d-441f-a4d3-1502f03e931c TCGA-RQ-A6JB-01 TCGA-RQ-A6JB-01A-11D-A31Y-05 TCGA-RQ-A6JB-01 TCGA-RQ-A6JB-01A-11D-A31W-01 TCGA-RQ-A6JB-01 TCGA-RQ-A6JB-01 TCGA-RQ-A6JB-01A-11D-A31W-01 TCGA-RQ-A6JB-01A-11D-A31X-10 2b22fd4d-014d-441f-a4d3-1502f03e931c 1263085D-5F47-4802-BF56-D31EC61C301B 2b22fd4d-014d-441f-a4d3-1502f03e931c
48
+ TCGA-RQ-AAAT-01 TCGA-RQ-AAAT-01 TCGA-RQ-AAAT TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 63 TCGA-RQ-AAAT-F64663 TCGA-RQ-AAAT TCGA-RQ-AAAT-01A -23178 186 0 17 1 < or = 10% Scheduled Follow-up Submission Complete Remission/Response 2015-3-23 FEMALE 162.5 Primary DLBCL of the CNS No Negative C71.6 9680/3 C71.6 Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry|Immunohistochemistry| Positive|Negative|Positive|Positive|Positive|Negative| CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD30| YES 90 NO YES other Posterior Fossa 1.8 76 - 100% NO false No TCGA-RQ-AAAT.66B90AE3-785B-4866-8B56-7B3B37EF38B5.pdf AAAT TUMOR FREE Complete Remission/Response NO Primary Tumor 01 7th NO NO YES RQ Brain A LIVING 68.2 2013 7f531556-60c1-482c-9c1d-4a9ab00c7eac 7f531556-60c1-482c-9c1d-4a9ab00c7eac TCGA-RQ-AAAT-01 TCGA-RQ-AAAT-01A-11D-A39G-05 TCGA-RQ-AAAT-01 TCGA-RQ-AAAT-01A-11D-A38W-01 TCGA-RQ-AAAT-01 TCGA-RQ-AAAT-01 TCGA-RQ-AAAT-01A-11D-A38W-01 TCGA-RQ-AAAT-01A-11D-A38X-10 7f531556-60c1-482c-9c1d-4a9ab00c7eac 7f531556-60c1-482c-9c1d-4a9ab00c7eac
49
+ TCGA-VB-A8QN-01 TCGA-VB-A8QN-01 TCGA-VB-A8QN TCGA Large B-cell Lymphoma (DLBC) diffuse large B-cell lymphoma Lymphatic tissue 55 TCGA-VB-A8QN-F56126 TCGA-VB-A8QN TCGA-VB-A8QN-01A Stage III -20270 256 0 0 YES Scheduled Follow-up Submission 2014-11-11 MALE 180 Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal) None No Negative C83.3 9680/3 C16.9 YES 1390 NO YES other 10 NO false No TCGA-VB-A8QN.A661F75B-6FD2-4294-8103-969308EFF4EF.pdf A8QN TUMOR FREE NO Primary Tumor 01 7th NO YES NO VB Stomach A LIVING 75 2013 9602264c-a350-4e8b-84f0-07f5710e1f24 9602264c-a350-4e8b-84f0-07f5710e1f24 TCGA-VB-A8QN-01 TCGA-VB-A8QN-01A-11D-A383-05 TCGA-VB-A8QN-01 TCGA-VB-A8QN-01A-11D-A381-01 TCGA-VB-A8QN-01 TCGA-VB-A8QN-01 TCGA-VB-A8QN-01A-11D-A381-01 TCGA-VB-A8QN-01A-11D-A382-10 9602264c-a350-4e8b-84f0-07f5710e1f24 888126C6-C3B9-4619-BA53-BA484E69AD7C 9602264c-a350-4e8b-84f0-07f5710e1f24
input/TCGA/TCGA_Large_Bcell_Lymphoma_(DLBC)/TCGA.DLBC.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:b435ff94dce18d4a2f50e9439950919904debf18ce2e6c4f9128a559c2a38b6a
3
+ size 3913518
input/TCGA/TCGA_Ocular_melanomas_(UVM)/TCGA.UVM.sampleMap_UVM_clinicalMatrix ADDED
@@ -0,0 +1,81 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ sampleID _INTEGRATION _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy age_at_initial_pathologic_diagnosis bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode clinical_M clinical_N clinical_T clinical_stage cytogenetic_abnormality days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_after_initial_treatment extranocular_nodule_size extrascleral_extension extravascular_matrix_patterns eye_color form_completion_date gender gene_expression_profile height histological_type history_of_neoadjuvant_treatment icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified initial_pathologic_diagnosis_method initial_weight is_ffpe lost_follow_up metastatic_site mitotic_count new_neoplasm_event_occurrence_anatomic_site new_neoplasm_event_type new_neoplasm_occurrence_anatomic_site_text new_tumor_event_additional_surgery_procedure new_tumor_event_after_initial_treatment oct_embedded other_dx other_metastatic_site pathologic_M pathologic_N pathologic_T pathologic_stage pathology_report_file_name patient_death_reason patient_id person_neoplasm_cancer_status postoperative_rx_tx radiation_therapy sample_type sample_type_id system_version tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tumor_basal_diameter tumor_basal_diameter_mx tumor_infiltrating_lymphocytes tumor_infiltrating_macrophages tumor_morphology_percentage tumor_shape_pathologic_clinical tumor_thickness tumor_thickness_measurement tumor_tissue_site vial_number vital_status weight year_of_initial_pathologic_diagnosis _GENOMIC_ID_TCGA_UVM_mutation_bcgsc_gene _GENOMIC_ID_TCGA_UVM_gistic2thd _GENOMIC_ID_TCGA_UVM_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_UVM_miRNA_HiSeq _GENOMIC_ID_TCGA_UVM_PDMRNAseqCNV _GENOMIC_ID_TCGA_UVM_exp_HiSeqV2 _GENOMIC_ID_TCGA_UVM_gistic2 _GENOMIC_ID_TCGA_UVM_exp_HiSeqV2_percentile _GENOMIC_ID_TCGA_UVM_mutation_bcm_gene _GENOMIC_ID_TCGA_UVM_hMethyl450 _GENOMIC_ID_TCGA_UVM_mutation_ucsc_maf_gene _GENOMIC_ID_TCGA_UVM_mutation_broad_gene _GENOMIC_ID_TCGA_UVM_RPPA _GENOMIC_ID_TCGA_UVM_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_UVM_mutation_curated_broad_gene _GENOMIC_ID_TCGA_UVM_PDMRNAseq _GENOMIC_ID_data/public/TCGA/UVM/miRNA_HiSeq_gene
2
+ TCGA-RZ-AB0B-01 TCGA-RZ-AB0B-01 TCGA-RZ-AB0B TCGA Ocular melanomas (UVM) uveal melanoma Eye 47 TCGA-RZ-AB0B MX NX Stage IV -17514 149 0 Blue 2014-6-9 FEMALE 157.48 Epithelioid Cell No C69.80 8770/3 C69.8 YES Enucleation Liver No M1 T4b Stage IV Metastatic Uveal Melanoma AB0B TUMOR FREE Primary Tumor 01 7th YES NO RZ >90% 12.7 Pathologic Measurement Choroid|Ciliary body DECEASED 186 2013 TCGA-RZ-AB0B-01A-11D-A39W-08 TCGA-RZ-AB0B-01A-11D-A39V-01 f147b580-725f-401a-ad5f-9baabe99aac9 TCGA-RZ-AB0B-01 TCGA-RZ-AB0B-01 f147b580-725f-401a-ad5f-9baabe99aac9 TCGA-RZ-AB0B-01A-11D-A39V-01 f147b580-725f-401a-ad5f-9baabe99aac9 TCGA-RZ-AB0B-01A-11D-A39W-08 TCGA-RZ-AB0B-01A-11D-A39X-05 TCGA-RZ-AB0B-01A-11D-A39W-08 TCGA-RZ-AB0B-01A-11D-A39W-08 f147b580-725f-401a-ad5f-9baabe99aac9 TCGA-RZ-AB0B-01A-11D-A39W-08 TCGA-RZ-AB0B-01 TCGA-RZ-AB0B-01
3
+ TCGA-V3-A9ZX-01 TCGA-V3-A9ZX-01 TCGA-V3-A9ZX TCGA Ocular melanomas (UVM) uveal melanoma Eye NO NO 56 TCGA-V3-A9ZX-F71700 TCGA-V3-A9ZX TCGA-V3-A9ZX-01A MX NX T2b Stage IIB Chromosome 6p gain|Chromosome 8q gain -20539 15 0 470 233 2015-3-30 MALE Epithelioid Cell|Spindle Cell No C69.30 8770/3 C69.3 YES Enucleation 150 NO NO None 35 Liver Distant Metastasis YES YES true No MX NX T2b Stage IIB TCGA-V3-A9ZX.CB5480FC-4BE1-478D-BEB5-39D74FD3F2E8.pdf A9ZX TUMOR FREE NO NO Primary Tumor 01 7th YES NO V3 11.5 Pathologic Measurement Many Few 1-30%|61-90% 8.1 Pathologic Measurement Choroid|Ciliary body A LIVING 2013 TCGA-V3-A9ZX-01A-11D-A39W-08 TCGA-V3-A9ZX-01A-11D-A39V-01 50c214e8-6c8a-45c2-8f64-6aa3256f639b TCGA-V3-A9ZX-01 TCGA-V3-A9ZX-01 50c214e8-6c8a-45c2-8f64-6aa3256f639b TCGA-V3-A9ZX-01A-11D-A39V-01 50c214e8-6c8a-45c2-8f64-6aa3256f639b TCGA-V3-A9ZX-01A-11D-A39W-08 TCGA-V3-A9ZX-01A-11D-A39X-05 TCGA-V3-A9ZX-01A-11D-A39W-08 TCGA-V3-A9ZX-01A-11D-A39W-08 9A2C60AE-C0F6-4AFF-B7A2-517D8CD8FFBF 50c214e8-6c8a-45c2-8f64-6aa3256f639b TCGA-V3-A9ZX-01A-11D-A39W-08 TCGA-V3-A9ZX-01 TCGA-V3-A9ZX-01
4
+ TCGA-V3-A9ZY-01 TCGA-V3-A9ZY-01 TCGA-V3-A9ZY TCGA Ocular melanomas (UVM) uveal melanoma Eye 54 TCGA-V3-A9ZY-F71701 TCGA-V3-A9ZY TCGA-V3-A9ZY-01A MX NX T3a Stage IIB Chromosome 6p gain -19894 4 0 459 2015-3-30 MALE Epithelioid Cell No C69.30 8771/3 C69.3 YES Enucleation 20 NO NO None 3 NO true No MX NX T3a Stage IIB TCGA-V3-A9ZY.163AE028-0550-4AEF-89A3-83600276EE4B.pdf A9ZY TUMOR FREE NO NO Primary Tumor 01 7th YES NO V3 7.79 Pathologic Measurement 1-30% 12.18 Pathologic Measurement Choroid A LIVING 2013 TCGA-V3-A9ZY-01A-11D-A39W-08 TCGA-V3-A9ZY-01A-11D-A39V-01 862a5b7e-42b8-45de-a0fd-0f52263ee97c TCGA-V3-A9ZY-01 TCGA-V3-A9ZY-01 862a5b7e-42b8-45de-a0fd-0f52263ee97c TCGA-V3-A9ZY-01A-11D-A39V-01 862a5b7e-42b8-45de-a0fd-0f52263ee97c TCGA-V3-A9ZY-01A-11D-A39W-08 TCGA-V3-A9ZY-01A-11D-A39X-05 TCGA-V3-A9ZY-01A-11D-A39W-08 TCGA-V3-A9ZY-01A-11D-A39W-08 862a5b7e-42b8-45de-a0fd-0f52263ee97c TCGA-V3-A9ZY-01A-11D-A39W-08 TCGA-V3-A9ZY-01 TCGA-V3-A9ZY-01
5
+ TCGA-V4-A9E5-01 TCGA-V4-A9E5-01 TCGA-V4-A9E5 TCGA Ocular melanomas (UVM) uveal melanoma Eye 51 TCGA-V4-A9E5-F72767 TCGA-V4-A9E5 M0 N0 T4b Stage IIIB -18948 0 2499 NO Brown 2015-11-23 FEMALE 167 Spindle Cell No C69.30 8720/3 C69.3 YES Enucleation NO 16 NO No M0 N0 T4b Stage IIIB A9E5 TUMOR FREE NO NO Primary Tumor 01 7th NO YES V4 20 Pathologic Measurement >90% 13 Echographic Measurement Choroid|Ciliary body LIVING 60 2008 TCGA-V4-A9E5-01A-11D-A39W-08 TCGA-V4-A9E5-01A-11D-A39V-01 bb755636-09e2-43e0-a957-79928a6e4f73 TCGA-V4-A9E5-01 TCGA-V4-A9E5-01 bb755636-09e2-43e0-a957-79928a6e4f73 TCGA-V4-A9E5-01A-11D-A39V-01 bb755636-09e2-43e0-a957-79928a6e4f73 TCGA-V4-A9E5-01A-11D-A39W-08 TCGA-V4-A9E5-01A-11D-A39X-05 TCGA-V4-A9E5-01A-11D-A39W-08 TCGA-V4-A9E5-01A-11D-A39W-08 bb755636-09e2-43e0-a957-79928a6e4f73 TCGA-V4-A9E5-01A-11D-A39W-08 TCGA-V4-A9E5-01 TCGA-V4-A9E5-01
6
+ TCGA-V4-A9E7-01 TCGA-V4-A9E7-01 TCGA-V4-A9E7 TCGA Ocular melanomas (UVM) uveal melanoma Eye 76 TCGA-V4-A9E7 TCGA-V4-A9E7-01A M0 N0 T4a Stage IIIA Chromosome 3 loss|Chromosome 8q gain -28025 711 415 0 Green 2014-5-22 MALE 170 Epithelioid Cell|Spindle Cell No C69.30 8771/3 C69.3 YES Enucleation 40 NO 20 YES false No M0 N0 T4a Stage IIIA TCGA-V4-A9E7.83D9F1B8-553B-47E7-83D9-5663FCEF17A1.pdf Metastatic Uveal Melanoma A9E7 WITH TUMOR NO NO Primary Tumor 01 7th NO YES V4 20 Pathologic Measurement 61-90%|1-30% 15 Echographic Measurement Choroid A DECEASED 67 2011 TCGA-V4-A9E7-01A-11D-A39W-08 TCGA-V4-A9E7-01A-11D-A39V-01 8b6e8309-2206-4269-8b92-0f42702cbc3d TCGA-V4-A9E7-01 TCGA-V4-A9E7-01 8b6e8309-2206-4269-8b92-0f42702cbc3d TCGA-V4-A9E7-01A-11D-A39V-01 8b6e8309-2206-4269-8b92-0f42702cbc3d TCGA-V4-A9E7-01A-11D-A39W-08 TCGA-V4-A9E7-01A-11D-A39X-05 TCGA-V4-A9E7-01A-11D-A39W-08 TCGA-V4-A9E7-01A-11D-A39W-08 8b6e8309-2206-4269-8b92-0f42702cbc3d TCGA-V4-A9E7-01A-11D-A39W-08 TCGA-V4-A9E7-01 TCGA-V4-A9E7-01
7
+ TCGA-V4-A9E8-01 TCGA-V4-A9E8-01 TCGA-V4-A9E8 TCGA Ocular melanomas (UVM) uveal melanoma Eye 49 TCGA-V4-A9E8 M0 N0 T4a Stage IIIA Chromosome 3 loss|Chromosome 6p gain|Chromosome 8q gain -18073 808 0 NO Brown 2014-5-22 MALE 175 Epithelioid Cell|Spindle Cell No C69.30 8771/3 C69.3 YES Enucleation 4 YES No M0 N0 T4a Stage IIIA Metastatic Uveal Melanoma A9E8 WITH TUMOR NO NO Primary Tumor 01 7th NO YES V4 19 Pathologic Measurement 61-90%|1-30% Dome 9 Echographic Measurement Choroid DECEASED 89 2011 TCGA-V4-A9E8-01A-11D-A39W-08 TCGA-V4-A9E8-01A-11D-A39V-01 d3e970b2-7551-4fef-9473-867bb8c4e09d TCGA-V4-A9E8-01 TCGA-V4-A9E8-01 d3e970b2-7551-4fef-9473-867bb8c4e09d TCGA-V4-A9E8-01A-11D-A39V-01 d3e970b2-7551-4fef-9473-867bb8c4e09d TCGA-V4-A9E8-01A-11D-A39W-08 TCGA-V4-A9E8-01A-11D-A39X-05 TCGA-V4-A9E8-01A-11D-A39W-08 TCGA-V4-A9E8-01A-11D-A39W-08 d3e970b2-7551-4fef-9473-867bb8c4e09d TCGA-V4-A9E8-01A-11D-A39W-08 TCGA-V4-A9E8-01 TCGA-V4-A9E8-01
8
+ TCGA-V4-A9E9-01 TCGA-V4-A9E9-01 TCGA-V4-A9E9 TCGA Ocular melanomas (UVM) uveal melanoma Eye 50 TCGA-V4-A9E9-F72777 TCGA-V4-A9E9 TCGA-V4-A9E9-01A M0 N0 T4a Stage IIIA Chromosome 1 loss -18387 675 0 1246 NO Brown 2015-11-24 MALE 160 Spindle Cell No C69.30 8772/3 C69.3 YES Enucleation 70 NO NO 4 NO false No M0 N0 T4a Stage IIIA TCGA-V4-A9E9.C8E6E160-2B5D-466D-8C44-42516303F5A9.pdf A9E9 TUMOR FREE NO NO Primary Tumor 01 7th NO YES V4 19 Pathologic Measurement >90% 12 Echographic Measurement Choroid A LIVING 65 2012 TCGA-V4-A9E9-01A-11D-A39W-08 TCGA-V4-A9E9-01A-11D-A39V-01 e971e2c8-4056-41a3-a44c-9ef5c1f33896 TCGA-V4-A9E9-01 TCGA-V4-A9E9-01 e971e2c8-4056-41a3-a44c-9ef5c1f33896 TCGA-V4-A9E9-01A-11D-A39V-01 e971e2c8-4056-41a3-a44c-9ef5c1f33896 TCGA-V4-A9E9-01A-11D-A39W-08 TCGA-V4-A9E9-01A-11D-A39X-05 TCGA-V4-A9E9-01A-11D-A39W-08 TCGA-V4-A9E9-01A-11D-A39W-08 1A6217EE-C26F-4236-A9C0-35583FC36179 e971e2c8-4056-41a3-a44c-9ef5c1f33896 TCGA-V4-A9E9-01A-11D-A39W-08 TCGA-V4-A9E9-01 TCGA-V4-A9E9-01
9
+ TCGA-V4-A9EA-01 TCGA-V4-A9EA-01 TCGA-V4-A9EA TCGA Ocular melanomas (UVM) uveal melanoma Eye 66 TCGA-V4-A9EA-F72779 TCGA-V4-A9EA TCGA-V4-A9EA-01A M0 N0 T4a Stage IIIA Chromosome 6p gain|Chromosome 8q gain -24234 666 0 1348 NO Brown 2015-11-24 MALE 170 Spindle Cell No C69.30 8772/3 C69.3 YES Enucleation 60 NO NO 8 NO false No M0 N0 T4a Stage IIIA TCGA-V4-A9EA.98EC98E0-F65F-40F7-A499-E9F6C8DF6C02.pdf A9EA TUMOR FREE NO NO Primary Tumor 01 7th NO YES V4 16 Pathologic Measurement >90% Mushroom 12 Echographic Measurement Choroid A LIVING 75 2012 TCGA-V4-A9EA-01A-11D-A39W-08 TCGA-V4-A9EA-01A-11D-A39V-01 a96481d1-916b-4707-a374-0b20ae649a05 TCGA-V4-A9EA-01 TCGA-V4-A9EA-01 a96481d1-916b-4707-a374-0b20ae649a05 TCGA-V4-A9EA-01A-11D-A39V-01 a96481d1-916b-4707-a374-0b20ae649a05 TCGA-V4-A9EA-01A-11D-A39W-08 TCGA-V4-A9EA-01A-11D-A39X-05 TCGA-V4-A9EA-01A-11D-A39W-08 TCGA-V4-A9EA-01A-11D-A39W-08 72D674AD-322D-4356-A37E-F297CBAE07EC a96481d1-916b-4707-a374-0b20ae649a05 TCGA-V4-A9EA-01A-11D-A39W-08 TCGA-V4-A9EA-01 TCGA-V4-A9EA-01
10
+ TCGA-V4-A9EC-01 TCGA-V4-A9EC-01 TCGA-V4-A9EC TCGA Ocular melanomas (UVM) uveal melanoma Eye 75 TCGA-V4-A9EC-F66660 TCGA-V4-A9EC TCGA-V4-A9EC-01A M0 N0 T3a Stage IIB -27655 615 0 743 NO Brown 2014-10-22 FEMALE 166 Spindle Cell No C69.30 8772/3 C69.3 YES Enucleation 40 NO NO 32 NO false No M0 N0 T3a Stage IIB TCGA-V4-A9EC.A2A74023-0861-4C39-B9D1-FC97AA980C5E.pdf A9EC TUMOR FREE NO NO Primary Tumor 01 7th NO YES V4 17 Pathologic Measurement >90% Mushroom 9 Echographic Measurement Choroid A LIVING 60 2012 TCGA-V4-A9EC-01A-11D-A39W-08 TCGA-V4-A9EC-01A-11D-A39V-01 5bbb5bfd-1842-449a-89bc-2ec5990c0b1d TCGA-V4-A9EC-01 TCGA-V4-A9EC-01 5bbb5bfd-1842-449a-89bc-2ec5990c0b1d TCGA-V4-A9EC-01A-11D-A39V-01 5bbb5bfd-1842-449a-89bc-2ec5990c0b1d TCGA-V4-A9EC-01A-11D-A39W-08 TCGA-V4-A9EC-01A-11D-A39X-05 TCGA-V4-A9EC-01A-11D-A39W-08 TCGA-V4-A9EC-01A-11D-A39W-08 5bbb5bfd-1842-449a-89bc-2ec5990c0b1d TCGA-V4-A9EC-01A-11D-A39W-08 TCGA-V4-A9EC-01 TCGA-V4-A9EC-01
11
+ TCGA-V4-A9ED-01 TCGA-V4-A9ED-01 TCGA-V4-A9ED TCGA Ocular melanomas (UVM) uveal melanoma Eye 45 TCGA-V4-A9ED-F72781 TCGA-V4-A9ED TCGA-V4-A9ED-01A M0 N0 T3b Stage IIIA Chromosome 3 loss|Chromosome 8q gain -16528 566 0 1078 NO Green 2015-11-24 MALE 175 Spindle Cell No C69.40 8772/3 C69.4 YES Enucleation 50 NO NO 4 NO false No M0 N0 T3b Stage IIIA TCGA-V4-A9ED.0A53BD62-157E-4D8D-B88A-6ACA3DAD61D0.pdf A9ED TUMOR FREE NO NO Primary Tumor 01 7th NO YES V4 16 Pathologic Measurement >90% 11 Echographic Measurement Choroid|Ciliary body A LIVING 85 2012 TCGA-V4-A9ED-01A-11D-A39W-08 TCGA-V4-A9ED-01A-11D-A39V-01 74414dbc-deae-4350-a11d-faa265c96715 TCGA-V4-A9ED-01 TCGA-V4-A9ED-01 74414dbc-deae-4350-a11d-faa265c96715 TCGA-V4-A9ED-01A-11D-A39V-01 74414dbc-deae-4350-a11d-faa265c96715 TCGA-V4-A9ED-01A-11D-A39W-08 TCGA-V4-A9ED-01A-11D-A39X-05 TCGA-V4-A9ED-01A-11D-A39W-08 TCGA-V4-A9ED-01A-11D-A39W-08 74414dbc-deae-4350-a11d-faa265c96715 TCGA-V4-A9ED-01A-11D-A39W-08 TCGA-V4-A9ED-01 TCGA-V4-A9ED-01
12
+ TCGA-V4-A9EE-01 TCGA-V4-A9EE-01 TCGA-V4-A9EE TCGA Ocular melanomas (UVM) uveal melanoma Eye 86 TCGA-V4-A9EE M0 N0 T3a Stage IIB -31421 398 0 NO 2014-6-10 MALE 178 Epithelioid Cell No C69.30 8771/3 C69.3 YES Enucleation 4 YES No M0 N0 T3a Stage IIB Metastatic Uveal Melanoma A9EE WITH TUMOR NO NO Primary Tumor 01 7th NO YES V4 16 Pathologic Measurement >90% Dome 11 Echographic Measurement Choroid DECEASED 97 2012 TCGA-V4-A9EE-01A-11D-A39W-08 TCGA-V4-A9EE-01A-11D-A39V-01 c6f6c556-9f0a-4f1d-96ca-08af287acbfe TCGA-V4-A9EE-01 TCGA-V4-A9EE-01 c6f6c556-9f0a-4f1d-96ca-08af287acbfe TCGA-V4-A9EE-01A-11D-A39V-01 c6f6c556-9f0a-4f1d-96ca-08af287acbfe TCGA-V4-A9EE-01A-11D-A39W-08 TCGA-V4-A9EE-01A-11D-A39X-05 TCGA-V4-A9EE-01A-11D-A39W-08 TCGA-V4-A9EE-01A-11D-A39W-08 c6f6c556-9f0a-4f1d-96ca-08af287acbfe TCGA-V4-A9EE-01A-11D-A39W-08 TCGA-V4-A9EE-01 TCGA-V4-A9EE-01
13
+ TCGA-V4-A9EF-01 TCGA-V4-A9EF-01 TCGA-V4-A9EF TCGA Ocular melanomas (UVM) uveal melanoma Eye 56 TCGA-V4-A9EF-F72784 TCGA-V4-A9EF TCGA-V4-A9EF-01A M0 N0 T4b Stage IIIB Chromosome 3 loss|Chromosome 8q gain -20763 535 0 1165 NO Brown 2015-11-24 MALE 170 Spindle Cell No C69.30 8772/3 C69.3 YES Enucleation 60 NO NO 16 NO false No M0 N0 T4b Stage IIIB TCGA-V4-A9EF.816380AA-CC87-4221-B41C-9A02E2201D02.pdf A9EF TUMOR FREE YES NO Primary Tumor 01 7th NO YES V4 16 Pathologic Measurement >90% Mushroom 14 Echographic Measurement Choroid|Ciliary body A LIVING 82 2012 TCGA-V4-A9EF-01A-21D-A39W-08 TCGA-V4-A9EF-01A-21D-A39V-01 410ebafa-bacb-477e-9902-55cc0bdc8464 TCGA-V4-A9EF-01 TCGA-V4-A9EF-01 410ebafa-bacb-477e-9902-55cc0bdc8464 TCGA-V4-A9EF-01A-21D-A39V-01 410ebafa-bacb-477e-9902-55cc0bdc8464 TCGA-V4-A9EF-01A-21D-A39W-08 TCGA-V4-A9EF-01A-21D-A39X-05 TCGA-V4-A9EF-01A-21D-A39W-08 TCGA-V4-A9EF-01A-21D-A39W-08 410ebafa-bacb-477e-9902-55cc0bdc8464 TCGA-V4-A9EF-01A-21D-A39W-08 TCGA-V4-A9EF-01 TCGA-V4-A9EF-01
14
+ TCGA-V4-A9EH-01 TCGA-V4-A9EH-01 TCGA-V4-A9EH TCGA Ocular melanomas (UVM) uveal melanoma Eye 53 TCGA-V4-A9EH-F66669 TCGA-V4-A9EH TCGA-V4-A9EH-01A M0 N0 T4c Stage IIIB -19573 474 0 670 <=5mm YES Brown 2014-10-22 MALE 169 Spindle Cell No C69.30 8772/3 C69.3 YES Enucleation 90 NO NO 4 NO false No M0 N0 T4c Stage IIIB TCGA-V4-A9EH.C0F9EB5A-8CBD-4BDB-A67C-B205AC198A42.pdf A9EH TUMOR FREE NO NO Primary Tumor 01 7th NO YES V4 22 Pathologic Measurement >90% Mushroom 14 Echographic Measurement Choroid A LIVING 80 2012 TCGA-V4-A9EH-01A-11D-A39W-08 TCGA-V4-A9EH-01A-11D-A39V-01 cb1516d5-4cd5-4a6d-95fa-852ac03f8935 TCGA-V4-A9EH-01 TCGA-V4-A9EH-01 cb1516d5-4cd5-4a6d-95fa-852ac03f8935 TCGA-V4-A9EH-01A-11D-A39V-01 cb1516d5-4cd5-4a6d-95fa-852ac03f8935 TCGA-V4-A9EH-01A-11D-A39W-08 TCGA-V4-A9EH-01A-11D-A39X-05 TCGA-V4-A9EH-01A-11D-A39W-08 TCGA-V4-A9EH-01A-11D-A39W-08 5F818701-4A6B-4667-A2EE-D3AC4600BBBD cb1516d5-4cd5-4a6d-95fa-852ac03f8935 TCGA-V4-A9EH-01A-11D-A39W-08 TCGA-V4-A9EH-01 TCGA-V4-A9EH-01
15
+ TCGA-V4-A9EI-01 TCGA-V4-A9EI-01 TCGA-V4-A9EI TCGA Ocular melanomas (UVM) uveal melanoma Eye NO NO 78 TCGA-V4-A9EI-F68799 TCGA-V4-A9EI TCGA-V4-A9EI-01A M0 N0 T4c Stage IIIB -28562 483 389 0 203 <=5mm YES Green 2015-1-27 MALE 172 Epithelioid Cell No C69.30 8771/3 C69.3 YES Enucleation 50 NO NO 40 Liver Distant Metastasis NO YES false No M0 N0 T4c Stage IIIB TCGA-V4-A9EI.E7477E21-C96C-4003-92C3-86896441757A.pdf Metastatic Uveal Melanoma A9EI WITH TUMOR NO YES Primary Tumor 01 7th NO YES V4 24 Pathologic Measurement >90% Mushroom 16 Echographic Measurement Choroid A DECEASED 80 2012 TCGA-V4-A9EI-01A-11D-A39W-08 TCGA-V4-A9EI-01A-11D-A39V-01 45ec0ad2-7de5-4f39-9088-c5a9eb46b10b TCGA-V4-A9EI-01 TCGA-V4-A9EI-01 45ec0ad2-7de5-4f39-9088-c5a9eb46b10b TCGA-V4-A9EI-01A-11D-A39V-01 45ec0ad2-7de5-4f39-9088-c5a9eb46b10b TCGA-V4-A9EI-01A-11D-A39W-08 TCGA-V4-A9EI-01A-11D-A39X-05 TCGA-V4-A9EI-01A-11D-A39W-08 TCGA-V4-A9EI-01A-11D-A39W-08 45ec0ad2-7de5-4f39-9088-c5a9eb46b10b TCGA-V4-A9EI-01A-11D-A39W-08 TCGA-V4-A9EI-01 TCGA-V4-A9EI-01
16
+ TCGA-V4-A9EJ-01 TCGA-V4-A9EJ-01 TCGA-V4-A9EJ TCGA Ocular melanomas (UVM) uveal melanoma Eye 38 TCGA-V4-A9EJ-F72826 TCGA-V4-A9EJ TCGA-V4-A9EJ-01A M0 N0 T3a Stage IIB Chromosome 6p gain -13958 399 0 746 NO Brown 2015-11-25 MALE 183 Spindle Cell No C69.30 8772/3 C69.3 YES Enucleation 50 NO NO NO false No M0 N0 T3a Stage IIB TCGA-V4-A9EJ.3677656F-1D21-4DE4-8DB5-F1681A72FA80.pdf A9EJ TUMOR FREE NO NO Primary Tumor 01 7th NO YES V4 15 Pathologic Measurement >90% Dome 12 Echographic Measurement Choroid A LIVING 82 2012 TCGA-V4-A9EJ-01A-11D-A39W-08 TCGA-V4-A9EJ-01A-11D-A39V-01 a6b94568-34e2-40f4-a5e6-8d73be0b7e6d TCGA-V4-A9EJ-01 TCGA-V4-A9EJ-01 a6b94568-34e2-40f4-a5e6-8d73be0b7e6d TCGA-V4-A9EJ-01A-11D-A39V-01 a6b94568-34e2-40f4-a5e6-8d73be0b7e6d TCGA-V4-A9EJ-01A-11D-A39W-08 TCGA-V4-A9EJ-01A-11D-A39X-05 TCGA-V4-A9EJ-01A-11D-A39W-08 TCGA-V4-A9EJ-01A-11D-A39W-08 8A031C6C-482B-4EA0-BF97-E818151D4ED1 a6b94568-34e2-40f4-a5e6-8d73be0b7e6d TCGA-V4-A9EJ-01A-11D-A39W-08 TCGA-V4-A9EJ-01 TCGA-V4-A9EJ-01
17
+ TCGA-V4-A9EK-01 TCGA-V4-A9EK-01 TCGA-V4-A9EK TCGA Ocular melanomas (UVM) uveal melanoma Eye 37 TCGA-V4-A9EK-F72828 TCGA-V4-A9EK TCGA-V4-A9EK-01A M0 N0 T3a Stage IIB Chromosome 6p gain|Chromosome 8q gain -13731 377 0 1028 NO Brown 2015-11-25 FEMALE 147 Spindle Cell No C69.30 8772/3 C69.3 YES Enucleation 60 NO NO NO false No M0 N0 T3a Stage IIB TCGA-V4-A9EK.9495F79F-3227-454F-942C-05CEC78273B5.pdf A9EK TUMOR FREE NO NO Primary Tumor 01 7th NO YES V4 18 Pathologic Measurement >90% Dome 12 Echographic Measurement Choroid|Ciliary body A LIVING 47 2012 TCGA-V4-A9EK-01A-11D-A39W-08 TCGA-V4-A9EK-01A-11D-A39V-01 66dc8005-3575-4b72-8c02-4f920bdfd8e3 TCGA-V4-A9EK-01 TCGA-V4-A9EK-01 66dc8005-3575-4b72-8c02-4f920bdfd8e3 TCGA-V4-A9EK-01A-11D-A39V-01 66dc8005-3575-4b72-8c02-4f920bdfd8e3 TCGA-V4-A9EK-01A-11D-A39W-08 TCGA-V4-A9EK-01A-11D-A39X-05 TCGA-V4-A9EK-01A-11D-A39W-08 TCGA-V4-A9EK-01A-11D-A39W-08 66dc8005-3575-4b72-8c02-4f920bdfd8e3 TCGA-V4-A9EK-01A-11D-A39W-08 TCGA-V4-A9EK-01 TCGA-V4-A9EK-01
18
+ TCGA-V4-A9EL-01 TCGA-V4-A9EL-01 TCGA-V4-A9EL TCGA Ocular melanomas (UVM) uveal melanoma Eye YES 60 TCGA-V4-A9EL-F72829 TCGA-V4-A9EL TCGA-V4-A9EL-01A M0 N0 T4a Stage IIIA Chromosome 3 loss|Chromosome 8q gain -22150 376 0 982 472 NO 2015-11-25 MALE 170 Epithelioid Cell No C69.30 8771/3 C69.3 YES Enucleation 50 NO NO Liver Distant Metastasis NO YES false Yes M0 N0 T4a Stage IIIA TCGA-V4-A9EL.036B1D86-3517-47E4-B285-BACE886AC434.pdf A9EL WITH TUMOR NO NO Primary Tumor 01 7th NO YES V4 21 Pathologic Measurement >90% 10 Echographic Measurement Choroid A LIVING 83 2012 TCGA-V4-A9EL-01A-11D-A39W-08 TCGA-V4-A9EL-01A-11D-A39V-01 be27b78a-f543-497a-96d8-44e21898b502 TCGA-V4-A9EL-01 TCGA-V4-A9EL-01 be27b78a-f543-497a-96d8-44e21898b502 TCGA-V4-A9EL-01A-11D-A39V-01 be27b78a-f543-497a-96d8-44e21898b502 TCGA-V4-A9EL-01A-11D-A39W-08 TCGA-V4-A9EL-01A-11D-A39X-05 TCGA-V4-A9EL-01A-11D-A39W-08 TCGA-V4-A9EL-01A-11D-A39W-08 5D343394-8363-4197-919D-71B6E26CD9B2 be27b78a-f543-497a-96d8-44e21898b502 TCGA-V4-A9EL-01A-11D-A39W-08 TCGA-V4-A9EL-01 TCGA-V4-A9EL-01
19
+ TCGA-V4-A9EM-01 TCGA-V4-A9EM-01 TCGA-V4-A9EM TCGA Ocular melanomas (UVM) uveal melanoma Eye 53 TCGA-V4-A9EM-F72831 TCGA-V4-A9EM M0 N0 T4a Stage IIIA Chromosome 6p gain|Chromosome 8q gain -19413 0 966 Brown 2015-11-25 MALE 193 Epithelioid Cell No C69.30 8771/3 C69.3 YES Enucleation NO 16 NO No M0 N0 T4a Stage IIIA A9EM TUMOR FREE YES NO Primary Tumor 01 7th NO YES V4 22 Pathologic Measurement >90% 12 Echographic Measurement Choroid LIVING 100 2012 TCGA-V4-A9EM-01A-11D-A39W-08 TCGA-V4-A9EM-01A-11D-A39V-01 e68d3264-a868-4857-8b75-4b49207b2298 TCGA-V4-A9EM-01 TCGA-V4-A9EM-01 e68d3264-a868-4857-8b75-4b49207b2298 TCGA-V4-A9EM-01A-11D-A39V-01 e68d3264-a868-4857-8b75-4b49207b2298 TCGA-V4-A9EM-01A-11D-A39W-08 TCGA-V4-A9EM-01A-11D-A39X-05 TCGA-V4-A9EM-01A-11D-A39W-08 TCGA-V4-A9EM-01A-11D-A39W-08 e68d3264-a868-4857-8b75-4b49207b2298 TCGA-V4-A9EM-01A-11D-A39W-08 TCGA-V4-A9EM-01 TCGA-V4-A9EM-01
20
+ TCGA-V4-A9EO-01 TCGA-V4-A9EO-01 TCGA-V4-A9EO TCGA Ocular melanomas (UVM) uveal melanoma Eye 74 TCGA-V4-A9EO-F72832 TCGA-V4-A9EO TCGA-V4-A9EO-01A M0 N0 T4a Stage IIIA Chromosome 1 loss|Chromosome 3 loss|Chromosome 8q gain -27190 272 0 773 NO 2015-11-25 MALE 172 Epithelioid Cell|Spindle Cell No C69.40 8770/3 C69.4 YES Enucleation 60 NO NO 16 NO false No M0 N0 T4a Stage IIIA TCGA-V4-A9EO.04475A61-A4E9-482C-B0B8-48B852636AE3.pdf A9EO TUMOR FREE NO NO Primary Tumor 01 7th NO YES V4 25 Pathologic Measurement 61-90%|1-30% Mushroom 14 Echographic Measurement Choroid|Ciliary body A LIVING 69 2013 TCGA-V4-A9EO-01A-12D-A39W-08 TCGA-V4-A9EO-01A-12D-A39V-01 bef017dc-614b-4e50-9bb1-1ef9cbc4733b TCGA-V4-A9EO-01 TCGA-V4-A9EO-01 bef017dc-614b-4e50-9bb1-1ef9cbc4733b TCGA-V4-A9EO-01A-12D-A39V-01 bef017dc-614b-4e50-9bb1-1ef9cbc4733b TCGA-V4-A9EO-01A-12D-A39W-08 TCGA-V4-A9EO-01A-12D-A39X-05 TCGA-V4-A9EO-01A-12D-A39W-08 TCGA-V4-A9EO-01A-12D-A39W-08 1E678DCA-D21A-4FA6-9327-46C1941186F8 bef017dc-614b-4e50-9bb1-1ef9cbc4733b TCGA-V4-A9EO-01A-12D-A39W-08 TCGA-V4-A9EO-01 TCGA-V4-A9EO-01
21
+ TCGA-V4-A9EQ-01 TCGA-V4-A9EQ-01 TCGA-V4-A9EQ TCGA Ocular melanomas (UVM) uveal melanoma Eye 64 TCGA-V4-A9EQ TCGA-V4-A9EQ-01A M0 N0 T4a Stage IIIA Chromosome 1 loss|Chromosome 3 loss|Chromosome 8q gain -23408 1262 455 0 NO Blue 2014-6-10 MALE 176 Epithelioid Cell|Spindle Cell No C69.30 8770/3 C69.3 YES Enucleation NO YES false No M0 N0 T4a Stage IIIA TCGA-V4-A9EQ.141E5856-DC2C-4684-BC4E-509E43B3914E.pdf Metastatic Uveal Melanoma A9EQ WITH TUMOR YES NO Primary Tumor 01 7th NO YES V4 21 Pathologic Measurement 61-90%|1-30% Dome 14 Echographic Measurement Choroid|Ciliary body A DECEASED 69 2010 TCGA-V4-A9EQ-01A-11D-A39W-08 TCGA-V4-A9EQ-01A-11D-A39V-01 4a63fd9a-7138-4590-a18c-a2684d24c60f TCGA-V4-A9EQ-01 TCGA-V4-A9EQ-01 4a63fd9a-7138-4590-a18c-a2684d24c60f TCGA-V4-A9EQ-01A-11D-A39V-01 4a63fd9a-7138-4590-a18c-a2684d24c60f TCGA-V4-A9EQ-01A-11D-A39W-08 TCGA-V4-A9EQ-01A-11D-A39X-05 TCGA-V4-A9EQ-01A-11D-A39W-08 TCGA-V4-A9EQ-01A-11D-A39W-08 4a63fd9a-7138-4590-a18c-a2684d24c60f TCGA-V4-A9EQ-01A-11D-A39W-08 TCGA-V4-A9EQ-01 TCGA-V4-A9EQ-01
22
+ TCGA-V4-A9ES-01 TCGA-V4-A9ES-01 TCGA-V4-A9ES TCGA Ocular melanomas (UVM) uveal melanoma Eye YES 54 TCGA-V4-A9ES-F72833 TCGA-V4-A9ES M0 N0 T3b Stage IIIA Chromosome 1 loss|Chromosome 3 loss -20054 0 1511 1299 NO Brown 2015-11-25 FEMALE 156 Epithelioid Cell|Spindle Cell No C69.30 8770/3 C69.3 YES Enucleation NO 32 Liver Distant Metastasis YES No M0 N0 T3b Stage IIIA A9ES WITH TUMOR YES NO Primary Tumor 01 7th NO YES V4 16 Pathologic Measurement 31-60%|31-60% 12 Echographic Measurement Choroid|Ciliary body LIVING 68 2011 TCGA-V4-A9ES-01A-11D-A39W-08 TCGA-V4-A9ES-01A-11D-A39V-01 e18a3b30-dcfc-43eb-b975-29d92bb221ea TCGA-V4-A9ES-01 TCGA-V4-A9ES-01 e18a3b30-dcfc-43eb-b975-29d92bb221ea TCGA-V4-A9ES-01A-11D-A39V-01 e18a3b30-dcfc-43eb-b975-29d92bb221ea TCGA-V4-A9ES-01A-11D-A39W-08 TCGA-V4-A9ES-01A-11D-A39X-05 TCGA-V4-A9ES-01A-11D-A39W-08 TCGA-V4-A9ES-01A-11D-A39W-08 e18a3b30-dcfc-43eb-b975-29d92bb221ea TCGA-V4-A9ES-01A-11D-A39W-08 TCGA-V4-A9ES-01 TCGA-V4-A9ES-01
23
+ TCGA-V4-A9ET-01 TCGA-V4-A9ET-01 TCGA-V4-A9ET TCGA Ocular melanomas (UVM) uveal melanoma Eye 57 TCGA-V4-A9ET-F72834 TCGA-V4-A9ET TCGA-V4-A9ET-01A M0 N0 T4b Stage IIIB Chromosome 6p gain -21113 746 0 1362 NO Blue 2015-11-25 MALE 177 Spindle Cell|Epithelioid Cell No C69.30 8770/3 C69.3 YES Enucleation 30 NO NO 8 NO false No M0 N0 T4b Stage IIIB TCGA-V4-A9ET.7D7514B8-A5CE-48D5-8B83-BC06F1718696.pdf A9ET TUMOR FREE NO NO Primary Tumor 01 7th NO YES V4 17 Pathologic Measurement 31-60%|31-60% 13 Echographic Measurement Choroid|Ciliary body|Iris A LIVING 95 2011 TCGA-V4-A9ET-01A-11D-A39W-08 TCGA-V4-A9ET-01A-11D-A39V-01 29dffd79-dbc1-4cf3-b79e-264c680af667 TCGA-V4-A9ET-01 TCGA-V4-A9ET-01 29dffd79-dbc1-4cf3-b79e-264c680af667 TCGA-V4-A9ET-01A-11D-A39V-01 29dffd79-dbc1-4cf3-b79e-264c680af667 TCGA-V4-A9ET-01A-11D-A39W-08 TCGA-V4-A9ET-01A-11D-A39X-05 TCGA-V4-A9ET-01A-11D-A39W-08 TCGA-V4-A9ET-01A-11D-A39W-08 29dffd79-dbc1-4cf3-b79e-264c680af667 TCGA-V4-A9ET-01A-11D-A39W-08 TCGA-V4-A9ET-01 TCGA-V4-A9ET-01
24
+ TCGA-V4-A9EU-01 TCGA-V4-A9EU-01 TCGA-V4-A9EU TCGA Ocular melanomas (UVM) uveal melanoma Eye 83 TCGA-V4-A9EU-F66794 TCGA-V4-A9EU M0 N0 T4d Stage IIIC Chromosome 3 loss|Chromosome 8q gain -30409 0 708 86 <=5mm YES Green 2014-10-23 FEMALE 154 Epithelioid Cell No C69.40 8771/3 C69.4 YES Enucleation YES Other, specify New Primary Tumor Biliary YES No M0 N0 T4d Stage IIIC A9EU WITH TUMOR NO NO Primary Tumor 01 7th NO YES V4 20 Pathologic Measurement >90% 11 Echographic Measurement Choroid|Ciliary body LIVING 52 2011 TCGA-V4-A9EU-01A-11D-A39W-08 TCGA-V4-A9EU-01A-11D-A39V-01 c3d39ee9-f15a-4f10-a04c-1a42e612e387 TCGA-V4-A9EU-01 TCGA-V4-A9EU-01 c3d39ee9-f15a-4f10-a04c-1a42e612e387 TCGA-V4-A9EU-01A-11D-A39V-01 c3d39ee9-f15a-4f10-a04c-1a42e612e387 TCGA-V4-A9EU-01A-11D-A39W-08 TCGA-V4-A9EU-01A-11D-A39X-05 TCGA-V4-A9EU-01A-11D-A39W-08 TCGA-V4-A9EU-01A-11D-A39W-08 c3d39ee9-f15a-4f10-a04c-1a42e612e387 TCGA-V4-A9EU-01A-11D-A39W-08 TCGA-V4-A9EU-01 TCGA-V4-A9EU-01
25
+ TCGA-V4-A9EV-01 TCGA-V4-A9EV-01 TCGA-V4-A9EV TCGA Ocular melanomas (UVM) uveal melanoma Eye 59 TCGA-V4-A9EV-F72838 TCGA-V4-A9EV TCGA-V4-A9EV-01A M0 N0 T4a Stage IIIA Chromosome 3 loss|Chromosome 8q gain -21855 679 1269 0 836 NO Blue 2015-11-25 FEMALE 152 Spindle Cell|Epithelioid Cell No C69.30 8770/3 C69.3 YES Enucleation 80 NO NO 0 Distant Metastasis YES false No M0 N0 T4a Stage IIIA TCGA-V4-A9EV.E2B9489B-520E-4BBB-ADF1-4981E1C3374D.pdf Metastatic Uveal Melanoma A9EV WITH TUMOR NO NO Primary Tumor 01 7th NO YES V4 20 Pathologic Measurement 31-60%|31-60% 13 Echographic Measurement Choroid A DECEASED 103 2012 TCGA-V4-A9EV-01A-11D-A39W-08 TCGA-V4-A9EV-01A-11D-A39V-01 96045fce-b112-4125-8be3-bb998a8e98c0 TCGA-V4-A9EV-01 TCGA-V4-A9EV-01 96045fce-b112-4125-8be3-bb998a8e98c0 TCGA-V4-A9EV-01A-11D-A39V-01 96045fce-b112-4125-8be3-bb998a8e98c0 TCGA-V4-A9EV-01A-11D-A39W-08 TCGA-V4-A9EV-01A-11D-A39X-05 TCGA-V4-A9EV-01A-11D-A39W-08 TCGA-V4-A9EV-01A-11D-A39W-08 96045fce-b112-4125-8be3-bb998a8e98c0 TCGA-V4-A9EV-01A-11D-A39W-08 TCGA-V4-A9EV-01 TCGA-V4-A9EV-01
26
+ TCGA-V4-A9EW-01 TCGA-V4-A9EW-01 TCGA-V4-A9EW TCGA Ocular melanomas (UVM) uveal melanoma Eye YES YES 44 TCGA-V4-A9EW-F66800 TCGA-V4-A9EW TCGA-V4-A9EW-01A M0 N0 T4a Stage IIIA Chromosome 1 loss -16140 606 0 1211 381 NO Blue 2015-11-25 FEMALE 156 Spindle Cell|Epithelioid Cell No C69.30 8770/3 C69.3 YES Enucleation 30 NO NO 40 Liver Distant Metastasis NO NO false No M0 N0 T4a Stage IIIA TCGA-V4-A9EW.7C41C1C2-D937-4DFC-9A8D-5E2944A7CC71.pdf A9EW WITH TUMOR NO NO Primary Tumor 01 7th NO YES V4 19 Pathologic Measurement 31-60%|31-60% 9 Echographic Measurement Choroid A LIVING 51 2012 TCGA-V4-A9EW-01A-11D-A39W-08 TCGA-V4-A9EW-01A-11D-A39V-01 44f37fd7-4c70-4646-b915-b7be1e078935 TCGA-V4-A9EW-01 TCGA-V4-A9EW-01 44f37fd7-4c70-4646-b915-b7be1e078935 TCGA-V4-A9EW-01A-11D-A39V-01 44f37fd7-4c70-4646-b915-b7be1e078935 TCGA-V4-A9EW-01A-11D-A39W-08 TCGA-V4-A9EW-01A-11D-A39X-05 TCGA-V4-A9EW-01A-11D-A39W-08 TCGA-V4-A9EW-01A-11D-A39W-08 44f37fd7-4c70-4646-b915-b7be1e078935 TCGA-V4-A9EW-01A-11D-A39W-08 TCGA-V4-A9EW-01 TCGA-V4-A9EW-01
27
+ TCGA-V4-A9EX-01 TCGA-V4-A9EX-01 TCGA-V4-A9EX TCGA Ocular melanomas (UVM) uveal melanoma Eye 55 TCGA-V4-A9EX TCGA-V4-A9EX-01A M0 N0 T4a Stage IIIA Chromosome 3 loss|Chromosome 8q gain -20447 606 730 0 NO Brown 2014-6-11 FEMALE 163 Epithelioid Cell No C69.30 8771/3 C69.3 YES Enucleation 60 NO YES false No M0 N0 T4a Stage IIIA TCGA-V4-A9EX.24B158B0-2477-4843-9CA8-467A8ACD547A.pdf Metastatic Uveal Melanoma A9EX WITH TUMOR NO NO Primary Tumor 01 7th NO YES V4 17 Pathologic Measurement >90% Mushroom 15 Echographic Measurement Choroid A DECEASED 77 2012 TCGA-V4-A9EX-01A-11D-A39W-08 TCGA-V4-A9EX-01A-11D-A39V-01 1a5ca572-92cb-482d-a04b-65aa519c9fde TCGA-V4-A9EX-01 TCGA-V4-A9EX-01 1a5ca572-92cb-482d-a04b-65aa519c9fde TCGA-V4-A9EX-01A-11D-A39V-01 1a5ca572-92cb-482d-a04b-65aa519c9fde TCGA-V4-A9EX-01A-11D-A39W-08 TCGA-V4-A9EX-01A-11D-A39X-05 TCGA-V4-A9EX-01A-11D-A39W-08 TCGA-V4-A9EX-01A-11D-A39W-08 1a5ca572-92cb-482d-a04b-65aa519c9fde TCGA-V4-A9EX-01A-11D-A39W-08 TCGA-V4-A9EX-01 TCGA-V4-A9EX-01
28
+ TCGA-V4-A9EY-01 TCGA-V4-A9EY-01 TCGA-V4-A9EY TCGA Ocular melanomas (UVM) uveal melanoma Eye 66 TCGA-V4-A9EY-F72841 TCGA-V4-A9EY M0 N0 T4a Stage IIIA Chromosome 6p gain -24187 0 837 NO Blue 2015-11-25 FEMALE 168 Spindle Cell No C69.30 8772/3 C69.3 YES Enucleation NO 8 NO No M0 N0 T4a Stage IIIA A9EY TUMOR FREE NO NO Primary Tumor 01 7th NO YES V4 20 Pathologic Measurement >90% 10 Echographic Measurement Choroid LIVING 90 2012 TCGA-V4-A9EY-01A-11D-A39W-08 TCGA-V4-A9EY-01A-11D-A39V-01 a52f64d0-6f5f-4a7e-8d19-ad5ed83aef21 TCGA-V4-A9EY-01 TCGA-V4-A9EY-01 a52f64d0-6f5f-4a7e-8d19-ad5ed83aef21 TCGA-V4-A9EY-01A-11D-A39V-01 a52f64d0-6f5f-4a7e-8d19-ad5ed83aef21 TCGA-V4-A9EY-01A-11D-A39W-08 TCGA-V4-A9EY-01A-11D-A39X-05 TCGA-V4-A9EY-01A-11D-A39W-08 TCGA-V4-A9EY-01A-11D-A39W-08 a52f64d0-6f5f-4a7e-8d19-ad5ed83aef21 TCGA-V4-A9EY-01A-11D-A39W-08 TCGA-V4-A9EY-01 TCGA-V4-A9EY-01
29
+ TCGA-V4-A9EZ-01 TCGA-V4-A9EZ-01 TCGA-V4-A9EZ TCGA Ocular melanomas (UVM) uveal melanoma Eye 78 TCGA-V4-A9EZ-F66806 TCGA-V4-A9EZ M0 N0 T3a Stage IIB Chromosome 1 loss -28619 0 599 NO Blue 2014-10-23 FEMALE 165 Spindle Cell|Epithelioid Cell No C69.30 8770/3 C69.3 YES Enucleation NO NO No M0 N0 T3a Stage IIB A9EZ TUMOR FREE NO NO Primary Tumor 01 7th NO YES V4 18 Pathologic Measurement 61-90%|1-30% Dome 11 Echographic Measurement Choroid LIVING 58 2012 TCGA-V4-A9EZ-01A-11D-A39W-08 TCGA-V4-A9EZ-01A-11D-A39V-01 ace08b32-d427-4d62-b455-a37a7010be68 TCGA-V4-A9EZ-01 TCGA-V4-A9EZ-01 ace08b32-d427-4d62-b455-a37a7010be68 TCGA-V4-A9EZ-01A-11D-A39V-01 ace08b32-d427-4d62-b455-a37a7010be68 TCGA-V4-A9EZ-01A-11D-A39W-08 TCGA-V4-A9EZ-01A-11D-A39X-05 TCGA-V4-A9EZ-01A-11D-A39W-08 TCGA-V4-A9EZ-01A-11D-A39W-08 ace08b32-d427-4d62-b455-a37a7010be68 TCGA-V4-A9EZ-01A-11D-A39W-08 TCGA-V4-A9EZ-01 TCGA-V4-A9EZ-01
30
+ TCGA-V4-A9F0-01 TCGA-V4-A9F0-01 TCGA-V4-A9F0 TCGA Ocular melanomas (UVM) uveal melanoma Eye YES NO 59 TCGA-V4-A9F0-F66808 TCGA-V4-A9F0 M0 N0 T4b Stage IIIB Chromosome 3 loss|Chromosome 8q gain -21675 945 0 607 489 NO Brown 2015-11-25 MALE 160 Epithelioid Cell|Spindle Cell No C69.40 8770/3 C69.4 YES Enucleation NO Liver Distant Metastasis NO NO No M0 N0 T4b Stage IIIB Metastatic Uveal Melanoma A9F0 WITH TUMOR NO NO Primary Tumor 01 7th NO YES V4 20 Pathologic Measurement 31-60%|31-60% Dome 10 Echographic Measurement Choroid|Ciliary body DECEASED 71 2012 TCGA-V4-A9F0-01A-11D-A39W-08 TCGA-V4-A9F0-01A-11D-A39V-01 cac889a5-fc02-4e4d-94e1-41a22e839473 TCGA-V4-A9F0-01 TCGA-V4-A9F0-01 cac889a5-fc02-4e4d-94e1-41a22e839473 TCGA-V4-A9F0-01A-11D-A39V-01 cac889a5-fc02-4e4d-94e1-41a22e839473 TCGA-V4-A9F0-01A-11D-A39W-08 TCGA-V4-A9F0-01A-11D-A39X-05 TCGA-V4-A9F0-01A-11D-A39W-08 TCGA-V4-A9F0-01A-11D-A39W-08 cac889a5-fc02-4e4d-94e1-41a22e839473 TCGA-V4-A9F0-01A-11D-A39W-08 TCGA-V4-A9F0-01 TCGA-V4-A9F0-01
31
+ TCGA-V4-A9F1-01 TCGA-V4-A9F1-01 TCGA-V4-A9F1 TCGA Ocular melanomas (UVM) uveal melanoma Eye 46 TCGA-V4-A9F1-F72843 TCGA-V4-A9F1 M0 N0 T3a Stage IIB Chromosome 3 loss|Chromosome 8q gain -16852 0 938 NO Brown 2015-11-25 FEMALE 150 Epithelioid Cell No C69.30 8771/3 C69.3 YES Enucleation NO NO No M0 N0 T3a Stage IIB A9F1 TUMOR FREE YES NO Primary Tumor 01 7th NO YES V4 16 Pathologic Measurement >90% 8 Echographic Measurement Choroid LIVING 50 2012 TCGA-V4-A9F1-01A-11D-A39W-08 TCGA-V4-A9F1-01A-11D-A39V-01 c8390739-3d2e-4838-bed7-7eb4c2449958 TCGA-V4-A9F1-01 TCGA-V4-A9F1-01 c8390739-3d2e-4838-bed7-7eb4c2449958 TCGA-V4-A9F1-01A-11D-A39V-01 c8390739-3d2e-4838-bed7-7eb4c2449958 TCGA-V4-A9F1-01A-11D-A39W-08 TCGA-V4-A9F1-01A-11D-A39X-05 TCGA-V4-A9F1-01A-11D-A39W-08 TCGA-V4-A9F1-01A-11D-A39W-08 c8390739-3d2e-4838-bed7-7eb4c2449958 TCGA-V4-A9F1-01A-11D-A39W-08 TCGA-V4-A9F1-01 TCGA-V4-A9F1-01
32
+ TCGA-V4-A9F2-01 TCGA-V4-A9F2-01 TCGA-V4-A9F2 TCGA Ocular melanomas (UVM) uveal melanoma Eye 78 TCGA-V4-A9F2-F72844 TCGA-V4-A9F2 M0 N0 T3b Stage IIIA Chromosome 6p gain -28832 0 734 NO Green 2015-11-25 FEMALE 160 Spindle Cell No C69.40 8772/3 C69.4 YES Enucleation NO 12 NO No M0 N0 T3b Stage IIIA A9F2 TUMOR FREE NO NO Primary Tumor 01 7th NO YES V4 14 Pathologic Measurement >90% Dome 11 Echographic Measurement Choroid|Ciliary body LIVING 50 2012 TCGA-V4-A9F2-01A-11D-A39W-08 TCGA-V4-A9F2-01A-11D-A39V-01 dcc60493-195a-46a1-87e2-0805fc7b317c TCGA-V4-A9F2-01 TCGA-V4-A9F2-01 dcc60493-195a-46a1-87e2-0805fc7b317c TCGA-V4-A9F2-01A-11D-A39V-01 dcc60493-195a-46a1-87e2-0805fc7b317c TCGA-V4-A9F2-01A-11D-A39W-08 TCGA-V4-A9F2-01A-11D-A39X-05 TCGA-V4-A9F2-01A-11D-A39W-08 TCGA-V4-A9F2-01A-11D-A39W-08 dcc60493-195a-46a1-87e2-0805fc7b317c TCGA-V4-A9F2-01A-11D-A39W-08 TCGA-V4-A9F2-01 TCGA-V4-A9F2-01
33
+ TCGA-V4-A9F3-01 TCGA-V4-A9F3-01 TCGA-V4-A9F3 TCGA Ocular melanomas (UVM) uveal melanoma Eye YES NO 49 TCGA-V4-A9F3-F66815 TCGA-V4-A9F3 TCGA-V4-A9F3-01A M0 N0 T4a Stage IIIA Chromosome 3 loss|Chromosome 6p gain|Chromosome 8q gain -17997 366 873 0 525 329 NO 2015-11-25 FEMALE 170 Epithelioid Cell No C69.30 8771/3 C69.3 YES Enucleation 40 NO NO 20 Liver Distant Metastasis NO NO false No M0 N0 T4a Stage IIIA TCGA-V4-A9F3.B9FDCA7F-FA12-4FAB-B0B2-92FA9125E6FE.pdf A9F3 WITH TUMOR YES NO Primary Tumor 01 7th NO YES V4 18 Pathologic Measurement >90% Dome 13 Echographic Measurement Choroid|Ciliary body A DECEASED 89 2012 TCGA-V4-A9F3-01A-11D-A39W-08 TCGA-V4-A9F3-01A-11D-A39V-01 5eba7c31-9866-41d9-a9b3-d4b80ee7f631 TCGA-V4-A9F3-01 TCGA-V4-A9F3-01 5eba7c31-9866-41d9-a9b3-d4b80ee7f631 TCGA-V4-A9F3-01A-11D-A39V-01 5eba7c31-9866-41d9-a9b3-d4b80ee7f631 TCGA-V4-A9F3-01A-11D-A39W-08 TCGA-V4-A9F3-01A-11D-A39X-05 TCGA-V4-A9F3-01A-11D-A39W-08 TCGA-V4-A9F3-01A-11D-A39W-08 5eba7c31-9866-41d9-a9b3-d4b80ee7f631 TCGA-V4-A9F3-01A-11D-A39W-08 TCGA-V4-A9F3-01 TCGA-V4-A9F3-01
34
+ TCGA-V4-A9F4-01 TCGA-V4-A9F4-01 TCGA-V4-A9F4 TCGA Ocular melanomas (UVM) uveal melanoma Eye 41 TCGA-V4-A9F4-F72846 TCGA-V4-A9F4 TCGA-V4-A9F4-01A M0 N0 T4a Stage IIIA Chromosome 6p gain|Chromosome 8q gain -15332 316 0 634 NO Green 2015-11-25 MALE 168 Spindle Cell|Epithelioid Cell No C69.30 8770/3 C69.3 YES Enucleation 80 NO NO NO false No M0 N0 T4a Stage IIIA TCGA-V4-A9F4.5D2ABEAA-D18A-4B35-BBAF-9E1B34D0E07C.pdf A9F4 TUMOR FREE NO NO Primary Tumor 01 7th NO YES V4 20 Pathologic Measurement 61-90%|1-30% Dome 12 Echographic Measurement Choroid A LIVING 91 2013 TCGA-V4-A9F4-01A-11D-A39W-08 TCGA-V4-A9F4-01A-11D-A39V-01 9f1ac770-6106-40f8-9f7e-2538d1b3336a TCGA-V4-A9F4-01 TCGA-V4-A9F4-01 9f1ac770-6106-40f8-9f7e-2538d1b3336a TCGA-V4-A9F4-01A-11D-A39V-01 9f1ac770-6106-40f8-9f7e-2538d1b3336a TCGA-V4-A9F4-01A-11D-A39W-08 TCGA-V4-A9F4-01A-11D-A39X-05 TCGA-V4-A9F4-01A-11D-A39W-08 TCGA-V4-A9F4-01A-11D-A39W-08 0024ECAA-70E9-4231-937B-59035FB91F5A 9f1ac770-6106-40f8-9f7e-2538d1b3336a TCGA-V4-A9F4-01A-11D-A39W-08 TCGA-V4-A9F4-01 TCGA-V4-A9F4-01
35
+ TCGA-V4-A9F5-01 TCGA-V4-A9F5-01 TCGA-V4-A9F5 TCGA Ocular melanomas (UVM) uveal melanoma Eye NO NO 85 TCGA-V4-A9F5-F66818 TCGA-V4-A9F5 M1b N0 T4e Stage IV Chromosome 3 loss|Chromosome 8q gain -31314 0 203 78 >5mm YES Blue 2014-10-23 FEMALE 150 Epithelioid Cell|Spindle Cell No C69.30 8770/3 C69.3 YES Enucleation NO Liver|Cutaneous 40 Liver Distant Metastasis NO YES No M1b N0 T4e Stage IV A9F5 WITH TUMOR NO NO Primary Tumor 01 7th NO YES V4 22 Pathologic Measurement 61-90%|1-30% 10 Echographic Measurement Choroid|Ciliary body LIVING 72 2013 TCGA-V4-A9F5-01A-11D-A39W-08 TCGA-V4-A9F5-01A-11D-A39V-01 ac171614-a8cb-42eb-ab5c-84964727866d TCGA-V4-A9F5-01 TCGA-V4-A9F5-01 ac171614-a8cb-42eb-ab5c-84964727866d TCGA-V4-A9F5-01A-11D-A39V-01 ac171614-a8cb-42eb-ab5c-84964727866d TCGA-V4-A9F5-01A-11D-A39W-08 TCGA-V4-A9F5-01A-11D-A39X-05 TCGA-V4-A9F5-01A-11D-A39W-08 TCGA-V4-A9F5-01A-11D-A39W-08 ac171614-a8cb-42eb-ab5c-84964727866d TCGA-V4-A9F5-01A-11D-A39W-08 TCGA-V4-A9F5-01 TCGA-V4-A9F5-01
36
+ TCGA-V4-A9F7-01 TCGA-V4-A9F7-01 TCGA-V4-A9F7 TCGA Ocular melanomas (UVM) uveal melanoma Eye 78 TCGA-V4-A9F7-F72847 TCGA-V4-A9F7 M0 N0 T3a Stage IIB Chromosome 6p gain -28822 0 1256 NO Blue 2015-11-25 FEMALE 150 Spindle Cell|Epithelioid Cell No C69.30 8770/3 C69.3 YES Enucleation NO 20 NO No M0 N0 T3a Stage IIB A9F7 TUMOR FREE NO NO Primary Tumor 01 7th NO YES V4 15 Pathologic Measurement 61-90%|1-30% Mushroom 9 Echographic Measurement Choroid LIVING 41 2011 TCGA-V4-A9F7-01A-11D-A39W-08 TCGA-V4-A9F7-01A-11D-A39V-01 e6e92830-45a9-4a95-ab45-2c36bdbe827b TCGA-V4-A9F7-01 TCGA-V4-A9F7-01 e6e92830-45a9-4a95-ab45-2c36bdbe827b TCGA-V4-A9F7-01A-11D-A39V-01 e6e92830-45a9-4a95-ab45-2c36bdbe827b TCGA-V4-A9F7-01A-11D-A39W-08 TCGA-V4-A9F7-01A-11D-A39X-05 TCGA-V4-A9F7-01A-11D-A39W-08 TCGA-V4-A9F7-01A-11D-A39W-08 e6e92830-45a9-4a95-ab45-2c36bdbe827b TCGA-V4-A9F7-01A-11D-A39W-08 TCGA-V4-A9F7-01 TCGA-V4-A9F7-01
37
+ TCGA-V4-A9F8-01 TCGA-V4-A9F8-01 TCGA-V4-A9F8 TCGA Ocular melanomas (UVM) uveal melanoma Eye 68 TCGA-V4-A9F8-F70739 TCGA-V4-A9F8 M0 N0 T4a Stage IIIA Chromosome 3 loss|Chromosome 8q gain -25168 0 597 NO Brown 2015-3-3 MALE 165 Epithelioid Cell|Spindle Cell No C69.30 8770/3 C69.3 YES Enucleation NO NO No M0 N0 T4a Stage IIIA A9F8 TUMOR FREE NO NO Primary Tumor 01 7th NO YES V4 20 Pathologic Measurement Many 61-90%|1-30% Mushroom 12 Echographic Measurement Choroid LIVING 68 2012 TCGA-V4-A9F8-01A-11D-A39W-08 TCGA-V4-A9F8-01A-11D-A39V-01 f35b99b4-82aa-40f7-bd9e-add95533b3d5 TCGA-V4-A9F8-01 TCGA-V4-A9F8-01 f35b99b4-82aa-40f7-bd9e-add95533b3d5 TCGA-V4-A9F8-01A-11D-A39V-01 f35b99b4-82aa-40f7-bd9e-add95533b3d5 TCGA-V4-A9F8-01A-11D-A39W-08 TCGA-V4-A9F8-01A-11D-A39X-05 TCGA-V4-A9F8-01A-11D-A39W-08 TCGA-V4-A9F8-01A-11D-A39W-08 f35b99b4-82aa-40f7-bd9e-add95533b3d5 TCGA-V4-A9F8-01A-11D-A39W-08 TCGA-V4-A9F8-01 TCGA-V4-A9F8-01
38
+ TCGA-VD-A8K7-01 TCGA-VD-A8K7-01 TCGA-VD-A8K7 TCGA Ocular melanomas (UVM) uveal melanoma Eye 39 TCGA-VD-A8K7-F72853 TCGA-VD-A8K7 TCGA-VD-A8K7-01B M0 N0 T4a Stage IIIA Chromosome 6p gain -14294 798 0 1459 NO Loops 2015-12-1 MALE Spindle Cell No C69.30 8772/3 C69.3 YES Enucleation NO NO None 4 NO false No MX NX T4a Stage IIIA TCGA-VD-A8K7.29FC671C-98D1-4A34-8FC7-5C667E5FDB36.pdf A8K7 TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 16.5 Echographic Measurement Few Few >90% Dome 12.5 Echographic Measurement Choroid B LIVING 2011 TCGA-VD-A8K7-01B-11D-A39W-08 TCGA-VD-A8K7-01B-11D-A39V-01 1a827c90-eb77-4ec0-8f51-5c7c1c09593a TCGA-VD-A8K7-01 TCGA-VD-A8K7-01 1a827c90-eb77-4ec0-8f51-5c7c1c09593a TCGA-VD-A8K7-01B-11D-A39V-01 1a827c90-eb77-4ec0-8f51-5c7c1c09593a TCGA-VD-A8K7-01B-11D-A39W-08 TCGA-VD-A8K7-01B-11D-A39X-05 TCGA-VD-A8K7-01B-11D-A39W-08 TCGA-VD-A8K7-01B-11D-A39W-08 1a827c90-eb77-4ec0-8f51-5c7c1c09593a TCGA-VD-A8K7-01B-11D-A39W-08 TCGA-VD-A8K7-01 TCGA-VD-A8K7-01
39
+ TCGA-VD-A8K8-01 TCGA-VD-A8K8-01 TCGA-VD-A8K8 TCGA Ocular melanomas (UVM) uveal melanoma Eye 56 TCGA-VD-A8K8-F72854 TCGA-VD-A8K8 TCGA-VD-A8K8-01A M0 N0 T4a Stage IIIA Chromosome 3 loss|Chromosome 8q gain -20454 763 1377 0 20 NO Loops 2015-12-1 FEMALE Epithelioid Cell|Spindle Cell No C69.30 8770/3 C69.3 YES Enucleation 20 NO NO None 12 Distant Metastasis YES false No MX NX T3a Stage IIB TCGA-VD-A8K8.859216F2-7122-4F06-B65E-380D3F22F4ED.pdf Metastatic Uveal Melanoma A8K8 WITH TUMOR NO NO Primary Tumor 01 7th NO YES VD 18.4 Echographic Measurement Few Few 1-30%|61-90% Dome 10.3 Echographic Measurement Choroid A DECEASED 2011 TCGA-VD-A8K8-01A-11D-A39W-08 TCGA-VD-A8K8-01A-11D-A39V-01 5647d775-827e-478b-ae8b-a7b872ad3fe6 TCGA-VD-A8K8-01 TCGA-VD-A8K8-01 5647d775-827e-478b-ae8b-a7b872ad3fe6 TCGA-VD-A8K8-01A-11D-A39V-01 5647d775-827e-478b-ae8b-a7b872ad3fe6 TCGA-VD-A8K8-01A-11D-A39W-08 TCGA-VD-A8K8-01A-11D-A39X-05 TCGA-VD-A8K8-01A-11D-A39W-08 TCGA-VD-A8K8-01A-11D-A39W-08 5647d775-827e-478b-ae8b-a7b872ad3fe6 TCGA-VD-A8K8-01A-11D-A39W-08 TCGA-VD-A8K8-01 TCGA-VD-A8K8-01
40
+ TCGA-VD-A8K9-01 TCGA-VD-A8K9-01 TCGA-VD-A8K9 TCGA Ocular melanomas (UVM) uveal melanoma Eye 71 TCGA-VD-A8K9-F72855 TCGA-VD-A8K9 M0 N0 T3a Stage IIB -26292 0 1424 NO 2015-12-1 FEMALE Spindle Cell No C69.30 8774/3 C69.3 YES Enucleation NO None 7 NO No MX NX T2a Stage IIA A8K9 TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 14.5 Echographic Measurement Few Few >90% Dome 6.8 Echographic Measurement Choroid LIVING 2011 TCGA-VD-A8K9-01A-11D-A39W-08 TCGA-VD-A8K9-01A-11D-A39V-01 cf875269-5309-4c0e-bc92-95318feeb2da TCGA-VD-A8K9-01 TCGA-VD-A8K9-01 cf875269-5309-4c0e-bc92-95318feeb2da TCGA-VD-A8K9-01A-11D-A39V-01 cf875269-5309-4c0e-bc92-95318feeb2da TCGA-VD-A8K9-01A-11D-A39W-08 TCGA-VD-A8K9-01A-11D-A39X-05 TCGA-VD-A8K9-01A-11D-A39W-08 TCGA-VD-A8K9-01A-11D-A39W-08 cf875269-5309-4c0e-bc92-95318feeb2da TCGA-VD-A8K9-01A-11D-A39W-08 TCGA-VD-A8K9-01 TCGA-VD-A8K9-01
41
+ TCGA-VD-A8KA-01 TCGA-VD-A8KA-01 TCGA-VD-A8KA TCGA Ocular melanomas (UVM) uveal melanoma Eye NO NO 22 TCGA-VD-A8KA-F67956 TCGA-VD-A8KA M0 N0 T3a Stage IIB Chromosome 1 loss|Chromosome 6p gain|Chromosome 8q gain -8271 0 1178 1122 NO Loops 2015-12-1 MALE Spindle Cell|Epithelioid Cell No C69.30 8770/3 C69.3 YES Local Resection-Exoresection, wall resection NO None 12 Other, specify Locoregional Recurrence Choroid YES NO No MX NX T3a Stage IIB A8KA WITH TUMOR NO NO Primary Tumor 01 7th NO YES VD 15.9 Echographic Measurement Few 61-90%|1-30% 8.5 Echographic Measurement Choroid LIVING 2011 TCGA-VD-A8KA-01B-11D-A39W-08 TCGA-VD-A8KA-01B-11D-A39V-01 fd80bdb7-d293-49e0-8b72-0dd50fbeaac1 TCGA-VD-A8KA-01 TCGA-VD-A8KA-01 fd80bdb7-d293-49e0-8b72-0dd50fbeaac1 TCGA-VD-A8KA-01B-11D-A39V-01 fd80bdb7-d293-49e0-8b72-0dd50fbeaac1 TCGA-VD-A8KA-01B-11D-A39W-08 TCGA-VD-A8KA-01B-11D-A39X-05 TCGA-VD-A8KA-01B-11D-A39W-08 TCGA-VD-A8KA-01B-11D-A39W-08 fd80bdb7-d293-49e0-8b72-0dd50fbeaac1 TCGA-VD-A8KA-01B-11D-A39W-08 TCGA-VD-A8KA-01 TCGA-VD-A8KA-01
42
+ TCGA-VD-A8KB-01 TCGA-VD-A8KB-01 TCGA-VD-A8KB TCGA Ocular melanomas (UVM) uveal melanoma Eye NO YES 66 TCGA-VD-A8KB-F67958 TCGA-VD-A8KB TCGA-VD-A8KB-01A M0 N0 T3a Stage IIB Chromosome 6p gain -24393 763 0 1354 1032 NO 2015-12-1 FEMALE Epithelioid Cell|Spindle Cell No C69.30 8700/3 C69.3 YES Local Resection-Exoresection, wall resection 20 NO NO None 7 Other, specify Locoregional Recurrence Choroid NO NO false No MX NX T3a Stage IIB TCGA-VD-A8KB.C9A25B61-433D-47D7-9F2C-820205292D13.pdf A8KB TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 17.1 Echographic Measurement Few 1-30%|61-90% 7.7 Echographic Measurement Choroid A LIVING 2011 TCGA-VD-A8KB-01A-11D-A39W-08 TCGA-VD-A8KB-01A-11D-A39V-01 35c73123-2cca-4a05-a5ff-a7897065355b TCGA-VD-A8KB-01 TCGA-VD-A8KB-01 35c73123-2cca-4a05-a5ff-a7897065355b TCGA-VD-A8KB-01A-11D-A39V-01 35c73123-2cca-4a05-a5ff-a7897065355b TCGA-VD-A8KB-01A-11D-A39W-08 TCGA-VD-A8KB-01A-11D-A39X-05 TCGA-VD-A8KB-01A-11D-A39W-08 TCGA-VD-A8KB-01A-11D-A39W-08 35c73123-2cca-4a05-a5ff-a7897065355b TCGA-VD-A8KB-01A-11D-A39W-08 TCGA-VD-A8KB-01 TCGA-VD-A8KB-01
43
+ TCGA-VD-A8KD-01 TCGA-VD-A8KD-01 TCGA-VD-A8KD TCGA Ocular melanomas (UVM) uveal melanoma Eye 72 TCGA-VD-A8KD TCGA-VD-A8KD-01A M1 N0 T4a Stage IV Chromosome 3 loss|Chromosome 8q gain -26457 603 114 0 NO Loops 2014-5-9 MALE Epithelioid Cell|Spindle Cell No C69.30 8770/3 C69.3 YES Enucleation 90 NO None 7 YES false No M1 NX T4a Stage IV TCGA-VD-A8KD.20DFC61D-E721-4798-A88C-808785CE740A.pdf Metastatic Uveal Melanoma A8KD WITH TUMOR NO NO Primary Tumor 01 7th NO YES VD 15.6 Echographic Measurement Moderate Numbers Few 1-30%|61-90% Mushroom 15.2 Echographic Measurement Choroid A DECEASED 2012 TCGA-VD-A8KD-01A-11D-A39W-08 TCGA-VD-A8KD-01A-11D-A39V-01 2d48d8a6-2bb0-45d7-a87e-4d2959a33b2b TCGA-VD-A8KD-01 TCGA-VD-A8KD-01 2d48d8a6-2bb0-45d7-a87e-4d2959a33b2b TCGA-VD-A8KD-01A-11D-A39V-01 2d48d8a6-2bb0-45d7-a87e-4d2959a33b2b TCGA-VD-A8KD-01A-11D-A39W-08 TCGA-VD-A8KD-01A-11D-A39X-05 TCGA-VD-A8KD-01A-11D-A39W-08 TCGA-VD-A8KD-01A-11D-A39W-08 2d48d8a6-2bb0-45d7-a87e-4d2959a33b2b TCGA-VD-A8KD-01A-11D-A39W-08 TCGA-VD-A8KD-01 TCGA-VD-A8KD-01
44
+ TCGA-VD-A8KE-01 TCGA-VD-A8KE-01 TCGA-VD-A8KE TCGA Ocular melanomas (UVM) uveal melanoma Eye 74 TCGA-VD-A8KE-F67961 TCGA-VD-A8KE TCGA-VD-A8KE-01A M0 N0 T2a Stage IIA -27290 609 0 821 NO Loops 2015-2-26 FEMALE Epithelioid Cell|Spindle Cell No C69.30 8770/3 C69.3 YES Enucleation 20 NO NO None 3 NO false No MX NX T2a Stage IIA TCGA-VD-A8KE.C9CCC817-9FA1-401A-A075-282B0AB10207.pdf A8KE TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 10.8 Echographic Measurement Few 31-60%|31-60% Mushroom 8.4 Echographic Measurement Choroid A LIVING 2012 TCGA-VD-A8KE-01A-11D-A39W-08 TCGA-VD-A8KE-01A-11D-A39V-01 207c04e4-3a0c-415f-941a-191d1b5b9401 TCGA-VD-A8KE-01 TCGA-VD-A8KE-01 207c04e4-3a0c-415f-941a-191d1b5b9401 TCGA-VD-A8KE-01A-11D-A39V-01 207c04e4-3a0c-415f-941a-191d1b5b9401 TCGA-VD-A8KE-01A-11D-A39W-08 TCGA-VD-A8KE-01A-11D-A39X-05 TCGA-VD-A8KE-01A-11D-A39W-08 TCGA-VD-A8KE-01A-11D-A39W-08 207c04e4-3a0c-415f-941a-191d1b5b9401 TCGA-VD-A8KE-01A-11D-A39W-08 TCGA-VD-A8KE-01 TCGA-VD-A8KE-01
45
+ TCGA-VD-A8KF-01 TCGA-VD-A8KF-01 TCGA-VD-A8KF TCGA Ocular melanomas (UVM) uveal melanoma Eye 68 TCGA-VD-A8KF TCGA-VD-A8KF-01A M0 N0 T4b Stage IIIB Chromosome 3 loss|Chromosome 8q gain -25066 309 40 0 NO Loops 2014-5-9 MALE Epithelioid Cell No C69.80 8770/3 C69.8 YES Enucleation 120 NO None 16 YES false No MX NX T4b Stage IIIB TCGA-VD-A8KF.9FFFF089-4156-4221-BCAC-20EEB748944C.pdf Metastatic Uveal Melanoma A8KF WITH TUMOR NO NO Primary Tumor 01 7th NO YES VD 19.2 Echographic Measurement Few 61-90% Diffuse 7.2 Echographic Measurement Choroid|Ciliary body A DECEASED 2013 TCGA-VD-A8KF-01A-11D-A39W-08 TCGA-VD-A8KF-01A-11D-A39V-01 976c3fd8-2aec-4dc9-9343-cf0df50b60a3 TCGA-VD-A8KF-01 TCGA-VD-A8KF-01 976c3fd8-2aec-4dc9-9343-cf0df50b60a3 TCGA-VD-A8KF-01A-11D-A39V-01 976c3fd8-2aec-4dc9-9343-cf0df50b60a3 TCGA-VD-A8KF-01A-11D-A39W-08 TCGA-VD-A8KF-01A-11D-A39X-05 TCGA-VD-A8KF-01A-11D-A39W-08 TCGA-VD-A8KF-01A-11D-A39W-08 FF615D33-1982-4B75-87CD-5C43D6A800D4 976c3fd8-2aec-4dc9-9343-cf0df50b60a3 TCGA-VD-A8KF-01A-11D-A39W-08 TCGA-VD-A8KF-01 TCGA-VD-A8KF-01
46
+ TCGA-VD-A8KG-01 TCGA-VD-A8KG-01 TCGA-VD-A8KG TCGA Ocular melanomas (UVM) uveal melanoma Eye 47 TCGA-VD-A8KG-F67962 TCGA-VD-A8KG M0 N0 T2a Stage IIA Chromosome 3 loss|Chromosome 6p gain -17417 0 19 NO 2015-2-26 FEMALE Spindle Cell No C69.30 8774/3 C69.3 YES Enucleation NO None 1 NO No MX NX T2a Stage IIA A8KG TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 11.3 Echographic Measurement Few >90% Dome 7.6 Echographic Measurement Choroid LIVING 2012 TCGA-VD-A8KG-01A-11D-A39W-08 TCGA-VD-A8KG-01A-11D-A39V-01 a9c824b6-4214-4c8a-9914-0d418f609e5d TCGA-VD-A8KG-01 TCGA-VD-A8KG-01 a9c824b6-4214-4c8a-9914-0d418f609e5d TCGA-VD-A8KG-01A-11D-A39V-01 a9c824b6-4214-4c8a-9914-0d418f609e5d TCGA-VD-A8KG-01A-11D-A39W-08 TCGA-VD-A8KG-01A-11D-A39X-05 TCGA-VD-A8KG-01A-11D-A39W-08 TCGA-VD-A8KG-01A-11D-A39W-08 a9c824b6-4214-4c8a-9914-0d418f609e5d TCGA-VD-A8KG-01A-11D-A39W-08 TCGA-VD-A8KG-01 TCGA-VD-A8KG-01
47
+ TCGA-VD-A8KH-01 TCGA-VD-A8KH-01 TCGA-VD-A8KH TCGA Ocular melanomas (UVM) uveal melanoma Eye 69 TCGA-VD-A8KH-F72858 TCGA-VD-A8KH TCGA-VD-A8KH-01A M0 N0 T4b Stage IIIB Chromosome 1 loss|Chromosome 3 loss -25388 497 0 1158 NO Loops 2015-12-1 MALE Epithelioid Cell|Spindle Cell No C69.80 8770/3 C69.8 YES Enucleation 70 NO NO None 2 NO false No MX NX T4b Stage IIIB TCGA-VD-A8KH.0032F50D-7E01-438A-979B-CAF5D65419DB.pdf A8KH TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 16.9 Echographic Measurement Few 1-30%|61-90% Mushroom 12.4 Echographic Measurement Choroid|Ciliary body A LIVING 2012 TCGA-VD-A8KH-01A-11D-A39W-08 TCGA-VD-A8KH-01A-11D-A39V-01 8b011797-71ab-4903-b227-0602a8ab2c95 TCGA-VD-A8KH-01 TCGA-VD-A8KH-01 8b011797-71ab-4903-b227-0602a8ab2c95 TCGA-VD-A8KH-01A-11D-A39V-01 8b011797-71ab-4903-b227-0602a8ab2c95 TCGA-VD-A8KH-01A-11D-A39W-08 TCGA-VD-A8KH-01A-11D-A39X-05 TCGA-VD-A8KH-01A-11D-A39W-08 TCGA-VD-A8KH-01A-11D-A39W-08 8b011797-71ab-4903-b227-0602a8ab2c95 TCGA-VD-A8KH-01A-11D-A39W-08 TCGA-VD-A8KH-01 TCGA-VD-A8KH-01
48
+ TCGA-VD-A8KI-01 TCGA-VD-A8KI-01 TCGA-VD-A8KI TCGA Ocular melanomas (UVM) uveal melanoma Eye 68 TCGA-VD-A8KI-F72859 TCGA-VD-A8KI M0 N0 T3a Stage IIB Chromosome 3 loss|Chromosome 6p gain|Chromosome 8q gain -24966 1113 0 38 NO 2015-12-1 MALE Epithelioid Cell|Spindle Cell No C69.30 8770/3 C69.3 YES Enucleation NO None 5 Distant Metastasis YES No MX NX T3a Stage IIB Metastatic Uveal Melanoma A8KI WITH TUMOR NO NO Primary Tumor 01 7th NO YES VD 17.6 Echographic Measurement Few Few 31-60%|31-60% Dome 11.0 Echographic Measurement Choroid DECEASED 2012 TCGA-VD-A8KI-01A-11D-A39W-08 TCGA-VD-A8KI-01A-11D-A39V-01 a7c9b6b2-0654-446b-90f3-4ec3cf181e3b TCGA-VD-A8KI-01 TCGA-VD-A8KI-01 a7c9b6b2-0654-446b-90f3-4ec3cf181e3b TCGA-VD-A8KI-01A-11D-A39V-01 a7c9b6b2-0654-446b-90f3-4ec3cf181e3b TCGA-VD-A8KI-01A-11D-A39W-08 TCGA-VD-A8KI-01A-11D-A39X-05 TCGA-VD-A8KI-01A-11D-A39W-08 TCGA-VD-A8KI-01A-11D-A39W-08 a7c9b6b2-0654-446b-90f3-4ec3cf181e3b TCGA-VD-A8KI-01A-11D-A39W-08 TCGA-VD-A8KI-01 TCGA-VD-A8KI-01
49
+ TCGA-VD-A8KJ-01 TCGA-VD-A8KJ-01 TCGA-VD-A8KJ TCGA Ocular melanomas (UVM) uveal melanoma Eye 53 TCGA-VD-A8KJ-F72860 TCGA-VD-A8KJ M0 N0 T3a Stage IIB -19562 0 1150 NO 2015-12-1 MALE Spindle Cell|Epithelioid Cell No C69.30 8770/3 C69.3 YES Enucleation NO None 18 NO No MX NX T3a Stage IIB A8KJ TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 16.9 Echographic Measurement Few Few 61-90%|1-30% Dome 10.6 Echographic Measurement Choroid LIVING 2011 TCGA-VD-A8KJ-01A-11D-A39W-08 TCGA-VD-A8KJ-01A-11D-A39V-01 c36ca54a-8e53-414a-905f-bc777f892a76 TCGA-VD-A8KJ-01 TCGA-VD-A8KJ-01 c36ca54a-8e53-414a-905f-bc777f892a76 TCGA-VD-A8KJ-01A-11D-A39V-01 c36ca54a-8e53-414a-905f-bc777f892a76 TCGA-VD-A8KJ-01A-11D-A39W-08 TCGA-VD-A8KJ-01A-11D-A39X-05 TCGA-VD-A8KJ-01A-11D-A39W-08 TCGA-VD-A8KJ-01A-11D-A39W-08 c36ca54a-8e53-414a-905f-bc777f892a76 TCGA-VD-A8KJ-01A-11D-A39W-08 TCGA-VD-A8KJ-01 TCGA-VD-A8KJ-01
50
+ TCGA-VD-A8KK-01 TCGA-VD-A8KK-01 TCGA-VD-A8KK TCGA Ocular melanomas (UVM) uveal melanoma Eye 54 TCGA-VD-A8KK-F67967 TCGA-VD-A8KK TCGA-VD-A8KK-01A M0 N0 T4a Stage IIIA Chromosome 3 loss|Chromosome 8q gain -19958 273 0 64 NO Loops 2015-2-26 MALE Spindle Cell No C69.30 8774/3 C69.3 YES Enucleation 50 NO NO None 7 NO false No MX NX T4a Stage IIIA TCGA-VD-A8KK.2C7A9333-9CCF-4E1E-A3DC-BE9ED78858B3.pdf A8KK TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 19.5 Echographic Measurement Few Few >90% Dome 10.9 Echographic Measurement Choroid A LIVING 2013 TCGA-VD-A8KK-01A-11D-A39W-08 TCGA-VD-A8KK-01A-11D-A39V-01 7e2c1a80-8fea-4341-b7e2-4e97191078ca TCGA-VD-A8KK-01 TCGA-VD-A8KK-01 7e2c1a80-8fea-4341-b7e2-4e97191078ca TCGA-VD-A8KK-01A-11D-A39V-01 7e2c1a80-8fea-4341-b7e2-4e97191078ca TCGA-VD-A8KK-01A-11D-A39W-08 TCGA-VD-A8KK-01A-11D-A39X-05 TCGA-VD-A8KK-01A-11D-A39W-08 TCGA-VD-A8KK-01A-11D-A39W-08 7e2c1a80-8fea-4341-b7e2-4e97191078ca TCGA-VD-A8KK-01A-11D-A39W-08 TCGA-VD-A8KK-01 TCGA-VD-A8KK-01
51
+ TCGA-VD-A8KL-01 TCGA-VD-A8KL-01 TCGA-VD-A8KL TCGA Ocular melanomas (UVM) uveal melanoma Eye 77 TCGA-VD-A8KL-F67969 TCGA-VD-A8KL M0 N0 T3a Stage IIB Chromosome 3 loss|Chromosome 6p gain|Chromosome 8q gain -28450 0 638 NO 2015-2-26 FEMALE Spindle Cell|Epithelioid Cell No C69.30 8770/3 C69.3 YES Enucleation NO None 2 NO No MX NX T3a Stage IIB A8KL TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 17.9 Echographic Measurement Few 61-90%|1-30% Dome 8.1 Echographic Measurement Choroid LIVING 2013 TCGA-VD-A8KL-01A-11D-A39W-08 TCGA-VD-A8KL-01A-11D-A39V-01 aae660ac-0442-46d1-ae42-fe007cb14cb7 TCGA-VD-A8KL-01 TCGA-VD-A8KL-01 aae660ac-0442-46d1-ae42-fe007cb14cb7 TCGA-VD-A8KL-01A-11D-A39V-01 aae660ac-0442-46d1-ae42-fe007cb14cb7 TCGA-VD-A8KL-01A-11D-A39W-08 TCGA-VD-A8KL-01A-11D-A39X-05 TCGA-VD-A8KL-01A-11D-A39W-08 TCGA-VD-A8KL-01A-11D-A39W-08 aae660ac-0442-46d1-ae42-fe007cb14cb7 TCGA-VD-A8KL-01A-11D-A39W-08 TCGA-VD-A8KL-01 TCGA-VD-A8KL-01
52
+ TCGA-VD-A8KM-01 TCGA-VD-A8KM-01 TCGA-VD-A8KM TCGA Ocular melanomas (UVM) uveal melanoma Eye 65 TCGA-VD-A8KM-F67970 TCGA-VD-A8KM TCGA-VD-A8KM-01A M0 N0 T3a Stage IIB Chromosome 3 loss|Chromosome 6p gain|Chromosome 8q gain -24047 200 0 4 NO 2015-2-26 MALE Epithelioid Cell No C69.30 8770/3 C69.3 YES Enucleation 10 NO NO None 2 NO false No MX NX T3a Stage IIB TCGA-VD-A8KM.519C82A6-289D-4DB7-B484-8FDFDA1A1B40.pdf A8KM TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 16.6 Echographic Measurement Few Few 61-90% Dome 8.9 Echographic Measurement Choroid A LIVING 2013 TCGA-VD-A8KM-01A-11D-A39W-08 TCGA-VD-A8KM-01A-11D-A39V-01 001443c3-137d-46ae-a767-87d453b32fbb TCGA-VD-A8KM-01 TCGA-VD-A8KM-01 001443c3-137d-46ae-a767-87d453b32fbb TCGA-VD-A8KM-01A-11D-A39V-01 001443c3-137d-46ae-a767-87d453b32fbb TCGA-VD-A8KM-01A-11D-A39W-08 TCGA-VD-A8KM-01A-11D-A39X-05 TCGA-VD-A8KM-01A-11D-A39W-08 TCGA-VD-A8KM-01A-11D-A39W-08 001443c3-137d-46ae-a767-87d453b32fbb TCGA-VD-A8KM-01A-11D-A39W-08 TCGA-VD-A8KM-01 TCGA-VD-A8KM-01
53
+ TCGA-VD-A8KN-01 TCGA-VD-A8KN-01 TCGA-VD-A8KN TCGA Ocular melanomas (UVM) uveal melanoma Eye 60 TCGA-VD-A8KN-F67972 TCGA-VD-A8KN M0 N0 T3a Stage IIB Chromosome 3 loss|Chromosome 8q gain -21935 0 68 NO Loops 2015-2-26 FEMALE Epithelioid Cell|Spindle Cell No C69.30 8770/3 C69.3 YES Enucleation NO None 2 NO No MX NX T2a Stage IIA A8KN TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 15.1 Echographic Measurement Few Few 31-60%|1-30% Dome 4.4 Echographic Measurement Choroid LIVING 2013 TCGA-VD-A8KN-01A-11D-A39W-08 TCGA-VD-A8KN-01A-11D-A39V-01 e21a08db-30de-4b61-adb2-0a291137572d TCGA-VD-A8KN-01 TCGA-VD-A8KN-01 e21a08db-30de-4b61-adb2-0a291137572d TCGA-VD-A8KN-01A-11D-A39V-01 e21a08db-30de-4b61-adb2-0a291137572d TCGA-VD-A8KN-01A-11D-A39W-08 TCGA-VD-A8KN-01A-11D-A39X-05 TCGA-VD-A8KN-01A-11D-A39W-08 TCGA-VD-A8KN-01A-11D-A39W-08 e21a08db-30de-4b61-adb2-0a291137572d TCGA-VD-A8KN-01A-11D-A39W-08 TCGA-VD-A8KN-01 TCGA-VD-A8KN-01
54
+ TCGA-VD-A8KO-01 TCGA-VD-A8KO-01 TCGA-VD-A8KO TCGA Ocular melanomas (UVM) uveal melanoma Eye 51 TCGA-VD-A8KO-F67973 TCGA-VD-A8KO TCGA-VD-A8KO-01A M0 N0 T4a Stage IIIA Chromosome 6p gain -18844 373 0 795 NO Loops 2015-2-26 MALE Spindle Cell No C69.30 8774/3 C69.3 YES Enucleation 30 NO NO None 4 NO false No MX NX T2a Stage IIA TCGA-VD-A8KO.21AF9D90-AD49-4757-B96A-F536F40408E7.pdf A8KO TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 16.2 Echographic Measurement Few >90% Dome 14.8 Echographic Measurement Choroid A LIVING 2012 TCGA-VD-A8KO-01A-11D-A39W-08 TCGA-VD-A8KO-01A-11D-A39V-01 97c340e4-54be-4016-a335-be29ba5e8e94 TCGA-VD-A8KO-01 TCGA-VD-A8KO-01 97c340e4-54be-4016-a335-be29ba5e8e94 TCGA-VD-A8KO-01A-11D-A39V-01 97c340e4-54be-4016-a335-be29ba5e8e94 TCGA-VD-A8KO-01A-11D-A39W-08 TCGA-VD-A8KO-01A-11D-A39X-05 TCGA-VD-A8KO-01A-11D-A39W-08 TCGA-VD-A8KO-01A-11D-A39W-08 97c340e4-54be-4016-a335-be29ba5e8e94 TCGA-VD-A8KO-01A-11D-A39W-08 TCGA-VD-A8KO-01 TCGA-VD-A8KO-01
55
+ TCGA-VD-AA8M-01 TCGA-VD-AA8M-01 TCGA-VD-AA8M TCGA Ocular melanomas (UVM) uveal melanoma Eye 64 TCGA-VD-AA8M-F67975 TCGA-VD-AA8M TCGA-VD-AA8M-01A M0 N0 T3a Stage IIB -23507 132 0 6 NO Loops 2015-2-26 MALE Spindle Cell|Epithelioid Cell No C69.30 8770/3 C69.3 YES Enucleation 60 NO NO None 7 NO false No M0 N0 T2a Stage IIA TCGA-VD-AA8M.F501AF08-A89D-4B4B-9A18-07DC938DB233.pdf AA8M TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 13.2 Echographic Measurement Few Few 61-90%|1-30% Dome 6.5 Echographic Measurement Choroid A LIVING 2013 TCGA-VD-AA8M-01A-11D-A39W-08 TCGA-VD-AA8M-01A-11D-A39V-01 0bc1d5cb-2064-4ae7-b821-1e999ef57fa5 TCGA-VD-AA8M-01 TCGA-VD-AA8M-01 0bc1d5cb-2064-4ae7-b821-1e999ef57fa5 TCGA-VD-AA8M-01A-11D-A39V-01 0bc1d5cb-2064-4ae7-b821-1e999ef57fa5 TCGA-VD-AA8M-01A-11D-A39W-08 TCGA-VD-AA8M-01A-11D-A39X-05 TCGA-VD-AA8M-01A-11D-A39W-08 TCGA-VD-AA8M-01A-11D-A39W-08 0bc1d5cb-2064-4ae7-b821-1e999ef57fa5 TCGA-VD-AA8M-01A-11D-A39W-08 TCGA-VD-AA8M-01 TCGA-VD-AA8M-01
56
+ TCGA-VD-AA8N-01 TCGA-VD-AA8N-01 TCGA-VD-AA8N TCGA Ocular melanomas (UVM) uveal melanoma Eye 86 TCGA-VD-AA8N-F67976 TCGA-VD-AA8N M0 N0 T4a Stage IIIA Chromosome 3 loss|Chromosome 8q gain -31475 0 44 NO Loops 2015-2-26 MALE Epithelioid Cell|Spindle Cell No C69.30 8770/3 C69.3 YES Enucleation NO None 21 NO No M0 N0 T3a Stage IIB AA8N TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 17.2 Echographic Measurement Few Few 61-90%|1-30% Dome 14.5 Echographic Measurement Choroid LIVING 2013 TCGA-VD-AA8N-01A-11D-A39W-08 TCGA-VD-AA8N-01A-11D-A39V-01 fc0c860a-7c68-457d-bc75-dbade64050c9 TCGA-VD-AA8N-01 TCGA-VD-AA8N-01 fc0c860a-7c68-457d-bc75-dbade64050c9 TCGA-VD-AA8N-01A-11D-A39V-01 fc0c860a-7c68-457d-bc75-dbade64050c9 TCGA-VD-AA8N-01A-11D-A39W-08 TCGA-VD-AA8N-01A-11D-A39X-05 TCGA-VD-AA8N-01A-11D-A39W-08 TCGA-VD-AA8N-01A-11D-A39W-08 fc0c860a-7c68-457d-bc75-dbade64050c9 TCGA-VD-AA8N-01A-11D-A39W-08 TCGA-VD-AA8N-01 TCGA-VD-AA8N-01
57
+ TCGA-VD-AA8O-01 TCGA-VD-AA8O-01 TCGA-VD-AA8O TCGA Ocular melanomas (UVM) uveal melanoma Eye 77 TCGA-VD-AA8O-F67977 TCGA-VD-AA8O TCGA-VD-AA8O-01A M0 N0 T3a Stage IIB Chromosome 3 loss -28250 72 606 0 228 NO Loops 2015-12-1 MALE Epithelioid Cell|Spindle Cell No C69.30 8770/3 C69.3 YES Enucleation 40 NO NO None 2 Distant Metastasis YES false No M0 N0 T3a Stage IIB TCGA-VD-AA8O.47696668-32A5-44CB-8141-3613B07CC231.pdf Metastatic Uveal Melanoma AA8O WITH TUMOR NO NO Primary Tumor 01 7th NO YES VD 17.3 Echographic Measurement Moderate Numbers Few 61-90%|1-30% Dome 11.9 Echographic Measurement Choroid|Ciliary body A DECEASED 2013 TCGA-VD-AA8O-01A-11D-A39W-08 TCGA-VD-AA8O-01A-11D-A39V-01 098382bd-486c-45fe-bdf9-b6b92a595951 TCGA-VD-AA8O-01 TCGA-VD-AA8O-01 098382bd-486c-45fe-bdf9-b6b92a595951 TCGA-VD-AA8O-01A-11D-A39V-01 098382bd-486c-45fe-bdf9-b6b92a595951 TCGA-VD-AA8O-01A-11D-A39W-08 TCGA-VD-AA8O-01A-11D-A39X-05 TCGA-VD-AA8O-01A-11D-A39W-08 TCGA-VD-AA8O-01A-11D-A39W-08 098382bd-486c-45fe-bdf9-b6b92a595951 TCGA-VD-AA8O-01A-11D-A39W-08 TCGA-VD-AA8O-01 TCGA-VD-AA8O-01
58
+ TCGA-VD-AA8P-01 TCGA-VD-AA8P-01 TCGA-VD-AA8P TCGA Ocular melanomas (UVM) uveal melanoma Eye 64 TCGA-VD-AA8P-F67979 TCGA-VD-AA8P M0 N0 T3a Stage IIB Chromosome 1 loss|Chromosome 3 loss|Chromosome 8q gain -23555 0 86 NO 2015-2-26 FEMALE Spindle Cell No C69.30 8774/3 C69.3 YES Enucleation NO None 8 NO No M0 N0 T3a Stage IIB AA8P TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 10.6 Echographic Measurement Few 61-90% Dome 10.4 Echographic Measurement Choroid LIVING 2013 TCGA-VD-AA8P-01A-11D-A39W-08 TCGA-VD-AA8P-01A-11D-A39V-01 ef2acd8c-22e3-4c71-a8b3-87bb62befa65 TCGA-VD-AA8P-01 TCGA-VD-AA8P-01 ef2acd8c-22e3-4c71-a8b3-87bb62befa65 TCGA-VD-AA8P-01A-11D-A39V-01 ef2acd8c-22e3-4c71-a8b3-87bb62befa65 TCGA-VD-AA8P-01A-11D-A39W-08 TCGA-VD-AA8P-01A-11D-A39X-05 TCGA-VD-AA8P-01A-11D-A39W-08 TCGA-VD-AA8P-01A-11D-A39W-08 ef2acd8c-22e3-4c71-a8b3-87bb62befa65 TCGA-VD-AA8P-01A-11D-A39W-08 TCGA-VD-AA8P-01 TCGA-VD-AA8P-01
59
+ TCGA-VD-AA8Q-01 TCGA-VD-AA8Q-01 TCGA-VD-AA8Q TCGA Ocular melanomas (UVM) uveal melanoma Eye 71 TCGA-VD-AA8Q-F72861 TCGA-VD-AA8Q TCGA-VD-AA8Q-01A M0 N0 T3a Stage IIB -26285 104 636 0 2 NO 2015-12-1 MALE Spindle Cell No C69.30 8774/3 C69.3 YES Enucleation 30 NO NO None 1 Distant Metastasis YES false No M0 N0 T3a Stage IIB TCGA-VD-AA8Q.BA6A5CAA-0D65-4F4F-A15B-EB0D4ABC1D87.pdf Metastatic Uveal Melanoma AA8Q TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 13.9 Echographic Measurement Few Few >90% Dome 10.1 Echographic Measurement Choroid A DECEASED 2013 TCGA-VD-AA8Q-01A-11D-A39W-08 TCGA-VD-AA8Q-01A-11D-A39V-01 3ec8356c-b035-44a5-8f51-8aad764da4ac TCGA-VD-AA8Q-01 TCGA-VD-AA8Q-01 3ec8356c-b035-44a5-8f51-8aad764da4ac TCGA-VD-AA8Q-01A-11D-A39V-01 3ec8356c-b035-44a5-8f51-8aad764da4ac TCGA-VD-AA8Q-01A-11D-A39W-08 TCGA-VD-AA8Q-01A-11D-A39X-05 TCGA-VD-AA8Q-01A-11D-A39W-08 TCGA-VD-AA8Q-01A-11D-A39W-08 3ec8356c-b035-44a5-8f51-8aad764da4ac TCGA-VD-AA8Q-01A-11D-A39W-08 TCGA-VD-AA8Q-01 TCGA-VD-AA8Q-01
60
+ TCGA-VD-AA8R-01 TCGA-VD-AA8R-01 TCGA-VD-AA8R TCGA Ocular melanomas (UVM) uveal melanoma Eye 78 TCGA-VD-AA8R-F67985 TCGA-VD-AA8R M0 N0 T3a Stage IIB -28841 0 6 NO 2015-2-26 FEMALE Spindle Cell No C69.30 8770/3 C69.3 YES Enucleation NO None 4 NO No M0 N0 T3a Stage IIB AA8R TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 14.1 Echographic Measurement Few Few 61-90% Dome 6.6 Echographic Measurement Choroid LIVING 2013 TCGA-VD-AA8R-01A-11D-A39W-08 TCGA-VD-AA8R-01A-11D-A39V-01 d05d0b28-7c88-4192-9897-54bd3aacfaa3 TCGA-VD-AA8R-01 TCGA-VD-AA8R-01 d05d0b28-7c88-4192-9897-54bd3aacfaa3 TCGA-VD-AA8R-01A-11D-A39V-01 d05d0b28-7c88-4192-9897-54bd3aacfaa3 TCGA-VD-AA8R-01A-11D-A39W-08 TCGA-VD-AA8R-01A-11D-A39X-05 TCGA-VD-AA8R-01A-11D-A39W-08 TCGA-VD-AA8R-01A-11D-A39W-08 d05d0b28-7c88-4192-9897-54bd3aacfaa3 TCGA-VD-AA8R-01A-11D-A39W-08 TCGA-VD-AA8R-01 TCGA-VD-AA8R-01
61
+ TCGA-VD-AA8S-01 TCGA-VD-AA8S-01 TCGA-VD-AA8S TCGA Ocular melanomas (UVM) uveal melanoma Eye 40 TCGA-VD-AA8S-F67986 TCGA-VD-AA8S M0 N0 T3a Stage IIB Chromosome 6p gain -14681 0 427 NO 2015-2-26 MALE Spindle Cell No C69.30 8772/3 C69.3 YES Enucleation NO None 2 NO No M0 N0 T2a Stage IIA AA8S TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 13.4 Echographic Measurement Few Few >90% Dome 6.4 Echographic Measurement Choroid LIVING 2013 TCGA-VD-AA8S-01B-11D-A39W-08 TCGA-VD-AA8S-01B-11D-A39V-01 e22176fd-5103-42c7-b5e6-555d883a39aa TCGA-VD-AA8S-01 TCGA-VD-AA8S-01 e22176fd-5103-42c7-b5e6-555d883a39aa TCGA-VD-AA8S-01B-11D-A39V-01 e22176fd-5103-42c7-b5e6-555d883a39aa TCGA-VD-AA8S-01B-11D-A39W-08 TCGA-VD-AA8S-01B-11D-A39X-05 TCGA-VD-AA8S-01B-11D-A39W-08 TCGA-VD-AA8S-01B-11D-A39W-08 e22176fd-5103-42c7-b5e6-555d883a39aa TCGA-VD-AA8S-01B-11D-A39W-08 TCGA-VD-AA8S-01 TCGA-VD-AA8S-01
62
+ TCGA-VD-AA8T-01 TCGA-VD-AA8T-01 TCGA-VD-AA8T TCGA Ocular melanomas (UVM) uveal melanoma Eye 83 TCGA-VD-AA8T-F70589 TCGA-VD-AA8T TCGA-VD-AA8T-01A M0 N0 T3a Stage IIB Chromosome 3 loss|Chromosome 8q gain -30475 69 0 49 NO Loops 2015-2-26 FEMALE Spindle Cell No C69.80 8772/3 C69.8 YES Enucleation 40 NO NO None 2 NO false No M0 N0 T2a Stage IIA TCGA-VD-AA8T.FFC65F78-4178-4E52-B5AF-1808C61EAED0.pdf AA8T TUMOR FREE NO NO Primary Tumor 01 7th NO YES VD 14.6 Echographic Measurement Few Few >90% Dome 9.5 Echographic Measurement Choroid|Ciliary body A LIVING 2013 TCGA-VD-AA8T-01A-11D-A39W-08 TCGA-VD-AA8T-01A-11D-A39V-01 6b21f292-1752-4682-b885-9cc145c4a5a9 TCGA-VD-AA8T-01 TCGA-VD-AA8T-01 6b21f292-1752-4682-b885-9cc145c4a5a9 TCGA-VD-AA8T-01A-11D-A39V-01 6b21f292-1752-4682-b885-9cc145c4a5a9 TCGA-VD-AA8T-01A-11D-A39W-08 TCGA-VD-AA8T-01A-11D-A39X-05 TCGA-VD-AA8T-01A-11D-A39W-08 TCGA-VD-AA8T-01A-11D-A39W-08 6b21f292-1752-4682-b885-9cc145c4a5a9 TCGA-VD-AA8T-01A-11D-A39W-08 TCGA-VD-AA8T-01 TCGA-VD-AA8T-01
63
+ TCGA-WC-A87T-01 TCGA-WC-A87T-01 TCGA-WC-A87T TCGA Ocular melanomas (UVM) uveal melanoma Eye 64 TCGA-WC-A87T-F70300 TCGA-WC-A87T M0 N0 T3 Stage IIB -23409 0 2600 NO Other Complex Patterns 2015-7-28 MALE Class 1b 187 Spindle Cell|Epithelioid Cell No C69.30 8774/3 C69.3 YES Enucleation NO None NO No M0 N0 T3a Stage IIB A87T TUMOR FREE NO NO Primary Tumor 01 7th NO YES WC 11 Pathologic Measurement >90%|0% Mushroom 10 Pathologic Measurement Choroid LIVING 92.6 2007 TCGA-WC-A87T-01A-11D-A39W-08 TCGA-WC-A87T-01A-11D-A39V-01 a6221e12-d28b-4539-94ac-133d4999e5e4 TCGA-WC-A87T-01 TCGA-WC-A87T-01 a6221e12-d28b-4539-94ac-133d4999e5e4 TCGA-WC-A87T-01A-11D-A39V-01 a6221e12-d28b-4539-94ac-133d4999e5e4 TCGA-WC-A87T-01A-11D-A39W-08 TCGA-WC-A87T-01A-11D-A39X-05 TCGA-WC-A87T-01A-11D-A39W-08 TCGA-WC-A87T-01A-11D-A39W-08 a6221e12-d28b-4539-94ac-133d4999e5e4 TCGA-WC-A87T-01A-11D-A39W-08 TCGA-WC-A87T-01 TCGA-WC-A87T-01
64
+ TCGA-WC-A87U-01 TCGA-WC-A87U-01 TCGA-WC-A87U TCGA Ocular melanomas (UVM) uveal melanoma Eye 73 TCGA-WC-A87U TCGA-WC-A87U-01A M0 N0 T3 Stage IIB -26933 2199 1581 0 NO Loops 2014-3-12 MALE 170 Spindle Cell No C69.80 8774/3 C69.8 YES Enucleation 20 NO Other NO true Yes metastatic pancreatic cancer to the liver M0 N0 T3b Stage IIIA TCGA-WC-A87U.ACEB9450-95DD-483A-A7FD-99EA22359785.pdf Other, specify A87U WITH TUMOR NO NO Primary Tumor 01 7th NO YES WC 18 Pathologic Measurement >90% Dome 6 Pathologic Measurement Choroid|Ciliary body A DECEASED 80.9 2007 TCGA-WC-A87U-01A-11D-A39W-08 TCGA-WC-A87U-01A-11D-A39V-01 20584a83-28a9-46f0-b9f6-90facf34c76e TCGA-WC-A87U-01 TCGA-WC-A87U-01 20584a83-28a9-46f0-b9f6-90facf34c76e TCGA-WC-A87U-01A-11D-A39V-01 20584a83-28a9-46f0-b9f6-90facf34c76e TCGA-WC-A87U-01A-11D-A39W-08 TCGA-WC-A87U-01A-11D-A39X-05 TCGA-WC-A87U-01A-11D-A39W-08 TCGA-WC-A87U-01A-11D-A39W-08 20584a83-28a9-46f0-b9f6-90facf34c76e TCGA-WC-A87U-01A-11D-A39W-08 TCGA-WC-A87U-01 TCGA-WC-A87U-01
65
+ TCGA-WC-A87W-01 TCGA-WC-A87W-01 TCGA-WC-A87W TCGA Ocular melanomas (UVM) uveal melanoma Eye NO 57 TCGA-WC-A87W-F62755 TCGA-WC-A87W M0 N0 T2 Stage IIA -20872 0 1703 625 NO 2015-12-1 FEMALE Class 1 158 Spindle Cell No C69.30 8772/3 C69.3 YES Enucleation NO None Other, specify New Primary Tumor left nasofacial sulcus YES NO No M0 N0 T2a Stage IIA A87W TUMOR FREE NO NO Primary Tumor 01 7th NO YES WC 13 Pathologic Measurement >90% Dome 5 Pathologic Measurement Choroid LIVING 90.3 2010 TCGA-WC-A87W-01A-11D-A39W-08 TCGA-WC-A87W-01A-11D-A39V-01 ffff66b2-a9ac-46ba-93c8-11f6a637e16c TCGA-WC-A87W-01 TCGA-WC-A87W-01 ffff66b2-a9ac-46ba-93c8-11f6a637e16c TCGA-WC-A87W-01A-11D-A39V-01 ffff66b2-a9ac-46ba-93c8-11f6a637e16c TCGA-WC-A87W-01A-11D-A39W-08 TCGA-WC-A87W-01A-11D-A39X-05 TCGA-WC-A87W-01A-11D-A39W-08 TCGA-WC-A87W-01A-11D-A39W-08 ffff66b2-a9ac-46ba-93c8-11f6a637e16c TCGA-WC-A87W-01A-11D-A39W-08 TCGA-WC-A87W-01 TCGA-WC-A87W-01
66
+ TCGA-WC-A87Y-01 TCGA-WC-A87Y-01 TCGA-WC-A87Y TCGA Ocular melanomas (UVM) uveal melanoma Eye 59 TCGA-WC-A87Y-F72863 TCGA-WC-A87Y TCGA-WC-A87Y-01A M0 N0 T3 Stage IIIA -21865 896 1314 0 369 YES 2015-12-1 MALE Class 2 177 Spindle Cell|Epithelioid Cell No C69.30 8770/3 C69.3 YES Enucleation 20 NO NO None NO true No M0 N0 T3 TCGA-WC-A87Y.BE3CE26C-C3EC-442E-A618-BB6DEC18C2E7.pdf Metastatic Uveal Melanoma A87Y TUMOR FREE NO YES Primary Tumor 01 7th NO YES WC 13 Pathologic Measurement 61-90%|1-30% Dome 7 Pathologic Measurement Choroid A DECEASED 96.4 2011 TCGA-WC-A87Y-01A-11D-A39W-08 TCGA-WC-A87Y-01A-11D-A39V-01 17f88e17-e1ff-43eb-b97f-55f562c786f1 TCGA-WC-A87Y-01 TCGA-WC-A87Y-01 17f88e17-e1ff-43eb-b97f-55f562c786f1 TCGA-WC-A87Y-01A-11D-A39V-01 17f88e17-e1ff-43eb-b97f-55f562c786f1 TCGA-WC-A87Y-01A-11D-A39W-08 TCGA-WC-A87Y-01A-11D-A39X-05 TCGA-WC-A87Y-01A-11D-A39W-08 TCGA-WC-A87Y-01A-11D-A39W-08 17f88e17-e1ff-43eb-b97f-55f562c786f1 TCGA-WC-A87Y-01A-11D-A39W-08 TCGA-WC-A87Y-01 TCGA-WC-A87Y-01
67
+ TCGA-WC-A880-01 TCGA-WC-A880-01 TCGA-WC-A880 TCGA Ocular melanomas (UVM) uveal melanoma Eye 63 TCGA-WC-A880-F72864 TCGA-WC-A880 TCGA-WC-A880-01A M0 N0 T3 Stage IIB -23325 728 0 1258 NO 2015-12-1 MALE Class 1b 175 Epithelioid Cell|Spindle Cell No C69.30 8770/3 C69.3 YES Enucleation 30 NO NO None NO true No M0 N0 T4a Stage IIIA TCGA-WC-A880.A0BBA530-98EA-4989-9ABC-26A92615EF27.pdf A880 TUMOR FREE NO NO Primary Tumor 01 7th NO YES WC 20 Pathologic Measurement 61-90%|1-30% Dome 9 Pathologic Measurement Choroid A LIVING 90.2 2011 TCGA-WC-A880-01A-11D-A39W-08 TCGA-WC-A880-01A-11D-A39V-01 6fa36fef-2408-48b9-be0d-3624a2066b3a TCGA-WC-A880-01 TCGA-WC-A880-01 6fa36fef-2408-48b9-be0d-3624a2066b3a TCGA-WC-A880-01A-11D-A39V-01 6fa36fef-2408-48b9-be0d-3624a2066b3a TCGA-WC-A880-01A-11D-A39W-08 TCGA-WC-A880-01A-11D-A39X-05 TCGA-WC-A880-01A-11D-A39W-08 TCGA-WC-A880-01A-11D-A39W-08 6fa36fef-2408-48b9-be0d-3624a2066b3a TCGA-WC-A880-01A-11D-A39W-08 TCGA-WC-A880-01 TCGA-WC-A880-01
68
+ TCGA-WC-A881-01 TCGA-WC-A881-01 TCGA-WC-A881 TCGA Ocular melanomas (UVM) uveal melanoma Eye 75 TCGA-WC-A881-F70301 TCGA-WC-A881 TCGA-WC-A881-01A M0 N0 T4 Stage IIB -27443 680 0 1065 NO 2015-7-28 MALE Class 1a 182 Spindle Cell No C69.30 8772/3 C69.3 YES Enucleation 30 NO NO None NO true Yes M0 N0 T3a Stage IIB TCGA-WC-A881.6D728871-8D6D-47B7-8A29-66870CA78A91.pdf A881 TUMOR FREE NO NO Primary Tumor 01 7th NO YES WC 18 Pathologic Measurement >90% Dome 12 Pathologic Measurement Choroid A LIVING 96.5 2011 TCGA-WC-A881-01A-12D-A39W-08 TCGA-WC-A881-01A-12D-A39V-01 56b27734-cf5d-49e0-8d28-768b16db4769 TCGA-WC-A881-01 TCGA-WC-A881-01 56b27734-cf5d-49e0-8d28-768b16db4769 TCGA-WC-A881-01A-12D-A39V-01 56b27734-cf5d-49e0-8d28-768b16db4769 TCGA-WC-A881-01A-12D-A39W-08 TCGA-WC-A881-01A-12D-A39X-05 TCGA-WC-A881-01A-12D-A39W-08 TCGA-WC-A881-01A-12D-A39W-08 56b27734-cf5d-49e0-8d28-768b16db4769 TCGA-WC-A881-01A-12D-A39W-08 TCGA-WC-A881-01 TCGA-WC-A881-01
69
+ TCGA-WC-A882-01 TCGA-WC-A882-01 TCGA-WC-A882 TCGA Ocular melanomas (UVM) uveal melanoma Eye 50 TCGA-WC-A882-F72865 TCGA-WC-A882 TCGA-WC-A882-01A M0 N0 T3 Stage IIB -18612 610 0 1112 NO 2015-12-1 FEMALE Class 2 165 Spindle Cell No C69.80 8772/3 C69.8 YES Enucleation 50 NO NO None NO true No M0 N0 T2b Stage IIB TCGA-WC-A882.BCFE115C-4472-4221-86B3-75B122F9B425.pdf A882 TUMOR FREE NO NO Primary Tumor 01 7th NO YES WC 12 Pathologic Measurement >90% 8 Pathologic Measurement Choroid|Ciliary body A LIVING 73.2 2012 TCGA-WC-A882-01A-11D-A39W-08 TCGA-WC-A882-01A-11D-A39V-01 843b1db2-5b28-4b3d-bede-1ba7d1d91756 TCGA-WC-A882-01 TCGA-WC-A882-01 843b1db2-5b28-4b3d-bede-1ba7d1d91756 TCGA-WC-A882-01A-11D-A39V-01 843b1db2-5b28-4b3d-bede-1ba7d1d91756 TCGA-WC-A882-01A-11D-A39W-08 TCGA-WC-A882-01A-11D-A39X-05 TCGA-WC-A882-01A-11D-A39W-08 TCGA-WC-A882-01A-11D-A39W-08 843b1db2-5b28-4b3d-bede-1ba7d1d91756 TCGA-WC-A882-01A-11D-A39W-08 TCGA-WC-A882-01 TCGA-WC-A882-01
70
+ TCGA-WC-A883-01 TCGA-WC-A883-01 TCGA-WC-A883 TCGA Ocular melanomas (UVM) uveal melanoma Eye 76 TCGA-WC-A883 TCGA-WC-A883-01A M0 N0 T4 Stage IIIC -27953 300 241 0 <=5mm YES 2014-3-12 FEMALE Class 2 149 Spindle Cell|Epithelioid Cell No C69.30 8770/3 C69.3 YES Enucleation 30 NO None NO true No M0 N0 T3c Stage IIIA TCGA-WC-A883.FDE93561-B0B0-495F-8BBD-932EA3B7D02D.pdf A883 WITH TUMOR NO NO Primary Tumor 01 7th NO YES WC 18 Pathologic Measurement 61-90%|1-30% Diffuse 4 Pathologic Measurement Choroid A DECEASED 58.5 2012 TCGA-WC-A883-01A-12D-A39W-08 TCGA-WC-A883-01A-12D-A39V-01 72a3ee9c-134d-4338-8287-c0fd9dc493ff TCGA-WC-A883-01 TCGA-WC-A883-01 72a3ee9c-134d-4338-8287-c0fd9dc493ff TCGA-WC-A883-01A-12D-A39V-01 72a3ee9c-134d-4338-8287-c0fd9dc493ff TCGA-WC-A883-01A-12D-A39W-08 TCGA-WC-A883-01A-12D-A39X-05 TCGA-WC-A883-01A-12D-A39W-08 TCGA-WC-A883-01A-12D-A39W-08 72a3ee9c-134d-4338-8287-c0fd9dc493ff TCGA-WC-A883-01A-12D-A39W-08 TCGA-WC-A883-01 TCGA-WC-A883-01
71
+ TCGA-WC-A884-01 TCGA-WC-A884-01 TCGA-WC-A884 TCGA Ocular melanomas (UVM) uveal melanoma Eye 35 TCGA-WC-A884-F70303 TCGA-WC-A884 M0 N0 T4b Stage IIIB -12840 0 12 NO 2015-7-28 FEMALE Class 1b 149 Epithelioid Cell|Spindle Cell No C69.80 8770/3 C69.8 YES Enucleation YES None NO No M0 N0 T4b Stage IIIB A884 TUMOR FREE NO NO Primary Tumor 01 7th NO YES WC 20 Pathologic Measurement 61-90%|1-30% 10 Pathologic Measurement Choroid|Ciliary body|Iris LIVING 101.9 2013 TCGA-WC-A884-01A-11D-A39W-08 TCGA-WC-A884-01A-11D-A39V-01 c1bc5e85-db3f-41a5-bcfc-32f9c7b5cfee TCGA-WC-A884-01 TCGA-WC-A884-01 c1bc5e85-db3f-41a5-bcfc-32f9c7b5cfee TCGA-WC-A884-01A-11D-A39V-01 c1bc5e85-db3f-41a5-bcfc-32f9c7b5cfee TCGA-WC-A884-01A-11D-A39W-08 TCGA-WC-A884-01A-11D-A39X-05 TCGA-WC-A884-01A-11D-A39W-08 TCGA-WC-A884-01A-11D-A39W-08 c1bc5e85-db3f-41a5-bcfc-32f9c7b5cfee TCGA-WC-A884-01A-11D-A39W-08 TCGA-WC-A884-01 TCGA-WC-A884-01
72
+ TCGA-WC-A885-01 TCGA-WC-A885-01 TCGA-WC-A885 TCGA Ocular melanomas (UVM) uveal melanoma Eye 60 TCGA-WC-A885-F72866 TCGA-WC-A885 TCGA-WC-A885-01A M0 N0 T3 Stage IIB -21978 196 0 686 NO 2015-12-1 MALE Class 1b 176 Spindle Cell No C69.30 8772/3 C69.3 YES Enucleation 50 NO NO None NO true No M0 N0 T2a Stage IIA TCGA-WC-A885.1D5AEA80-D8C7-444F-BFB4-1B3822C8D17B.pdf A885 TUMOR FREE NO NO Primary Tumor 01 7th NO YES WC 12 Pathologic Measurement >90% Dome 6 Pathologic Measurement Choroid A LIVING 90 2013 TCGA-WC-A885-01A-11D-A39W-08 TCGA-WC-A885-01A-11D-A39V-01 dcf7eb63-242a-4a7f-9986-1eb75227b9cd TCGA-WC-A885-01 TCGA-WC-A885-01 dcf7eb63-242a-4a7f-9986-1eb75227b9cd TCGA-WC-A885-01A-11D-A39V-01 dcf7eb63-242a-4a7f-9986-1eb75227b9cd TCGA-WC-A885-01A-11D-A39W-08 TCGA-WC-A885-01A-11D-A39X-05 TCGA-WC-A885-01A-11D-A39W-08 TCGA-WC-A885-01A-11D-A39W-08 231C39CD-3C7A-42A7-8B6A-2C374CD99947 dcf7eb63-242a-4a7f-9986-1eb75227b9cd TCGA-WC-A885-01A-11D-A39W-08 TCGA-WC-A885-01 TCGA-WC-A885-01
73
+ TCGA-WC-A888-01 TCGA-WC-A888-01 TCGA-WC-A888 TCGA Ocular melanomas (UVM) uveal melanoma Eye 76 TCGA-WC-A888-F72867 TCGA-WC-A888 M0 N0 T3 Stage IIB -28117 575 0 52 NO 2015-12-1 MALE 166 Epithelioid Cell|Spindle Cell No C69.30 8770/3 C69.3 YES Enucleation NO None NO No M0 N0 T3a Stage IIB A888 TUMOR FREE NO NO Primary Tumor 01 7th NO YES WC 15 Pathologic Measurement 61-90%|1-30% Dome 11 Pathologic Measurement Choroid DECEASED 54.9 2013 TCGA-WC-A888-01A-11D-A39W-08 TCGA-WC-A888-01A-11D-A39V-01 a790f7ac-9316-4ce4-983a-16d1c3513960 TCGA-WC-A888-01 TCGA-WC-A888-01 a790f7ac-9316-4ce4-983a-16d1c3513960 TCGA-WC-A888-01A-11D-A39V-01 a790f7ac-9316-4ce4-983a-16d1c3513960 TCGA-WC-A888-01A-11D-A39W-08 TCGA-WC-A888-01A-11D-A39X-05 TCGA-WC-A888-01A-11D-A39W-08 TCGA-WC-A888-01A-11D-A39W-08 a790f7ac-9316-4ce4-983a-16d1c3513960 TCGA-WC-A888-01A-11D-A39W-08 TCGA-WC-A888-01 TCGA-WC-A888-01
74
+ TCGA-WC-A88A-01 TCGA-WC-A88A-01 TCGA-WC-A88A TCGA Ocular melanomas (UVM) uveal melanoma Eye 75 TCGA-WC-A88A TCGA-WC-A88A-01A M1b NX T4d Stage IV -27722 57 82 0 <=5mm YES 2014-3-12 MALE Class 2 180 Spindle Cell|Epithelioid Cell No C69.30 8770/3 C69.3 YES Enucleation 60 NO Liver NO true No M1b NX T4d Stage IV TCGA-WC-A88A.8A79DCBE-B2F9-48B3-AA7C-1F16608CF1C7.pdf Metastatic Uveal Melanoma A88A WITH TUMOR NO NO Primary Tumor 01 7th NO YES WC 25 Pathologic Measurement >90%|1-30% 12 Pathologic Measurement Choroid A DECEASED 106.8 2013 TCGA-WC-A88A-01A-11D-A39W-08 TCGA-WC-A88A-01A-11D-A39V-01 020c941f-5fc2-4804-8de6-a20d2b5d6d60 TCGA-WC-A88A-01 TCGA-WC-A88A-01 020c941f-5fc2-4804-8de6-a20d2b5d6d60 TCGA-WC-A88A-01A-11D-A39V-01 020c941f-5fc2-4804-8de6-a20d2b5d6d60 TCGA-WC-A88A-01A-11D-A39W-08 TCGA-WC-A88A-01A-11D-A39X-05 TCGA-WC-A88A-01A-11D-A39W-08 TCGA-WC-A88A-01A-11D-A39W-08 82279E57-C164-430F-B328-89C5448DAEA8 020c941f-5fc2-4804-8de6-a20d2b5d6d60 TCGA-WC-A88A-01A-11D-A39W-08 TCGA-WC-A88A-01 TCGA-WC-A88A-01
75
+ TCGA-WC-AA9A-01 TCGA-WC-AA9A-01 TCGA-WC-AA9A TCGA Ocular melanomas (UVM) uveal melanoma Eye 70 TCGA-WC-AA9A TCGA-WC-AA9A-01A M0 N0 Stage IIA -25641 959 453 0 NO 2014-6-25 FEMALE 158 Spindle Cell No C69.30 8772/3 C69.3 YES Enucleation 30 NO None YES false Yes NX T2a Stage IIA TCGA-WC-AA9A.A910FE6E-4D5B-43F9-88D9-679147FEA50F.pdf Metastatic Uveal Melanoma AA9A WITH TUMOR NO NO Primary Tumor 01 7th NO YES WC 14 Pathologic Measurement >90% 6 Pathologic Measurement Choroid A DECEASED 61.1 2011 TCGA-WC-AA9A-01A-11D-A39W-08 TCGA-WC-AA9A-01A-11D-A39V-01 613d32ad-0ac5-461f-99eb-83fdbd200076 TCGA-WC-AA9A-01 TCGA-WC-AA9A-01 613d32ad-0ac5-461f-99eb-83fdbd200076 TCGA-WC-AA9A-01A-11D-A39V-01 613d32ad-0ac5-461f-99eb-83fdbd200076 TCGA-WC-AA9A-01A-11D-A39W-08 TCGA-WC-AA9A-01A-11D-A39X-05 TCGA-WC-AA9A-01A-11D-A39W-08 TCGA-WC-AA9A-01A-11D-A39W-08 613d32ad-0ac5-461f-99eb-83fdbd200076 TCGA-WC-AA9A-01A-11D-A39W-08 TCGA-WC-AA9A-01 TCGA-WC-AA9A-01
76
+ TCGA-WC-AA9E-01 TCGA-WC-AA9E-01 TCGA-WC-AA9E TCGA Ocular melanomas (UVM) uveal melanoma Eye 60 TCGA-WC-AA9E-F72868 TCGA-WC-AA9E TCGA-WC-AA9E-01A M0 N0 T3 Stage IIIC -21976 272 0 838 NO 2015-12-1 MALE Class 1b 176 Spindle Cell No C69.30 8774/3 C69.3 YES Enucleation 60 NO NO None 3 NO false No NX T2a Stage IIA TCGA-WC-AA9E.28ADDF38-07FD-4354-8F17-C0E4310514C9.pdf AA9E WITH TUMOR NO YES Primary Tumor 01 7th NO YES WC 12 Pathologic Measurement >90% 6 Pathologic Measurement Choroid A LIVING 90 2013 TCGA-WC-AA9E-01A-11D-A39W-08 TCGA-WC-AA9E-01A-11D-A39V-01 284f7003-5c83-48c7-84b5-f08d4875cbb1 TCGA-WC-AA9E-01 TCGA-WC-AA9E-01 284f7003-5c83-48c7-84b5-f08d4875cbb1 TCGA-WC-AA9E-01A-11D-A39V-01 284f7003-5c83-48c7-84b5-f08d4875cbb1 TCGA-WC-AA9E-01A-11D-A39W-08 TCGA-WC-AA9E-01A-11D-A39X-05 TCGA-WC-AA9E-01A-11D-A39W-08 TCGA-WC-AA9E-01A-11D-A39W-08 95B0D945-F79A-437E-8499-0F51476E7FBC 284f7003-5c83-48c7-84b5-f08d4875cbb1 TCGA-WC-AA9E-01A-11D-A39W-08 TCGA-WC-AA9E-01 TCGA-WC-AA9E-01
77
+ TCGA-YZ-A980-01 TCGA-YZ-A980-01 TCGA-YZ-A980 TCGA Ocular melanomas (UVM) uveal melanoma Eye NO NO 75 TCGA-YZ-A980-F66464 TCGA-YZ-A980 M0 N0 T3b Stage IIIA -27716 0 1862 1556 NO 2015-7-14 MALE 177.8 Spindle Cell|Epithelioid Cell No C69.30 8770/3 C69.3 YES Enucleation NO None 24 Other, specify New Primary Tumor Scalp YES NO No MX NX T3b Stage IIIA A980 TUMOR FREE NO NO Primary Tumor 01 7th NO YES YZ 14 Pathologic Measurement 61-90%|1-30% 9 Pathologic Measurement Choroid|Ciliary body LIVING 81.103 2010 TCGA-YZ-A980-01A-11D-A39W-08 TCGA-YZ-A980-01A-11D-A39V-01 c03a3f09-9bed-4efe-8d8a-ac4624d5fa2c TCGA-YZ-A980-01 TCGA-YZ-A980-01 c03a3f09-9bed-4efe-8d8a-ac4624d5fa2c TCGA-YZ-A980-01A-11D-A39V-01 c03a3f09-9bed-4efe-8d8a-ac4624d5fa2c TCGA-YZ-A980-01A-11D-A39W-08 TCGA-YZ-A980-01A-11D-A39X-05 TCGA-YZ-A980-01A-11D-A39W-08 TCGA-YZ-A980-01A-11D-A39W-08 c03a3f09-9bed-4efe-8d8a-ac4624d5fa2c TCGA-YZ-A980-01A-11D-A39W-08 TCGA-YZ-A980-01 TCGA-YZ-A980-01
78
+ TCGA-YZ-A982-01 TCGA-YZ-A982-01 TCGA-YZ-A982 TCGA Ocular melanomas (UVM) uveal melanoma Eye 79 TCGA-YZ-A982-F66471 TCGA-YZ-A982 TCGA-YZ-A982-01A M0 N0 T4b Stage IIIB Chromosome 8q gain -28938 178 0 495 NO 2014-10-16 FEMALE 156.2 Spindle Cell No C69.90 8772/3 C69.9 YES Enucleation 90 NO NO None 6 NO false No MX NX T4b Stage IIIB TCGA-YZ-A982.6D118D76-61C0-4643-A525-53E3313C149D.pdf A982 TUMOR FREE NO NO Primary Tumor 01 7th NO YES YZ 23.64 Echographic Measurement >90% 15.51 Echographic Measurement Choroid|Ciliary body A LIVING 89.982 2013 TCGA-YZ-A982-01A-11D-A39W-08 TCGA-YZ-A982-01A-11D-A39V-01 5282f669-d5f4-4545-bf0d-b2e2927b4255 TCGA-YZ-A982-01 TCGA-YZ-A982-01 5282f669-d5f4-4545-bf0d-b2e2927b4255 TCGA-YZ-A982-01A-11D-A39V-01 5282f669-d5f4-4545-bf0d-b2e2927b4255 TCGA-YZ-A982-01A-11D-A39W-08 TCGA-YZ-A982-01A-11D-A39X-05 TCGA-YZ-A982-01A-11D-A39W-08 TCGA-YZ-A982-01A-11D-A39W-08 5282f669-d5f4-4545-bf0d-b2e2927b4255 TCGA-YZ-A982-01A-11D-A39W-08 TCGA-YZ-A982-01 TCGA-YZ-A982-01
79
+ TCGA-YZ-A983-01 TCGA-YZ-A983-01 TCGA-YZ-A983 TCGA Ocular melanomas (UVM) uveal melanoma Eye NO NO 51 TCGA-YZ-A983-F72869 TCGA-YZ-A983 TCGA-YZ-A983-01A M0 N0 T3a Stage IIB Chromosome 6p gain -18769 230 0 798 NO 2015-12-1 FEMALE 161.3 Epithelioid Cell No C69.30 8771/3 C69.3 YES Enucleation 40 NO NO None 1 Liver Distant Metastasis NO YES false No MX NX T3a Stage IIB TCGA-YZ-A983.04B1F253-2351-4BA6-A289-A22BC1E19C35.pdf A983 TUMOR FREE NO NO Primary Tumor 01 7th NO YES YZ 16 Pathologic Measurement Few >90% 10 Pathologic Measurement Choroid A LIVING 59.784 2013 TCGA-YZ-A983-01A-11D-A39W-08 TCGA-YZ-A983-01A-11D-A39V-01 0a0fb835-dda7-464d-b83c-a2bd68402c6b TCGA-YZ-A983-01 TCGA-YZ-A983-01 0a0fb835-dda7-464d-b83c-a2bd68402c6b TCGA-YZ-A983-01A-11D-A39V-01 0a0fb835-dda7-464d-b83c-a2bd68402c6b TCGA-YZ-A983-01A-11D-A39W-08 TCGA-YZ-A983-01A-11D-A39X-05 TCGA-YZ-A983-01A-11D-A39W-08 TCGA-YZ-A983-01A-11D-A39W-08 0a0fb835-dda7-464d-b83c-a2bd68402c6b TCGA-YZ-A983-01A-11D-A39W-08 TCGA-YZ-A983-01 TCGA-YZ-A983-01
80
+ TCGA-YZ-A984-01 TCGA-YZ-A984-01 TCGA-YZ-A984 TCGA Ocular melanomas (UVM) uveal melanoma Eye 50 TCGA-YZ-A984-F70463 TCGA-YZ-A984 TCGA-YZ-A984-01A MX N0 T4a Stage IIIA -18342 971 1396 0 946 NO 2015-2-17 FEMALE 172.7 Spindle Cell|Epithelioid Cell No C69.30 8770/3 C69.3 YES Enucleation 30 NO NO None NO false No MX NX T3a Stage IIB TCGA-YZ-A984.ECC9EDD8-CE51-49B8-9B3A-52D69920080F.pdf Metastatic Uveal Melanoma A984 WITH TUMOR NO NO Primary Tumor 01 7th NO YES YZ 15 Pathologic Measurement 61-90%|1-30% 14 Pathologic Measurement Choroid A DECEASED 75.932 2011 TCGA-YZ-A984-01A-11D-A39W-08 TCGA-YZ-A984-01A-11D-A39V-01 2e81aa42-67f0-4a4b-911d-a6772e8f0d8b TCGA-YZ-A984-01 TCGA-YZ-A984-01 2e81aa42-67f0-4a4b-911d-a6772e8f0d8b TCGA-YZ-A984-01A-11D-A39V-01 2e81aa42-67f0-4a4b-911d-a6772e8f0d8b TCGA-YZ-A984-01A-11D-A39W-08 TCGA-YZ-A984-01A-11D-A39X-05 TCGA-YZ-A984-01A-11D-A39W-08 TCGA-YZ-A984-01A-11D-A39W-08 2e81aa42-67f0-4a4b-911d-a6772e8f0d8b TCGA-YZ-A984-01A-11D-A39W-08 TCGA-YZ-A984-01 TCGA-YZ-A984-01
81
+ TCGA-YZ-A985-01 TCGA-YZ-A985-01 TCGA-YZ-A985 TCGA Ocular melanomas (UVM) uveal melanoma Eye 41 TCGA-YZ-A985-F72870 TCGA-YZ-A985 M0 N0 T4a Stage IIIA Chromosome 3 loss -15164 0 1184 NO 2015-12-1 FEMALE 155.6 Spindle Cell No C69.30 8772/3 C69.3 YES Enucleation NO None NO No MX NX T4a Stage IIIA A985 TUMOR FREE NO NO Primary Tumor 01 7th NO YES YZ 19 Pathologic Measurement >90% 10 Pathologic Measurement Choroid LIVING 115.395 2012 TCGA-YZ-A985-01A-11D-A39W-08 TCGA-YZ-A985-01A-11D-A39V-01 ca6eb99c-bd11-4cca-9507-a1fd60afe813 TCGA-YZ-A985-01 TCGA-YZ-A985-01 ca6eb99c-bd11-4cca-9507-a1fd60afe813 TCGA-YZ-A985-01A-11D-A39V-01 ca6eb99c-bd11-4cca-9507-a1fd60afe813 TCGA-YZ-A985-01A-11D-A39W-08 TCGA-YZ-A985-01A-11D-A39X-05 TCGA-YZ-A985-01A-11D-A39W-08 TCGA-YZ-A985-01A-11D-A39W-08 ca6eb99c-bd11-4cca-9507-a1fd60afe813 TCGA-YZ-A985-01A-11D-A39W-08 TCGA-YZ-A985-01 TCGA-YZ-A985-01
input/TCGA/TCGA_Ovarian_Cancer_(OV)/TCGA.OV.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:cdf6d12bde3707a909def64df62de2b79d9bbfcf229e77066ded91dc119bfec7
3
+ size 22808782
input/TCGA/TCGA_Ovarian_Cancer_(OV)/TCGA.OV.sampleMap_OV_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Pancreatic_Cancer_(PAAD)/TCGA.PAAD.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:d38d05a162999e94379d1c1ad23dab1d358b9d7dafc6cbf82657d751a43ae6c5
3
+ size 13930570
input/TCGA/TCGA_Pancreatic_Cancer_(PAAD)/TCGA.PAAD.sampleMap_PAAD_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Pheochromocytoma_Paraganglioma_(PCPG)/TCGA.PCPG.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:eac6d5310abceb8a35b0f7f2e0ce51d85609b8a9a6006fea9c6b0d64742e69b6
3
+ size 13627047
input/TCGA/TCGA_Pheochromocytoma_Paraganglioma_(PCPG)/TCGA.PCPG.sampleMap_PCPG_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Prostate_Cancer_(PRAD)/TCGA.PRAD.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:29a5cacf72df6cf1380ab04e26719b75dcf67dc6fc35a9574646fc0b6799f3b9
3
+ size 37958926
input/TCGA/TCGA_Prostate_Cancer_(PRAD)/TCGA.PRAD.sampleMap_PRAD_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Rectal_Cancer_(READ)/TCGA.READ.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:ea571989fd0288de5280172326fa1dc1b96bcd0cc195f1bbdf3898801d0b29da
3
+ size 8160444
input/TCGA/TCGA_Rectal_Cancer_(READ)/TCGA.READ.sampleMap_READ_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Sarcoma_(SARC)/TCGA.SARC.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:600fb4e614b86b072a6860cee856b9adb6e54d48f198ddecaab67ea43c190b3b
3
+ size 19604794
input/TCGA/TCGA_Sarcoma_(SARC)/TCGA.SARC.sampleMap_SARC_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Stomach_Cancer_(STAD)/TCGA.STAD.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:37fa25cf9012dfbc094eee2260cbbebd543eb7dcc299f056b126a5bcf56dcfe1
3
+ size 32858371
input/TCGA/TCGA_Stomach_Cancer_(STAD)/TCGA.STAD.sampleMap_STAD_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Testicular_Cancer_(TGCT)/TCGA.TGCT.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:7d318531cebc8af3f3361810873033d2046ef58ad0dccbb071272b9bc871285e
3
+ size 12292030
input/TCGA/TCGA_Testicular_Cancer_(TGCT)/TCGA.TGCT.sampleMap_TGCT_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Thymoma_(THYM)/TCGA.THYM.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:7000c75d098775021f27f345258ab9d622493558370ba3422dc1124565e8677c
3
+ size 9409065
input/TCGA/TCGA_Thymoma_(THYM)/TCGA.THYM.sampleMap_THYM_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Thyroid_Cancer_(THCA)/TCGA.THCA.sampleMap_THCA_clinicalMatrix ADDED
The diff for this file is too large to render. See raw diff
 
input/TCGA/TCGA_Uterine_Carcinosarcoma_(UCS)/TCGA.UCS.sampleMap_HiSeqV2_PANCAN.gz ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:fcf4861545e651ba65db5fdadc8deb8de95075b47f020d1dd7b51ff23209edb2
3
+ size 4872211
input/TCGA/TCGA_Uterine_Carcinosarcoma_(UCS)/TCGA.UCS.sampleMap_UCS_clinicalMatrix ADDED
@@ -0,0 +1,58 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ sampleID CDE_ID_3226963 _INTEGRATION _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy age_at_initial_pathologic_diagnosis aln_pos_ihc aln_pos_light_micro anatomic_neoplasm_subdivision bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode birth_control_pill_history_usage_category clinical_stage colorectal_cancer days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_new_tumor_event_additional_surgery_procedure days_to_new_tumor_event_after_initial_treatment diabetes form_completion_date gender height histological_type history_of_neoadjuvant_treatment horm_ther hypertension icd_10 icd_o_3_histology icd_o_3_site informed_consent_verified initial_pathologic_diagnosis_method initial_weight is_ffpe lost_follow_up menopause_status new_neoplasm_event_occurrence_anatomic_site new_neoplasm_event_type new_neoplasm_occurrence_anatomic_site_text new_tumor_event_additional_surgery_procedure new_tumor_event_after_initial_treatment oct_embedded other_dx pathology_report_file_name patient_id pct_tumor_invasion peritoneal_wash person_neoplasm_cancer_status pln_pos_ihc pln_pos_light_micro postoperative_rx_tx pregnancies primary_therapy_outcome_success prior_tamoxifen_administered_usage_category radiation_therapy recurrence_second_surgery_neoplasm_surgical_procedure_name residual_tumor sample_type sample_type_id surgical_approach system_version tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site total_aor_lnp total_aor_lnr total_pelv_lnp total_pelv_lnr tumor_tissue_site vial_number vital_status weight year_of_initial_pathologic_diagnosis _GENOMIC_ID_TCGA_UCS_miRNA_HiSeq _GENOMIC_ID_TCGA_UCS_RPPA _GENOMIC_ID_data/public/TCGA/UCS/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_UCS_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_UCS_exp_HiSeqV2 _GENOMIC_ID_TCGA_UCS_mutation_bcm_gene _GENOMIC_ID_TCGA_UCS_exp_HiSeqV2_percentile _GENOMIC_ID_TCGA_UCS_mutation_curated_broad_gene _GENOMIC_ID_TCGA_UCS_gistic2thd _GENOMIC_ID_TCGA_UCS_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_UCS_mutation_broad_gene _GENOMIC_ID_TCGA_UCS_PDMRNAseqCNV _GENOMIC_ID_TCGA_UCS_gistic2 _GENOMIC_ID_TCGA_UCS_mutation_bcgsc_gene _GENOMIC_ID_TCGA_UCS_hMethyl450 _GENOMIC_ID_TCGA_UCS_PDMRNAseq
2
+ TCGA-N5-A4R8-01 TCGA-N5-A4R8-01 TCGA-N5-A4R8 TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 65 0 0 TCGA-N5-A4R8 TCGA-N5-A4R8-01A Former User Stage IA NO -24102 3487 3115 0 NO 2013-5-26 FEMALE 164 Uterine Carcinosarcoma/ MMMT: Heterologous Type No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C55 8950/3 C55.9 YES Office Endometrial Biopsy 420 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) true No TCGA-N5-A4R8.AF57F4A5-49C7-4896-AB32-EF6E72DAA70F.pdf A4R8 15 negative 0 0 YES 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES N5 0 8 0 26 Uterus A DECEASED 54 2003 TCGA-N5-A4R8-01 6C23BF5E-1CFB-4A31-97E1-FEB692B45364 TCGA-N5-A4R8-01 03833ac9-5483-4ae8-a108-24f2aa63feed 03833ac9-5483-4ae8-a108-24f2aa63feed TCGA-N5-A4R8-01A-11D-A28R-08 03833ac9-5483-4ae8-a108-24f2aa63feed TCGA-N5-A4R8-01A-11D-A28R-08 03833ac9-5483-4ae8-a108-24f2aa63feed TCGA-N5-A4R8-01A-11D-A28R-08 TCGA-N5-A4R8-01A-11D-A28R-08 TCGA-N5-A4R8-01A-11D-A28S-05 TCGA-N5-A4R8-01
3
+ TCGA-N5-A4RA-01 MSS TCGA-N5-A4RA-01 TCGA-N5-A4RA TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 63 0 3 TCGA-N5-A4RA TCGA-N5-A4RA-01A Never Used Stage IIIC2 NO -23359 2958 1591 0 NO 2013-5-26 FEMALE 152 Uterine Carcinosarcoma/ MMMT: Heterologous Type No No, I have never taken menopausal hormone therapy. NO C55 8950/3 C55.9 YES Office Endometrial Biopsy 230 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) true No TCGA-N5-A4RA.24ADBD38-726C-4778-B41A-C0517A6905DF.pdf A4RA 67 negative 0 1 YES 2 Never Used NO RX Primary Tumor 01 open 2009 NO YES N5 3 5 1 6 Uterus A DECEASED 72 2004 TCGA-N5-A4RA-01 3A0F16CB-B991-4CD0-A6E8-3F8DAB90E0FD TCGA-N5-A4RA-01 8c610081-9e45-4970-bff6-966aff8a7948 8c610081-9e45-4970-bff6-966aff8a7948 TCGA-N5-A4RA-01A-11D-A28R-08 8c610081-9e45-4970-bff6-966aff8a7948 TCGA-N5-A4RA-01A-11D-A28R-08 TCGA-N5-A4RA-01A-11D-A28Q-01 8c610081-9e45-4970-bff6-966aff8a7948 TCGA-N5-A4RA-01A-11D-A28R-08 TCGA-N5-A4RA-01 TCGA-N5-A4RA-01A-11D-A28Q-01 TCGA-N5-A4RA-01A-11D-A28R-08 TCGA-N5-A4RA-01A-11D-A28S-05 TCGA-N5-A4RA-01
4
+ TCGA-N5-A4RD-01 MSS TCGA-N5-A4RD-01 TCGA-N5-A4RD TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 69 0 0 TCGA-N5-A4RD TCGA-N5-A4RD-01A Former User Stage IVB NO -25413 2157 142 0 NO 2013-5-26 FEMALE 159 Uterine Carcinosarcoma/ MMMT: Heterologous Type No No, I have never taken menopausal hormone therapy. YES C55 8950/3 C55.9 YES Dilation and curettage procedure 370 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES true No TCGA-N5-A4RD.D309E728-C6C7-4A38-AD9E-4C6C41491DB3.pdf A4RD 82 positive WITH TUMOR 0 0 3 Progressive Disease Never Used R2 Primary Tumor 01 open 2009 NO YES N5 0 0 0 1 Uterus A DECEASED 59 2007 TCGA-N5-A4RD-01 E99C1CFC-4F1A-4828-BD89-74558631C9FE TCGA-N5-A4RD-01 960b6453-c8a5-4f0d-9b4e-85406407f297 960b6453-c8a5-4f0d-9b4e-85406407f297 TCGA-N5-A4RD-01A-11D-A28R-08 960b6453-c8a5-4f0d-9b4e-85406407f297 TCGA-N5-A4RD-01A-11D-A28R-08 TCGA-N5-A4RD-01A-11D-A28Q-01 960b6453-c8a5-4f0d-9b4e-85406407f297 TCGA-N5-A4RD-01A-11D-A28R-08 TCGA-N5-A4RD-01 TCGA-N5-A4RD-01A-11D-A28Q-01 TCGA-N5-A4RD-01A-11D-A28R-08 TCGA-N5-A4RD-01A-11D-A28S-05 TCGA-N5-A4RD-01
5
+ TCGA-N5-A4RF-01 MSS TCGA-N5-A4RF-01 TCGA-N5-A4RF TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 68 0 0 Endometrium TCGA-N5-A4RF-F58166 TCGA-N5-A4RF TCGA-N5-A4RF-01A Never Used Stage IA NO -25041 1476 0 1806 NO 2014-4-1 FEMALE 146 Uterine Carcinosarcoma/MMMT: Homologous Type No No, I have never taken menopausal hormone therapy. NO C54.1 8950/3 C54.1 YES Office Endometrial Biopsy 60 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No TCGA-N5-A4RF.A059F776-AF5B-4FF8-950C-2087D94395EC.pdf A4RF 28 negative TUMOR FREE 0 0 YES 1 Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 NO YES N5 0 9 0 32 Uterus A LIVING 49 2008 TCGA-N5-A4RF-01 TCGA-N5-A4RF-01 8e485caf-30e1-4ccd-8325-4c17da610fff 8e485caf-30e1-4ccd-8325-4c17da610fff TCGA-N5-A4RF-01A-11D-A28R-08 8e485caf-30e1-4ccd-8325-4c17da610fff TCGA-N5-A4RF-01A-11D-A28R-08 TCGA-N5-A4RF-01A-11D-A28Q-01 8e485caf-30e1-4ccd-8325-4c17da610fff TCGA-N5-A4RF-01A-11D-A28R-08 TCGA-N5-A4RF-01 TCGA-N5-A4RF-01A-11D-A28Q-01 TCGA-N5-A4RF-01A-11D-A28R-08 TCGA-N5-A4RF-01A-11D-A28S-05 TCGA-N5-A4RF-01
6
+ TCGA-N5-A4RJ-01 MSS TCGA-N5-A4RJ-01 TCGA-N5-A4RJ TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 61 0 3 Endometrium TCGA-N5-A4RJ TCGA-N5-A4RJ-01A Never Used Stage IVB NO -22341 1198 550 0 NO 2013-5-26 FEMALE 158 Uterine Carcinosarcoma/ MMMT: Heterologous Type No No, I have never taken menopausal hormone therapy. YES C54.1 8950/3 C54.1 YES Dilation and curettage procedure 390 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES true No TCGA-N5-A4RJ.5885F0D2-678E-4294-99EE-E0EC7046FC84.pdf A4RJ 6 positive WITH TUMOR 0 0 YES 2 Complete Remission/Response Never Used NO RX Primary Tumor 01 open 2009 NO YES N5 3 3 0 0 Uterus A DECEASED 84 2009 TCGA-N5-A4RJ-01 C2B4413D-2665-49AE-BA7E-5235C8D9824A TCGA-N5-A4RJ-01 a80a6064-0b35-4132-b93e-3ce8ae9eed4b a80a6064-0b35-4132-b93e-3ce8ae9eed4b TCGA-N5-A4RJ-01A-11D-A28R-08 a80a6064-0b35-4132-b93e-3ce8ae9eed4b TCGA-N5-A4RJ-01A-11D-A28R-08 TCGA-N5-A4RJ-01A-11D-A28Q-01 a80a6064-0b35-4132-b93e-3ce8ae9eed4b TCGA-N5-A4RJ-01A-11D-A28R-08 TCGA-N5-A4RJ-01 TCGA-N5-A4RJ-01A-11D-A28Q-01 TCGA-N5-A4RJ-01A-11D-A28R-08 TCGA-N5-A4RJ-01A-11D-A28S-05 TCGA-N5-A4RJ-01
7
+ TCGA-N5-A4RM-01 MSS TCGA-N5-A4RM-01 TCGA-N5-A4RM TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 62 0 0 Endometrium TCGA-N5-A4RM TCGA-N5-A4RM-01A Never Used Stage IVB NO -22886 830 148 0 NO 2013-5-26 FEMALE 152 Uterine Carcinosarcoma/ MMMT: Heterologous Type No No, I have never taken menopausal hormone therapy. YES C54.1 8950/3 C54.1 YES Office Endometrial Biopsy 250 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES true No TCGA-N5-A4RM.C188B8E8-B564-45A6-B356-B4D7C64B8DA5.pdf A4RM 40 positive WITH TUMOR 0 0 YES 1 Progressive Disease Never Used NO RX Primary Tumor 01 open 2009 NO YES N5 0 3 0 18 Uterus A DECEASED 70 2010 TCGA-N5-A4RM-01 9B7D1925-90E6-4EED-BEC5-1044048135B7 TCGA-N5-A4RM-01 0526f969-084d-4f40-beac-0ef3acf02e3b 0526f969-084d-4f40-beac-0ef3acf02e3b TCGA-N5-A4RM-01A-11D-A28R-08 0526f969-084d-4f40-beac-0ef3acf02e3b TCGA-N5-A4RM-01A-11D-A28R-08 TCGA-N5-A4RM-01A-11D-A28Q-01 0526f969-084d-4f40-beac-0ef3acf02e3b TCGA-N5-A4RM-01A-11D-A28R-08 TCGA-N5-A4RM-01 TCGA-N5-A4RM-01A-11D-A28Q-01 TCGA-N5-A4RM-01A-11D-A28R-08 TCGA-N5-A4RM-01A-11D-A28S-05 TCGA-N5-A4RM-01
8
+ TCGA-N5-A4RN-01 MSS TCGA-N5-A4RN-01 TCGA-N5-A4RN TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 71 0 0 Endometrium TCGA-N5-A4RN-F58165 TCGA-N5-A4RN TCGA-N5-A4RN-01A Never Used Stage IVB NO -26054 590 0 1053 NO 2014-4-1 FEMALE 152 Uterine Carcinosarcoma/MMMT: Homologous Type No No, I have never taken menopausal hormone therapy. NO C54.1 8950/3 C54.1 YES Office Endometrial Biopsy 340 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES true Yes TCGA-N5-A4RN.4A261649-F965-46BA-99A9-53AE715702ED.pdf A4RN 28 WITH TUMOR 0 1 YES 2 Complete Remission/Response Never Used NO RX Primary Tumor 01 open 2009 NO YES N5 0 0 1 8 Uterus A LIVING 76 2011 TCGA-N5-A4RN-01 2F3CF88E-20B1-4760-B431-6A769A3FC073 TCGA-N5-A4RN-01 5c465e7d-fb8b-4b59-82e8-fba4535e5af0 5c465e7d-fb8b-4b59-82e8-fba4535e5af0 TCGA-N5-A4RN-01A-12D-A28R-08 5c465e7d-fb8b-4b59-82e8-fba4535e5af0 TCGA-N5-A4RN-01A-12D-A28R-08 TCGA-N5-A4RN-01A-12D-A28Q-01 5c465e7d-fb8b-4b59-82e8-fba4535e5af0 TCGA-N5-A4RN-01A-12D-A28R-08 TCGA-N5-A4RN-01 TCGA-N5-A4RN-01A-12D-A28Q-01 TCGA-N5-A4RN-01A-12D-A28R-08 TCGA-N5-A4RN-01A-12D-A28S-05 TCGA-N5-A4RN-01
9
+ TCGA-N5-A4RO-01 MSS TCGA-N5-A4RO-01 TCGA-N5-A4RO TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 67 0 5 TCGA-N5-A4RO TCGA-N5-A4RO-01A Stage IIIC2 NO -24823 3983 685 0 2013-5-26 FEMALE 166 Uterine Carcinosarcoma/MMMT: Homologous Type No YES C55 8950/3 C55.9 YES Office Endometrial Biopsy 210 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES true No TCGA-N5-A4RO.EB1B2478-CC59-427E-B548-ED14C4116E46.pdf A4RO 94 negative WITH TUMOR 0 9 YES 4+ Progressive Disease Never Used YES RX Primary Tumor 01 open 2009 NO YES N5 5 10 9 13 Uterus A DECEASED 78 2002 TCGA-N5-A4RO-01 5AD1EE35-05CD-4393-B5FB-3F3DE3C94147 TCGA-N5-A4RO-01 f2e47c09-469f-42b3-b309-e2ffc5483f82 f2e47c09-469f-42b3-b309-e2ffc5483f82 TCGA-N5-A4RO-01A-11D-A28R-08 f2e47c09-469f-42b3-b309-e2ffc5483f82 TCGA-N5-A4RO-01A-11D-A28R-08 TCGA-N5-A4RO-01A-11D-A28Q-01 f2e47c09-469f-42b3-b309-e2ffc5483f82 TCGA-N5-A4RO-01A-11D-A28R-08 TCGA-N5-A4RO-01 TCGA-N5-A4RO-01A-11D-A28Q-01 TCGA-N5-A4RO-01A-11D-A28R-08 TCGA-N5-A4RO-01A-11D-A28S-05 TCGA-N5-A4RO-01
10
+ TCGA-N5-A4RS-01 MSS TCGA-N5-A4RS-01 TCGA-N5-A4RS TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 65 0 0 TCGA-N5-A4RS TCGA-N5-A4RS-01A Never Used Stage IB NO -23893 1997 911 0 NO 2013-5-26 FEMALE 155 Uterine Carcinosarcoma/MMMT: Homologous Type No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C55 8950/3 C55.9 YES Office Endometrial Biopsy 330 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES true No TCGA-N5-A4RS.8748D172-D225-42D5-809C-54654425BF17.pdf A4RS 60 negative WITH TUMOR 0 0 YES 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES N5 0 5 0 12 Uterus A DECEASED 60 2007 TCGA-N5-A4RS-01 5A1A312C-366F-4E57-998A-4D0744E16276 TCGA-N5-A4RS-01 d4088bb7-b9cb-4d1b-bec3-4e8a230b7c04 d4088bb7-b9cb-4d1b-bec3-4e8a230b7c04 TCGA-N5-A4RS-01A-11D-A28R-08 d4088bb7-b9cb-4d1b-bec3-4e8a230b7c04 TCGA-N5-A4RS-01A-11D-A28R-08 TCGA-N5-A4RS-01A-11D-A28Q-01 d4088bb7-b9cb-4d1b-bec3-4e8a230b7c04 TCGA-N5-A4RS-01A-11D-A28R-08 TCGA-N5-A4RS-01 TCGA-N5-A4RS-01A-11D-A28Q-01 TCGA-N5-A4RS-01A-11D-A28R-08 TCGA-N5-A4RS-01A-11D-A28S-05 TCGA-N5-A4RS-01
11
+ TCGA-N5-A4RT-01 MSI-L TCGA-N5-A4RT-01 TCGA-N5-A4RT TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 69 Endometrium TCGA-N5-A4RT-F60686 TCGA-N5-A4RT TCGA-N5-A4RT-01A Never Used Stage IIIC1 NO -25386 1977 0 2485 2014-6-13 FEMALE 172 Uterine Carcinosarcoma/MMMT: Homologous Type No Yes, I have taken menopausal hormone therapy in the past, but no longer do. C54.1 8950/3 C54.1 YES Office Endometrial Biopsy 300 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true Yes TCGA-N5-A4RT.AD77201F-0CF7-4C9B-ABDE-94F4FCAF3C0C.pdf A4RT 69 negative TUMOR FREE 0 3 YES 3 Complete Remission/Response Never Used YES RX Primary Tumor 01 Minimally Invasive 2009 NO YES N5 0 3 13 Uterus A LIVING 56 2007 TCGA-N5-A4RT-01 4F536CB4-6F8F-4F64-AABF-5706B208CAB9 TCGA-N5-A4RT-01 7c6c3d40-6de0-4b6a-85ef-bf4cefd00cda 7c6c3d40-6de0-4b6a-85ef-bf4cefd00cda TCGA-N5-A4RT-01A-11D-A28R-08 7c6c3d40-6de0-4b6a-85ef-bf4cefd00cda TCGA-N5-A4RT-01A-11D-A28R-08 TCGA-N5-A4RT-01A-11D-A28Q-01 7c6c3d40-6de0-4b6a-85ef-bf4cefd00cda TCGA-N5-A4RT-01A-11D-A28R-08 TCGA-N5-A4RT-01 TCGA-N5-A4RT-01A-11D-A28Q-01 TCGA-N5-A4RT-01A-11D-A28R-08 TCGA-N5-A4RT-01A-11D-A28S-05 TCGA-N5-A4RT-01
12
+ TCGA-N5-A4RU-01 MSS TCGA-N5-A4RU-01 TCGA-N5-A4RU TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 54 0 4 Endometrium TCGA-N5-A4RU TCGA-N5-A4RU-01A Former User Stage IIIC2 NO -20025 1988 1526 0 NO 2013-5-26 FEMALE 160 Uterine Carcinosarcoma/MMMT: Homologous Type No No, I have never taken menopausal hormone therapy. NO C54.1 8950/3 C54.1 YES Office Endometrial Biopsy 310 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES true No TCGA-N5-A4RU.D41E40C0-6BC6-4002-956C-924E128161A9.pdf A4RU 7 positive WITH TUMOR 0 0 YES 2 Complete Remission/Response Never Used NO RX Primary Tumor 01 open 2009 NO YES N5 4 7 0 1 Uterus A DECEASED 58 2007 TCGA-N5-A4RU-01 TCGA-N5-A4RU-01 1956ab9a-1a1d-46fe-9b2f-e5f908c6b462 1956ab9a-1a1d-46fe-9b2f-e5f908c6b462 TCGA-N5-A4RU-01A-31D-A28R-08 1956ab9a-1a1d-46fe-9b2f-e5f908c6b462 TCGA-N5-A4RU-01A-31D-A28R-08 TCGA-N5-A4RU-01A-31D-A28Q-01 1956ab9a-1a1d-46fe-9b2f-e5f908c6b462 TCGA-N5-A4RU-01A-31D-A28R-08 TCGA-N5-A4RU-01 TCGA-N5-A4RU-01A-31D-A28Q-01 TCGA-N5-A4RU-01A-31D-A28R-08 TCGA-N5-A4RU-01A-31D-A28S-05 TCGA-N5-A4RU-01
13
+ TCGA-N5-A4RV-01 MSS TCGA-N5-A4RV-01 TCGA-N5-A4RV TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 62 0 0 TCGA-N5-A4RV-F60885 TCGA-N5-A4RV TCGA-N5-A4RV-01A Stage IA NO -22978 1747 0 2042 NO 2014-6-18 FEMALE 152 Uterine Carcinosarcoma/MMMT: Homologous Type No No, I have never taken menopausal hormone therapy. NO C55 8950/3 C55.9 YES Office Endometrial Biopsy 180 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No TCGA-N5-A4RV.A03181A9-52A0-4326-8E75-137D8E874307.pdf A4RV 0 negative TUMOR FREE 0 0 YES 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES N5 0 6 0 10 Uterus A LIVING 55 2008 TCGA-N5-A4RV-01 84702292-56B5-4CFC-9451-51F8F564E6F7 TCGA-N5-A4RV-01 08dbecd4-ba05-4d62-b76c-62fddccdb167 08dbecd4-ba05-4d62-b76c-62fddccdb167 TCGA-N5-A4RV-01A-21D-A28R-08 08dbecd4-ba05-4d62-b76c-62fddccdb167 TCGA-N5-A4RV-01A-21D-A28R-08 TCGA-N5-A4RV-01A-21D-A28Q-01 08dbecd4-ba05-4d62-b76c-62fddccdb167 TCGA-N5-A4RV-01A-21D-A28R-08 TCGA-N5-A4RV-01 TCGA-N5-A4RV-01A-21D-A28Q-01 TCGA-N5-A4RV-01A-21D-A28R-08 TCGA-N5-A4RV-01A-21D-A28S-05 TCGA-N5-A4RV-01
14
+ TCGA-N5-A59E-01 MSS TCGA-N5-A59E-01 TCGA-N5-A59E TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 62 0 0 Myometrium TCGA-N5-A59E TCGA-N5-A59E-01A Never Used Stage IVB NO -22650 567 447 0 2013-5-26 FEMALE 155 Uterine Carcinosarcoma/ MMMT: Heterologous Type No No, I have never taken menopausal hormone therapy. YES C54.2 8950/3 C54.2 YES Office Endometrial Biopsy 350 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES true No TCGA-N5-A59E.326826BF-E3D8-42FC-AFFE-B6F454F1C0BC.pdf A59E 71 WITH TUMOR 0 0 YES 3 Complete Remission/Response Never Used NO RX Primary Tumor 01 open 2009 NO YES N5 0 0 0 2 Uterus A DECEASED 88 2011 TCGA-N5-A59E-01 31C0CA6C-09CA-432A-A760-0AFF26F51821 TCGA-N5-A59E-01 6b0e1d8f-1575-4e76-a0e5-7820c37b5db2 6b0e1d8f-1575-4e76-a0e5-7820c37b5db2 TCGA-N5-A59E-01A-11D-A28R-08 6b0e1d8f-1575-4e76-a0e5-7820c37b5db2 TCGA-N5-A59E-01A-11D-A28R-08 TCGA-N5-A59E-01A-11D-A28Q-01 6b0e1d8f-1575-4e76-a0e5-7820c37b5db2 TCGA-N5-A59E-01A-11D-A28R-08 TCGA-N5-A59E-01 TCGA-N5-A59E-01A-11D-A28Q-01 TCGA-N5-A59E-01A-11D-A28R-08 TCGA-N5-A59E-01A-11D-A28S-05 TCGA-N5-A59E-01
15
+ TCGA-N5-A59F-01 MSS TCGA-N5-A59F-01 TCGA-N5-A59F TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 65 0 0 Endometrium TCGA-N5-A59F TCGA-N5-A59F-01A Never Used Stage IB NO -23826 238 361 0 NO 2013-5-26 FEMALE 172 Uterine Carcinosarcoma/MMMT: Homologous Type No No, I have never taken menopausal hormone therapy. NO C54.1 8950/3 C54.1 YES Cytology (e.g. Peritoneal or pleural fluid) 170 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES true No TCGA-N5-A59F.5666CA72-D8E1-4781-8AE7-2321BDB57323.pdf A59F 67 positive WITH TUMOR 0 0 YES 1 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES N5 0 2 0 3 Uterus A DECEASED 73 2012 TCGA-N5-A59F-01 E3509505-B404-4864-8782-22C7649D9A55 TCGA-N5-A59F-01 ba2489c7-7b74-4495-8c3a-b6c00886d438 ba2489c7-7b74-4495-8c3a-b6c00886d438 TCGA-N5-A59F-01A-11D-A28R-08 ba2489c7-7b74-4495-8c3a-b6c00886d438 TCGA-N5-A59F-01A-11D-A28R-08 TCGA-N5-A59F-01A-11D-A28Q-01 ba2489c7-7b74-4495-8c3a-b6c00886d438 TCGA-N5-A59F-01A-11D-A28R-08 TCGA-N5-A59F-01 TCGA-N5-A59F-01A-11D-A28Q-01 TCGA-N5-A59F-01A-11D-A28R-08 TCGA-N5-A59F-01A-11D-A28S-05 TCGA-N5-A59F-01
16
+ TCGA-N6-A4V9-01 MSS TCGA-N6-A4V9-01 TCGA-N6-A4V9 TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 59 Endometrium TCGA-N6-A4V9-F69548 TCGA-N6-A4V9 TCGA-N6-A4V9-01A Stage IA -21677 456 0 979 NO 2015-1-13 FEMALE 163 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No YES C54.1 8950/3 C54.1 YES Tumor resection 280 NO NO NO true No TCGA-N6-A4V9.3E0AABEC-8BE5-455F-A3AE-978273210E67.pdf A4V9 18 negative TUMOR FREE 12 0 YES Complete Remission/Response Never Used YES R0 Primary Tumor 01 open 2009 YES NO N6 7 19 Uterus A LIVING 86 2011 TCGA-N6-A4V9-01 9F93AD68-A580-4A15-8FFA-1F57DAB3C6CF TCGA-N6-A4V9-01 90f0894e-91d4-49d8-b9c3-4bd5a73aaab6 90f0894e-91d4-49d8-b9c3-4bd5a73aaab6 TCGA-N6-A4V9-01A-11D-A28R-08 90f0894e-91d4-49d8-b9c3-4bd5a73aaab6 TCGA-N6-A4V9-01A-11D-A28R-08 TCGA-N6-A4V9-01A-11D-A28Q-01 90f0894e-91d4-49d8-b9c3-4bd5a73aaab6 TCGA-N6-A4V9-01A-11D-A28R-08 TCGA-N6-A4V9-01 TCGA-N6-A4V9-01A-11D-A28Q-01 TCGA-N6-A4V9-01A-11D-A28R-08 TCGA-N6-A4V9-01A-11D-A28S-05 TCGA-N6-A4V9-01
17
+ TCGA-N6-A4VC-01 MSS TCGA-N6-A4VC-01 TCGA-N6-A4VC TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 83 TCGA-N6-A4VC TCGA-N6-A4VC-01A Stage III NO -30643 1268 597 0 YES 2014-2-3 FEMALE 164 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No YES C54.1 8950/3 C54.1 YES Dilation and curettage procedure 210 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES true No TCGA-N6-A4VC.543944F8-C7D6-4757-B9B9-01891EE30B74.pdf A4VC positive WITH TUMOR 14 0 YES 0 Progressive Disease NO R2 Primary Tumor 01 Minimally Invasive 2009 YES NO N6 1 15 Uterus A DECEASED 82 2009 TCGA-N6-A4VC-01 766A154F-C88B-4C51-B9A8-DA1F4B5D8D63 TCGA-N6-A4VC-01 a6c39216-f81d-49fb-a0ea-fdcc4498ef03 a6c39216-f81d-49fb-a0ea-fdcc4498ef03 TCGA-N6-A4VC-01A-11D-A28R-08 a6c39216-f81d-49fb-a0ea-fdcc4498ef03 TCGA-N6-A4VC-01A-11D-A28R-08 TCGA-N6-A4VC-01A-11D-A28Q-01 a6c39216-f81d-49fb-a0ea-fdcc4498ef03 TCGA-N6-A4VC-01A-11D-A28R-08 TCGA-N6-A4VC-01 TCGA-N6-A4VC-01A-11D-A28Q-01 TCGA-N6-A4VC-01A-11D-A28R-08 TCGA-N6-A4VC-01A-11D-A28S-05 TCGA-N6-A4VC-01
18
+ TCGA-N6-A4VD-01 MSS TCGA-N6-A4VD-01 TCGA-N6-A4VD TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 81 Myometrium TCGA-N6-A4VD TCGA-N6-A4VD-01A Stage IIIA YES -29658 1297 112 0 NO 2014-2-3 FEMALE Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No YES C54.1 8950/3 C54.1 YES 400 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES true Yes TCGA-N6-A4VD.B1D9BFB6-3943-457E-ACBC-89504A5CD7E0.pdf A4VD WITH TUMOR 0 NO Progressive Disease NO RX Primary Tumor 01 open 2009 YES NO N6 2 Uterus A DECEASED 2009 TCGA-N6-A4VD-01 DF527126-8F38-4B15-B85E-98E3EBA3BF26 TCGA-N6-A4VD-01 0b008d55-f6c2-4fc4-bb20-2bb02f8dbbfe 0b008d55-f6c2-4fc4-bb20-2bb02f8dbbfe TCGA-N6-A4VD-01A-11D-A28R-08 0b008d55-f6c2-4fc4-bb20-2bb02f8dbbfe TCGA-N6-A4VD-01A-11D-A28R-08 TCGA-N6-A4VD-01A-11D-A28Q-01 0b008d55-f6c2-4fc4-bb20-2bb02f8dbbfe TCGA-N6-A4VD-01A-11D-A28R-08 TCGA-N6-A4VD-01 TCGA-N6-A4VD-01A-11D-A28Q-01 TCGA-N6-A4VD-01A-11D-A28R-08 TCGA-N6-A4VD-01A-11D-A28S-05 TCGA-N6-A4VD-01
19
+ TCGA-N6-A4VE-01 MSS TCGA-N6-A4VE-01 TCGA-N6-A4VE TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 84 1 Endometrium TCGA-N6-A4VE TCGA-N6-A4VE-01A Stage IIIC NO -30794 2537 291 0 NO 2014-2-3 FEMALE Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No NO C54.1 8950/3 C54.1 YES Core needle biopsy 230 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES true Yes TCGA-N6-A4VE.2619DFD3-EE8B-4199-87B2-2E5E378386EA.pdf A4VE negative WITH TUMOR 5 YES 2 Progressive Disease YES R1 Primary Tumor 01 Minimally Invasive 2009 YES NO N6 3 13 Uterus A DECEASED 2006 TCGA-N6-A4VE-01 7E669B56-E0F4-45F4-9CF6-F4EDD26F245C TCGA-N6-A4VE-01 51ce9c93-c640-46fb-891d-b06a98d1f156 51ce9c93-c640-46fb-891d-b06a98d1f156 TCGA-N6-A4VE-01A-11D-A28R-08 51ce9c93-c640-46fb-891d-b06a98d1f156 TCGA-N6-A4VE-01A-11D-A28R-08 TCGA-N6-A4VE-01A-11D-A28Q-01 51ce9c93-c640-46fb-891d-b06a98d1f156 TCGA-N6-A4VE-01A-11D-A28R-08 TCGA-N6-A4VE-01 TCGA-N6-A4VE-01A-11D-A28Q-01 TCGA-N6-A4VE-01A-11D-A28R-08 TCGA-N6-A4VE-01A-11D-A28S-05 TCGA-N6-A4VE-01
20
+ TCGA-N6-A4VF-01 MSS TCGA-N6-A4VF-01 TCGA-N6-A4VF TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 51 Endometrium TCGA-N6-A4VF Stage IB -18806 522 0 YES 2014-2-5 FEMALE 157 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C54.1 8950/3 C54.1 YES Cytology (e.g. Peritoneal or pleural fluid) Peri (6-12 months since last menstrual period) NO No A4VF negative TUMOR FREE 0 YES Never Used NO R0 Primary Tumor 01 open 2009 YES NO N6 4 Uterus DECEASED 167 2009 TCGA-N6-A4VF-01 TCGA-N6-A4VF-01 b75312b2-f817-4bcd-a334-4639e3a0dba6 b75312b2-f817-4bcd-a334-4639e3a0dba6 TCGA-N6-A4VF-01A-31D-A28R-08 b75312b2-f817-4bcd-a334-4639e3a0dba6 TCGA-N6-A4VF-01A-31D-A28R-08 TCGA-N6-A4VF-01A-31D-A28Q-01 b75312b2-f817-4bcd-a334-4639e3a0dba6 TCGA-N6-A4VF-01A-31D-A28R-08 TCGA-N6-A4VF-01 TCGA-N6-A4VF-01A-31D-A28Q-01 TCGA-N6-A4VF-01A-31D-A28R-08 TCGA-N6-A4VF-01A-31D-A28S-05 TCGA-N6-A4VF-01
21
+ TCGA-N6-A4VG-01 MSS TCGA-N6-A4VG-01 TCGA-N6-A4VG TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 77 Endometrium TCGA-N6-A4VG-F69549 TCGA-N6-A4VG Stage IVB NO -28428 0 1574 493 NO 2015-1-13 FEMALE 162 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No NO C54.1 8950/3 C54.1 YES Office Endometrial Biopsy NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Lymph Node(s) Locoregional Recurrence YES No A4VG 40 positive WITH TUMOR 3 YES 2 Progressive Disease Never Used YES R1 Primary Tumor 01 open 2009 YES NO N6 7 Uterus LIVING 76 2010 TCGA-N6-A4VG-01 TCGA-N6-A4VG-01 e551561c-5794-4358-bc9f-0a970350f865 e551561c-5794-4358-bc9f-0a970350f865 TCGA-N6-A4VG-01A-31D-A28R-08 e551561c-5794-4358-bc9f-0a970350f865 TCGA-N6-A4VG-01A-31D-A28R-08 TCGA-N6-A4VG-01A-31D-A28Q-01 e551561c-5794-4358-bc9f-0a970350f865 TCGA-N6-A4VG-01A-31D-A28R-08 TCGA-N6-A4VG-01 TCGA-N6-A4VG-01A-31D-A28Q-01 TCGA-N6-A4VG-01A-31D-A28R-08 TCGA-N6-A4VG-01A-31D-A28S-05 TCGA-N6-A4VG-01
22
+ TCGA-N7-A4Y0-01 MSI-H TCGA-N7-A4Y0-01 TCGA-N7-A4Y0 TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 65 0 0 Endometrium TCGA-N7-A4Y0 TCGA-N7-A4Y0-01A Stage IIIC NO -23983 3605 771 0 YES 2014-1-17 FEMALE 157 Uterine Carcinosarcoma/ MMMT: Heterologous Type No C54.1 8950/3 C54.1 YES Tumor resection 240 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES true No TCGA-N7-A4Y0.04D78BF5-445D-4F04-90ED-4AC0C8995915.pdf A4Y0 72 negative WITH TUMOR 2 2 NO 2 YES Primary Tumor 01 open 1988 NO YES N7 0 7 2 6 Uterus A DECEASED 70 2003 DC81D710-7A85-411E-8408-BE7019870C29 b197b605-5323-4d94-a232-d7b98b2454d5 b197b605-5323-4d94-a232-d7b98b2454d5 TCGA-N7-A4Y0-01A-12D-A28R-08 b197b605-5323-4d94-a232-d7b98b2454d5 TCGA-N7-A4Y0-01A-12D-A28R-08 TCGA-N7-A4Y0-01A-12D-A28Q-01 b197b605-5323-4d94-a232-d7b98b2454d5 TCGA-N7-A4Y0-01A-12D-A28R-08 TCGA-N7-A4Y0-01 TCGA-N7-A4Y0-01A-12D-A28Q-01 TCGA-N7-A4Y0-01A-12D-A28R-08 TCGA-N7-A4Y0-01A-12D-A28S-05 TCGA-N7-A4Y0-01
23
+ TCGA-N7-A4Y5-01 MSS TCGA-N7-A4Y5-01 TCGA-N7-A4Y5 TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 87 Endometrium TCGA-N7-A4Y5 TCGA-N7-A4Y5-01A Stage IIB -32058 2744 8 0 NO 2014-1-17 FEMALE 140 Uterine Carcinosarcoma/ MMMT: Heterologous Type No YES C54.1 8950/3 C54.1 YES Tumor resection 120 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No TCGA-N7-A4Y5.0C2C2709-04EB-4872-AF03-9CE87E9DD22C.pdf A4Y5 100 WITH TUMOR NO 0 Progressive Disease NO Primary Tumor 01 open 1988 NO YES N7 0 0 Uterus A DECEASED 42 2005 TCGA-N7-A4Y5-01 415DB39D-D48C-4F3D-8C4C-2A2A040A0411 TCGA-N7-A4Y5-01 e3acad0b-f296-4aed-b08f-e88a3d5f9bf3 e3acad0b-f296-4aed-b08f-e88a3d5f9bf3 TCGA-N7-A4Y5-01A-12D-A28R-08 e3acad0b-f296-4aed-b08f-e88a3d5f9bf3 TCGA-N7-A4Y5-01A-12D-A28R-08 TCGA-N7-A4Y5-01A-12D-A28Q-01 e3acad0b-f296-4aed-b08f-e88a3d5f9bf3 TCGA-N7-A4Y5-01A-12D-A28R-08 TCGA-N7-A4Y5-01 TCGA-N7-A4Y5-01A-12D-A28Q-01 TCGA-N7-A4Y5-01A-12D-A28R-08 TCGA-N7-A4Y5-01A-12D-A28S-05 TCGA-N7-A4Y5-01
24
+ TCGA-N7-A4Y8-01 MSS TCGA-N7-A4Y8-01 TCGA-N7-A4Y8 TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 72 Endometrium TCGA-N7-A4Y8 TCGA-N7-A4Y8-01A Stage IVB NO -26650 1057 378 0 NO 2014-1-17 FEMALE 157 Uterine Carcinosarcoma/ MMMT: Heterologous Type No No, I have never taken menopausal hormone therapy. YES C55 8950/3 C55.9 YES Tumor resection 460 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES true No TCGA-N7-A4Y8.BFA19641-03C8-49B1-B4F9-CAC9E4C3DC76.pdf A4Y8 83 positive WITH TUMOR 2 2 YES 2 Partial Remission/Response Never Used NO RX Primary Tumor 01 open 2009 NO YES N7 0 2 2 Uterus A DECEASED 64 2010 TCGA-N7-A4Y8-01 6BF3F15E-A9E9-407C-9AEB-4A22A2BAA4A3 TCGA-N7-A4Y8-01 b658fcd0-13d5-42f0-8fc3-789c3db5af32 b658fcd0-13d5-42f0-8fc3-789c3db5af32 TCGA-N7-A4Y8-01A-11D-A28R-08 b658fcd0-13d5-42f0-8fc3-789c3db5af32 TCGA-N7-A4Y8-01A-11D-A28R-08 TCGA-N7-A4Y8-01A-11D-A28Q-01 b658fcd0-13d5-42f0-8fc3-789c3db5af32 TCGA-N7-A4Y8-01A-11D-A28R-08 TCGA-N7-A4Y8-01 TCGA-N7-A4Y8-01A-11D-A28Q-01 TCGA-N7-A4Y8-01A-11D-A28R-08 TCGA-N7-A4Y8-01A-11D-A28S-05 TCGA-N7-A4Y8-01
25
+ TCGA-N7-A59B-01 MSS TCGA-N7-A59B-01 TCGA-N7-A59B TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 69 0 0 Endometrium TCGA-N7-A59B-F71660 TCGA-N7-A59B TCGA-N7-A59B-01A Stage IA NO -25360 122 0 827 NO 2015-3-27 FEMALE 152 Uterine Carcinosarcoma/MMMT: Homologous Type No No, I have never taken menopausal hormone therapy. YES C54.1 8950/3 C54.1 YES Tumor resection 160 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No TCGA-N7-A59B.3B9F80E7-26D2-4F99-B070-37715ECAC9AC.pdf A59B 0 negative TUMOR FREE 0 0 [Discrepancy] 2 Complete Remission/Response Never Used [Discrepancy] R0 Primary Tumor 01 open 2009 NO YES N7 0 5 0 10 Uterus A LIVING 95 2012 TCGA-N7-A59B-01 92770EB4-65F7-4329-A195-8A7FCF8464B7 TCGA-N7-A59B-01 54fe4146-6557-457a-90c5-73cfe7d849d4 54fe4146-6557-457a-90c5-73cfe7d849d4 TCGA-N7-A59B-01A-11D-A28R-08 54fe4146-6557-457a-90c5-73cfe7d849d4 TCGA-N7-A59B-01A-11D-A28R-08 TCGA-N7-A59B-01A-11D-A28Q-01 54fe4146-6557-457a-90c5-73cfe7d849d4 TCGA-N7-A59B-01A-11D-A28R-08 TCGA-N7-A59B-01 TCGA-N7-A59B-01A-11D-A28Q-01 TCGA-N7-A59B-01A-11D-A28R-08 TCGA-N7-A59B-01A-11D-A28S-05 TCGA-N7-A59B-01
26
+ TCGA-N8-A4PI-01 MSS TCGA-N8-A4PI-01 TCGA-N8-A4PI TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 71 0 Endometrium TCGA-N8-A4PI TCGA-N8-A4PI-01A Stage IA NO -26270 1094 810 0 NO 2013-3-4 FEMALE 160 Uterine Carcinosarcoma/ MMMT: Heterologous Type No YES C54.1 8980/3 C54.1 YES Office Endometrial Biopsy 240 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES false No TCGA-N8-A4PI.B8CDB9DC-9537-4DA1-A8A5-A6F64708669E.pdf A4PI 43 negative WITH TUMOR 0 YES 2 Partial Remission/Response NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO N8 0 8 0 21 Uterus A DECEASED 99 2009 TCGA-N8-A4PI-01 DCA903D4-8699-4D9E-B0D2-8A449B4265A2 TCGA-N8-A4PI-01 f078ae6b-598a-43e3-a49d-61819e00a906 f078ae6b-598a-43e3-a49d-61819e00a906 TCGA-N8-A4PI-01A-21D-A28R-08 f078ae6b-598a-43e3-a49d-61819e00a906 TCGA-N8-A4PI-01A-21D-A28R-08 TCGA-N8-A4PI-01A-21D-A28Q-01 f078ae6b-598a-43e3-a49d-61819e00a906 TCGA-N8-A4PI-01A-21D-A28R-08 TCGA-N8-A4PI-01 TCGA-N8-A4PI-01A-21D-A28Q-01 TCGA-N8-A4PI-01A-21D-A28R-08 TCGA-N8-A4PI-01A-21D-A28S-05 TCGA-N8-A4PI-01
27
+ TCGA-N8-A4PL-01 MSS TCGA-N8-A4PL-01 TCGA-N8-A4PL TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 82 0 Endometrium TCGA-N8-A4PL TCGA-N8-A4PL-01A Stage IA NO -30069 672 418 0 NO 2013-3-4 FEMALE 156 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No YES C54.1 8950/3 C54.1 YES Office Endometrial Biopsy 580 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES false No TCGA-N8-A4PL.150B8690-8425-46A2-A818-B8C2E145790F.pdf A4PL 0 negative WITH TUMOR 0 NO 3 Progressive Disease NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO N8 0 7 0 17 Uterus A DECEASED 60 2011 TCGA-N8-A4PL-01 C6471750-525E-4B77-9F42-BC7DA36B9648 TCGA-N8-A4PL-01 3cdbc075-9550-40ae-9ee7-2ef5d5301b6d 3cdbc075-9550-40ae-9ee7-2ef5d5301b6d TCGA-N8-A4PL-01A-11D-A28R-08 3cdbc075-9550-40ae-9ee7-2ef5d5301b6d TCGA-N8-A4PL-01A-11D-A28R-08 TCGA-N8-A4PL-01A-11D-A28Q-01 3cdbc075-9550-40ae-9ee7-2ef5d5301b6d TCGA-N8-A4PL-01A-11D-A28R-08 TCGA-N8-A4PL-01 TCGA-N8-A4PL-01A-11D-A28Q-01 TCGA-N8-A4PL-01A-11D-A28R-08 TCGA-N8-A4PL-01A-11D-A28S-05 TCGA-N8-A4PL-01
28
+ TCGA-N8-A4PM-01 MSS TCGA-N8-A4PM-01 TCGA-N8-A4PM TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus YES NO 73 0 Fundus uteri TCGA-N8-A4PM-F56668 TCGA-N8-A4PM TCGA-N8-A4PM-01A Stage IB NO -26971 435 0 829 524 NO 2014-2-17 FEMALE 155 Uterine Carcinosarcoma/MMMT: Homologous Type No No, I have never taken menopausal hormone therapy. YES C54.3 8980/3 C54.3 YES Office Endometrial Biopsy 660 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Lymph Node(s) Locoregional Recurrence NO YES false Yes TCGA-N8-A4PM.1DB40FDF-F0BD-495A-8DAA-B0FDE4BA5337.pdf A4PM 63 WITH TUMOR 0 YES 1 Complete Remission/Response NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO N8 0 11 0 14 Uterus A LIVING 92 2011 TCGA-N8-A4PM-01 0032411A-4506-495D-8067-F07125F0BF75 TCGA-N8-A4PM-01 3222c877-1ff5-4b73-a76b-9ce3130b9b2b 3222c877-1ff5-4b73-a76b-9ce3130b9b2b TCGA-N8-A4PM-01A-11D-A28R-08 3222c877-1ff5-4b73-a76b-9ce3130b9b2b TCGA-N8-A4PM-01A-11D-A28R-08 TCGA-N8-A4PM-01A-11D-A28Q-01 3222c877-1ff5-4b73-a76b-9ce3130b9b2b TCGA-N8-A4PM-01A-11D-A28R-08 TCGA-N8-A4PM-01 TCGA-N8-A4PM-01A-11D-A28Q-01 TCGA-N8-A4PM-01A-11D-A28R-08 TCGA-N8-A4PM-01A-11D-A28S-05 TCGA-N8-A4PM-01
29
+ TCGA-N8-A4PN-01 MSS TCGA-N8-A4PN-01 TCGA-N8-A4PN TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 68 Endometrium TCGA-N8-A4PN-F56676 TCGA-N8-A4PN TCGA-N8-A4PN-01A Stage IIIC1 NO -25064 390 0 812 NO 2014-2-17 FEMALE 158 Uterine Carcinosarcoma/MMMT: Homologous Type No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C54.1 8980/3 C54.1 YES Dilation and curettage procedure 1180 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO false No TCGA-N8-A4PN.DF47A171-5805-4D4A-BB30-C686434323B4.pdf A4PN 33 TUMOR FREE 3 0 YES 2 Complete Remission/Response YES R0 Primary Tumor 01 Minimally Invasive 2009 YES NO N8 0 3 20 Uterus A LIVING 63 2011 TCGA-N8-A4PN-01 16233C3A-6644-429C-A95F-6265E962F7D7 TCGA-N8-A4PN-01 7c34cec8-0cc8-409d-9a3d-30ef4b63583d 7c34cec8-0cc8-409d-9a3d-30ef4b63583d TCGA-N8-A4PN-01A-11D-A28R-08 7c34cec8-0cc8-409d-9a3d-30ef4b63583d TCGA-N8-A4PN-01A-11D-A28R-08 TCGA-N8-A4PN-01A-11D-A28Q-01 7c34cec8-0cc8-409d-9a3d-30ef4b63583d TCGA-N8-A4PN-01A-11D-A28R-08 TCGA-N8-A4PN-01 TCGA-N8-A4PN-01A-11D-A28Q-01 TCGA-N8-A4PN-01A-11D-A28R-08 TCGA-N8-A4PN-01A-11D-A28S-05 TCGA-N8-A4PN-01
30
+ TCGA-N8-A4PO-01 Indeterminate TCGA-N8-A4PO-01 TCGA-N8-A4PO TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 66 Lower uterine segment/Isthmus uteri TCGA-N8-A4PO-F57593 TCGA-N8-A4PO TCGA-N8-A4PO-01A Stage II NO -24124 362 0 781 NO 2014-3-17 FEMALE 138 Uterine Carcinosarcoma/ MMMT: Heterologous Type No YES C54.0 8980/3 C54.0 YES Office Endometrial Biopsy 890 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES false No TCGA-N8-A4PO.E13D4B38-F4E5-41EB-A590-087C97EA4DEA.pdf A4PO 33 negative WITH TUMOR YES 3 Complete Remission/Response NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO N8 0 0 Uterus A LIVING 119 2011 TCGA-N8-A4PO-01 FF48F3C0-07A9-4757-86EE-542B6DD44BBD TCGA-N8-A4PO-01 ace88000-3521-402e-986c-3b74560aaf5a ace88000-3521-402e-986c-3b74560aaf5a TCGA-N8-A4PO-01A-11D-A28R-08 ace88000-3521-402e-986c-3b74560aaf5a TCGA-N8-A4PO-01A-11D-A28R-08 TCGA-N8-A4PO-01A-11D-A28Q-01 ace88000-3521-402e-986c-3b74560aaf5a TCGA-N8-A4PO-01A-11D-A28R-08 TCGA-N8-A4PO-01 TCGA-N8-A4PO-01A-11D-A28Q-01 TCGA-N8-A4PO-01A-11D-A28R-08 TCGA-N8-A4PO-01A-11D-A28S-05 TCGA-N8-A4PO-01
31
+ TCGA-N8-A4PP-01 MSS TCGA-N8-A4PP-01 TCGA-N8-A4PP TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus NO YES 88 Endometrium TCGA-N8-A4PP-F56669 TCGA-N8-A4PP TCGA-N8-A4PP-01A Stage IIIC1 NO -32415 189 611 0 219 327 YES 2014-3-18 FEMALE 161 Uterine Carcinosarcoma/MMMT: Homologous Type No YES C54.1 8980/3 C54.1 YES Office Endometrial Biopsy 900 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Pelvis Locoregional Recurrence NO YES false Yes TCGA-N8-A4PP.0DB7C027-8B7F-422C-8B0A-8B71CB972119.pdf A4PP 50 WITH TUMOR 1 NO 4+ Partial Remission/Response NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO N8 0 1 1 Uterus A DECEASED 57 2012 TCGA-N8-A4PP-01 2DDF68FE-A2CD-4054-857F-97FB23C6CB29 TCGA-N8-A4PP-01 8e5750ac-5a31-4e86-a635-d0842320ebdb 8e5750ac-5a31-4e86-a635-d0842320ebdb TCGA-N8-A4PP-01A-11D-A28R-08 8e5750ac-5a31-4e86-a635-d0842320ebdb TCGA-N8-A4PP-01A-11D-A28R-08 TCGA-N8-A4PP-01A-11D-A28Q-01 8e5750ac-5a31-4e86-a635-d0842320ebdb TCGA-N8-A4PP-01A-11D-A28R-08 TCGA-N8-A4PP-01 TCGA-N8-A4PP-01A-11D-A28Q-01 TCGA-N8-A4PP-01A-11D-A28R-08 TCGA-N8-A4PP-01A-11D-A28S-05 TCGA-N8-A4PP-01
32
+ TCGA-N8-A4PQ-01 MSS TCGA-N8-A4PQ-01 TCGA-N8-A4PQ TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 76 6 Endometrium TCGA-N8-A4PQ-F56675 TCGA-N8-A4PQ TCGA-N8-A4PQ-01A Never Used Stage IIIC2 NO -27772 173 0 572 NO 2014-2-18 FEMALE 145 Uterine Carcinosarcoma/ MMMT: Heterologous Type No No, I have never taken menopausal hormone therapy. NO C54.1 8950/3 C54.1 YES Incisional Biopsy 830 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO false No TCGA-N8-A4PQ.31816D42-F2BA-4A85-86B9-0DEA359F7EAE.pdf A4PQ 8 TUMOR FREE 7 YES 4+ Complete Remission/Response NO R0 Primary Tumor 01 open 2009 YES NO N8 6 6 7 12 Uterus A LIVING 75 2012 TCGA-N8-A4PQ-01 EDA97410-9EC2-4BC7-9AF3-C576D8D1314E TCGA-N8-A4PQ-01 584307d6-c6a0-4f69-b5ae-34a9d66dd10c 584307d6-c6a0-4f69-b5ae-34a9d66dd10c TCGA-N8-A4PQ-01A-11D-A28R-08 584307d6-c6a0-4f69-b5ae-34a9d66dd10c TCGA-N8-A4PQ-01A-11D-A28R-08 TCGA-N8-A4PQ-01A-11D-A28Q-01 584307d6-c6a0-4f69-b5ae-34a9d66dd10c TCGA-N8-A4PQ-01A-11D-A28R-08 TCGA-N8-A4PQ-01 TCGA-N8-A4PQ-01A-11D-A28Q-01 TCGA-N8-A4PQ-01A-11D-A28R-08 TCGA-N8-A4PQ-01A-11D-A28S-05 TCGA-N8-A4PQ-01
33
+ TCGA-N8-A56S-01 MSS TCGA-N8-A56S-01 TCGA-N8-A56S TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus YES 75 TCGA-N8-A56S-F45258 TCGA-N8-A56S TCGA-N8-A56S-01A Stage IB NO -27519 93 371 0 155 199 NO 2013-10-29 FEMALE 168 Uterine Carcinosarcoma/ MMMT: Heterologous Type No YES C54.1 8950/3 C54.1 YES Dilation and curettage procedure 1670 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Lung Progression of Disease NO YES false No TCGA-N8-A56S.59082C41-B569-4EC1-9D1C-2B21D69A7F60.pdf A56S 94 WITH TUMOR YES 3 Stable Disease NO R0 Primary Tumor 01 Minimally Invasive 2009 YES NO N8 0 0 Uterus A DECEASED 68 2012 TCGA-N8-A56S-01 7CD0537F-0AD7-4504-BB27-29CE0DAE20B7 TCGA-N8-A56S-01 50b4f1de-010d-4cbb-b140-9b86af6a7e59 50b4f1de-010d-4cbb-b140-9b86af6a7e59 TCGA-N8-A56S-01A-11D-A28R-08 50b4f1de-010d-4cbb-b140-9b86af6a7e59 TCGA-N8-A56S-01A-11D-A28R-08 TCGA-N8-A56S-01A-11D-A28Q-01 50b4f1de-010d-4cbb-b140-9b86af6a7e59 TCGA-N8-A56S-01A-11D-A28R-08 TCGA-N8-A56S-01 TCGA-N8-A56S-01A-11D-A28Q-01 TCGA-N8-A56S-01A-11D-A28R-08 TCGA-N8-A56S-01A-11D-A28S-05 TCGA-N8-A56S-01
34
+ TCGA-N9-A4PZ-01 MSS TCGA-N9-A4PZ-01 TCGA-N9-A4PZ TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 77 0 1 Endometrium TCGA-N9-A4PZ TCGA-N9-A4PZ-01A Never Used Stage IIIC2 NO -28211 2779 667 0 NO 2013-11-14 FEMALE 162 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No No, I have never taken menopausal hormone therapy. NO C55 8950/3 C55.9 YES Dilation and curettage procedure 350 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES false No TCGA-N9-A4PZ.BF339822-1A65-465B-BD96-DCCE41FCB2D6.pdf A4PZ 22.2 WITH TUMOR 0 1 YES 2 Complete Remission/Response Never Used YES R2 Primary Tumor 01 Minimally Invasive 2009 NO YES N9 1 3 1 2 Uterus A DECEASED 70 2005 TCGA-N9-A4PZ-01 5273EB9A-F896-4397-AFCB-783495309F47 TCGA-N9-A4PZ-01 e7e86373-4d0a-4e3e-9209-3d6beaa448b1 e7e86373-4d0a-4e3e-9209-3d6beaa448b1 TCGA-N9-A4PZ-01A-22D-A28R-08 e7e86373-4d0a-4e3e-9209-3d6beaa448b1 TCGA-N9-A4PZ-01A-22D-A28R-08 TCGA-N9-A4PZ-01A-22D-A28Q-01 e7e86373-4d0a-4e3e-9209-3d6beaa448b1 TCGA-N9-A4PZ-01A-22D-A28R-08 TCGA-N9-A4PZ-01 TCGA-N9-A4PZ-01A-22D-A28Q-01 TCGA-N9-A4PZ-01A-22D-A28R-08 TCGA-N9-A4PZ-01A-22D-A28S-05 TCGA-N9-A4PZ-01
35
+ TCGA-N9-A4Q1-01 MSS TCGA-N9-A4Q1-01 TCGA-N9-A4Q1 TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 70 0 0 Lower uterine segment/Isthmus uteri TCGA-N9-A4Q1 TCGA-N9-A4Q1-01A Never Used Stage II NO -25791 2779 2043 0 YES 2013-11-15 FEMALE 166 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No No, I have never taken menopausal hormone therapy. NO C55 8950/3 C55.9 YES Office Endometrial Biopsy 290 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES false No TCGA-N9-A4Q1.C51B6612-4221-4214-AADE-FDDD8A7C5BF2.pdf A4Q1 59 WITH TUMOR 0 0 YES 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES N9 0 4 0 5 Uterus A DECEASED 77 2005 TCGA-N9-A4Q1-01 AD682A1B-86AF-4B84-8006-2EC024F0DFB8 TCGA-N9-A4Q1-01 b7c59af0-c0e2-4455-ab8c-2ea30b37a14f b7c59af0-c0e2-4455-ab8c-2ea30b37a14f TCGA-N9-A4Q1-01A-11D-A28R-08 b7c59af0-c0e2-4455-ab8c-2ea30b37a14f TCGA-N9-A4Q1-01A-11D-A28R-08 TCGA-N9-A4Q1-01A-11D-A28Q-01 b7c59af0-c0e2-4455-ab8c-2ea30b37a14f TCGA-N9-A4Q1-01A-11D-A28R-08 TCGA-N9-A4Q1-01 TCGA-N9-A4Q1-01A-11D-A28Q-01 TCGA-N9-A4Q1-01A-11D-A28R-08 TCGA-N9-A4Q1-01A-11D-A28S-05 TCGA-N9-A4Q1-01
36
+ TCGA-N9-A4Q3-01 MSS TCGA-N9-A4Q3-01 TCGA-N9-A4Q3 TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 65 0 0 Endometrium TCGA-N9-A4Q3 TCGA-N9-A4Q3-01A Never Used Stage IA NO -24031 1347 0 1672 NO 2013-11-19 FEMALE 162 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No Yes, I have taken menopausal hormone therapy in the past, but no longer do. YES C55 8950/3 C55.9 YES Office Endometrial Biopsy 250 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES false No TCGA-N9-A4Q3.85013BAC-C695-4E3D-A217-060E35024A40.pdf A4Q3 0 negative WITH TUMOR 0 0 YES 2 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES N9 0 5 0 20 Uterus A LIVING 90 2009 TCGA-N9-A4Q3-01 B4A5381D-BD8B-4B45-A838-D00950EF9108 TCGA-N9-A4Q3-01 3afded82-2855-4d17-9ee7-a66fb5e5543a 3afded82-2855-4d17-9ee7-a66fb5e5543a TCGA-N9-A4Q3-01A-11D-A28R-08 3afded82-2855-4d17-9ee7-a66fb5e5543a TCGA-N9-A4Q3-01A-11D-A28R-08 TCGA-N9-A4Q3-01A-11D-A28Q-01 3afded82-2855-4d17-9ee7-a66fb5e5543a TCGA-N9-A4Q3-01A-11D-A28R-08 TCGA-N9-A4Q3-01 TCGA-N9-A4Q3-01A-11D-A28Q-01 TCGA-N9-A4Q3-01A-11D-A28R-08 TCGA-N9-A4Q3-01A-11D-A28S-05 TCGA-N9-A4Q3-01
37
+ TCGA-N9-A4Q4-01 MSS TCGA-N9-A4Q4-01 TCGA-N9-A4Q4 TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 61 0 0 Endometrium TCGA-N9-A4Q4 TCGA-N9-A4Q4-01A Never Used Stage IIIC NO -22575 1050 0 1089 NO 2013-11-18 FEMALE 148 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No Yes, I have taken menopausal hormone therapy in the past, but no longer do. NO C55 8950/3 C55.9 YES Office Endometrial Biopsy 540 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO false No TCGA-N9-A4Q4.502B9D8B-51F7-4DD0-9BDA-79AACEB2AC21.pdf A4Q4 8.3 0 1 3 Complete Remission/Response Never Used R0 Primary Tumor 01 Minimally Invasive 2009 NO YES N9 0 9 0 7 Uterus A LIVING 68 2010 TCGA-N9-A4Q4-01 971C7E6E-5EF6-4791-9A83-653FAAEBB4B4 TCGA-N9-A4Q4-01 79909da6-6a85-47ae-ae1e-e05ca22c0b9a 79909da6-6a85-47ae-ae1e-e05ca22c0b9a TCGA-N9-A4Q4-01A-11D-A28R-08 79909da6-6a85-47ae-ae1e-e05ca22c0b9a TCGA-N9-A4Q4-01A-11D-A28R-08 TCGA-N9-A4Q4-01A-11D-A28Q-01 79909da6-6a85-47ae-ae1e-e05ca22c0b9a TCGA-N9-A4Q4-01A-11D-A28R-08 TCGA-N9-A4Q4-01 TCGA-N9-A4Q4-01A-11D-A28Q-01 TCGA-N9-A4Q4-01A-11D-A28R-08 TCGA-N9-A4Q4-01A-11D-A28S-05 TCGA-N9-A4Q4-01
38
+ TCGA-N9-A4Q7-01 MSS TCGA-N9-A4Q7-01 TCGA-N9-A4Q7 TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 69 0 0 Endometrium TCGA-N9-A4Q7 TCGA-N9-A4Q7-01A Former User Stage IA NO -25419 438 0 604 NO 2013-11-21 FEMALE 161 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No No, I have never taken menopausal hormone therapy. NO C55 8950/3 C55.9 YES Dilation and curettage procedure 420 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO false No TCGA-N9-A4Q7.0E5E42BD-AB48-4889-BFC8-1D6E6657CB85.pdf A4Q7 33 TUMOR FREE 0 0 YES 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES N9 0 10 0 7 Uterus A LIVING 95 2011 TCGA-N9-A4Q7-01 C6A5318F-A38A-402D-8F82-739E3149DEEE TCGA-N9-A4Q7-01 fc25de3e-e364-4e5b-aa61-a06353bba212 fc25de3e-e364-4e5b-aa61-a06353bba212 TCGA-N9-A4Q7-01A-11D-A28R-08 fc25de3e-e364-4e5b-aa61-a06353bba212 TCGA-N9-A4Q7-01A-11D-A28R-08 TCGA-N9-A4Q7-01A-11D-A28Q-01 fc25de3e-e364-4e5b-aa61-a06353bba212 TCGA-N9-A4Q7-01A-11D-A28R-08 TCGA-N9-A4Q7-01 TCGA-N9-A4Q7-01A-11D-A28Q-01 TCGA-N9-A4Q7-01A-11D-A28R-08 TCGA-N9-A4Q7-01A-11D-A28S-05 TCGA-N9-A4Q7-01
39
+ TCGA-N9-A4Q8-01 MSS TCGA-N9-A4Q8-01 TCGA-N9-A4Q8 TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 68 0 0 Endometrium TCGA-N9-A4Q8 TCGA-N9-A4Q8-01A Former User Stage IA NO -25185 456 481 0 NO 2013-11-22 FEMALE 157 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No No, I have never taken menopausal hormone therapy. NO C55 8950/3 C55.9 YES Dilation and curettage procedure 420 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES false No TCGA-N9-A4Q8.7C192804-4D60-4F00-B932-C4B416A04F58.pdf A4Q8 4.2 WITH TUMOR 0 0 NO 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES N9 0 9 0 17 Uterus A DECEASED 63 2011 TCGA-N9-A4Q8-01 TCGA-N9-A4Q8-01 8aba6f2e-3772-4c3d-a3bf-3dd214c36235 8aba6f2e-3772-4c3d-a3bf-3dd214c36235 TCGA-N9-A4Q8-01A-31D-A28R-08 8aba6f2e-3772-4c3d-a3bf-3dd214c36235 TCGA-N9-A4Q8-01A-31D-A28R-08 TCGA-N9-A4Q8-01A-31D-A28Q-01 8aba6f2e-3772-4c3d-a3bf-3dd214c36235 TCGA-N9-A4Q8-01A-31D-A28R-08 TCGA-N9-A4Q8-01 TCGA-N9-A4Q8-01A-31D-A28Q-01 TCGA-N9-A4Q8-01A-31D-A28R-08 TCGA-N9-A4Q8-01A-31D-A28S-05 TCGA-N9-A4Q8-01
40
+ TCGA-NA-A4QV-01 MSS TCGA-NA-A4QV-01 TCGA-NA-A4QV TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 72 0 0 TCGA--A4QV-F59445 TCGA--A4QV TCGA--A4QV-01A Stage IB NO -26379 3861 0 4269 NO 2014-5-13 FEMALE 170 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No No, I have never taken menopausal hormone therapy. YES C54.9 8090/3 C54.9 YES Dilation and curettage procedure 460 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No TCGA--A4QV.B2A672EA-7D36-4634-A52E-45BAE2F93D0E.pdf A4QV negative TUMOR FREE 0 0 NO 3 Complete Remission/Response Never Used NO R2 Primary Tumor 01 2009 YES NO 0 0 0 16 Uterus A LIVING 79 2002 TCGA-NA-A4QV-01 28E351CB-AACA-48C7-BB9B-8E492B656E89 TCGA-NA-A4QV-01 159474f4-6c46-4f61-9ff7-06534563a45e 159474f4-6c46-4f61-9ff7-06534563a45e TCGA-NA-A4QV-01A-11D-A28R-08 159474f4-6c46-4f61-9ff7-06534563a45e TCGA-NA-A4QV-01A-11D-A28R-08 TCGA-NA-A4QV-01A-11D-A28Q-01 159474f4-6c46-4f61-9ff7-06534563a45e TCGA-NA-A4QV-01A-11D-A28R-08 TCGA-NA-A4QV-01 TCGA-NA-A4QV-01A-11D-A28Q-01 TCGA-NA-A4QV-01A-11D-A28R-08 TCGA-NA-A4QV-01A-11D-A28S-05 TCGA-NA-A4QV-01
41
+ TCGA-NA-A4QW-01 MSS TCGA-NA-A4QW-01 TCGA-NA-A4QW TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 61 0 0 TCGA--A4QW-F59446 TCGA--A4QW TCGA--A4QW-01A Former User Stage IIA NO -22588 2143 0 2457 NO 2014-5-13 FEMALE 155 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No No, I have never taken menopausal hormone therapy. NO C54.9 8950/3 C54.9 YES Office Endometrial Biopsy 1080 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No TCGA--A4QW.BC92A01F-F97A-4046-A850-44CD79BEBD65.pdf A4QW TUMOR FREE 0 0 YES 2 Complete Remission/Response Never Used YES Primary Tumor 01 1988 YES NO 0 2 0 19 Uterus A LIVING 66 2007 TCGA-NA-A4QW-01 1D21C121-3B76-497D-A172-7C2DD1A56E96 TCGA-NA-A4QW-01 9e1ca236-58c8-46bd-adca-241462b17a91 9e1ca236-58c8-46bd-adca-241462b17a91 TCGA-NA-A4QW-01A-11D-A28R-08 9e1ca236-58c8-46bd-adca-241462b17a91 TCGA-NA-A4QW-01A-11D-A28R-08 TCGA-NA-A4QW-01A-11D-A28Q-01 9e1ca236-58c8-46bd-adca-241462b17a91 TCGA-NA-A4QW-01A-11D-A28R-08 TCGA-NA-A4QW-01 TCGA-NA-A4QW-01A-11D-A28Q-01 TCGA-NA-A4QW-01A-11D-A28R-08 TCGA-NA-A4QW-01A-11D-A28S-05 TCGA-NA-A4QW-01
42
+ TCGA-NA-A4QX-01 MSS TCGA-NA-A4QX-01 TCGA-NA-A4QX TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 60 TCGA--A4QX TCGA--A4QX-01A Stage IVB -22264 1325 838 0 833 2013-8-20 FEMALE Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No C55 8980/3 C55.9 YES 1120 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES true No TCGA--A4QX.9E2960D7-2884-429F-9EE7-997FA498FA11.pdf A4QX WITH TUMOR NO YES R2 Primary Tumor 01 2009 YES NO Uterus A DECEASED 2009 TCGA-NA-A4QX-01 C8C1EE98-6173-406C-8F52-DC0B6BD4AA8A TCGA-NA-A4QX-01 7bfcca01-2c84-4dd6-9781-7f1be17ce0f0 7bfcca01-2c84-4dd6-9781-7f1be17ce0f0 TCGA-NA-A4QX-01A-11D-A28R-08 7bfcca01-2c84-4dd6-9781-7f1be17ce0f0 TCGA-NA-A4QX-01A-11D-A28R-08 TCGA-NA-A4QX-01A-11D-A28Q-01 7bfcca01-2c84-4dd6-9781-7f1be17ce0f0 TCGA-NA-A4QX-01A-11D-A28R-08 TCGA-NA-A4QX-01 TCGA-NA-A4QX-01A-11D-A28Q-01 TCGA-NA-A4QX-01A-11D-A28R-08 TCGA-NA-A4QX-01A-11D-A28S-05 TCGA-NA-A4QX-01
43
+ TCGA-NA-A4QY-01 MSS TCGA-NA-A4QY-01 TCGA-NA-A4QY TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 62 TCGA--A4QY TCGA--A4QY-01A Stage III -22756 1101 114 0 2013-8-20 FEMALE Uterine Carcinosarcoma/ MMMT: Heterologous Type No C55 8951/3 C55.9 YES Dilation and curettage procedure 420 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No TCGA--A4QY.8C27661B-E1AD-4436-AD4D-D9DAEF99362D.pdf A4QY WITH TUMOR NO NO Primary Tumor 01 2009 YES NO Uterus A DECEASED 2009 TCGA-NA-A4QY-01 34B1A9D9-CE8E-409D-982D-9F71D1A7D8F7 TCGA-NA-A4QY-01 29f9f4c4-da13-4e12-926a-d3b111a7599e 29f9f4c4-da13-4e12-926a-d3b111a7599e TCGA-NA-A4QY-01A-11D-A28R-08 29f9f4c4-da13-4e12-926a-d3b111a7599e TCGA-NA-A4QY-01A-11D-A28R-08 TCGA-NA-A4QY-01A-11D-A28Q-01 29f9f4c4-da13-4e12-926a-d3b111a7599e TCGA-NA-A4QY-01A-11D-A28R-08 TCGA-NA-A4QY-01 TCGA-NA-A4QY-01A-11D-A28Q-01 TCGA-NA-A4QY-01A-11D-A28R-08 TCGA-NA-A4QY-01A-11D-A28S-05 TCGA-NA-A4QY-01
44
+ TCGA-NA-A4R0-01 MSS TCGA-NA-A4R0-01 TCGA-NA-A4R0 TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 80 TCGA--A4R0 TCGA--A4R0-01A Stage IVB NO -29449 929 541 0 NO 2013-11-12 FEMALE 162 Uterine Carcinosarcoma/ MMMT: Heterologous Type No No, I have never taken menopausal hormone therapy. NO C54.3 8980/3 C54.3 YES Office Endometrial Biopsy 350 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No TCGA--A4R0.E835F67C-2B15-4896-B167-6BFE0CEA836A.pdf A4R0 37.5 WITH TUMOR YES 3 NO R2 Primary Tumor 01 Minimally Invasive 2009 YES NO 0 0 Uterus A DECEASED 57 2010 TCGA-NA-A4R0-01 D86A96DB-7A37-4892-868D-5D4F3A8D0A62 TCGA-NA-A4R0-01 9dc972de-6fe4-46aa-a7a4-2be7708d50f7 9dc972de-6fe4-46aa-a7a4-2be7708d50f7 TCGA-NA-A4R0-01A-11D-A28R-08 9dc972de-6fe4-46aa-a7a4-2be7708d50f7 TCGA-NA-A4R0-01A-11D-A28R-08 TCGA-NA-A4R0-01A-11D-A28Q-01 9dc972de-6fe4-46aa-a7a4-2be7708d50f7 TCGA-NA-A4R0-01A-11D-A28R-08 TCGA-NA-A4R0-01 TCGA-NA-A4R0-01A-11D-A28Q-01 TCGA-NA-A4R0-01A-11D-A28R-08 TCGA-NA-A4R0-01A-11D-A28S-05 TCGA-NA-A4R0-01
45
+ TCGA-NA-A4R1-01 MSI-H TCGA-NA-A4R1-01 TCGA-NA-A4R1 TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 75 TCGA--A4R1 TCGA--A4R1-01A Stage IIIC1 -27688 306 203 0 2013-8-20 FEMALE Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No C55 8980/3 C55.9 YES Office Endometrial Biopsy 1010 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No TCGA--A4R1.8F3FD045-61EF-4A5C-92DA-257DCAE2E65E.pdf A4R1 WITH TUMOR NO YES R2 Primary Tumor 01 2009 YES NO Uterus A DECEASED 2012 TCGA-NA-A4R1-01 AD795D81-3D46-4908-AC92-60F8D00788EE TCGA-NA-A4R1-01 693ee4fa-6ddc-42ce-b125-89e9661c8f8e 693ee4fa-6ddc-42ce-b125-89e9661c8f8e TCGA-NA-A4R1-01A-11D-A28R-08 693ee4fa-6ddc-42ce-b125-89e9661c8f8e TCGA-NA-A4R1-01A-11D-A28R-08 TCGA-NA-A4R1-01A-11D-A28Q-01 693ee4fa-6ddc-42ce-b125-89e9661c8f8e TCGA-NA-A4R1-01A-11D-A28R-08 TCGA-NA-A4R1-01 TCGA-NA-A4R1-01A-11D-A28Q-01 TCGA-NA-A4R1-01A-11D-A28R-08 TCGA-NA-A4R1-01A-11D-A28S-05 TCGA-NA-A4R1-01
46
+ TCGA-NA-A5I1-01 MSS TCGA-NA-A5I1-01 TCGA-NA-A5I1 TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 80 TCGA--A5I1-F59466 TCGA--A5I1 Stage IIIB NO -29329 2680 0 2596 2553 NO 2014-5-14 FEMALE 142 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No No, I have never taken menopausal hormone therapy. YES C55 8980/3 C55.9 YES Office Endometrial Biopsy NO Pelvis Distant Metastasis NO YES No A5I1 negative WITH TUMOR NO 3 Complete Remission/Response Never Used YES R2 Primary Tumor 01 1988 YES NO 0 0 Uterus DECEASED 45 2006 TCGA-NA-A5I1-01 TCGA-NA-A5I1-01 da1f25e8-297f-4f1c-8d2c-cb0815f2fdff da1f25e8-297f-4f1c-8d2c-cb0815f2fdff TCGA-NA-A5I1-01A-21D-A28R-08 da1f25e8-297f-4f1c-8d2c-cb0815f2fdff TCGA-NA-A5I1-01A-21D-A28R-08 TCGA-NA-A5I1-01A-21D-A28Q-01 da1f25e8-297f-4f1c-8d2c-cb0815f2fdff TCGA-NA-A5I1-01A-21D-A28R-08 TCGA-NA-A5I1-01 TCGA-NA-A5I1-01A-21D-A28Q-01 TCGA-NA-A5I1-01A-21D-A28R-08 TCGA-NA-A5I1-01A-21D-A28S-05 TCGA-NA-A5I1-01
47
+ TCGA-ND-A4W6-01 MSS TCGA-ND-A4W6-01 TCGA-ND-A4W6 TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 67 0 1 Endometrium TCGA-ND-A4W6-F42968 TCGA-ND-A4W6 TCGA-ND-A4W6-01A Never Used Stage IIIC NO -24835 351 317 0 NO 2013-5-10 FEMALE 170 Uterine Carcinosarcoma/ MMMT: Heterologous Type No No, I have never taken menopausal hormone therapy. YES C54.1 8950/3 C54.1 YES Office Endometrial Biopsy 260 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No TCGA-ND-A4W6.F3CE442E-9166-401C-9E54-4852EC7285F2.pdf A4W6 100 negative WITH TUMOR 0 0 NO 2 Progressive Disease Never Used NO R2 Primary Tumor 01 Minimally Invasive 2009 NO YES ND 1 1 0 0 Uterus A DECEASED 67 2012 TCGA-ND-A4W6-01 E70E0EEF-C8BB-463E-968D-01040A57B4BA TCGA-ND-A4W6-01 20179843-10c8-48ea-bffe-6a9e756be0ac 20179843-10c8-48ea-bffe-6a9e756be0ac TCGA-ND-A4W6-01A-11D-A28R-08 20179843-10c8-48ea-bffe-6a9e756be0ac TCGA-ND-A4W6-01A-11D-A28R-08 TCGA-ND-A4W6-01A-11D-A28Q-01 20179843-10c8-48ea-bffe-6a9e756be0ac TCGA-ND-A4W6-01A-11D-A28R-08 TCGA-ND-A4W6-01 TCGA-ND-A4W6-01A-11D-A28Q-01 TCGA-ND-A4W6-01A-11D-A28R-08 TCGA-ND-A4W6-01A-11D-A28S-05 TCGA-ND-A4W6-01
48
+ TCGA-ND-A4WA-01 MSS TCGA-ND-A4WA-01 TCGA-ND-A4WA TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 90 0 0 Endometrium TCGA-ND-A4WA-F44312 TCGA-ND-A4WA TCGA-ND-A4WA-01A Stage IC NO -32872 3122 714 0 NO 2013-6-18 FEMALE 150 Uterine Carcinosarcoma/ MMMT: Heterologous Type No YES C54.1 8950/3 C54.1 YES Office Endometrial Biopsy 200 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No TCGA-ND-A4WA.BEFD5412-08C0-4A14-82D4-9E1D71FD3EC7.pdf A4WA 51 positive TUMOR FREE 0 0 NO 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 Minimally Invasive 1988 NO YES ND 0 0 0 0 Uterus A DECEASED 44 2004 TCGA-ND-A4WA-01 7FDE9FE2-C19E-4D2A-841B-A6254A516B76 TCGA-ND-A4WA-01 9f487e9c-1e44-4751-aa67-c56db741630d 9f487e9c-1e44-4751-aa67-c56db741630d TCGA-ND-A4WA-01A-12D-A28R-08 9f487e9c-1e44-4751-aa67-c56db741630d TCGA-ND-A4WA-01A-12D-A28R-08 TCGA-ND-A4WA-01A-12D-A28Q-01 9f487e9c-1e44-4751-aa67-c56db741630d TCGA-ND-A4WA-01A-12D-A28R-08 TCGA-ND-A4WA-01 TCGA-ND-A4WA-01A-12D-A28Q-01 TCGA-ND-A4WA-01A-12D-A28R-08 TCGA-ND-A4WA-01A-12D-A28S-05 TCGA-ND-A4WA-01
49
+ TCGA-ND-A4WC-01 MSS TCGA-ND-A4WC-01 TCGA-ND-A4WC TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 83 0 0 Endometrium TCGA-ND-A4WC-F58371 TCGA-ND-A4WC TCGA-ND-A4WC-01A Never Used Stage IB NO -30434 438 0 766 NO 2014-4-8 FEMALE 152 Uterine Carcinosarcoma/MMMT: Homologous Type No No, I have never taken menopausal hormone therapy. YES C54.3 8950/3 C54.3 YES Office Endometrial Biopsy 190 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true Yes TCGA-ND-A4WC.9B899153-4DC8-445B-85B7-9DCBFB1E34A3.pdf A4WC 51 negative TUMOR FREE 0 0 YES 4+ Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 2009 NO YES ND 0 5 0 12 Uterus A LIVING 67 2011 TCGA-ND-A4WC-01 B4DDBBBD-AF8A-4500-A975-C95F2DF1B3A7 TCGA-ND-A4WC-01 275381ab-7622-430a-8405-f849e6109e6f 275381ab-7622-430a-8405-f849e6109e6f TCGA-ND-A4WC-01A-21D-A28R-08 275381ab-7622-430a-8405-f849e6109e6f TCGA-ND-A4WC-01A-21D-A28R-08 TCGA-ND-A4WC-01A-21D-A28Q-01 275381ab-7622-430a-8405-f849e6109e6f TCGA-ND-A4WC-01A-21D-A28R-08 TCGA-ND-A4WC-01 TCGA-ND-A4WC-01A-21D-A28Q-01 TCGA-ND-A4WC-01A-21D-A28R-08 TCGA-ND-A4WC-01A-21D-A28S-05 TCGA-ND-A4WC-01
50
+ TCGA-ND-A4WF-01 MSS TCGA-ND-A4WF-01 TCGA-ND-A4WF TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 77 0 0 Endometrium TCGA-ND-A4WF-F42975 TCGA-ND-A4WF TCGA-ND-A4WF-01A Never Used Stage IIIA NO -28398 2022 167 0 YES 2013-5-10 FEMALE 160 Uterine Carcinosarcoma/ MMMT: Heterologous Type No No, I have never taken menopausal hormone therapy. YES C54.3 8950/3 C54.3 YES Office Endometrial Biopsy 200 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No TCGA-ND-A4WF.6D68C38D-2C12-4C40-ABB1-4E1995BE96C6.pdf A4WF 100 negative WITH TUMOR 0 0 NO 2 Progressive Disease Never Used YES R2 Primary Tumor 01 Minimally Invasive 1988 NO YES ND 0 0 0 0 Uterus A DECEASED 72 2007 TCGA-ND-A4WF-01 FF2A65DB-ABB3-460B-980F-67C1E50E96AD TCGA-ND-A4WF-01 056147b5-8802-4981-9774-5fce244c4db3 056147b5-8802-4981-9774-5fce244c4db3 TCGA-ND-A4WF-01A-11D-A28R-08 056147b5-8802-4981-9774-5fce244c4db3 TCGA-ND-A4WF-01A-11D-A28R-08 TCGA-ND-A4WF-01A-11D-A28Q-01 056147b5-8802-4981-9774-5fce244c4db3 TCGA-ND-A4WF-01A-11D-A28R-08 TCGA-ND-A4WF-01 TCGA-ND-A4WF-01A-11D-A28Q-01 TCGA-ND-A4WF-01A-11D-A28R-08 TCGA-ND-A4WF-01A-11D-A28S-05 TCGA-ND-A4WF-01
51
+ TCGA-NF-A4WU-01 MSS TCGA-NF-A4WU-01 TCGA-NF-A4WU TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 59 0 0 TCGA-NF-A4WU Stage IA NO -21901 0 298 NO 2013-6-5 FEMALE 159 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No No, I have never taken menopausal hormone therapy. NO C55 8980/3 C55.9 YES Office Endometrial Biopsy Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO No A4WU negative TUMOR FREE 0 0 NO 2 Complete Remission/Response NO R0 Primary Tumor 01 Minimally Invasive 2009 NO YES NF 0 21 0 24 Uterus LIVING 83 2011 TCGA-NF-A4WU-01 TCGA-NF-A4WU-01 ae61e232-f7b7-4b31-8cb5-d31efc782d6b ae61e232-f7b7-4b31-8cb5-d31efc782d6b TCGA-NF-A4WU-01A-11D-A28R-08 ae61e232-f7b7-4b31-8cb5-d31efc782d6b TCGA-NF-A4WU-01A-11D-A28R-08 TCGA-NF-A4WU-01A-11D-A28Q-01 ae61e232-f7b7-4b31-8cb5-d31efc782d6b TCGA-NF-A4WU-01A-11D-A28R-08 TCGA-NF-A4WU-01 TCGA-NF-A4WU-01A-11D-A28Q-01 TCGA-NF-A4WU-01A-11D-A28R-08 TCGA-NF-A4WU-01A-11D-A28S-05 TCGA-NF-A4WU-01
52
+ TCGA-NF-A4WX-01 MSS TCGA-NF-A4WX-01 TCGA-NF-A4WX TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 61 0 0 TCGA-NF-A4WX Stage IV NO -22407 0 452 NO 2013-6-5 FEMALE 157 Uterine Carcinosarcoma/ MMMT: Heterologous Type No YES C55 8950/3 C55.9 YES Office Endometrial Biopsy Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO No A4WX 0 positive TUMOR FREE 0 0 YES 0 Complete Remission/Response NO R0 Primary Tumor 01 open 2009 NO YES NF 0 11 0 24 Uterus LIVING 83 2011 TCGA-NF-A4WX-01 TCGA-NF-A4WX-01 ce2ac3f1-b078-40ca-8894-56d323841e19 ce2ac3f1-b078-40ca-8894-56d323841e19 TCGA-NF-A4WX-01A-11D-A28R-08 ce2ac3f1-b078-40ca-8894-56d323841e19 TCGA-NF-A4WX-01A-11D-A28R-08 TCGA-NF-A4WX-01A-11D-A28Q-01 ce2ac3f1-b078-40ca-8894-56d323841e19 TCGA-NF-A4WX-01A-11D-A28R-08 TCGA-NF-A4WX-01 TCGA-NF-A4WX-01A-11D-A28Q-01 TCGA-NF-A4WX-01A-11D-A28R-08 TCGA-NF-A4WX-01A-11D-A28S-05 TCGA-NF-A4WX-01
53
+ TCGA-NF-A4X2-01 MSS TCGA-NF-A4X2-01 TCGA-NF-A4X2 TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 59 0 0 TCGA-NF-A4X2 TCGA-NF-A4X2-01A Stage II NO -21908 341 0 81 NO 2013-6-5 FEMALE 157 Uterine Carcinosarcoma/ MMMT: Heterologous Type No NO C55 8950/3 C55.9 YES Office Endometrial Biopsy 210 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No TCGA-NF-A4X2.7FC4954E-727C-40F0-8EAF-5C405E7F6B37.pdf A4X2 negative TUMOR FREE 0 0 NO Complete Remission/Response NO R0 Primary Tumor 01 Minimally Invasive 2009 NO YES NF 0 16 0 34 Uterus A LIVING 75 2012 TCGA-NF-A4X2-01 EECC465E-0429-4144-9B4D-248645466AFE TCGA-NF-A4X2-01 45c6de9f-284f-4264-9945-d6942a5168f2 45c6de9f-284f-4264-9945-d6942a5168f2 TCGA-NF-A4X2-01A-11D-A28R-08 45c6de9f-284f-4264-9945-d6942a5168f2 TCGA-NF-A4X2-01A-11D-A28R-08 TCGA-NF-A4X2-01A-11D-A28Q-01 45c6de9f-284f-4264-9945-d6942a5168f2 TCGA-NF-A4X2-01A-11D-A28R-08 TCGA-NF-A4X2-01 TCGA-NF-A4X2-01A-11D-A28Q-01 TCGA-NF-A4X2-01A-11D-A28R-08 TCGA-NF-A4X2-01A-11D-A28S-05 TCGA-NF-A4X2-01
54
+ TCGA-NF-A5CP-01 MSS TCGA-NF-A5CP-01 TCGA-NF-A5CP TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 90 0 7 TCGA-NF-A5CP TCGA-NF-A5CP-01A Stage IIIC2 NO -32871 1980 167 0 NO 2013-6-5 FEMALE 162 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No YES C55 8950/3 C55.9 YES Office Endometrial Biopsy 110 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES true No TCGA-NF-A5CP.030AF2D0-D3BA-4F61-8AA9-95701F8E43CF.pdf A5CP 100 positive WITH TUMOR 0 7 NO 2 Progressive Disease NO Primary Tumor 01 Minimally Invasive 2009 NO YES NF 7 10 7 18 Uterus A DECEASED 77 2007 TCGA-NF-A5CP-01 2B90D563-F21F-4C70-9C8F-5E4CB3EA9DB3 TCGA-NF-A5CP-01 5ab14c08-9c7e-4eb8-83dd-96e374118ec2 5ab14c08-9c7e-4eb8-83dd-96e374118ec2 TCGA-NF-A5CP-01A-12D-A28R-08 5ab14c08-9c7e-4eb8-83dd-96e374118ec2 TCGA-NF-A5CP-01A-12D-A28R-08 TCGA-NF-A5CP-01A-12D-A28Q-01 5ab14c08-9c7e-4eb8-83dd-96e374118ec2 TCGA-NF-A5CP-01A-12D-A28R-08 TCGA-NF-A5CP-01 TCGA-NF-A5CP-01A-12D-A28Q-01 TCGA-NF-A5CP-01A-12D-A28R-08 TCGA-NF-A5CP-01A-12D-A28S-05 TCGA-NF-A5CP-01
55
+ TCGA-NG-A4VU-01 MSS TCGA-NG-A4VU-01 TCGA-NG-A4VU TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 63 Endometrium TCGA-NG-A4VU TCGA-NG-A4VU-01A Stage IIIB NO -23323 500 442 0 NO 2013-6-24 FEMALE 154 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No YES C54.1 8950/3 C54.1 YES Office Endometrial Biopsy 170 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES false No TCGA-NG-A4VU.F9FF5984-7961-4B52-B649-D074BC0FFA44.pdf A4VU 10.53 positive WITH TUMOR YES 4+ Progressive Disease Never Used NO RX Primary Tumor 01 Minimally Invasive 2009 NO YES NG 0 0 Uterus A DECEASED 83 2011 TCGA-NG-A4VU-01 4E4D6C48-30FD-4266-8EA6-56D066FBD0AB TCGA-NG-A4VU-01 e565ea3a-60d0-4db1-a963-292f5e2af690 e565ea3a-60d0-4db1-a963-292f5e2af690 TCGA-NG-A4VU-01A-11D-A28R-08 e565ea3a-60d0-4db1-a963-292f5e2af690 TCGA-NG-A4VU-01A-11D-A28R-08 TCGA-NG-A4VU-01A-11D-A28Q-01 e565ea3a-60d0-4db1-a963-292f5e2af690 TCGA-NG-A4VU-01A-11D-A28R-08 TCGA-NG-A4VU-01 TCGA-NG-A4VU-01A-11D-A28Q-01 TCGA-NG-A4VU-01A-11D-A28R-08 TCGA-NG-A4VU-01A-11D-A28S-05 TCGA-NG-A4VU-01
56
+ TCGA-NG-A4VW-01 MSS TCGA-NG-A4VW-01 TCGA-NG-A4VW TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 74 0 Endometrium TCGA-NG-A4VW TCGA-NG-A4VW-01A Stage IC NO -27326 2264 949 0 NO 2013-6-24 FEMALE 170 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No No, I have never taken menopausal hormone therapy. NO C54.1 8950/3 C54.1 YES Office Endometrial Biopsy 450 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) YES false No TCGA-NG-A4VW.0E53A074-3A7D-4C4B-8336-9C53DA3AF315.pdf A4VW 54.54 negative WITH TUMOR 0 YES 3 Complete Remission/Response Never Used YES R0 Primary Tumor 01 Minimally Invasive 1988 NO YES NG 0 4 0 22 Uterus A DECEASED 81 2006 TCGA-NG-A4VW-01 22429576-2C17-4EB7-82F4-660C5186B30B TCGA-NG-A4VW-01 59425df4-da6f-4d4f-a417-7f35c87740ab 59425df4-da6f-4d4f-a417-7f35c87740ab TCGA-NG-A4VW-01A-11D-A28R-08 59425df4-da6f-4d4f-a417-7f35c87740ab TCGA-NG-A4VW-01A-11D-A28R-08 TCGA-NG-A4VW-01A-11D-A28Q-01 59425df4-da6f-4d4f-a417-7f35c87740ab TCGA-NG-A4VW-01A-11D-A28R-08 TCGA-NG-A4VW-01 TCGA-NG-A4VW-01A-11D-A28Q-01 TCGA-NG-A4VW-01A-11D-A28R-08 TCGA-NG-A4VW-01A-11D-A28S-05 TCGA-NG-A4VW-01
57
+ TCGA-QM-A5NM-01 MSS TCGA-QM-A5NM-01 TCGA-QM-A5NM TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus NO NO 67 0 0 Endometrium TCGA-QM-A5NM-F56900 TCGA-QM-A5NM TCGA-QM-A5NM-01A Former User Stage IA NO -24781 98 0 587 155 153 NO 2014-2-25 FEMALE 160 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No No, I have never taken menopausal hormone therapy. NO C54.1 8950/3 C54.1 YES Office Endometrial Biopsy 80 NO NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Other, specify Locoregional Recurrence Vagina YES YES true Yes TCGA-QM-A5NM.9AEE4573-A7FC-47A8-88AF-CFE1EB9CF74B.pdf A5NM 90 negative WITH TUMOR YES 3 Never Used YES Excisional Biopsy RX Primary Tumor 01 Minimally Invasive 2009 YES NO QM 0 2 0 Uterus A LIVING 73 2012 TCGA-QM-A5NM-01 TCGA-QM-A5NM-01 96a39ec9-1d40-46f2-8681-9aaa75a9d77f 96a39ec9-1d40-46f2-8681-9aaa75a9d77f TCGA-QM-A5NM-01A-11D-A28R-08 96a39ec9-1d40-46f2-8681-9aaa75a9d77f TCGA-QM-A5NM-01A-11D-A28R-08 TCGA-QM-A5NM-01A-11D-A28Q-01 96a39ec9-1d40-46f2-8681-9aaa75a9d77f TCGA-QM-A5NM-01A-11D-A28R-08 TCGA-QM-A5NM-01 TCGA-QM-A5NM-01A-11D-A28Q-01 TCGA-QM-A5NM-01A-11D-A28R-08 TCGA-QM-A5NM-01A-11D-A28S-05 TCGA-QM-A5NM-01
58
+ TCGA-QN-A5NN-01 MSI-L TCGA-QN-A5NN-01 TCGA-QN-A5NN TCGA Uterine Carcinosarcoma (UCS) uterine carcinosarcoma Uterus 55 Endometrium TCGA-QN-A5NN TCGA-QN-A5NN-01A Stage IB NO -20318 253 0 0 NO 2013-11-14 FEMALE 157 Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS No No, I have never taken menopausal hormone therapy. NO C54.1 8950/3 C54.1 YES Tumor resection 390 NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No TCGA-QN-A5NN.424FC113-5168-4051-A809-E244AB97FD72.pdf A5NN 33 TUMOR FREE 0 NO 0 Complete Remission/Response Never Used NO R0 Primary Tumor 01 open 2009 YES NO QN 0 6 Uterus A LIVING 50 2012 TCGA-QN-A5NN-01 E2EB916D-6DBC-4FEE-85FF-1DBE6F367C4F TCGA-QN-A5NN-01 e8f1e9bb-0c3d-4e62-a1f6-f2d352258c8e e8f1e9bb-0c3d-4e62-a1f6-f2d352258c8e TCGA-QN-A5NN-01A-11D-A28R-08 e8f1e9bb-0c3d-4e62-a1f6-f2d352258c8e TCGA-QN-A5NN-01A-11D-A28R-08 TCGA-QN-A5NN-01A-11D-A28Q-01 e8f1e9bb-0c3d-4e62-a1f6-f2d352258c8e TCGA-QN-A5NN-01A-11D-A28R-08 TCGA-QN-A5NN-01 TCGA-QN-A5NN-01A-11D-A28Q-01 TCGA-QN-A5NN-01A-11D-A28R-08 TCGA-QN-A5NN-01A-11D-A28S-05 TCGA-QN-A5NN-01
metadata/gene_synonym.json ADDED
The diff for this file is too large to render. See raw diff
 
metadata/task_info.json ADDED
The diff for this file is too large to render. See raw diff
 
output/preprocess/Pheochromocytoma_and_Paraganglioma/clinical_data/GSE19422.csv ADDED
@@ -0,0 +1,91 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ ,Pheochromocytoma_and_Paraganglioma
2
+ GSM482992,1
3
+ GSM482993,1
4
+ GSM482994,1
5
+ GSM482995,1
6
+ GSM482996,1
7
+ GSM482997,1
8
+ GSM482998,1
9
+ GSM482999,1
10
+ GSM483000,1
11
+ GSM483001,1
12
+ GSM483002,1
13
+ GSM483003,1
14
+ GSM483004,1
15
+ GSM483005,1
16
+ GSM483006,1
17
+ GSM483007,1
18
+ GSM483008,1
19
+ GSM483009,1
20
+ GSM483010,1
21
+ GSM483011,1
22
+ GSM483012,1
23
+ GSM483013,1
24
+ GSM483014,1
25
+ GSM483015,1
26
+ GSM483016,1
27
+ GSM483017,1
28
+ GSM483018,1
29
+ GSM483019,1
30
+ GSM483020,1
31
+ GSM483021,1
32
+ GSM483022,1
33
+ GSM483023,1
34
+ GSM483024,1
35
+ GSM483025,1
36
+ GSM483026,1
37
+ GSM483027,1
38
+ GSM483028,1
39
+ GSM483029,1
40
+ GSM483030,1
41
+ GSM483031,1
42
+ GSM483032,1
43
+ GSM483033,1
44
+ GSM483034,1
45
+ GSM483035,1
46
+ GSM483036,1
47
+ GSM483037,1
48
+ GSM483038,1
49
+ GSM483039,1
50
+ GSM483040,1
51
+ GSM483041,1
52
+ GSM483042,1
53
+ GSM483043,1
54
+ GSM483044,1
55
+ GSM483045,1
56
+ GSM483046,1
57
+ GSM483047,1
58
+ GSM483048,1
59
+ GSM483049,1
60
+ GSM483050,1
61
+ GSM483051,1
62
+ GSM483052,1
63
+ GSM483053,1
64
+ GSM483054,1
65
+ GSM483055,1
66
+ GSM483056,1
67
+ GSM483057,1
68
+ GSM483058,1
69
+ GSM483059,1
70
+ GSM483060,1
71
+ GSM483061,1
72
+ GSM483062,1
73
+ GSM483063,1
74
+ GSM483064,1
75
+ GSM483065,1
76
+ GSM483066,1
77
+ GSM483067,1
78
+ GSM483068,1
79
+ GSM483069,1
80
+ GSM483070,1
81
+ GSM483071,1
82
+ GSM483072,1
83
+ GSM483073,1
84
+ GSM483074,1
85
+ GSM483075,1
86
+ GSM483076,1
87
+ GSM483077,1
88
+ GSM483078,1
89
+ GSM483079,1
90
+ GSM483080,1
91
+ GSM483081,1
output/preprocess/Pheochromocytoma_and_Paraganglioma/clinical_data/GSE19987.csv ADDED
@@ -0,0 +1,2 @@
 
 
 
1
+ ,GSM62248,GSM62249,GSM62250,GSM62251,GSM62252,GSM62253,GSM62254,GSM62255,GSM62256,GSM62257,GSM62258,GSM62259,GSM62260,GSM62261,GSM62262,GSM62263,GSM62264,GSM62265,GSM62266,GSM62267,GSM62268,GSM62269,GSM62270,GSM62271,GSM62272,GSM62273,GSM62274,GSM62275,GSM62276,GSM62277,GSM62278,GSM62279,GSM62280,GSM62281,GSM62282,GSM62283,GSM62284,GSM62285,GSM62286,GSM62287,GSM62288,GSM62289,GSM62290,GSM62291,GSM62292,GSM62293,GSM62294,GSM62295,GSM62296,GSM62297,GSM62298,GSM62299,GSM62300,GSM62301,GSM62302,GSM62303,GSM62304,GSM62305,GSM62306,GSM62307,GSM62308,GSM62309,GSM62310,GSM62311,GSM62312,GSM62313,GSM62314,GSM62315,GSM62316,GSM62317,GSM62318,GSM62319,GSM62320,GSM62321,GSM62322
2
+ Pheochromocytoma_and_Paraganglioma,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0
output/preprocess/Pheochromocytoma_and_Paraganglioma/clinical_data/GSE33371.csv ADDED
@@ -0,0 +1,4 @@
 
 
 
 
 
1
+ GSM825367,GSM825368,GSM825369,GSM825370,GSM825371,GSM825372,GSM825373,GSM825374,GSM825375,GSM825376,GSM825377,GSM825378,GSM825379,GSM825380,GSM825381,GSM825382,GSM825383,GSM825384,GSM825385,GSM825386,GSM825387,GSM825388,GSM825389,GSM825390,GSM825391,GSM825392,GSM825393,GSM825394,GSM825395,GSM825396,GSM825397,GSM825398,GSM825399,GSM825400,GSM825401,GSM825402,GSM825403,GSM825404,GSM825405,GSM825406,GSM825407,GSM825408,GSM825409,GSM825410,GSM825411,GSM825412,GSM825413,GSM825414,GSM825415,GSM825416,GSM825417,GSM825418,GSM825419,GSM825420,GSM825421,GSM825422,GSM825423,GSM825424,GSM825425,GSM825426,GSM825427,GSM825428,GSM825429,GSM825430,GSM825431
2
+ 0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3
+ 71.0,58.0,71.0,44.0,32.0,28.0,55.0,78.0,41.0,58.0,45.0,28.0,57.0,25.0,25.0,56.0,33.0,44.0,71.0,56.0,51.0,32.0,38.0,49.0,62.0,59.0,52.0,54.0,48.0,55.0,64.0,45.0,5.0,49.0,45.0,48.0,77.0,47.0,55.0,52.0,34.0,35.0,52.0,48.0,45.0,39.0,40.0,31.0,87.0,45.0,41.0,5.0,32.0,50.0,55.0,19.0,61.0,33.0,31.0,60.0,51.0,71.0,25.0,47.0,49.0
4
+ 0.0,0.0,1.0,1.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0